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Glossary of Terms  
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armpit, are removed in order to reduce the likelihood 
of cancer spreading to other parts of the body. 
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body. The bandages provide low pressure when 
resting and high pressure when exercising. The 
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including padding, which offers protection to fragile 
skin and tissues and ensures a uniform, cylindrical 
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removed in order to reduce the likelihood of cancer 
spreading to other parts of the body. 
 
Simple Lymphatic Drainage Specialised self-massage based on the principles of 
Manual Lymphatic Drainage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Abstract 
Lymphoedema is a chronic condition characterised by swelling. It results from impairment of 
the lymphatic system following cancer treatment, congenital malformation or other medical 
conditions. This study is the first conducted in Ireland to investigate lymphoedema service 
provision from practitioner and patient perspectives, in addition to exploring the impact of 
lymphoedema on patients’ quality of life. Phase one involved a postal survey of 108 
practitioners. Phase two involved five focus groups conducted throughout the country with a 
total of 33 patients. Phase three involved administering a postal survey and World Health 
Organisation (WHO) quality of life measure to 735 patients. Following integration of the 
mixed methods data, two super-ordinate themes emerged: lymphoedema - an 
unacknowledged condition; and the legacy of lymphoedema’s association with cancer. The 
first theme related to poor awareness of lymphoedema resulting in under-resourced, 
insufficient service provision, and feelings of isolation for patients. The second theme related 
to inequitable service provision for patients with non-cancer-related lymphoedema; and 
lymphoedema as a constant reminder of patients’ cancer treatment. Recommendations for 
lymphoedema service provision and patient support were made in light of these themes.  
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Chapter 1: Introduction 
Introduction 
In a healthy body, all tissues are kept alive by the circulatory system which provides a supply 
of oxygen, nutrients and water, and removes waste products. As blood does not reach every 
corner of the body a fluid known as interstitial fluid provides the supplies to each cell (British 
Lymphology Society, 2007). When there is an imbalance in the distribution of the fluid and 
particles in the space between the body’s cells, smaller particles and approximately ninety 
percent of the fluid are reabsorbed into the blood capillaries to return to the heart through 
the veins (Clinical Resource Efficiency Support Team, 2008; Keeley, 2006). The remaining 
larger particles and fluid are absorbed by the lymphatic system (Keeley, 2006; Muscari, 2004; 
National Cancer Institute, 2008; Ridner, 2002).  
 
Once the interstitial fluid enters the lymphatic system it is known as lymph or lymph fluid. 
Lymph fluid consists of water; protein; cellular debris; toxins; bacteria; dead, dying or mutant 
cells and enzymes; hormones; some fat cells and other macromolecules, as well as excess 
fluid (Sneddon & Lewis, 2007). The lymph fluid is collected into superficial vessels, known as 
initial lymphatics. Light skin pressure, muscle contraction or relaxation, and blood vessel 
pulsation assist the initial lymphatics in passing the lymph fluid through precollector vessels, 
collecting vessels and lymph nodes which are located progressively deeper under the skin 
(Ridner, 2002; Sneddon & Lewis, 2007). Finally the fluid is filtered by the lymph nodes and 
approximately forty percent of it is returned to the bloodstream (CREST, 2008; Lacovara & 
Yoder, 2006; Morrell et al., 2005). When this drainage by the lymphatic system is 
compromised, fluid accumulates in the space around the cells of the body. The resultant 
swelling is known as lymphoedema (Morrell et al., 2005).  
 
The lymphatic system plays a major role in the body’s immune system by producing white 
blood cells which are then carried throughout the body in response to inflammation signals 
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(CREST, 2008; Lacovara & Yoder, 2006). Therefore when the lymphatic system is impaired, 
as in lymphoedema, the body is much more susceptible to infection (CREST, 2008).   
The Current Study 
Lymphoedema refers to swelling or oedema which is comprised of lymph fluid. It is caused by 
damage to or malformation of the lymphatic system. It is a chronic, incurable condition 
believed to affect at least 1.33 per 1,000 of the population (Moffatt et al., 2003). 
Lymphoedema can lead to pain, discomfort, and increased susceptibility to skin infections 
such as cellulitis, which may require hospitalisation (Morgan, Franks & Moffatt, 2005). 
Lymphoedema can also have significant psychological and social consequences including 
depression, anxiety, isolation and disability (Morgan, Franks et al., 2005; McWayne & Heiney, 
2005; Tobin et al., 1993; Williams et al., 2004).  
 
Previous studies of lymphoedema service provision in Australia and the UK have found 
arbitrarily located, disjointed and under-resourced services (Australasian Lymphology 
Association, 2003; BreastCare Victoria, 2005; Department of Health Social Services and Public 
Safety, 2004; Morgan, 2006; Todd, 2006). While anecdotal evidence suggests that similar 
difficulties in lymphoedema service provision are present in Ireland, to date, there has been 
no research conducted on lymphoedema service provision or on patients’ experiences of living 
with lymphoedema in the Republic of Ireland. Without a clear picture from both practitioners’ 
and patients’ perspectives coordination between services, planning on how to develop and 
expand services and formulation on how to address gaps and inequalities cannot take place.  
 
The overall aims of the present study were to investigate current lymphoedema service 
provision from both service providers’ and patients’ perspectives, in addition to exploring 
patients’ experiences of living with lymphoedema in Ireland, for the first time.  
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Specific objectives include:  
• Providing an overall account of current service provision, documenting the 
range, location, funding, and referral pathways of services provided 
nationwide and exploring patients’ experiences of obtaining a diagnosis, 
searching for appropriate treatment, accessing treatment and availing of 
ongoing lymphoedema services.  
• Assessing service providers’ and patients’ recommendations for lymphoedema 
service development.  
• Exploring patients’ experiences of living with lymphoedema and the impact of 
the condition on daily life and quality of life.  
Overview of Thesis 
Literature Review 
Previous research on lymphoedema, its prevalence and treatment, service provision and 
patients’ experiences is outlined in the literature review in Chapter 2. In summary, studies on 
service provision in other countries have generally indicated arbitrarily located, disjointed and 
under-resourced services with inequitable service provision for those in rural areas and 
patients with non-cancer-related lymphoedema. Studies on patients’ experiences of the 
condition have reported impairments of patients’ physical wellbeing, capacity to engage in 
daily activities, psychosocial wellbeing and quality of life.    
Design 
A mixed methods design of service provider questionnaires, patient focus groups and patient 
questionnaires was chosen to explore the research aims. The rationale for choosing this 
methodology, and the sequence, priority and integration of methods is presented in Chapter 
3.  
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Phase 1: Service Provider Survey 
The first phase of the study involved a survey of service providers. The questionnaire 
explored treatments provided, funding sources, referral options, practitioners’ level of training 
and recommendations for service development. The term ‘service providers’ is used 
interchangeably with ‘practitioners’ throughout the thesis and is intended to refer to those 
who provide information and/or treatment to lymphoedema patients. A total of 320 
questionnaires were sent to physiotherapists, occupational therapists and breast care nurses 
working in university, regional and general hospitals; healthcare professionals working in 
private hospitals, homecare or palliative care teams, hospices, and cancer support services 
that provide a lymphoedema service; and private practitioners. There is no known nationally 
updated register of all professionals working with lymphoedema patients except the MLD 
Ireland listing of registered MLD therapists in Ireland. The intention was to distribute 
questionnaires to a wide variety of healthcare professionals who were known or potential 
lymphoedema practitioners. However it is likely that some healthcare professionals who were 
sent a questionnaire do not provide a lymphoedema service and therefore chose not to 
participate. 108 service providers returned a completed questionnaire. The results suggested 
that current lymphoedema service provision is insufficient and inequitable and that there are 
challenges to the continuation of services. The rationale for the inclusion of service provider 
surveys, the methodology, specific aims, results and discussion of the service provider phase 
are presented in Chapter 4.  
Phase 2: Patient Focus Groups 
The second phase of the study involved patient focus groups. A total of 33 lymphoedema 
patients participated in one of five focus groups conducted nationwide. Patients were 
recruited through hospitals in what were formerly known as the four Regional Health 
Authority Areas in Ireland, and through organisations which provide information and support 
to lymphoedema patients (e.g. Lymphoedema Ireland). The focus groups explored patients’ 
experiences of obtaining a diagnosis, seeking and accessing treatment, lymphoedema 
services and practitioners, living with lymphoedema, the impact of the condition on their 
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quality of life, and their recommendations for service development. Focus groups were 
analysed thematically. The emerging themes covered barriers to treatment; tension with 
healthcare professionals; lymphoedema affecting daily life; emotional factors; taking an active 
role in lymphoedema management; and deriving positives from living with lymphoedema. The 
rationale for the inclusion of patient focus groups, the methodology, specific aims, findings 
and discussion of the patient focus group phase are presented in Chapter 5.  
Phase 3: Patient Survey 
The final phase of the study involved a patient survey. The questionnaire explored patients’ 
experiences of obtaining a diagnosis, seeking and accessing treatment, lymphoedema 
services and practitioners, living with lymphoedema, the impact of the condition on their 
quality of life, and their recommendations for service development. A total of 1,529 
questionnaires were posted to patients accessed through hospitals, services and support 
organisations (e.g. Lymphoedema Ireland). Seven hundred and thirty-five questionnaires 
were returned. The main findings related to the inequitable nature of current service 
provision and the impact of the condition patients’ quality of life. The rationale for the 
inclusion of patient questionnaires, the methodology, specific aims, results and discussion of 
the patient questionnaire phase are presented in Chapter 6.  
Conclusion 
Finally following the integration of the results from all three phases two super-ordinate 
themes emerged: lymphoedema – an unacknowledged condition and the legacy of 
lymphoedema’s association with cancer. These super-ordinate themes in addition to 
recommendations for future research and policy developments are presented in the overall 
discussion in Chapter 7.  
 
 
 
 
 
 7 
Chapter 2: Literature Review 
Introduction 
This thesis examines service providers’ and patients’ opinions of lymphoedema service 
provision in addition to exploring patients’ experiences of living with lymphoedema. The 
following sections will outline the literature on the causes, classifications, prevalence, types, 
risk factors and treatment of lymphoedema. This is followed by sections detailing previous 
research on lymphoedema service provision in other countries, and on the impact of 
lymphoedema on patients’ physical and psychological wellbeing and on their quality of life. 
Finally the last section outlines the aims of the current study  
What is Lymphoedema  
Lymphoedema is a progressive, chronic, incurable condition that is caused by damage to or 
malformation of the lymphatic system. Typically it occurs due to the removal, or impairment 
of part of the lymphatic system following cancer treatment, trauma, infection or congenital 
malformation (DHSSPS, 2004; Moffatt, Doherty, & Morgan, 2006). The underlying physical 
and chemical processes that lead to lymphoedema are still not fully understood (Okeke et al., 
2004). However it is estimated that if lymphatic functioning is reduced below 20% of normal 
functioning, fluid which would normally be removed by the lymphatic system begins to 
accumulate in the tissues, causing noticeable swelling.  
 
The swelling or oedema usually takes place in the limbs, and may include the associated 
trunk of the body. However swelling can occur in other parts of the body such as the head, 
neck, breast, and genitalia, depending on the location of the lymphatic impairment (Medical 
Education Partnership, 2006; Sneddon & Lewis, 2007). The affected area can become 
progressively larger and the skin and underlying tissue can become thickened or fibrosed 
(resulting in skin conditions such as hyperkeratosis and papillomatosis).  
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Generally lymphoedema is regarded as swelling caused by lymphatic impairment lasting 
longer than 3 months that is not relieved by the use of diuretics (Burns et al., 2003; Harris et 
al., 2001; National Lymphoedema Network, 2006; Revis, 2008).  However, there is no 
consistent definition of clinically significant lymphoedema in the literature (Harris et al., 
2001). The International Society of Lymphology (2003) argues that there is a subclinical 
stage of lymphoedema, Grade 0, when the transport of lymph fluid is impaired but overt 
oedema or swelling is not yet present. Indeed some patients experience symptoms of 
heaviness, aching and tightness long before visible signs of swelling develop (Muscari, 2004). 
Mild or clinically significant lymphoedema is frequently classified as a 2cm circumference or a 
200ml volume difference between an affected and unaffected limb (Harris et al., 2001; 
Horning & Guhde, 2007). Grade 2 or moderate lymphoedema is often defined as a 20-40% 
volume differential. Grade 3 or severe lymphoedema is often defined as a greater than 40% 
volume disparity between an affected and unaffected limb (International Society of 
Lymphology, 2003). Advanced lymphoedema is referred to evocatively but perhaps 
insensitively as elephantiasis (Person et al., 2008). A positive Stemmer’s sign (i.e. the inability 
to pick up a fold of skin at the base of the second toe or of a finger due to thickening of the 
tissues) may only be present in moderate or severe stages of lymphoedema (CREST, 2008; 
Williams 2006).  
 
Other indicators include tissue texture, skin condition (including thickness), subjective 
sensations, frequency of episodes of cellulitis, increased susceptibility to bacterial and fungal 
infections, psycho-social morbidity, movement, decrease in functionality, distortion in the 
shape of the affected area, and the reaction of the swelling to gravity or pressure (BLS, 
2001b; Morrell et al., 2005, Williams 2003 cited in Hardy 2006). The only measures widely 
used are circumference or volume difference between the affected area and the contralateral 
limb, both of which relate to tissue swelling and are not appropriate for bilateral or midline 
swelling (i.e. swelling in the trunk of the body)  (BLS, 2001b). The International Society of 
Lymphology (2003) has called for a lymphoedema classification based on an improved 
understanding of the mechanisms underlying lymphoedema development including underlying 
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genetic disturbances which could encompass anatomic and functional characteristics. 
However there appears to have been little development on such a classification since then.  
Prevalence and Types of Lymphoedema  
There are many different types of lymphoedema i.e. primary lymphoedema arising from a 
congenital malformation of the lymphatic system and secondary lymphoedema arising from 
acquired damage or interference with the lymphatic system through a variety of medical 
conditions or treatments. As a result, there are cultural differences in the prevalence of 
lymphoedema as it is dependent on the type of lymphoedema most common in that region. 
The prevalence of lymphoedema in Ireland is not currently known. Therefore the prevalence 
rates presented in the following paragraphs, apart from those relating to lymphatic filariasis, 
are based on studies conducted in European countries.  
 
Moffatt and colleagues in 2003 conducted a major epidemiological study in what was formerly 
known as the South West London Community Trust in the UK. Initially the research team 
contacted all health professionals in the area to ascertain potential patients for inclusion in 
the study. Patients who were known to health professionals as being affected by or receiving 
treatment for lymphoedema were invited to participate. These patients were clinically 
examined, questioned about their medical and treatment history and asked to complete a 
demographic and socio-economic questionnaire, the McGill short form pain assessment tool 
and the SF-36, a quality of life measure.  On the basis of this, Moffatt et al. (2003) reported 
that lymphoedema is believed to affect 1.3 per 1,000 (or 0.13%) of the population. A similar 
figure of 0.14% was found by Petlund and colleagues in Norway in 1990 (Williams et al., 
2005).  However these figures are likely to underestimate the true prevalence of 
lymphoedema due to the lack of standardisation in diagnostic criteria and measurement 
practices, and the possibility that not all those with lymphoedema are receiving treatment 
(CREST, 2008; Moffatt et al., 2003; Rockson & Rivera, 2008).   
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Primary Lymphoedema 
Primary lymphoedema refers to lymphoedema resulting from developmental abnormalities or 
malformations of the lymphatic system (DHSSPS, 2004; NCI, 2008). It can be evident in 
infancy or may develop at the onset of puberty or in adulthood. Primary lymphoedema can 
have a gradual onset with swelling subsiding at night but then reappearing the following day 
for up to three months. Following that some degree of swelling is permanently evident 
(Billingham, 2006). Primary lymphoedema usually affects lower extremities (i.e. the legs and 
feet) and is more common among females (Lacovara & Yoder, 2006; Revis, 2008). The 
CREST report (2008) was undertaken to provide guidelines on the management of 
lymphoedema in Northern Ireland. These guidelines were developed to assist healthcare 
practitioners in the development of appropriate referral and treatment pathways to ensure 
early identification and treatment of the condition. The report details that primary 
lymphoedema can also present as an aspect of a number of syndromes: Turner’s syndrome, 
Milroy’s disease, Meige’s disease, and Klippel-Trenaunay syndrome, and the genetic basis of 
these syndromes is being investigated. The report also listed a series of studies which found 
varying prevalence rates of primary lymphoedema: 1 per 10,000, 1 in 33,000, and 1.5 per 
100,000 (CREST, 2008). However methodological restrictions such as convenience sampling, 
lack of standardisation on diagnostic methods and classification issues would account for the 
wide variation. Furthermore, Mortimer (1998) argues that in truth, patients are often 
diagnosed with primary lymphoedema when a cause cannot be identified and with secondary 
lymphoedema when a cause (or a number of causes) can be identified.  
Secondary Lymphoedema 
Secondary lymphoedema refers to lymphoedema which occurs as a consequence of acquired 
damage or obstruction of the lymphatic system. Essentially the swelling results from an injury 
to the lymphatic system and as a result the lymphatic system is unable to manage even 
normal levels of lymph fluid (Lacovara & Yoder, 2006). The risk of developing lymphoedema 
following the interference with the lymphatic system is lifelong. Secondary lymphoedema is 
more common among women. While originally this was attributed to the prevalence of 
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lymphoedema following breast cancer treatment, it was subsequently found that both primary 
and secondary lymphoedema are more common among women, although the reasons for this 
are not fully understood at present (Moffatt et al., 2003). Secondary lymphoedema can occur 
following infection (e.g. lymphatic filariasis), cancer or its treatment, trauma or tissue 
damage, venous disease, inflammatory conditions, and immobility or dependency (CREST, 
2008; DHSSPS, 2004; Hardy, 2006; NCI, 2008; Williams et al., 2005).  
Lymphatic Filariasis 
Worldwide, the most common form of lymphoedema is lymphatic filariasis. It is caused by a 
parasitic infection transmitted by mosquitoes which damages the lymphatic system (DHSSPS, 
2004; MEP, 2006). Filariasis is endemic in approximately 80 tropical and subtropical countries, 
and is particularly common in India, Africa, South-East Asia, the Pacific and the Americas 
(Wynd et al., 2007, World Health Organisation, 2000). The World Health Organisation (WHO) 
estimates that 120 million people are infected with the parasite and a billion are at risk of 
infection by living in endemic areas. The WHO counts lymphatic filariasis as the second most 
common cause of long-term disability after mental illness (Wynd et al., 2007).   
Lymphoedema Secondary to Cancer or its Treatment  
The most common cause of lymphoedema in countries were filariasis is not endemic is 
iatrogenic – i.e. inadvertently caused by treatment, usually cancer treatment (Rockson & 
Rivera, 2008). As cancer can metastasize to the lymph nodes, the treatment of cancer can 
include interference with, removal or radiation of lymph nodes. This is particularly relevant in 
breast cancer as metastatic spread to the axilla (i.e. the lymph nodes in the armpit) occurs in 
approximately 30% of breast cancer patients and is the strongest prognostic factor of a more 
advanced stage of breast cancer  (Morrell et al., 2005; Thomas-MacLean et al., 2008). There 
is a higher risk of developing lymphoedema following more extensive surgical procedures – 
for example, axillary lymph node dissection (ALND) where all lymph nodes in the axilla, or 
armpit, are removed in the treatment of breast cancer; as opposed to more conservative 
techniques, such as sentinel lymph node biopsy (SLNB) where only cancerous nodes are 
removed (Flessig et al., 2006; Golshan et al., 2003; Lacovara & Yoder, 2006; Leitch et al., 
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1998; Mansel et al., 2006; Rietman et al., 2004; Sener et al., 2001). However it is important 
to note that people with advanced-stage breast cancer will still require ALND and some 
patients may request ALND if they greatly fear cancer recurrence. Furthermore it is possible 
that SLNB may reduce the severity rather than the prevalence of lymphoedema and as a 
result people in the SLNB group may be at a subclinical stage for a longer period of time 
(Richmond, 2003; Rockson, 2002).  
 
Several studies have found that a combination of surgery and the irradiation of lymph nodes 
results in a greater risk of developing lymphoedema when compared with controls (Morrell et 
al., 2005; Williams et al., 2005). Radiation may result in an increased rate of fibrosis 
(hardened tissue) causing constriction of the lymphatic pathways, damage to the lymph 
nodes and a delay in the growth of new lymphatic vessels (Johansson et al., 2003; Morrell et 
al., 2005; Ridner, 2002). Essentially for cancer patients the risk of developing lymphoedema 
is increased by the surgical removal of nodes and tied off lymph vessels; scarring and fibrosis 
of lymph structures and surrounding tissues; and infection (Ridner, 2002).   
 
Goltner et al. (1988) and Soran et al. (2006) argue that damage to the lymphatic system may 
be present for almost all patients who have had breast surgery. Therefore the question of 
why some patients develop cancer-related lymphoedema while others do not has not been 
explored in depth (Williams, 2006a). There is much confusion over the possibility of certain 
factors predisposing individuals to developing cancer-related lymphoedema. Some studies 
have identified body weight gain, number of nodes removed, tumour size, or surgical 
technique employed as potential predisposing factors whereas in other studies these were not 
significant (Morrell et al., 2005). Furthermore, in order to promote clarity and permit 
comparison across studies there is a need for standardisation on the definition of 
lymphoedema and methods of assessment employed by researchers (Morrell et al., 2005). 
Therefore it is unclear at present whether cancer-related lymphoedema can be prevented. 
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The majority of research on the prevalence of secondary lymphoedema refers to breast-
cancer-related secondary lymphoedema. Indeed Moffatt et al. (2003) reported that 25% of 
the sample in their prevalence study had lymphoedema secondary to cancer treatment, but 
didn’t indicate what type of lymphoedema the rest of the sample experienced. In terms of the 
proportion of breast cancer patients that develop lymphoedema, the figures range from 6% 
to 70%, with the majority of studies reporting its prevalence to be between 20% and 25%, 
(DHSSPS, 2004; Harris et al., 2001; Petrek & Heelan, 1998). Again, variations in prevalence 
are due to differences in the definition of lymphoedema used, the methods of assessment, 
the source of patients, and the length of follow up after patients’ cancer treatment, which 
makes it difficult to compare prevalence across studies (CREST, 2008; DHSSPS, 2004; Harris 
et al., 2001; Petrek & Heelan, 1998; Williams et al., 2005). There is a lack of consensus on 
prevalence rates for lymphoedema secondary to other cancers but Williams and colleagues 
(2005) have produced a good review of findings to date.  
Lymphoedema Secondary to Other Conditions 
Other conditions which can result in lymphoedema include infections such as cellulitis (both a 
contributing factor and consequence of lymphoedema), severe acne, rosacea (a disorder of 
the skin causing flushing or redness of the face), surgical wound infection, and lymphadenitis 
(an infection of the lymph nodes) (CREST, 2008; Lu et al., 2008; Williams et al., 2005). 
Lymphoedema can also develop following significant scarring, large wounds and self harm 
(CREST, 2008). A retrospective study in a serious burns unit found a prevalence of 1% 
following trauma or tissue damage but additional research is required (CREST, 2008). Venous 
conditions such as deep vein thrombosis, chronic venous insufficiency, and intravenous drug 
use can also result in lymphoedema (Rockson & Rivera, 2008). Inflammatory conditions such 
as rheumatoid and psoriatic arthritis, dermatitis or eczema, and sarcoidosis can contribute to 
the development of secondary lymphoedema (CREST, 2008, DHSSPS, 2004). Immobility or 
dependency resulting from paralysis, chronic ill health, or obesity can result in lymphoedema 
as muscular contractions encourage the flow of lymph fluid through the lymphatic system 
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(CREST, 2008). However there is a paucity of research on the prevalence of lymphoedema 
secondary to these conditions.  
Conclusion 
The estimation of the population burden of disease has profound implications for strategic 
planning of service provision, and insurance and reimbursement issues but it also affects the 
motivation of pharmaceutical and biotechnology sectors to undertake the development of 
new treatment strategies (Rockson & Rivera, 2008). Therefore research estimating the 
prevalence of lymphoedema in the Republic of Ireland would be welcome.  
Risk Factors for Developing Lymphoedema 
As mentioned previously, lymphoedema can result from a number of medical conditions other 
than cancer. Therefore many of the risk factors for developing lymphoedema are often 
related to the causes, for example, the insertion of a pacemaker (which would indicate heart 
disease); and varicose vein stripping and vein harvesting (which would indicate venous 
disease) (Medical Education Partnership, 2006; Muscari, 2004).  
 
One consistently reported risk factor is weight gain, or having a high body mass index or 
waist circumference (Doherty, 2006; McWayne & Heiney, 2005; Muscari, 2004; Petrek et al., 
2001; Soran et al., 2006; Swenson et al., 2009). Age is another major risk factor as the 
overall prevalence of lymphoedema is 0.13% but for those over 65 years the prevalence is 
0.54% (Moffatt et al., 2003). Both age and being overweight or obese can also have an 
indirect impact in that they increase the likelihood of other risk factors being present such as 
venous disease, heart disease, and reduced mobility (Doherty, 2006; Petrek et al., 2001).  
 
Infection in the at-risk area greatly increases the chances of developing lymphoedema. 
Therefore skincare and risk avoidance is important (i.e. avoiding cuts, scrapes, burns, 
infection, extremes of temperature, restriction, carrying heavy loads, overuse, injections, 
blood pressure readings, and blood draws in the at risk area) (Horning & Guhde, 2007; MEP, 
2006; NCI, 2008; NLN, 2005; Rinehart-Ayres, 1998). However as bilateral lymph node 
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dissections are performed in some patients, it is important to be mindful that injections or 
blood draws in an at-risk area cannot always be avoided and do not necessarily lead to the 
development of lymphoedema (Muscari, 2004).  
 
At present it is unclear what particular jobs or activities can predispose individuals to 
developing lymphoedema (Petrek et al., 2001). This may depend on what part of the body is 
affected by a lymphatic impairment and therefore at risk of developing lymphoedema. For 
example, individuals at risk of developing lymphoedema in their lower limbs are often 
discouraged from engaging in activities or jobs which require long periods of standing. 
Individuals at risk of developing lymphoedema in their upper limbs are often discouraged 
from engaging in activities or jobs requiring repetitive arm motion. However there is little 
direct evidence for this. Indeed some recommendations on avoiding the development of 
lymphoedema may appear to be contradictory. For example, too little exercise can exacerbate 
symptoms but too much vigorous exercise can have a similar effect. As a result the position 
paper of the National Lymphedema Network (2008) suggests that individuals at risk of 
developing lymphoedema should be able to perform aerobic and resistive exercises using the 
at-risk body part if they initiate exercise at a low intensity, increase it gradually and wear a 
properly fitted compression garment when exercising. Yet once again, these 
recommendations are generally based on anecdotal rather than robust evidence.  
 
Air travel may also pose an additional risk and attention should be paid to sensations such as 
heaviness, fullness or aching in the at-risk area of the body during a flight (NLN, 2004). 
Ideally a compression garment recommended and sized by a trained and experienced 
garment fitter should be worn as a prophylactic measure (NLN, 2004). Individuals at risk of 
developing lymphoedema are advised to stay hydrated, walk around the cabin regularly (to 
prevent deep venous thrombosis), elevate and move the at risk area regularly (NLN, 2004). 
Again this advice is based on anecdotal rather than robust evidence.   
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In summary, the risk of developing lymphoedema is lifelong and patients and professionals 
need to be aware of risk reduction strategies (DHSSPS, 2004). A stronger evidence base on 
the risk factors for lymphoedema is required (Box et al., 2002; MEP, 2006; Muscari, 2004; 
Sitzia & Harlow, 2002). At present it is still unclear why individuals with the same medical 
history develop it and others do not, the wide variation in onset, progression and quality of 
tissue swelling and whether prior lymphatic system functioning has an impact (Sitzia & 
Harlow, 2002).  
Treatment 
 Although lymphoedema is a chronic condition, there are treatment options for symptom 
control, maintenance of the affected area and prevention of complications. Lymphoedema 
treatment is not solely concerned with the alleviation of swelling, but also vigilance and 
treatment of aggravating conditions such as infection (Harris et al., 2001; Mondry et al., 
2004). However it is important to note that essentially for patients a positive treatment 
outcome signifies improved quality of life as opposed to necessarily involving changes in 
volume (Williams, 2008).  
Decongestive Lymphatic Therapy 
Broadly speaking the consensus regarding the management of lymphoedema is to engage in 
the four cornerstones of care consisting of: skin care (to prevent infection), tailored exercise 
programmes (to encourage natural lymph flow), manual lymphatic drainage (specialised 
gentle massage to encourage the redirection of fluid to better functioning lymphatic 
pathways) and containment using compression garments and/or bandages (to encourage 
natural lymph flow and maintain any reduction in swelling) (DHSSPS, 2004; MEP, 2006; 
Morrell et al., 2005). The precise terminology relating to the four cornerstones of care is 
known by several names and acronyms. This reflects the fact that there are now several 
schools of lymphoedema treatment including the Casley-Smith, Földi, Klose, Leduc, and 
Vodder schools. Although the schools all follow the same basic principles, the precise 
techniques may vary (Casley-Smith et al., 1998; Williams, 2003; Williams, 2006b). For the 
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purposes of this thesis the term Decongestive Lymphatic Therapy or DLT will be used to refer 
to the treatment approach that involves the four cornerstones of care for lymphoedema.  
 
DLT is applied in two phases: an intensive phase and maintenance phase (Horning & Guhde, 
2007). The intensive phase involves Manual Lymphatic Drainage (MLD) and in some cases 
Multilayer Lymphoedema Bandaging (MLLB), being provided once or even twice daily by a 
specifically trained therapist for up to 6 weeks (BLS, 2001b; CREST, 2008).  
 
Manual Lymphatic Drainage (MLD) is a highly specialised form of massage involving slow and 
rhythmical movements with gentle pressure (Casley-Smith et al., 1998).  The individual’s 
unaffected side is treated first, and the therapist then moves fluid from the congested area to 
better functioning lymphatic pathways (MEP, 2006). It is recommended that MLD is followed 
with compression such as Multilayer Lymphoedema Bandaging (MLLB) and/or the wearing of 
compression garments in order to maintain the effects of the treatment (Casley-Smith et al., 
1998).  
 
In the maintenance phase the patient (or their carer) is encouraged to manage their 
condition using Simple Lymphatic Drainage (SLD, self-massage based on the principles of 
MLD), specific lymphoedema exercises and compression (garments or self-bandaging), all of 
which are designed to improve lymph flow. Daily skincare of the affected area is also 
encouraged to maintain the integrity of the skin and therefore avoid infection (Casley-Smith 
et al., 1998; MEP, 2006). If required the patient can seek intensive treatment if they 
experience a deterioration or sudden increase in swelling following an episode of cellulitis. 
Patients should be encouraged to attend follow up appointments for measurement for 
replacement compression garments (Williams, 2006a).   
Evidence for the Effectiveness of Decongestive Lymphatic Therapy 
There is little robust literature to support each of the components of Decongestive Lymphatic 
Therapy (Földi, Jünger & Partsch, 2005; Harris et al., 2001; Harris & Piller, 2003; MEP, 2006; 
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Partsch & Jünger, 2006; Sitzia & Harlow, 2002; Williams, 2006b). However Földi (1998) 
argues that each component of DLT is inadequate if applied in an isolated form; all four of 
the cornerstones of care should be applied and therefore evaluated as a systematic 
treatment.  
 
In a prospective trial of 20 patients, DLT was associated with consistently decreasing pain 
scores on a visual analogue scale and increasing quality of life scores (Mondry et al., 2004). 
Boris et al. (1997) found that if patients are compliant with wearing compression garments in 
the maintenance phase, the effects of DLT can be maintained for up to three years (cited in 
Rinehart-Ayres, 1998). Yet evidence for the management of lymphoedema remains weak 
often based on anecdotal rather than empirical evidence (Lacovara & Yoder, 2006). Further 
work is required to assess the best practice and cost effectiveness of different management 
regimens (Moffatt et al., 2003). Therefore clinical decision making has been heavily 
influenced by ritual and individual trial and error (Sitzia & Harlow, 2002). 
 
As a result the Lymphoedema Framework Project, a UK based research partnership, was 
established to raise the profile of lymphoedema and improve standards of care by involving 
specialist practitioners, patient groups and stakeholders in the wound care and compression 
garment industry. They consulted with an international panel of experts to produce an 
international consensus on lymphoedema management. In so doing, they found that there’s 
little formal guidance on how to combine expert opinion and formal scientific evidence and 
there are added challenges in including the opinions of alternative perspectives, for example 
practitioners and patient groups (Morgan, Moffatt & Doherty, 2006). Nevertheless the 
resulting document “Best Practice for the Management of Lymphoedema” by the Medical 
Education Partnership (MEP, 2006) has been endorsed by lymphology societies due to its 
practicality and the credibility associated with being drawn from national and international 
consensus (Morgan & Moffatt, 2006). Yet the requirement for empirical research to guide 
clinical practice and support patients’ claims for service provision and financial support for 
treatment remains.  
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Furthermore, for positive outcomes to be achieved in clinical practice, patients must be active 
in their care, have a high degree of vigilance, engage in preventive efforts and exhibit a high 
tolerance for treatment (for example, antibiotics for the treatment or prevention of infection, 
intensive daily MLD sessions, compression garments which are often uncomfortable, time 
consuming exercises and skin care, and the financial burden of seeking treatment and 
garments). Patient adherence to treatment plans is heavily affected by the consequences of 
noncompliance, the extent of the impact of living with uncontrolled lymphoedema and 
satisfaction with the treatment itself (Bogan et al., 1997).  Satisfaction in turn is influenced by 
the thoroughness of preparation for the maintenance stage, the practitioner’s affect and the 
patient’s self efficacy (Bogan et al., 1997). As a result the effectiveness of DLT cannot be 
investigated in isolation from a consideration of the patient’s adherence, the practitioner’s 
competence, the practitioner-patient relationship, and the patient’s psychological perspective.  
Reviews of Service Provision  
To date there have been no studies exploring current lymphoedema service provision in the 
Republic of Ireland. However a number of reports, reviews and empirical investigations of 
practitioners’ and patients’ perspectives on service provision have been produced in Australia, 
continental Europe and the UK. A summary of the findings is presented below.  
Australia  
The Australasian Lymphology Society (ALA) (2003) telephoned service providers to quantify 
lymphoedema service provision in Australia. They then surveyed an unspecified number of 
lymphoedema practitioners in order to explore current practice and details on topics such as 
compression garment provision. The ALA found that there is no pattern to the distribution of 
services between states, and even within states across urban and rural areas. Although they 
noted that this may be based on economic issues such as the distribution of a skilled 
workforce (ALA, 2003). Different hospitals provide different services not based on financial or 
epidemiological principles or therapeutic philosophy, and for little apparent reason (ALA, 
2003). The report also identified the inequitable nature of compression garment provision 
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with policies in Victoria and Tasmania guiding the appropriate prescription and equitable 
supply of garments to patients while patients in other states are required to pay for their 
garments. Overall the report indicated that lymphoedema services are provided with a serious 
lack of parity between the states, within states, and across individuals as a result (ALA, 
2003). However the authors acknowledged that due to the lack of an existing register of 
lymphoedema services and the voluntary nature of respondents’ participation it was possible 
that some services had been omitted from the study. The questionnaires employed by the 
researchers involved a small number of open questions. As a result it is possible that some 
respondents provided less detail than others thereby misrepresenting their service. 
Furthermore the study did not include patients’ perspectives on lymphoedema service 
provision.   
 
Subsequent to the ALA’s study, BreastCare Victoria (2005) conducted a mixed methods study 
on lymphoedema service provision in Victoria, Australia. The study employed a survey of 276 
patients; five focus groups with a total of 35 patients conducted by telephone to enable the 
participation of patients living in diverse locations; and a survey of 44 practitioners. In the 
terms of the results of the practitioner survey, the majority of services had the capacity to 
see approximately 1-15 patients per week. On average treatment sessions lasted 60 minutes 
and 79% of services provide home visits. The results also included an effective model of 
lymphoedema service provision in the Bendigo Health Service where a large, public 
lymphoedema service provides hub-and-spoke support to smaller, rural clinics through visiting 
clinicians and videoconferencing.  
 
Regarding referral sources, practitioners indicated that although general practitioners were 
the most common referral source, many had poor knowledge of lymphoedema; as a result 
referral can be haphazard (BreastCare Victoria, 2005). Practitioners reported that on average 
there are 0.77 whole time equivalent practitioners per service. Most of practitioners’ 
comments on compression garments related to the subsidisation programme being beneficial 
for patients and with prompt supply by compression garment providers. Although many noted 
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that not all patients are eligible for such subsidies and that a wider range of garments should 
be available to patients under the scheme.  Moreover practitioners reported that rural 
patients may be disadvantaged by the scheme as they are required to travel to specific 
garment suppliers in order to avail of the subsidies. Regarding practitioners’ 
recommendations for service development, comments related to services being available in 
more public hospices, additional training of new practitioners, improving the affordability of 
treatments for patients, improving awareness of lymphoedema particularly among medical 
and allied health professionals and the compilation of a booklet containing information on the 
condition, treatment options, location of services, subsidy schemes, compression garment 
suppliers and education programmes.    
 
In terms of the results from patient phases of the study, patients reported that diagnosis was 
made by a wide variety of health professionals or in several cases, by patients themselves or 
their family members. Some patients expressed dissatisfaction with the perceived lack of 
knowledge of lymphoedema and treatment alternatives among healthcare professionals as 
this could delay diagnosis and optimal management. Most had received information on 
lymphoedema either through their individual practitioner, group education sessions or 
through the lymphoedema association. Sixty percent of those who had sought treatment in 
the last year had received MLD in that time. Most of these treatments had been received 
once a week or less frequently. Fifty-nine percent of respondents reported being required to 
pay for their treatment and the minimum average charge for an individual treatment was 
$39.75. Thirty-one percent reported that they replace their garments at least three times a 
year as recommended by practitioners. Several patients reported this was due to the cost 
with 40.5% spending $1-$200 per year and 41.6% spending $201-$500 per year on 
garments.   
 
Eight-two percent of patients who had access to services expressed a high level of 
satisfaction with those services; however patients noted the gaps in provision in some 
suburban and rural areas (BreastCare Victoria, 2005). For example on average participants 
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living in urban areas were required to travel 18.2 kilometres in a one way trip to their service 
whereas patients living in rural areas travelled on average 44.9 kilometres in a one way trip 
to their service. Additionally there was evidence of inequity according to type of 
lymphoedema For example, on average patients with breast-cancer-related secondary 
lymphoedema waited 0.6 years for a diagnosis following the onset of symptoms whereas 
patients with primary lymphoedema were waiting on average 9.4 years. In terms of their 
overall recommendations for service development, patients reiterated the recommendations 
of service providers in that both emphasised improved awareness of lymphoedema among 
healthcare professionals and the general public, an increased number of lymphoedema 
practitioners, improved affordability of treatments and compression garments and widespread 
dissemination of information about services, garments and eligibility for financial assistance.  
 
While the study provided an interesting account of current service provision in Victoria, 
Australia, there were a number of limitations to the study. The authors noted that the views 
of practitioners working in some services and the views of patients not currently receiving 
treatment may not have been adequately represented (BreastCare Victoria, 2005). Moreover 
detailed information on the themes emerging from the patient focus groups was not 
provided. Nevertheless, the report’s lead author has indicated in private correspondence with 
the researcher that the work instigated by BreastCare Victoria has partly informed the 
development of strategies that are now being implemented across all cancer streams in 
Victoria. 
Continental Europe 
An empirical study on lymphoedema service provision in continental Europe could not be 
located. However MacLaren (2003) conducted a review on service provision in a number of 
countries in Europe. She reported that in Sweden and the Netherlands, a multidisciplinary 
team provides a range of services from outpatient care of mild and moderate lymphoedema 
to inpatient programmes for severe cases.  The ethos is to maximise self-care through 
outpatient attendance at professionally-led self-management groups and group interventions 
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on education and psychological support (MacLaren, 2003). These rehabilitation programmes 
are funded solely through health insurance. For those without health insurance, charitable 
organisations provide lymphoedema care (MacLaren, 2003). 
 
MacLaren (2003) also reported that Austria and Germany are seen as centres of excellence 
for therapist training and treatment.  There is a firm commitment to the four cornerstone 
approach (i.e. skin care, exercise, MLD and compression) with optional or prescribed extras 
such as attendance at fitness or dance class, weight loss programmes, therapeutic diets, and 
complementary health treatments (MacLaren, 2003). However despite the wide range of 
treatments available they are often not in close proximity to patient’s homes.  State 
certification is keenly sought by establishments wishing to provide rehabilitative or 
convalescent services in order that they are reimbursed to patients by the state.   
The United Kingdom  
The majority of the literature on lymphoedema service provision in the UK is derived from 
policy documents, reviews and reports rather than empirical investigations of service 
providers’ or patients’ experiences. However the few empirical studies that have been 
performed are outlined in subsequent sections.  
Policy Documents and Reports 
The Calman-Hine report of 1995, which set out the first overall policy for cancer care for 
England and Wales, stated that cancer centres and units should provide lymphoedema 
treatment for patients with breast-cancer-related secondary lymphoedema as a matter of 
course. Nevertheless many patients still do not have access to a full range of services. 
Charitable organisations have played an essential role in meeting the shortfall but as a result 
the provision of services can be uncoordinated (MacLaren, 2003). As the availability of MLD 
for National Health Service and hospice patients is limited, it is a lucrative area for private 
practice. While there are standards of care for lymphoedema services, they have yet to be 
enforced and the lack of national registration or licensing of therapists in the UK also 
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complicates the reimbursement of patients by their health insurers (BLS, 2001a; MacLaren, 
2003).  
 
The report of the Lymphoedema Services Review Group in Northern Ireland noted that ad 
hoc investment and funding is generally provided by cancer or physiotherapy services with 
scant consideration given to the sustainability of lymphoedema services (Department of 
Health, Social Services and Public Safety, 2004). Moreover practitioners experience 
professional isolation, problems with cover for leave and long waiting lists (DHSSPS, 2004). 
Moffatt et al. (2003) observed that many existing lymphoedema services are based in 
hospices or oncology departments and are by their very location restricting access to 
alternative patient groups. In order to explore these issues further, the following section 
presents the results of empirical studies involving the opinions of various healthcare 
professionals involved in lymphoedema service provision in the UK.  
Empirical Studies of Practitioners’ Opinions of Service Provision 
Tiwari et al. (2006) surveyed members of The Vascular Society of Great Britain and Ireland. 
Two hundred and fifty-one vascular consultants or 57% of members returned a completed 
questionnaire. Seventy-three percent of respondents believed that lymphoedema is managed 
inadequately in the UK and 72.9% of respondents believed that resources were insufficient 
(Tiwari et al., 2006). However this survey only included the opinions of vascular consultants 
who were members of the organisation and therefore did not involve a representative 
sample. The opinions of other healthcare professionals involved in the care of lymphoedema 
patients, such as oncology consultants, physiotherapists, occupational therapists, 
lymphoedema nurse specialists and nurses were also omitted.   
 
Following on from their previous involvement in the lymphoedema prevalence study, Morgan, 
Moody and colleagues (2005) conducted an educational needs assessment of 55 community 
nurses working in South West London. This was intended to be a first step towards 
developing educational programmes thereby improving lymphoedema services in that region. 
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They employed focus groups on real-world lymphoedema practice and self-assessment 
questionnaires of participants’ current knowledge and skill in the care of patients with 
lymphoedema. In only one category, skincare, a small majority of respondents (54%) rated 
themselves as having excellent or good knowledge and skill. In the remaining 10 categories 
the majority of respondents rated their knowledge and skill as poor or very poor. Participants 
reported that they often learned on the job from other nurses who had experience with 
lymphoedema which allows myths about the condition to be perpetuated (Morgan, Moody et 
al., 2005). While this study did provide information on the initiation of a model of educational 
needs assessment, it did not employ a representative sample rather a specific category of 
healthcare professionals working in a precise catchment area.  
Empirical Studies Incorporating Patients’ Experiences of Service Provision 
Bulley (2007) incorporated both practitioners’ and patients’ experiences in a needs 
assessment of lymphoedema services in Fife, Scotland. A variety of methods were employed: 
a telephone survey of general practitioners regarding referral procedures and face-to-face 
interviews were conducted with a purposive sample of five lymphoedema patients from one 
hospital (two with primary lymphoedema, three with breast-cancer-related secondary 
lymphoedema) and with five lymphoedema practitioners (two physiotherapists, two nurses 
and one private practitioner).  
 
The telephone survey of general practitioners revealed a lack of knowledge and awareness of 
lymphoedema, its management and of available services. Indeed one general practitioner 
said patients with lymphoedema ‘just have to live with it’ (Bulley, 2007, p.134). The patient 
interviews corroborated this as they reported how some healthcare professionals’ lack of 
awareness acted as a barrier when they were seeking a diagnosis and access to treatment. 
Poor geographical access and a lack of home visits discouraged some patients from accessing 
treatment while practitioners reported that increasing caseloads offered the potential of 
further limiting patients’ access to treatment.  Additionally practitioners reported that they 
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had been requested to engage in a prioritisation system by placing patients with non-cancer-
related lymphoedema on the waiting list, resulting in inequity of care (Bulley, 2007).  
 
While the needs assessment provides some insight into service provision in that area of 
Scotland, it was not conducted with representative samples of practitioners or patients. 
Indeed patients with non-cancer-related secondary lymphoedema (e.g. lymphoedema 
secondary to venous disease, infection, or inflammation) or patients with cancer-related but 
not breast-cancer-related secondary lymphoedema (e.g. lymphoedema secondary to 
lymphoma, gynaecological cancers or melanoma) were not included.  Moreover patients were 
accessed through one hospital and the scope of the study was confined to a small region. 
 
In terms of studies solely exploring patients’ experiences of lymphoedema service provision, 
the Lymphoedema Services Review Group in Northern Ireland received questionnaires from a 
total of 32 lymphoedema patients who were members of lymphoedema support organisations 
(DHSSPS, 2004). Participants who could access treatment were generally satisfied with it 
although they did note the difficulties in accessing such treatment. People with primary and 
non-cancer-related secondary lymphoedema and people living in rural areas reported that 
they continue to experience greater difficulty in accessing services (DHSSPS, 2004). 
Participants who couldn’t access initial and continuing care, reported that it can be “a 
constant struggle and I have no quality of life because of this” (DHSSPS, 2004 Page 32). 
However the report includes scant information on the results derived from this patient survey 
and as the survey was conducted only with patients accessed from support organisations it is 
unlikely to be representative of all lymphoedema patients in Northern Ireland.  
 
Lam et al. (2006) conducted a postal survey of the members of the Lymphoedema Support 
Network and received responses from 1,449 individuals, which represent 60% of the 
membership at that time. 61% of respondents with a history of cancer and therefore at 
lifelong risk of developing lymphoedema had not been told that they could develop 
lymphoedema. Overall half of respondents were satisfied with the assistance they received at 
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their first consultation. The proportion of those who were satisfied was lowest among those 
who consulted a GP initially (38%) and highest among those who consulted a nurse (77%).  
 
Lam et al.’s (2006) study also detailed several differences in the experiences of patients with 
various types of cancer. Patients with non-cancer-related lymphoedema were less satisfied 
than patients with cancer-related lymphoedema with the professional they consulted when 
they first became concerned with their swelling. Fewer patients with non-cancer-related 
lymphoedema had received the various elements of decongestive lymphatic therapy (DLT) 
when compared with patients with cancer-related lymphoedema. Additionally, patients with 
cancer-related lymphoedema were more likely to experience continued monitoring of their 
lymphoedema (79%) when compared with patients with non-cancer-related lymphoedema 
(57%). However once again this study was conducted with patients accessed from a support 
organisation and as a result the sample is unlikely to be representative of all lymphoedema 
patients in the UK.  
 
A series of qualitative studies have explored the difficulties lymphoedema patients’ experience 
in adapting to their condition. For example Hare (2000) conducted four focus groups with a 
total of 20 women with breast-cancer-related secondary lymphoedema accessed from a 
hospice lymphoedema service in the UK. Williams et al. (2004) employed a phenomenological 
approach and interviewed 15 patients with various types of lymphoedema from a specialist 
clinic in London. Both revealed themes relating to the difficulties patients experience in 
sourcing information about lymphoedema and receiving the correct diagnosis. Williams et al. 
(2004) termed this ‘fishing in the dark’. In a related point, both Hare (2000) and Williams et 
al. (2004) reported friction between patients and healthcare professionals when healthcare 
professionals failed to acknowledge the seriousness of the condition or the impact it has on 
patients’ quality of life. While these studies add depth to our understanding of patients’ 
experiences of lymphoedema service provision in the UK it is difficult to ascertain how 
representative participants’ experiences are until a quantitative study is conducted with a 
larger sample of patients.  
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Conclusion 
There is a considerable dearth of empirical research on lymphoedema service provision 
conducted with representative samples of practitioners and/or patients in Australia, 
continental Europe and in the UK. A derisory number of small scale quantitative studies have 
been conducted with specific groups of lymphoedema practitioners rather than considering 
input from multiple disciplines. While qualitative studies of patients’ experiences have added 
depth, the few quantitative studies that involved patients generally relied on the opinions of 
particular categories of patients such as members of lymphoedema support groups. To date 
one study attempted to access a wide variety of practitioners and patients to ascertain their 
views on lymphoedema service provision, namely the BreastCare Victoria (2005) study. As 
mentioned previously, this study has assisted in developing guidelines that have prompted 
the development of lymphoedema services.   
 
To date there has been no research conducted on service providers’ and patients’ experiences 
of lymphoedema service provision in the Republic of Ireland. Without a clear picture of 
current service provision in Ireland coordination between services, planning on how to 
develop and expand services, and formulation on how to address gaps and inequalities 
cannot take place. Therefore research that incorporates quantitative investigation of the 
experiences of a broad sample of practitioners and patients, in addition to qualitative findings 
to add depth, would be a first step in informing best practice in Ireland and an essential input 
to policy planning. Moreover such service development cannot be undertaken without an 
appreciation of patients’ experiences of living with the condition. The following section 
outlines previous research on this area.  
Patients’ Experiences of Living with Lymphoedema 
Lymphoedema affects many spheres of life, and is a unique and complex experience for each 
person (Woods, 1993). While bearing this in mind a number of researchers have attempted 
to explore general trends in patients’ experiences of living with lymphoedema. Studies have 
focused on the physical consequences of lymphoedema, the impact of the condition on daily 
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life, psychosocial consequences of living with lymphoedema and the impact on patients’ 
quality of life. Researchers have also investigated the relationship between physical and 
psychological wellbeing, for example how physical consequences can act as exacerbating and 
protective factors to psychological consequences. An account of the findings to date is 
presented below. 
Physical Consequences of Lymphoedema 
Lymphoedema can lead to discomfort; pain; sensations of burning, itching, and tightness 
(even to the point of a bursting sensation); loss of feeling as the affected area becomes more 
solid; muscle wastage; increasing intolerance to changes in temperature; sleep disturbance 
and in a small number of cases loss of hair has also been reported (Morgan, Franks & 
Moffatt, 2005; Robertson Squire, 2000). The heaviness of the limb can lead to extreme 
fatigue, compromised posture, muscle tightness and musculoskeletal problems (Muscari, 
2004; Passik & McDonald, 1998). Additionally fine motor movement may be affected as an 
upper limb increases in size (Carter, 1997, cited in Ridner, 2002). In terms of empirical 
studies, Moffatt and colleagues (2003) reported that 50% of patients in their prevalence 
study experienced pain or discomfort from their oedema and of those 56% were taking 
regular prescribed analgesia. Additionally, Lam et al. (2006) reported that 13% of participants 
indicated that pain, aching or tiredness affected their daily lives.  
 
Moreover, the pooling of bacteria-laden lymph fluid in the body results in an increased 
susceptibility to infection, such as cellulitis an infection in the layers of the skin. Cellulitis is 
both a risk factor and consequence of lymphoedema. The symptoms of cellulitis include 
flushed skin and increased swelling in the affected area, an elevated white blood count or an 
elevated temperature (International Society of Lymphology, 2003; Lacovara & Yoder, 2006). 
If left untreated cellulitis can progress to systemic infection such as septicaemia (DHSSPS, 
2004).  Cellulitis is treated with antibiotics and in some cases requires hospitalisation (CREST, 
2008; DHSSPS, 2004). Lymphoedema patients may experience recurring bouts of cellulitis 
and therefore patients may be advised to take low dose antibiotics as a preventative 
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measure. Moffatt et al.’s (2003) reported that 29% of their sample had experienced at least 
once such acute infection in the previous year. Twenty-seven percent of those had been 
admitted to hospital for intravenous antibiotics. Over the course of their lymphoedema, 15% 
of their sample had experienced one or more hospital admissions for this purpose.  
 
In summary, lymphoedema can involve symptoms such as pain, and tightness, but can also 
lead to associated conditions such as impaired mobility and cellulitis. However this literature 
should be considered in terms of the extent to which lymphoedema affects patients’ daily 
lives. The results in relation to this are presented in the next section.  
 
Impact of Lymphoedema on Daily Life 
Lam et al. (2006) conducted a quantitative study of 1,449 members of the Lymphoedema 
Support Network in the UK and found that 75% of respondents considered lymphoedema to 
impinge on their daily living. This included limitations on their general mobility, restrictions on 
the clothes they could wear, limitations on the activities they could perform, the unsightly 
appearance of the affected area or the additional time they spent caring for the 
lymphoedematous area. Although as mentioned previously this study only involved 
lymphoedema support group members and did not include lymphoedema patients who were 
not involved with a support group.  
 
Johansson et al. (2003) conducted a phenomenological study which involved interviews with 
twelve women experiencing breast-cancer-related secondary lymphoedema in Sweden. They 
reported themes relating to patients’ discovery and subsequently acceptance of lymphoedema 
as a chronic disease with no cure. This reiterates Williams et al.’s (2004) findings on this 
topic. Meanwhile Bogan et al. (2007) interviewed 7 patients with non-cancer-related 
lymphoedema that had completed a lymphoedema rehabilitation programme in a hospital in 
the Pacific Northwest of America. All participants had extreme cases of swelling in order to 
provide information-rich experiences thereby illuminating both the unusual and the typical. 
Johansson et al.’s (2003) findings corresponded with Bogan et al.’s (2007) theme of patients 
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‘making room’ for their lymphoedema or Williams et al.’s (2004) theme of patients ‘getting on 
with it’. This can range from the physical effort of daily self-management practices, (such as 
exercises, simple lymphatic drainage and compression garment or bandage application) to 
dealing with the mental strain imposed by chronic illness (Bogan et al., 2007).  
 
Additionally, lymphoedema can affect patients’ capacity to work. For example, as mentioned 
previously in the section on risk factors, patients with lymphoedema in their upper limb may 
be informed to avoid repetitive movements which might exacerbate symptoms; consequently 
work on a conveyor belt may be inadvisable. Patients with lymphoedema in their lower limb 
are advised to avoid prolonged periods of standing and therefore teaching may not be an 
ideal employment. More than 80% of respondents in Moffatt et al.’s (2003) prevalence study 
reported that they had taken time off work, 2% had to change occupation and 8% of 
respondents had to give up work entirely due to their lymphoedema. As a result 
lymphoedema may have a cumulative negative effect on patients’ wellbeing in that being 
impaired from working for a sustained period of time can result in psychological distress and 
depression due to financial pressures and challenges to an individual’s sense of self. 
Furthermore, an individual who is unemployed due to physical disability or incapacity rather 
than for other reasons is more likely to indicate symptoms within the range of a depressive 
disorder (Turner & Turner, 2004).  
 
In summary, lymphoedema can affect patients’ daily lives through impaired mobility, 
following the daily management plan and in some cases ability to work. As a result 
lymphoedema can have significant psychosocial consequences which are explored further in 
the next section. 
 
Psychosocial Consequences of Lymphoedema 
Thomas-MacLean (2005) argues that lymphoedema can be explored in terms of the 
complexities of living with an altered, imperfect body. She suggests that many lymphoedema 
patients see their bodies through the eyes of others and as a result perceive it negatively. 
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This can lead to the adoption of practices such as concealing, underplaying, manipulating, or 
denying stigmatised differences which allows the “world of normals” to go unchallenged (Ellis, 
1998 cited in Thomas-MacLean, 2005).  
 
Participants’ self-consciousness can be compounded by difficulties in finding clothing or shoes 
to cover the lymphoedematous area or being required to ask for help with daily chores 
(Johansson et al., 2003). Several qualitative studies reported how patients’ self-consciousness 
was also heightened by the reactions of others to their swelling or compression sleeve. For 
example themes such as ‘suffering silently’, (Hare, 2000) ‘alone and hiding from the world’ 
(Bogan et al. 2007) and ‘rehearsing the story and learning to open up’ (Williams et al. 2004) 
were reported. Indeed in Lam et al.’s (2006) quantitative study approximately half of their 
respondents reported that their social life was affected by their insecurity and self-
consciousness.  
 
Findings in relation to self-consciousness also arose in studies of patients in regions endemic 
with filariasis, the parasitic infection transmitted by mosquitoes which damages the lymphatic 
system. Person and colleagues (2008) conducted a qualitative study of 28 women with 
lymphatic filariasis in their lower limbs in the Dominican Republic. They incorporated 
interviews, focus groups, field notes and photographs of participants in their homes. As 
understanding of the causes of lymphoedema among the general public can be poor, 
participants experienced considerable stigma, and social isolation, as others feared the 
condition was contagious. As a result many reported feelings of hopelessness and despair 
(Person et al., 2008). 
 
Overall, in a review of eighteen quantitative and qualitative studies McWayne and Heiney 
(2005) reported that lymphoedema can lead to frustration, distress, depression and anxiety. 
Furthermore, for cancer survivors it may be difficult to separate the experiences of surviving 
cancer and living with lymphoedema as lymphoedema is often a constant reminder of cancer 
and its treatment (Carter, 1997 cited in Hare, 2000; Woods 1993). For some patients this can 
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result in feelings of not being able to get on with life (Passik & McDonald, 1998) and 
heightened fears of cancer recurrence (Engel et al., 2003; Thomas-MacLean, 2005). 
Conversely Waters (2007) conducted autobiographical interviews with primary lymphoedema 
patients and reported that they can experience the added concern of the potential heritability 
of their condition.  
 
While these studies offer some insight into the potential emotional difficulties experienced by 
patients, some studies have included actual psychological assessment in order to ascertain 
whether lymphoedema patients experience clinical levels of distress. Tobin and colleagues 
(1993) conducted formal psychiatric interviews and administered the Hospital Anxiety and 
Depression Scale (HADS), the Psychological Adjustment to Illness Scale (PAIS), and the 
Karnofsky Performance Scale, which measures physical functioning, to fifty patients with 
breast-cancer-related secondary lymphoedema and fifty matched control breast cancer 
survivors from The Royal Marsden Hospital in London. Tobin et al. (1993) found that 
lymphoedema patients showed greater psychological morbidity, impaired adjustment to 
illness and impaired physical functioning when compared with controls. However this was 
based on a relatively small sample of patients with one type of lymphoedema accessed from 
one hospital.   
 
Similarly, Passik and colleagues (1995) administered a series of measures including the Brief 
Symptom Inventory (BSI), which provides a global severity index based on subscales 
measuring levels of depression, anxiety, obsessive compulsivity, paranoia and psychoticism, 
and the Derogatis Sexual Functioning Inventory (DSFI). Their sample was composed of 69 
women with breast-cancer-related secondary lymphoedema from the lymphoedema clinic at 
the Memorial Sloan-Kettering Cancer Centre in New York.  They found that women with 
lymphoedema had high levels of psychological distress, high level of body image disturbance 
and evidence of sexual dysfunction. Once more this study was based on patients with breast-
cancer-related secondary lymphoedema and only included patients from one hospital. 
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Moreover both Tobin et al.’s (1993) study and Passik et al.’s (1995) study were conducted 
over ten years ago and as a result replication of these studies is required.  
 
While bearing in mind the significant emotional and psychological difficulties some 
lymphoedema patients can experience it is important to consider the social consequences of 
living with lymphoedema. For example, Radina and Armer (2001) conducted an ethnographic 
study to explore how the impact of lymphoedema extends beyond the individual patient to 
the wider family group. They interviewed six women with breast-cancer-related secondary 
lymphoedema and two professionals – an oncology nurse and a physiotherapist before 
observing participants’ interactions at a group meeting of a newly formed lymphoedema 
support group in central Missouri. Their first finding was that due to the limitations imposed 
by the condition, individuals with lymphoedema may modify their performance of particular 
household duties or request assistance in performing these tasks (Radina & Armer, 2001). 
This can be challenging as many individuals attribute part of their identity to being a 
homemaker, hands-on-parent or the person who repairs the home. In addition participants 
spoke of difficulties they experienced in asking for help given the importance they placed on 
being independent. The second finding was that the impact of lymphoedema on participants’ 
ability to perform daily tasks required participants and their families to cope with changes in 
relation to family functioning and relationships. For example, participants spoke of how the 
family is required to adapt to repeated stressors (e.g. changes in limb volume and other 
symptoms, bouts of cellulitis, etc.). Some families rally around and support the person 
affected by lymphoedema to regain balance in the family, while other families are more rigid, 
and therefore do not make any adaptations perpetuating the imbalance (Radina & Armer, 
2001). This study offers some insights into the psychosocial difficulties associated with 
lymphoedema; however the study would have been strengthened by interviews or focus 
groups involving participants’ family members. Also further research is required in order to 
explore whether these difficulties are experienced in the families of lymphoedema patients in 
other settings with a view to extrapolating practical material from such findings to support 
patients in addition to the members of their family unit and social network.   
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Bearing in mind the studies identifying lymphoedema patients’ self-consciousness, the impact 
of the condition on patients’ psychological wellbeing and the potential affect on patients’ 
wider social network, it is unsurprising that experiencing lymphoedema has been associated 
with lower quality of life scores. A summary of the results in relation to this is presented in 
the next section.  
 
Impact of Lymphoedema on Quality of Life  
Velanovich et al. (1999) requested 101 consecutive unselected patients who underwent 
breast surgery at the Henry Ford Hospital in Detroit, Michigan to complete the short form (SF-
36) health survey. This measures eight domains of quality of life including physical 
functioning, role-physical, role-emotional, bodily pain, vitality, mental health, social 
functioning and general health. All scores in the SF-36 are standardised so that the worst 
possible score is 0 and the optimum level of health in that domain is scored as 100. 
Participants were divided into one of three groups: patients who had breast surgery involving 
axillary lymph node dissection (ALND) who had developed lymphoedema, patients who had 
breast surgery involving ALND who hadn’t developed lymphoedema and patients who had 
breast surgery not involving ALND who hadn’t developed lymphoedema. Velanovich et al. 
(1999) found that patients who had breast surgery involving ALND and had developed 
lymphoedema scored significantly lower in the domains of role-emotional and bodily pain 
when compared with patients in the two other groups. The percentage of patients who were 
below one standard deviation of the national norm was significantly higher among patients 
who had previously received ALND and had developed lymphoedema than patients in the 
other two groups. This occurred in the domains of bodily pain, mental health and general 
health and it was higher although not significantly so in the role-emotional domain.  
 
Coster et al. (2001) administered the Functional Assessment of Cancer Therapy-Breast 
Cancer scale which assesses breast, emotional, functional, physical and social wellbeing with 
an additional four questions on arm morbidity (FACT-B+4) to 29 patients with breast-cancer-
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related secondary lymphoedema from a specific lymphoedema clinic in the UK. They found 
that lymphoedema patients had significantly lower scores on the FACT-B+4 when compared 
with 29 matched preoperative breast cancer patients.  
 
Beaulac et al. (2002) also administered the FACT-B+4 in their study of 151 breast cancer 
patients from Boston University Medical Centre, or Jordan Hospital in Plymouth 
Massachusetts. They found that patients with breast-cancer-related secondary lymphoedema 
scored significantly lower on the breast, emotional, functional and physical wellbeing 
subsections of the scale, when compared with breast cancer survivors who hadn’t developed 
lymphoedema. This was even after adjusting for other factors which can influence quality of 
life scores (e.g. range of motion of the limb, menopausal status and body mass index). 
However the results relating to the social wellbeing subsection were not statistically 
significant.  
 
Mak et al. (2009) administered the FACT-B+4 and a self-devised Arm Symptom Distress 
Scale, which includes questions on pain, numbness, tingling, limitation of movement, 
infection and interference with daily life to a total of 202 patients from the Prince of Wales 
Hospital in Hong Kong. One hundred and one of their participants had breast-cancer-related 
secondary lymphoedema and 101 were breast cancer survivors who hadn’t developed 
lymphoedema. They found that patients with breast-cancer-related secondary lymphoedema 
had significantly worse scores on the FACT-B+4 and Arm Symptom Distress Scale when 
compared with breast cancer survivors who hadn’t developed lymphoedema, matched by 
patient demographics and clinical factors (e.g. surgery date, axillary radiotherapy and cancer 
stage). Moreover, patients with more severe lymphoedema scored significantly lower than 
those with mild lymphoedema. However the studies by Velanovich et al. (1999), Coster et al. 
(2001), Beaulac et al. (2002), and Mak et al. (2009) involved samples of patients with breast-
cancer-related secondary lymphoedema accessed from one or two lymphoedema services 
and therefore did not involve broad samples of patients with other types of lymphoedema 
accessed from multiple settings.  
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Finally, as part of their lymphoedema prevalence study, Moffatt et al. (2003) compared 228 
lymphoedema patients’ scores on the SF-36 with published normative data for adults of 
working age and for elderly people. They found lymphoedema patients had clear deficits in all 
sub-scores of the SF-36 with the exception of the mental health and general health scores. 
The largest mean differences occurred in role-physical, role-emotional, social functioning and 
physical functioning subscales. All of these differences were significant at the p<0.001 level. 
Despite the psychological implications of lymphoedema outlined above, only 3% of 
participants received psychological support as a treatment strategy (Moffatt et al., 2003). 
While this study did consider patients with other types of lymphoedema sufficient information 
is lacking in that while the authors indicate that 25% of the sample had cancer-related 
secondary lymphoedema, the percentage with breast-cancer-related secondary 
lymphoedema, cancer-related (but not breast-cancer-related) secondary lymphoedema, non-
cancer-related secondary lymphoedema or primary lymphoedema were not reported. 
Furthermore the quality of life aspect of the study involved a relatively small sample derived 
from a particular catchment area, namely South West London.   
 
While these studies suggest that lymphoedema has a considerable impact on patients’ quality 
of life, this is qualified by the considerable time period since some of the studies were 
conducted and the lack of studies involving a broad sample involving patients with various 
types of lymphoedema accessed from multiple services or locations.  The previous sections 
have considered the physical conditions, daily limitations, psychosocial factors and quality of 
life issues associated with lymphoedema. The following section details research exploring the 
symbiotic relationship between these factors in exacerbating and protecting against the 
impact of lymphoedema on patients.  
 
Exacerbating and Protective Factors 
Regarding physical factors that may exacerbate the consequences of lymphoedema, Passik et 
al. (1995) found that severity of the swelling did not have a clear linear relationship with 
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levels of distress; rather the associated symptoms of lymphoedema had more of an impact. 
Experiencing lymphoedema in the dominant arm; poor skin quality; frequent bouts of 
cellulitis; and pain have all been cited as significant predictors of sexual and psychosocial 
morbidity (see McWayne & Heiney, 2005; and Morgan, Franks & Moffatt, 2005 for a review of 
studies; and Passik & McDonald, 1998 for a brief review of general research trends). Pain is 
of particular importance as it can also spark intrusive thoughts about cancer recurrence, 
isolation, and an avoidant coping style and is associated with low perceived social support 
(Passik & McDonald, 1998). These findings suggest that effective treatment and maintenance 
of physical symptoms can have significant benefits to patients. Indeed Morgan, Franks and 
Moffatt (2005) cite a study by Kirschbaum (1996) indicating that the implementation of 
evidence-based, patient-centred guidelines for the management of lymphoedema can 
improve quality of life outcomes.   
 
Regarding daily disturbances that can exacerbate the effects of lymphoedema, as previously 
mentioned, experiencing lymphoedema in the dominant arm has a significant effect on sexual 
and psychosocial morbidity (Passik et al., 1995). This may take place indirectly through 
greater functional limitations (Passik & McDonald, 1998).  
 
Studies relating to psychosocial factors have generally focused on the benefits of being aware 
of the risk of developing the condition in advance and coping styles. As mentioned previously 
qualitative studies have found that a lack of knowledge about lymphoedema can be hugely 
frustrating for patients in the initial stages of the condition (Bogan et al., 2007; Williams et 
al., 2004). Therefore it is unsurprising that McWayne & Heiney (2005) found that a lack of 
prior knowledge of the features of lymphoedema and one’s susceptibility to developing it, 
compounded by poor illness adjustment predicted higher levels of anxiety and depression. 
Hare (2000) reported that prior knowledge about lymphoedema helped to ease patients’ 
sense of loss, mourning and anxiety, and increased patients’ sense of being in control when 
they did develop lymphoedema.  Yet, the receipt of information in and of itself is not 
sufficient. Johansson et al. (2003) reported that patients considered much of the information 
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they received as inappropriate and unhelpful, (e.g. being told that lymphoedema can only 
develop within 6 months of cancer treatment, whereas in reality the risk is lifelong). 
Widespread inconsistency in the timing and delivery of patient information to those at risk 
can lead to many gaining the impression that it is their fault if lymphoedema develops, 
resulting in considerable distress (Martlew, 1999; Tobin et al., 1993).  
 
In terms of research on coping, an avoidant coping style was found to be a significant 
correlate of psychological distress as it is associated with greater body image concerns 
(Passik et al., 1995). Yet an active coping style didn’t necessarily benefit patients as 
individuals with lymphoedema in their dominant arm still had increased difficulty in adjusting 
to their condition (Passik et al., 1995). Therefore exacerbating and protective factors cannot 
be viewed in isolation.   
 
Johansson and colleagues (2003) identified problem-focused coping and emotion-focused 
coping as buffering patients against the negative consequences of living with the condition. 
Problem-focused coping related to patients using their unaffected arm to carry items, 
whereas emotion-focused coping related to patients regulating their emotional distress by 
consciously considering lymphoedema as a less important aspect of their lives. In their 
analysis of focus group data from a total of 20 women with breast-cancer-related secondary 
lymphoedema Hare (2000) identified emotion-focused coping. For example they reported 
how spirituality, ‘counting blessings’ and the sense of belonging and acceptance at the 
lymphoedema clinic acted as a defence against negative feelings associated with 
lymphoedema. Hare (2000) also reported the serendipitous finding that the focus groups 
themselves may have been beneficial for patients as several participants sent thank you cards 
to the researcher.  
 
A cross cultural study involving German, Japanese and South Korean patients with breast-
cancer-related secondary lymphoedema found that although there were no significant 
differences in terms of the impact of psychosocial factors between countries; depressive 
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coping and problematic social support exerted a negative effect on quality of life (Shim et al., 
2006 cited in CREST, 2008). Good social support may be protective by helping to counteract 
fears of abandonment and isolation, and have an indirect effect through treatment 
compliance and satisfaction thereby potentially improving physical symptoms (Passik et al., 
1995).  
 
Regarding protective factors within the family, in their secondary analysis of the data from 
their 2001 study, Radina and Armer (2004) reported the pattern that resiliency among 
lymphoedema patients (i.e. displaying good adjustment and adaptation to stressors) was 
associated with good prior family functioning (i.e. good adjustment and adaptation to 
previous stressors), family resources (i.e. individual, family and community characteristics and 
supports) and stressor appraisal (i.e. the meaning assigned to particular stressors such as 
spiritual beliefs, cultural values and past experiences). Further details and discussion of these 
findings is required. Also additional research on the experiences of patients and their wider 
social network is necessary in order to develop practical materials to support patients in 
addition to the members of their family unit and wider social network.   
 
In summary, physical consequences, daily limitations, psychosocial consequences and quality 
of life have a complicated interrelationship acting as exacerbating and protective factors. Yet 
existing studies looking at these topics are either qualitative and therefore have limited 
generalisability or are cross-sectional and correlational and therefore causality cannot be 
determined. Longitudinal research is required to explore this further. As a result few definite 
conclusions can be reached as to the mechanisms and interrelations of exacerbating and 
protective factors.  
Conclusions 
Previous research on the potential impact of lymphoedema on patients’ physical and 
psychosocial wellbeing, daily life and quality of life has been outlined. While these studies 
provide interesting insights into patients’ experiences of living with lymphoedema, it is 
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important to note their limitations. Several studies are retrospective and as a result patients’ 
perceptions of their lives before they had lymphoedema are irrevocably influenced by their 
experiences since their diagnosis (McWayne & Heiney, 2005). As a result longitudinal studies 
are required to explore patients’ experiences of lymphoedema as their level of swelling and 
other associated conditions fluctuate in severity. In addition, much of the research is 
ethnocentric and therefore there is a need for research which considers intra- and inter-
ethnic diversity, gender issues and the compound effect of poverty (Sneddon & Lewis, 2007).  
 
Qualitative studies have provided interesting insights but their generalisability is under 
question. Moreover most quantitative studies focused specifically on patients with breast-
cancer-related secondary lymphoedema and most quality of life studies focused exclusively 
on comparing patients with breast-cancer-related secondary lymphoedema to breast cancer 
survivors who hadn’t developed lymphoedema. Therefore quantitative research into the 
impact of lymphoedema on the quality of life of patients with other forms of lymphoedema 
has been neglected. Further research is needed to integrate these quantitative scales with 
clinical practice so that they are practical for use by practitioners at assessment and follow up 
(Williams, 2006a).  
 
Moreover, existing studies on exacerbating and protective factors are either qualitative and 
therefore have limited generalisability or are cross-sectional and correlational and therefore 
causality cannot be determined. Longitudinal research is required to explore this further. As a 
result few definite conclusions can be reached as to the mechanisms and interrelations of 
exacerbating and protective factors.  
 
Several researchers have called for evidence-based psychological interventions for 
lymphoedema patients on the basis that they would be cost-effective in the long term by 
improving treatment adherence, encouraging self-management, and therefore increasing the 
sustainability of lymphoedema services (McWayne & Heiney, 2005). In tandem with this, 
researchers have also called for the development of couple or family interventions in order to 
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bring further benefits for patients (McWayne & Heiney, 2005; Morgan, Franks & Moffatt, 
2005; Runowicz et al., 1998). However the methodological limitations of existing research 
suggest that this cannot take place until additional more robust research is conducted.  
 
There has been no initial exploratory research conducted in the Republic of Ireland on 
lymphoedema patients’ experiences of service provision and of living with the condition. Such 
research could serve as a first step to further explorations of the experiences of Irish patients 
and the members of their wider social networks, with a view to subsequently developing, 
piloting and rolling out effective evidence-based support programmes tailored for Irish 
patients, their families and friends.  The following research outlines general arguments for 
the importance of research on lymphoedema and the aims of the present study.  
Importance of Research on Lymphoedema and Aims of the Present Study 
Traditionally lymphoedema was viewed as an unimportant and untreatable side effect of 
cancer, and therefore didn’t receive a lot of attention within the research community 
(Morgan, Franks & Moffatt, 2005).  However in recent years lymphoedema is increasingly 
viewed as a significant and complex problem which can present a significant challenge to a 
person’s quality of life (Morgan, Franks & Moffatt, 2005).  This has been coupled with the 
realisation that lymphoedema rates are likely to increase due to the widely predicted increase 
in the number of people affected by cancer, surviving cancer and experiencing longer cancer 
remissions (Földi, 1998; Martlew, 1999; Thomas-MacLean, 2005). Age is a significant risk 
factor in the development of lymphoedema. The increase in life expectancy rates, particularly 
among women who themselves are more likely to develop lymphoedema, also points towards 
increasing lymphoedema prevalence (Földi, 1998; Sneddon & Lewis, 2007).  Incidence may 
also increase in a society where obesity is increasing and exercise levels are decreasing 
(DHSSPS, 2004; Sneddon & Lewis, 2007). In addition, the rates of lymphoedema are 
increasing worldwide due to lymphatic filariasis (Williams et al., 2005). Therefore as the 
number of people affected by lymphoedema increases, the need for additional research on 
lymphoedema becomes greater.  
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Apart from a general need for research on lymphoedema, as outlined above there is a need 
for more specific strands of research. As mentioned previously in the sections on service 
provision, much of the information on lymphoedema service provision is derived from reports 
based on consultations with a select group of stakeholders rather than empirical 
investigations of the opinions of representative samples of practitioners and patients. 
Moreover there is a need for additional research on patients’ experiences of living with 
lymphoedema including the psychological consequences of the condition and the impact of 
lymphoedema on quality of life. The development of services and interventions cannot take 
place without such an assessment of the current level of service provision and of patients’ 
needs. Specifically such research on service provision and the experiences of patients is 
required in the Republic of Ireland as no previous research has been conducted on 
lymphoedema to date.  
 
It is against this background of a dearth of research on lymphoedema that the current study 
was undertaken. The specific purpose of this research is to investigate lymphoedema service 
provision and the impact of the condition on patients’ lives in the Republic of Ireland for the 
first time. Given the chronic nature of lymphoedema, its impact on physical and psychological 
health and the potential increase in prevalence rates, it is imperative that lymphoedema 
patients have access to patient-centred, evenly distributed services. Moreover while 
practitioners are aware of the physical consequences of lymphoedema, until there is greater 
cognisance of the psychological and social implications of living with the condition, a 
comprehensive, multi-dimensional support service cannot be provided to patients. Therefore 
the overall aims of this study were to:  
• Provide an overall account of current service provision: documenting the range, 
location, funding, and referral pathways of services provided nationwide and 
exploring patients’ experiences of obtaining a diagnosis, searching for appropriate 
treatment, accessing treatment and availing of ongoing lymphoedema services.  
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• Ascertain service providers’ and patients’ recommendations for lymphoedema service 
development.  
• Explore patients’ experiences of living with lymphoedema and the impact of the 
condition on daily life and quality of life.  
 
The service provider survey, patient focus groups and patient survey phases of the study 
explored different aspects of these research aims and the specific aims of each phase are 
outlined in the relevant chapter.  Chapter 3 outlines the rationale for choosing such a mixed 
methods approach to meet these aims.  
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Chapter 3: Mixed Methods Approach 
This research study employed a mixed methods design to investigate patients’ and service 
providers’ experiences of lymphoedema service provision and to explore patients’ experiences 
of living with lymphoedema. The study design had three elements: service provider survey, 
patient focus groups and patient survey. The rationale for choosing this mixed methods 
design is presented below.  
Introduction to Mixed Methods 
A mixed methods study is one which includes both quantitative and qualitative methods. 
Quantitative methods generally involve primarily closed-ended questions in a questionnaire 
format where participants are encouraged to provide numerical data or to choose between 
predetermined categories of responses (Creswell & Plano Clark, 2007; Maxwell & Loomis, 
2003).  The results are analysed statistically and may be generalisable if the statistical power 
of the method is deemed sufficient. The quantitative method is best suited to answering 
questions on the frequency or extent of certain experiences or phenomena (Maxwell & 
Loomis, 2003). However the limitations of quantitative methods include the poor expression 
of the context in which participants live; the participants’ personal voice; and the personal 
biases and interpretations of researchers (Creswell & Plano Clark, 2007).  
 
In contrast qualitative methods involve open-ended data which is usually gathered through 
textual analysis or discussion (Creswell & Plano Clark, 2007; Maxwell & Loomis, 2003). Each 
qualitative method has specific strengths. For example, focus groups are semi-structured 
group discussions. Participants are encouraged to respond with the idiosyncratic expression 
and interpretation of their experience. Focus groups capitalise on the interaction within a 
group and allow the comparison of participant’s experiences and perceptions (Morgan, 1997). 
They can result in rich, experiential data if properly moderated and conducted in a non-
threatening atmosphere (Morgan, Franks et al., 2005).  Moreover, focus groups can result in 
serendipitous findings such as the empowerment of participants by making them feel like 
experts, which can in turn, benefit participants (Hare, 2000). Qualitative methods are strong 
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on expressing findings in participants’ own voices and exploring the reasons behind certain 
experiences. However they have been criticised for their subjectivity, the small samples 
involved and the consequent difficulties in generalising findings (Creswell & Plano Clark, 
2007).  
 
Historically there has been much debate in the research community over whether quantitative 
or qualitative methods are superior. This has been replaced by discussion on when it is most 
appropriate to use each method, and when quantitative and qualitative approaches should be 
combined within a single research study (Foster, 1997).  By combining methods within a 
single study, the intention is not to homogenise the research methods but rather to 
synthesise and preserve the unique qualities and advantages of both quantitative and 
qualitative methods (Maxwell & Loomis, 2003). Each method is stronger at exploring the 
answers to different, but related, research questions. By integrating findings within a single 
study, a mixed methods design can capitalise on the strengths of both quantitative and 
qualitative methods to provide a more complete depiction of a phenomenon, than either 
method could provide alone (Creswell & Plano Clark, 2007; Erzberger & Kelle, 2003; Ivankova 
et al., 2006).  
Rationale for Use of Mixed Methods Design in the Present Study 
There are several reasons why a mixed methods design supported the aims of this research 
study. Firstly the study aimed to explore lymphoedema service provision from both service 
provider and patient perspectives in the Republic of Ireland for the first time. A mixed 
methods design complemented this aim as it promotes the integration of findings from 
multiple perspectives and methods (Creswell & Plano Clark, 2007).  
 
Secondly this study aimed to explore patients’ experiences of living with lymphoedema, for 
the first time. Therefore an exploratory approach where one can qualitatively explore and 
identify variables, constructs and wordings before measuring these quantitatively, 
corresponded with this research aim (Creswell & Plano Clark, 2007; Morgan, 1997). As a 
 47 
result the focus groups were intended to assist in identifying topics of particular relevance to 
Irish lymphoedema patients with a view to including these in the design of a patient 
questionnaire.  
 
Thirdly, the use of a qualitative method was not solely to assist in the design of the 
quantitative patient questionnaire. One form of data would be insufficient in itself to explore 
patients’ experiences of living with a complex condition such as lymphoedema. The original 
research questions were concerned not just with the frequency of specific occurrences but 
also the interpretation and meaning given to these experiences by patients.  Therefore the 
qualitative aspect of the study was intended to assist in clarifying subtleties and cross-
validating findings (Creswell & Plano Clark, 2007). While the use of more than one type of 
data does not guarantee internal or external validity, it does encourage the researcher to 
consider the findings more critically and thereby present a more measured account of the 
findings to the audience (Fielding & Fielding, 1987). Several researchers have termed this 
process as triangulation (Fielding & Fielding, 1987). By integrating the results from various 
methods super-ordinate themes can emerge. Therefore it is argued that interpretations based 
on these super-ordinate themes will be more credible, dependable and more likely to 
accurately represent the complexities of reality (Farmer et al., 2006). However the term 
triangulation has since become associated with the misconception that the goal of mixed 
methods integration is to reach a fixed point or convergent findings (Erzberger & Kelle, 
2003). In reality the aim of mixed methods is to reveal infinite dimensions, angles and 
perspectives (Tobin & Begley, 2004). As a result there is a move within the mixed methods 
research community towards referring to this process as crystallisation, although the debate 
on nomenclature continues (Creswell & Plano Clark, 2007).  
 
Finally mixed methods have been utilised in previous lymphoedema research, albeit in a 
different sequence to the current study. The study by BreastCare Victoria (2005) employed 
patient questionnaires, followed by patient focus groups and practitioner questionnaires. The 
findings from this mixed methods study have partly informed the development of strategies 
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now being implemented across all cancer streams in Victoria, Australia. This study 
demonstrated the potential usefulness of a mixed methods design in addressing the aims of 
the study and in informing meaningful, practical recommendations.  
 
Given that mixed methods corresponds with the specific aims of this study and has been 
shown to be a beneficial aspect of previous lymphoedema research a mixed methods 
approach was adopted.  
Sequence of Methods                
This study involved three phases of data collection: service provider survey, patient focus 
groups, and patient survey.  
 
The first phase of the research employed practitioner questionnaires to ascertain the opinions 
and recommendations of practitioners working in lymphoedema service provision, and to 
guide the design of the patient focus group topic guide. Furthermore this phase assisted in 
mapping current lymphoedema service provision in the Republic of Ireland thereby facilitating 
the identification of services or organisations that patients could be accessed from in 
subsequent phases of the study.  
 
The second phase of the research involved focus groups conducted with patients. The focus 
group topic guide was influenced by the results of the service provider survey and a review of 
the literature. The intention of the focus groups was to explore patients’ experiences of 
lymphoedema, service provision, and the impact of the condition on quality of life.  Moreover 
the focus groups were intended to assist in identifying topics for inclusion in the patient 
questionnaires that hadn’t arisen from the review of existing literature or practitioner 
questionnaires.  
 
Finally the patient survey offered the potential to access a wider group of lymphoedema 
patients in order to calculate frequency data on patients’ experiences in relation to 
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lymphoedema service provision and the impact of lymphoedema on their quality of life. The 
sequence of methods is represented graphically in Figure 1 on page 50, which is based on 
Ivankova et al.’s (2006) guidelines for visual models of mixed methods studies.  
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Figure 1: Visual Diagram of the Research Design 
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Priority of Methods 
The priority of methods refers to which approach (i.e. qualitative, quantitative or both) that 
the researcher gives more weight or attention to in the data collection and analysis stages of 
the research (Ivankova et al., 2006). In Figure 1, the use of capital letters (QUAN/QUAL) is 
used to signify that the methods have been given equal status. Therefore neither approach 
(i.e. qualitative or quantitative) has been given more weight or attention in the data collection 
or analysis stages of the research (Ivankova et al., 2006). Although it must be noted that due 
to the sequential nature of this study, earlier phases of the research did have a bearing on 
the content of subsequent data collection methods. For example, the results of the service 
provider survey informed the design of both the patient focus group topic guide and patient 
questionnaire. Likewise the findings of the patient focus groups also influenced the design of 
the patient questionnaire.  
 
The perspectives of practitioners and patients have been given equal status in their views on 
lymphoedema service provision. Both samples provided a different viewpoint on the realities 
and interpretations of service provision and the study is richer for including both. However 
Farmer and colleagues (2006) suggest that certain samples or datasets may be more 
appropriate for answering different aspects of the research questions. For example in the 
BreastCare Victoria (2005) study, the service provider questionnaires provided information on 
topics, such as service structure, funding and level of staff training, that patients were likely 
to be less informed about. Conversely, patients were better placed to comment on other 
topics such as satisfaction with treatment. As a result, in the current study in cases when a 
particular sample is best placed to provide insight on a particular topic, emphasis has been 
given to the findings from that particular sample. The BreastCare Victoria (2005) study 
directed certain questions solely at patients (e.g. standards of care received). In the current 
study this topic was addressed to both service providers and patients in order to explore 
whether their perspectives differed considerably on this topic.   
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Within the patient data, the focus group findings and survey results were given equal status. 
The focus groups were intended to contribute more than merely influencing the content for 
the questionnaire. As mentioned previously, the complexity of participants’ experience of 
lymphoedema and lymphoedema service provision could not have been captured solely 
through the questionnaire design. The patient survey offers the opportunity of ascertaining 
how representative various experiences of lymphoedema and lymphoedema service provision 
are among a broader sample of patients, and of quantitatively measuring the impact of 
lymphoedema on patients’ quality of life in Ireland for the first time. Moreover, the patient 
survey provides additional information to correspond with, expand on or contradict the 
findings of the service provider survey and patient focus group phases.  
Integration of Findings 
Mixed methods research involves not just the inclusion of both quantitative and qualitative 
methods within a single research study but also the integration of the findings derived from 
both methods (Creswell & Plano Clark, 2007). As a result there is the potential for various 
outcomes: silence (where one dataset uncovers a theme or example whereas another dataset 
is silent about it); convergence (where all datasets produce the same findings on a theme or 
example); complementarity or divergence (where all sets of data feature a theme but have 
different perspectives on that theme); and contradiction or discrepancy (where datasets offer 
different findings on a theme) (Farmer et al., 2006; Johnson et al., 2007). Acceptance of 
each of these outcomes is legitimate as it involves admitting the complexity of the 
phenomenon under investigation (Slonim-Nevo & Nevo, 2009). Moreover it corresponds with 
the concept of crystallisation whereby a variety of perspectives and versions of the world are 
revealed (Erzberger & Kelle, 2003; Sandelowski, 1995 cited in Creswell & Plano Clark, 2007).  
 
The process of integration can take place at various stages of the study (Johnson et al., 
2007; Maxwell & Loomis, 2003). In the case of the current study, integration took place at 
the research planning, data collection and data analysis stages.  
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In terms of the research planning stage, research questions and sub-questions were related 
specifically to each phase of the research. Therefore it is to be expected that there may be 
silence regarding certain themes in one set of results when compared to others. For example, 
as mentioned previously, service providers are better placed to answer questions on the 
funding, staffing and staff educational levels within services whereas patients are unlikely to 
be as informed on these issues. Therefore questions have been tailored to the specific sample 
in question. Moreover as mentioned previously, the practitioner questionnaires were seen as 
integral to facilitating sampling in the patient phases of the research by assisting the research 
team in locating the lymphoedema services that patients could be accessed from.  
 
Integration took place in the data collection stage, in that the quantitative and qualitative 
components influenced subsequent phases of the research. As mentioned previously, the 
practitioner questionnaire phase of the research informed both the patient focus group and 
patient questionnaire phases. For example issues that arose from the service provider 
questionnaires (e.g. waiting times for treatment, cost of treatments, cost of compression 
garments, waiting times for compression garments to be delivered etc.) were then integrated 
into the later phases of the research involving patients. Likewise the patient focus groups also 
influenced the patient questionnaire design. For example, in the focus groups, some 
participants reported that they didn’t wear their compression garment as often as they had 
been advised to by their lymphoedema practitioner. As a result questions on this topic and 
the reasons for this were included in the patient questionnaire.   
 
Integration was also carried through into the data analysis stage. While the results of each 
phase of the research are explored in individual chapters, the final discussion chapter 
presents the overarching themes of this study. This structure is intended to promote clarity 
on the findings from each phase of the research while also providing space to integrate the 
findings from the three phases.  Farmer and colleagues (2006) reported that while many 
researchers maintain that the integration of findings utilises mixed methods to their full 
advantage, few give details of the specific procedures undertaken. Their approach was to 
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calculate how often various themes emerged from each datasets. However the intention in 
the current research was not to quantify qualitative findings. Therefore the themes arising 
from each phase of the research are explored separately in the relevant chapters and 
subsequently super-ordinate themes or metainferences are explored in the overall discussion 
in Chapter 7 (O’Catháin et al., 2007). Within the super-ordinate themes silence, convergence, 
complementarity and contradiction may be identified and where these arise each are 
discussed in turn.  
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Chapter 4: Service Provider Survey 
Introduction 
The first phase of the research was an exploration of service providers’ perspectives on 
lymphoedema service provision in order to set the scene for the patient phases. The inclusion 
of service provider questionnaires in the study had several purposes.  
 
Firstly, the questionnaires were utilised to map current lymphoedema service provision in 
Ireland for the first time, in order to identify the services or organisations that lymphoedema 
patients could be accessed from in subsequent phases of the study. The Australian 
Lymphology Association’s (2002) National Service Equity Survey mapped lymphoedema 
service provision in Australia and this information was used to guide practitioner 
questionnaire distribution in the later BreastCare Victoria (2005) study. However there was no 
known listing of lymphoedema services in Ireland at the time the current study was 
conducted. Therefore the first phase not only provided important data on service providers’ 
experiences but also facilitated the identification of a patient sample in later phases of the 
study.  
 
Secondly practitioners could offer an additional perspective on lymphoedema service 
provision.  As mentioned previously, the BreastCare Victoria (2005) study employed 
practitioner questionnaires to explore topics pertinent to lymphoedema service provision that 
patients would not necessarily be aware of such as the overall profile of patients attending 
services, descriptions of the full range of treatments provided, practitioners’ training needs, 
referral pathways, and levels and sources of funding. As a result the contribution of service 
providers would help to inform the report’s recommendations and ensure that they are based 
on current practice.  
 
Finally the results of the service provider survey could inform later phases of the research, 
involving lymphoedema patients. As the people directly involved in the care of those affected 
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by lymphoedema, service providers could enhance the research team’s understanding of 
patients’ experience of the condition, its management and the barriers to treatment. Thus the 
most pertinent topics could be emphasised during the development of measures of 
lymphoedema patients’ experiences i.e. the focus group topic guide and questionnaire. 
Although the BreastCare Victoria (2005) study employed patient questionnaires and focus 
groups in advance of their practitioner survey, they were guided in the development of those 
patient measures by a prior study of practitioners’ experiences by the Australian Lymphology 
Association (ALA). This earlier study conducted by the ALA in 2003 signposted some of the 
topics for inclusion in the BreastCare Victoria (2005) study, for example compression garment 
provision. However as the ALA study highlighted that lymphoedema service provision varies 
throughout the Australian states, the authors of the BreastCare Victoria study considered the 
inclusion of practitioners’ views in a later part of the study to be required nevertheless.  A 
study of Irish lymphoedema practitioners’ experiences had not been conducted prior to the 
current study and as a result a practitioner phase was incorporated into the early stages of 
the current study to provide insights into their experiences and guide the development of 
later phases.  
Specific Aims of Service Provider Survey 
The broad aims of the service provider questionnaire phase were to investigate practitioners’ 
experiences of lymphoedema service provision and explore their recommendations for 
lymphoedema service development. These general aims can be broken down into more 
specific objectives, which were to: 
• Ascertain the type, setting and location of lymphoedema services and the type of 
healthcare professionals providing these services.  
• Investigate service-based factors which may affect optimal lymphoedema service 
provision (e.g. practitioners’ experience in treating lymphoedema patients, time spent 
per week treating lymphoedema patients, sources of funding, staffing levels, cover 
for leave, referral pathways). 
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• Determine the breakdown of lymphoedema patients being seen in lymphoedema 
services (e.g. type of lymphoedema, location of lymphoedema in the body, age 
range, gender etc.).  
• Investigate what information and treatments are being provided and to explore 
potential barriers to treatment (e.g. distance to lymphoedema service, waiting times 
etc.) in order to inform subsequent patient phases of the research. 
• Investigate potential inequalities in lymphoedema service provision (e.g. preferential 
acceptance of referrals by services, waiting list prioritisation systems and 
practitioners’ ratings of the standard of care received by patients with different types 
of lymphoedema).  
• Explore issues that may affect lymphoedema service development (e.g. practitioners’ 
current level of training, barriers to accessing training).  
• Ascertain practitioners’ recommendations for lymphoedema service development.  
Method  
Identifying a Sample 
There is no known nationally updated register of all professionals working with lymphoedema 
patients except the MLD Ireland listing of registered MLD therapists in Ireland. Additionally 
there has been no previous research conducted on lymphoedema service provision in the 
Republic of Ireland to date. Therefore the first task was to identify where lymphoedema 
treatments were being provided and by which practitioners. The intention was to initially 
contact as many potential lymphoedema practitioners as possible in order to include the 
experiences of as many lymphoedema practitioners working in a variety of settings and 
services. The inclusion criteria were healthcare professionals with specific experience and 
knowledge of lymphoedema that currently hold or have held a position in a hospital or service 
in the previous six months which provides advice and care specific to lymphoedema (rather 
than that provided to any patient with skin conditions or swelling of an unspecific cause). This 
enabled the inclusion of managers of lymphoedema services, physiotherapy departments or 
occupational therapy departments who would be aware of the funding structures and staffing 
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levels in lymphoedema services but who may not personally treat lymphoedema patients. The 
exclusion criteria were healthcare professionals without specific experience and knowledge of 
lymphoedema working in services that provide advice and care that is not specific to 
lymphoedema and may be provided to patients with other forms of chronic oedema or related 
conditions. The exclusion criteria also applied to healthcare professionals with specific 
experience and knowledge of lymphoedema that did not currently hold or had not held a 
position in a hospital or service in the previous six months that provides advice and care 
specific to lymphoedema (rather than that provided to any patient with skin conditions or 
swelling of an unspecific cause).  
 
All university, regional, general and private hospitals; palliative care and homecare teams; 
cancer support centres; and hospices were telephoned to ascertain whether they provided a 
lymphoedema service according to the above mentioned criteria. As a result the questionnaire 
was sent to the following groups: 
• The managers in all physiotherapy and occupational therapy departments in 
university, regional and general hospitals; and named physiotherapists and 
occupational therapists in these departments who had previously been identified as 
having access to lymphoedema patients.  
• Breast care nurses in teaching, regional and general hospitals. Breast-cancer-related 
secondary lymphoedema is the most prevalent form of lymphoedema in the UK and 
this was also expected to be the case in the Republic of Ireland. Therefore, breast 
care nurses would be more likely than general nurses to have access to patients at 
risk of or experiencing lymphoedema. Moreover breast care nurses are the only 
professionals who specifically mention the care of lymphoedema in their practice 
guidelines (Irish Breast Care Nurses Association, 2004). Breast care nurses working 
in Breastcheck (the national breast cancer screening programme) were not included 
as they do not see breast cancer patients postoperatively and therefore would be 
less likely to have access to patients with lymphoedema.  
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• Service providers in private hospitals, homecare and palliative care teams, hospices, 
and cancer support centres that identified themselves as providing lymphoedema 
treatment.  
• Healthcare professionals of various professions (breast care nurses, physiotherapists, 
occupational therapists etc.) who had attended the introductory workshops on 
lymphoedema organised by Action Breast Cancer, a project of the Irish Cancer 
Society.  
• Private practitioners specialising in lymphoedema treatment. These were identified 
from various sources, e.g. listings of practitioners based in the Republic of Ireland on 
the MLD (Manual Lymphatic Drainage) Ireland and MLD UK websites (as accessed on 
the 16th of June 2008), the listing of trained MLD therapists from Ireland on the 
websites of the Földi and Vodder lymphoedema schools (as accessed on the 16th of 
June 2008), and the listing of MLD therapists trained in Ireland up to the 29th of 
August 2008. In some cases hospitals supplied the research team with the names 
and contact details of the private practitioners that they referred lymphoedema 
patients to and these practitioners’ names were also included in the database.  
 
Physiotherapists or occupational therapists in smaller hospitals, general practitioners,, general 
nurses and public health nurses were not included. While some of these healthcare 
professionals may provide advice and potentially fit compression garments, they are unlikely 
to have the same high volume of lymphoedema patients. They are less likely to provide 
specific information on lymphoedema as opposed to chronic oedema in general. As a result 
they would be less appropriate for inclusion in a study specifically exploring current 
lymphoedema service provision and recommendations on lymphoedema service development. 
Questionnaire Design 
The development of the questionnaire was guided by the topics covered and 
recommendations made in previous international literature on lymphoedema service 
provision, the expert opinion of a research advisory group - composed of lymphoedema 
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patients (one patient with primary lymphoedema since early adulthood and one patient with 
breast-cancer-related secondary lymphoedema), lymphoedema practitioners (a lymphoedema 
nurse specialist, occupational therapist and physiotherapist), consultants in related disciplines 
of venous disease and oncology, and research psychologists - and the practitioner 
questionnaire used in the BreastCare Victoria (2005) study. The Australian Lymphology 
Association’s (2003) practitioner questionnaire included a variety of broad, open questions 
(e.g. please determine the following details: practice, workload and therapy for public 
patients). A more comprehensive approach was required considering this was the first study 
to explore current lymphoedema service provision in Ireland. As the BreastCare Victoria 
(2005) study included a comprehensive practitioner questionnaire approval was sought and 
granted for the use and amendment of that questionnaire. However the questionnaire 
employed in the current study included additional items such as practitioners’ self-rating of 
their experience in relation to treating lymphoedema patients. 
 
The questionnaire used in the current study includes sections on: 
• General participant information (job title; whether the practitioner personally treats 
lymphoedema patients and if so for how long; and number of hours spent per week 
treating lymphoedema patients). 
• Lymphoedema service (setting of service; funding sources; staffing levels; patient 
waiting lists; source of referrals; capacity to treat referred patients).  
• Patient profile (number of patients currently being treated; duration of treatments; 
average number of treatments patients receive; percentage of patients with various 
types of lymphoedema and in various age ranges; and distances travelled by 
patients to access the service).  
• Treatments provided (types of information provided to patients who are at-risk and 
affected by lymphoedema; types of treatment provided; and issues related to 
compression garment supply).  
• Professional development (practitioners’ self-rating of knowledge, competency, 
experience and confidence in relation to treating lymphoedema patients; level of 
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training and continuous professional development attained; recommendations for 
professional development).  
• Service standards (ratings of the standard of care received by patients with various 
types of lymphoedema; and recommendations for service development).   
 
The questionnaire was piloted with a lymphoedema nurse specialist, occupational therapist 
and physiotherapist. Amendments were made to ensure the questionnaire was as succinct 
and clear as possible. The questionnaire was then reviewed and approved by the entire 
research advisory group. A copy of the questionnaire employed in the current study is 
included in Appendix C. 
Procedure 
A cover letter, information sheet, questionnaire (see Appendix A, B and C respectively) and a 
FREEPOST envelope, with which to return the questionnaire, were posted to practitioners. A 
thank you/reminder letter was sent to practitioners approximately two weeks after the initial 
questionnaire mailing to thank those who had participated and to prompt those who had not 
participated but wished to do so. The letter reminded recipients that they were not obliged to 
participate and could contact the research team at any time. A copy of the thank 
you/reminder letter is presented in Appendix D.   
Ethics 
Consent  
Approval was sought and granted from Dublin City University Research Ethics Committee to 
distribute the questionnaires to practitioners who met the inclusion criteria. All participants 
were over eighteen years of age and capable of informed consent. Participants were not 
requested to sign a consent form in order to protect their anonymity. Consent was assumed 
by the completion and return of the questionnaire. Participants were informed that they could 
decline the opportunity of completing the questionnaire and were not required to pay for the 
return of the questionnaire to the investigators. 
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Confidentiality 
All participants were assured of confidentiality at all times and through all stages of the 
research. Although the number of professionals working with people affected by 
lymphoedema is relatively small, it is a heterogeneous group (e.g. nurses, occupational 
therapists, physiotherapists, cancer specialists, private practitioners etc.). Furthermore, 
results are presented in terms of the entire data set and any potentially identifying 
information has been omitted. Participants were invited to provide their contact details at the 
end of the questionnaire if they were agreeable to being contacted by the research team for 
further information. This was also to enable the research team to map current lymphoedema 
service provision in order to identify the services or organisations that lymphoedema patients 
could be accessed from in subsequent phases of the study. Eighty-seven percent of the 
sample chose to supply their details. However this information along with the anonymous 
questionnaires is being stored in a locked filing cabinet which only members of the research 
team have access to. Practitioners’ contact details and data were inputted directly onto the 
researcher’s computer, which is password protected to ensure confidentiality of all electronic 
records. All identifying information and anonymous questionnaires will be shredded and 
disposed of five years after completion of the study by Dr. Pamela Gallagher, supervisor of 
this study. 
Risk Management 
The majority of information requested on the questionnaire was factual (e.g. number of 
professionals working in the service, number and profile of patients attending the service 
etc.) thereby posing minimal risk to participants.  All participants were supplied with the 
contact details of two of the investigators should they have any concerns or require additional 
information about the study. 
Data Analysis 
Questionnaire data was entered into the Statistical Program for the Social Sciences (SPSS) 
Version 17.0. Each participant did not respond to each item of the questionnaire. Therefore 
the results presented are based on the number of respondents to the individual question 
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rather than on the overall sample of 108 participants. Descriptive statistics such as 
frequencies and means were performed (e.g. percentage of participants who personally treat 
lymphoedema patients, mean number of patients seen per month etc.). It was intended to 
perform a standard one-way ANOVA to ascertain whether practitioners’ ratings of the 
standard of care received by patients with various types of lymphoedema differed 
significantly. However the Levene’s test was significant indicating that the assumption of 
homogeneity of variance was violated. Therefore the non-parametric equivalent, the Welch 
one-way ANOVA and post-hoc Dunnett’s T3 tests were performed. Where effect sizes were 
available, this information is provided in the text. Responses to open questions were typed 
into Microsoft Word (2003 Version) and analysed thematically. The findings are presented 
below in the results section.  
Results 
Participant and Service Information 
A total of 320 questionnaires were distributed to practitioners. Of the 320 practitioners who 
were sent the questionnaire, 28 were private practitioners and the remaining 292 worked in a 
total of 88 services throughout the country. Twenty-six practitioners indicated that they 
wouldn’t be returning questionnaires as they do not provide a lymphoedema service or were 
unable to complete the questionnaire at that time. Therefore out of a potential total of 294 
questionnaires, 108 completed questionnaires were received, resulting in a completed 
questionnaire response rate of 36.73%.   
 
Seventy-two practitioners, or 68.6% of respondents, personally treat lymphoedema patients 
(n=105). Eighteen practitioners or 17% of respondents work in a dedicated lymphoedema 
service (i.e. services that solely treat lymphoedema patients and are not required to treat 
patients with other conditions) (n=106). Participants who do not work in a dedicated service 
were asked whether their service is being developed. Twenty-seven practitioners or 37.5% of 
the 72 respondents to that question work in a service that is in the process of being 
developed. Participants who work in a service that is being developed were asked if their 
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service is being expanded. Sixteen practitioners or 34.8% of the 46 respondents to that 
question work in a service that is in the process of being expanded. The majority of the 
results presented below focus on the responses of practitioners who personally treat 
lymphoedema patients, unless otherwise specified, as this section of the sample is viewed as 
most relevant for the purposes of the research. Table 1 on pages 65 and 66 provides a brief 
overview of the service type, setting, location and practitioner breakdown for all respondents, 
respondents who personally treat lymphoedema patients, those working in dedicated services 
and respondents working in services that are being developed or expanded. In terms of 
occupation, ‘other’ refers to practitioners who indicated that they have an occupation that 
wasn’t listed on the original questionnaire (e.g. oncology nurse) or that they hold two 
occupations (e.g. MLD therapist and nurse, occupational therapist or physiotherapy 
manager).  
 
In general most practitioners work in large, public hospitals situated in counties with major 
cities or towns (i.e. Dublin, Cork, Galway, Donegal). The vast majority of practitioners who 
personally treat lymphoedema patients are physiotherapists/physiotherapy managers, Manual 
Lymphatic Drainage (MLD) therapists, occupational therapists (OTs)/OT managers, and MLD 
therapists who are also nurses, physiotherapists or OTs.  
 
 
Participants who personally treat lymphoedema patients have been doing so for an average 
of 56.33 months, over four and a half years (Range=1-360, SD=61.70, n=70) and spend on 
average 8.44 hours per week treating lymphoedema patients (Range=0.00-37.50, SD=8.95, 
n=62). This may indicate that treating lymphoedema patients is only part of the majority of 
participants’ caseloads. This may be due to practitioners purposely limiting the amount of 
time they spend per week treating lymphoedema patients as the measurement and intensive 
treatment of the affected area can be time consuming and physically demanding.  
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Table 1: Service Information and Practitioner Sample Breakdown 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    All Respondents    Practitioners who personally        Practitioners working      Practitioners working         Practitioners working 
    (n=108)    treat Lymphoedema Patients        in a Dedicated Service     in a Service that’s being        in a Service that’s being 
                       (n=72)   (n=18)                Developed                Expanded 
             (n=27)   (n=16) 
Service Type     
n    106   71   18   26   16 
Public    62.3%    64.8%   72.2%   61.5%   75% 
Private    17%    21.1%   16.7%   23.1%   6.3% 
Public and Private   20.8%   14.1 %   11.1%   15.4%   18.8% 
 
Service Setting 
n    108   72   18   27   16 
University Hospital   30.6%   22.2%   27.8%   22.2%   43.8% 
Regional Hospital   5.6%   5.6%   11.1%   7.4%   12.5% 
General Hospital   20.4%   16.7%   11.1%   25.9%   25% 
Private Hospital   7.4%   6.9%   5.6%   7.4%     - 
Community Health Centre  1.9%   1.4%     -     -     - 
Cancer Support Centre   2.8%   2.8%   11.1%   3.7%     - 
Hospice    4.6%   6.9%   11.1%   7.4%     - 
Private Practice   11.1%   16.7%   11.1%   14.8%   12.5% 
Other (Domiciliary in community;   15.7%   20.8%   11.1%   11.1%   6.3% 
Clinic in health centre & home visits; 
Specialist palliative care team;  
Primary care)        
 
County 
n    108   72   18   27   16 
Cavan    3.7%   4.2%     -   7.4%     - 
Clare    0.9%   1.4%     -     -     - 
Cork    14.8%   12.5%   11.1%   14.8%   12.5% 
Donegal    9.3%   13.9%     -   25.9%   18.8% 
Dublin    33.3%   34.7%   50%   18.5%   43.8% 
Galway    6.5%   4.2%     -   14.8%     - 
Kerry    0.9%   1.4%     -     -     -   
Kildare    0.9%   1.4%     -     -     - 
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Table 1: Service Information and Practitioner Sample Breakdown (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.); or Oncology Nurse. 
    All Respondents   Practitioners who personally     Practitioners working Practitioners working  Practitioners working 
    (n=108)    treat Lymphoedema Patients     in a Dedicated Service in a Service that’s being in a Service that’s being 
                       (n=72)   (n=18)         Developed         Expanded 
             (n=27)   (n=16) 
County (continued) 
Kilkenny    1.9%     -   11.1%     -     - 
Laois    3.7%   4.2%   5.6%   3.7%     - 
Limerick    1.9%     -   5.6%     -   6.3% 
Louth    2.8%   4.2%     -   3.7%   6.3% 
Mayo    1.9%   1.4%     -   3.7%     - 
Meath    2.8%   1.4%     -     -     - 
Monaghan    1.9%   1.4%     -   3.7%     - 
Sligo    0.9%   1.4%     -     -     - 
Tipperary    3.7%     -     -     -   6.3% 
Waterford    0.9%   1.4%   5.6%     -     - 
Westmeath    2.8%   2.8%     -     -   6.3% 
Wexford    2.8%   2.8%   11.1%     -     - 
Wicklow               1.9%   2.8%     -     -     - 
Occupation     
n    107   72   18   26   16 
Breast Care Nurse    13.1%   2.8%   27.8%   19.2%   12.5% 
Lymphoedema Nurse Specialist  1.9%   2.8%   11.1%     -     - 
MLD Therapist    10.3%   15.3%   11.1%   7.7%   6.3% 
Occupational Therapist   6.5%   8.3%     -   3.8%   6.3% 
OT Manager   3.7%   1.4%     -   3.8%     - 
Physiotherapist   39.3%   45.8%   16.7%   30.8%   31.3% 
Physio Manager   10.3%   2.8%   5.6%   7.7%   6.3% 
Other ~             15%   20.8%   27.8%   26.9%   37.5% 
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Funding of Services 
Twenty-six participants reported that they didn’t know the source of funding for their 
lymphoedema service and 5 practitioners indicated that their lymphoedema service received 
no funding. Sixty-two participants answered the question on what percentage of their 
services’ funding was received from various sources and the results are presented in Table 2 
below and continued on pages 68 and 69. The main source of funding for the majority of 
services is the physiotherapy budget, which is understandable given the high proportion of 
physiotherapists in the sample. ‘Other’ sources and patient contributions were the second and 
third most common sources of funding of respondents.  
  
Table 2: Sources of Funding of Lymphoedema Services  
 
~ Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, 
Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.) or Oncology Nurse.  
 
 
 
Source of Funding   n Mean %  SD   Range 
Breast Care   
All Respondents    62 9.35  21.42  0-100 
Breast Care Nurses    4 32.50                23.63  0-50 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8   0    0     0 
OT/OT Managers    5 20.00  27.39  0-50 
Physiotherapists/Physio Managers  30 8.33                23.06  0-100 
Other ~     12 8.33  19.46  0-50 
 
Oncology   
All Respondents     62 9.52  23.43  0-100 
Breast Care Nurses    4 35.00                23.81  0-50 
Lymphoedema Nurse Specialists  2 50.00                70.71  0-100 
MLD Therapists    8   0    0     0 
OT/OT Managers    5 20.00  27.39  0-50 
Physiotherapists/Physio Managers  30 3.33                12.69  0-50 
Other ~     12 12.50  31.08  0-100 
 
Physiotherapy  
All Respondents    62 31.85  44.93  0-100 
Breast Care Nurses    4 27.50                37.75  0-80 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8   0    0     0 
OT/OT Managers    5   0    0     0 
Physiotherapists/Physio Managers  30 58.83                47.30  0-100 
Other ~     12 8.33  28.87  0-100 
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Table 2: Sources of Funding of Lymphoedema Services (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~ Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, 
Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.) or Oncology Nurse.  
 
 
Source of Funding   n  Mean % SD  Range 
Occupational Therapy  
All Respondents    62 6.45  24.77  0-100 
Breast Care Nurses    4   0    0     0 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8   0    0     0 
OT/OT Managers    5 40.00                54.77  0-100 
Physiotherapists/Physio Managers  30   0    0     0 
Other ~     12 16.667  38.93  0-100 
 
Vascular  
All Respondents    62   0    0     0 
Breast Care Nurses    4   0    0     0 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8   0    0     0 
OT/OT Managers    5   0    0     0 
Physiotherapists/Physio Managers  30   0    0     0 
Other ~     12   0    0     0 
 
Dermatology 
All Respondents    62 0.08  0.64  0-5 
Breast Care Nurses    4   0    0     0 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8   0    0     0 
OT/OT Managers    5   0    0     0 
Physiotherapists/Physio Managers  30   0    0     0 
Other ~     12 0.42  1.44  0-5 
 
Community Health     
All Respondents    62 2.26  12.98  0-90 
Breast Care Nurses    4   0    0     0 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8   0    0     0 
OT/OT Managers    5   0    0     0 
Physiotherapists/Physio Managers  30 1.67  9.13  0-50 
Other ~     12 7.50  25.98  0-90 
 
Patient Contributions 
All Respondents    62 15.32  34.35  0-100 
Breast Care Nurses    4 5.00                10.00  0-20 
Lymphoedema Nurse Specialists  2   0    0     0 
MLD Therapists    8 65.63                42.38  0-100 
OT/OT Managers    5   0    0     0 
Physiotherapists/Physio Managers  30 10.00                30.51  0-100 
Other ~     12 8.75                27.31    0-95 
  69 
Table 2: Sources of Funding of Lymphoedema Services (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
~ Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, 
Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.) or Oncology Nurse.  
 
Staffing of Services 
Practitioners were asked to report how many practitioners from different backgrounds were 
employed in their service for the treatment of lymphoedema and the results are presented in 
Table 3.  
 
Table 3: Average Number of Practitioners Employed in Each Service for the Treatment of 
Lymphoedema 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Occupation (n=88)    Mean       SD       Range 
Nurse      0.42     0.89         0-5.00 
Occupational Therapist    0.29            0.52      0-2.00 
Physiotherapist     0.95     1.16      0-8.50 
Doctor      0.02            0.21      0-2.00 
Masseur/Masseuse     0.11            0.58      0-5.00 
Social Worker     0     0      0 
Psychologist     0     0      0 
Psychiatrist     0     0      0 
Podiatrist      0     0      0 
Administrative Staff     0.01     0.11      0-1.00 
Other (Refers to 0.50 of an Assistant Physio  0.03            0.24      0-2.00 
 or 2 MLD Therapists)      
 
Source of Funding    n  Mean % SD  Range 
Grant 
All Respondents    62 1.05  5.95  0-45 
Breast Care Nurses    4   0    0     0          
Lymphoedema Nurse Specialists  2 5.00  7.07  0-10 
MLD Therapists    8   0    0     0 
OT/OT Managers    5    0    0     0 
Physiotherapists/Physio Managers  30   0    0     0 
Other ~     12 4.58  13.05  0-45 
 
Other (i.e. Funding from Palliative Care, Private Donations, Community Fundraising etc.)  
All Respondents    62 22.66  39.93  0-100 
Breast Care Nurses    4 2.50                       5.00  0-10  
Lymphoedema Nurse Specialists  2 45.00                63.64  0-90 
MLD Therapists    8 39.29                43.25  0-100 
OT/OT Managers    5   0    0     0 
Physiotherapists/Physio Managers  30 17.83                 37.69  0-100 
Other ~     12 32.92  47.79  0-100 
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More physiotherapists are employed in the treatment of lymphoedema than any other 
profession, although it is worth noting that the average number of healthcare professionals 
employed in each service for the treatment of lymphoedema is low. No respondents reported 
working in a service that has a social worker, psychologist, or psychiatrist employed in the 
treatment of lymphoedema patients, despite the fact that psychosocial and mental health 
difficulties can be associated with lymphoedema.  
 
Eight percent of respondents reported that their service had vacant posts (n=90). This 
may reflect the HSE recruitment freeze when the funding for unfilled posts was no longer 
allocated and the posts were then lost. Moreover 76.5% of respondents reported that 
they didn’t have cover for annual leave, sick leave or maternity leave (n=81).  
Referral Pathways 
The 72 practitioners who personally treat lymphoedema patients were asked to indicate the 
most common sources of referrals to their lymphoedema service and the results are 
presented in Table 4. 
 
Table 4: Referral Sources  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referral Source                    (n=71)  
Hospital Oncology Clinics  78.9%   
Hospital General Surgical Clinics 40.8%   
Hospital Physiotherapy Clinics 31.0%   
Hospital Dermatology Clinics 19.7%   
Hospital Leg Ulcer Clinics 15.5%   
Hospital Vascular Clinics 31.0%   
Hospital General Medical Clinics 15.5%   
Hospital Tissue Viability Clinics 2.8%   
Community Physiotherapy Clinics 18.3%   
Community Leg Ulcer Clinics 2.8%   
General Practitioners 53.5%   
Patients Self-Referring 49.3%   
Family/Friends of Patients 22.5%   
Other (e.g. From Palliative Care Teams,   32.4%   
MLD Ireland, Cancer Care Centre, Rheumatologists,  
Private Consultants & General Community Clinic)    
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The most common referral sources were hospital oncology clinics, general practitioners and 
patients self-referring. Less than a third of respondents received referrals from the alternative 
potential referral sources. This suggests that poor awareness of lymphoedema and 
lymphoedema services among healthcare professionals in non-oncology settings results in low 
rates of referral. Indeed in comments to an open question on referrals, the following 
participants noted that a lack of knowledge on the part of other healthcare professionals, 
particularly general practitioners resulted in inappropriate or low numbers of referrals: 
Participant 26 (Physiotherapist working in a service which does not solely treat 
lymphoedema patients): We had to block GP referrals as they were 
incorrect referrals/wrong service/insufficient investigations into cause 
of swellings.  
Participant 43 (‘Other’ Practitioner - MLD Therapist and Physiotherapy Manager 
working in a dedicated lymphoedema service): Very low/little 
knowledge in GP clinics about lymphoedema and its treatment – 
referrals.  
 
Seventy-seven percent of respondents who personally treat lymphoedema patients, knew 
where to refer a patient to if they weren’t in a position to treat them (n = 66).  The question 
of how often the practitioner refers on was left open ended. Twenty-two practitioners 
indicated that they had to refer patients on an occasional, frequent or weekly basis whereas 
28 practitioners indicated it was rare or infrequent. This result, coupled with the results in 
Table 4, suggests that services do not receive referrals from all potential sources.  
 
According to respondents who personally treat lymphoedema patients, the mean percentage 
of patients who have gone abroad for treatment was 1.55 (Range = 0-30, SD = 5.11, n=64).  
Patient Profile 
Patient Numbers 
Table 5 on pages 72 and 73 presents the mean number of patients being seen and on the 
waiting lists of various types of practitioners who personally treat lymphoedema patients.  
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Table 5: Patient and Waiting List Numbers  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, 
Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.); or Oncology Nurse. 
      n Mean  SD   Range 
Patients Currently Being Seen by Practitioner 
Practitioners who personally treat Lymphoedema Patients 68 20.99  56.65  0-400 
Breast Care Nurses     2 47.50                3.54  45-50 
Lymphoedema Nurse Specialists   2 218.00                257.39  36-400 
MLD Therapists     9 11.33  12.72  1-40 
OT/OT Managers     7 8.00  9.71  1-24 
Physiotherapists/Physio Managers   33 11.45                28.92  0-160 
Other ~      15 24.00  50.69  0-200 
 
Patients Seen by Practitioner for Initial Consultation per Month  
Practitioners who personally treat Lymphoedema Patients 65 4.94  5.32  0-30 
Breast Care Nurses     2 19.50                14.85  9-30 
Lymphoedema Nurse Specialists   2 10.00               0.00  10-10 
MLD Therapists     9 6.44         3.47  2-12 
OT/OT Managers     7 4.71  6.82  1-20 
Physiotherapists/Physio Managers   32 3.13                2.61  0-10 
Other ~      13 5.46  5.74  0-20 
 
Patients Seen by Practitioner for Intensive Treatment per Month  
Practitioners who personally treat Lymphoedema Patients 51 3.24  4.97  0-25 
Breast Care Nurses     2 0.00                0.00  0-0 
Lymphoedema Nurse Specialists   1 25.00  0.00  25-25 
MLD Therapists     9 5.00  4.09  1-12    
OT/OT Managers     5 0.80  0.834  0-2 
Physiotherapists/Physio Managers   24 2.67                4.72  0-20 
Other ~      10 2.70  1.64  1-6 
 
Patients Seen by Practitioner for Follow Up per Month  
Practitioners who personally treat Lymphoedema Patients 62 9.18  15.76  0-105 
Breast Care Nurses     1 20.00             0.00  20-20 
Lymphoedema Nurse Specialists   2 32.50                  31.82  10-55 
MLD Therapists     10 9.80  5.53  1-20 
OT/OT Managers     7 4.43  4.28  1-11 
Physiotherapists/Physio Managers   30 7.93                19.30  0-105 
Other ~      12 9.75  11.79  1-40 
 
Patients on Waiting List for Initial Consultation  
Practitioners who personally treat Lymphoedema Patients 56 2.95  8.31  0-50 
Breast Care Nurses     1 0.00                0.00  0-0 
Lymphoedema Nurse Specialists   2 1.50                2.12  0-3 
MLD Therapists     8 1.13  2.10  0-5 
OT/OT Managers     4 1.00  0.82  0-2 
Physiotherapists/Physio Managers   28 1.68                3.67  0-15 
Other ~      13 7.85  15.12  0-50 
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Table 5: Patient and Waiting List Numbers (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, 
Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.); or Oncology Nurse. 
 
 
According to the total number of respondents who personally treat lymphoedema patients, 
practitioners are currently treating approximately 21 patients. They see on average 
approximately 5 patients for initial consultation per month, 3 for intensive treatment and 9 for 
follow up, i.e. a total of approximately 17 patients. However there was considerable variation 
in how participants approached these questions. For example in the case of number of 
patients being currently seen, the range is from 0 to 400 patients, which suggests that some 
respondents included all patients on their caseload and waiting list.  
 
Respondents who personally treat lymphoedema patients have on average approximately 3 
patients on the waiting list for initial consultation, 3 patients on the waiting list for intensive 
treatment and 6 patients on the waiting list for follow up consultations i.e. a total of 
approximately 12 patients. Again there appears to be some variation in the interpretation of 
the question with a wide range being reported regarding the number of patients on the 
waiting list for follow up consultations. The numbers on waiting lists are quite low. However 
bearing in mind that the average number of patients seen per month for various 
      n Mean  SD  Range 
Patients on Waiting list for Intensive Treatment  
Practitioners who personally treat Lymphoedema Patients 49 3.29  7.78  0-40 
Breast Care Nurses     0     -    -                    - 
Lymphoedema Nurse Specialists   1 3.00  0.00  3-3 
MLD Therapists     7 5.71  15.12  0-40 
OT/OT Managers     4 8.50  7.05  0-17 
Physiotherapists/Physio Managers   26 0.77                1.93  0-7 
Other ~      11 5.82  9.53  0-30 
 
Patients on Waiting List for Follow Up  
Practitioners who personally treat Lymphoedema Patients 52 5.87  19.32  0-120 
Breast Care Nurses     0     -    -                    - 
Lymphoedema Nurse Specialists   2 0                 0.00  0-0 
MLD Therapists     7 7.29  18.84  0-50 
OT/OT Managers     4 2.00  2.83  0-6 
Physiotherapists/Physio Managers   27 6.74                24.57  0-120 
Other ~      12 5.33  9.59  0-30 
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consultations is low and as mentioned previously the number of hours practitioners spend per 
week treating lymphoedema patients was also low at an average of 8 hours per week, these 
results together suggests that services are not being accessed by all patients or that the 
capacity of services is quite depleted.  
 
In terms of variations in responses according to type of healthcare professional, the average 
number of patients seen by breast care nurses is higher than the mean of the all respondents 
except in the case of patients seen each month for intensive treatment. This reflects the fact 
that breast care nurses’ role with lymphoedema patients is often more involved at the 
identification of lymphoedema symptoms, fitting of compression garments and provision of 
advice and support rather than intensive consultation. Likewise the high number of patients 
being seen by lymphoedema nurse specialists per month reflects the fact that they are 
specialised in the treatment of lymphoedema and as a result their entire caseload consists of 
lymphoedema patients. ‘Other’ practitioners had the highest mean number of patients on a 
waiting list for initial consultation whereas MLD Therapists reported the highest mean number 
of patients on waiting lists for intensive treatment and follow up consultations.  
Type of Lymphoedema Experienced by Patients  
Tables 6a and 6b on page 75 and Table 6c on page 76 present the breakdown of patients, 
seen in the last year by practitioners who personally treat lymphoedema patients, according 
to type of lymphoedema, location of lymphoedema and age when first treated respectively. 
Lymphoedema secondary to breast cancer was the most predominant type of lymphoedema 
experienced by patients treated in the last year by practitioners who personally treat 
lymphoedema patients. Lymphoedema secondary to other types of cancer was the second 
most predominant type of lymphoedema experienced by patients. These other types of 
cancer included: gynaecological/genital cancers (e.g. cervical, penile, testicular, ovarian etc.), 
skin cancer, prostate cancer and head/neck/throat cancers. Although they accounted for a 
small proportion of their caseloads, practitioners reported that some of the patients they 
treated in the last year had previously experienced the following types of cancers: lymphoma, 
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lung, sarcoma, mesothelioma (a form of cancer caused by exposure to asbestos), pancreatic, 
and bowel cancer. The third most predominant type of lymphoedema experienced by patients 
was primary lymphoedema. Patients with lymphoedema due to immobility, venous disease, 
tissue damage, infection and inflammation were rated as a much smaller percentage of 
respondents’ caseloads. 
 
Table 6a: Mean Percentages of Patients Treated in the last year, according to Type of 
Lymphoedema 
 
 
As breast-cancer-related-secondary lymphoedema was the most common type of 
lymphoedema experienced by patients it is unsurprising that the most common location of 
lymphoedema was in one arm.  
 
Table 6b: Mean Percentage of Patients Treated in the last year, according to Location of 
Lymphoedema 
 
 
 
 
 
 
Type of Lymphoedema (n=70)                                                    Mean %   SD  Range 
Primary lymphoedema  12.61 19.98 0-100 
Lymphoedema Secondary to Breast Cancer  56.07 32.60 0-100 
Lymphoedema Secondary to Other Types of Cancer  13.53 16.76 0-100 
Lymphoedema Secondary to Trauma and Tissue damage  3.47 12.90 0-90 
(e.g. Burns, Scarring, Large Wounds, Self Harm etc.)    
Lymphoedema Secondary to Venous Disease    4.36 10.88 0-67 
(e.g. DVT, Chronic Venous Insufficiency, Intravenous Drug Use etc.)   
Lymphoedema Secondary to Infection     3.50 8.57 0-50 
(e.g. Cellulitis, Lymphadenitis, Filariasis etc.)     
Lymphoedema Secondary to Inflammation    1.11 3.89 0-20 
(e.g. Rheumatoid/Psoriatic Arthritis, Eczema, Sarcoidosis etc.)   
Lymphoedema Secondary to Immobility and Dependency   4.90 15.40 0-100 
(e.g. Dependency, Obesity, Paralysis etc.)     
Location of Lymphoedema  (n=69)                                                Mean %   SD  Range 
Unilateral Upper Limb (i.e. in one arm)    57.67 32.17 0-100 
Bilateral Upper Limb (i.e. in both arms)    4.52 10.94 0-67 
Unilateral Lower Limb (i.e. in one leg)    16.75 20.49 0-100 
Bilateral Lower Limb (i.e. in both legs)    13.70 19.63 0-90 
Face and/or Neck        1.65 5.58 0-40 
Genitals         1.93 6.86 0-50 
Other (Includes those with lymphoedema in bilateral upper limb  0.88 3.87 0-25 
and lower limb, in the trunk of the body, or in the breast)  
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As lymphoedema is more common among those who are middle aged and older it is 
unsurprising that the majority of patients were over 51 years old when first treated.  
 
Table 6c: Mean Percentage of Patients Treated in the last year, according to Age when First 
Treated   
 
 
 
Information and Treatments Provided 
To At-Risk Patients 
Eighty-seven percent of respondents who personally treat lymphoedema patients provide 
advice to those at-risk of developing lymphoedema (n = 68). Fifty-nine practitioners 
responded to an open question on the type of advice practitioners provide and to what type 
of patient. The advice provided generally relates to skincare, avoidance of potential triggers 
of lymphoedema symptoms (e.g. cuts, abrasions, sunburn, air travel, blood pressure or 
injections in at risk arm etc.) and prophylactic measures (e.g. exercises, simple lymphatic 
drainage, compression garments etc.). The majority of respondents indicated this advice is 
provided to oncology patients, particularly breast cancer patients; however only three 
respondents provide this information to patients who were at risk of developing non-cancer-
related-secondary lymphoedema (e.g. vascular patients, obese patients and at-risk palliative 
patients).   
To Patients Affected by Lymphoedema 
From Table 7 on page 77 it appears that almost all respondents who personally treat 
lymphoedema patients provide education on skincare; when to seek further medical 
attention; and how to perform simple lymphatic drainage and lymphoedema exercises. 
Roughly three quarters of respondents provide Manual Lymphatic Drainage (MLD) and 
Age Range (n=69)                                                                            Mean %   SD  Range 
Less than 18 years old      0.62 1.97 0-10 
19-35 years       6.61 14.33 0-100 
36-50 years       29.20 23.73 0-100 
51-65 years       43.17 25.51 0-100 
Over 66 years old       20.49 22.70 0-90 
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compression such as Multi-Later Lymphoedema Bandaging (MLLB) or compression garment 
fitting, which are regarded as essential for the effective management of lymphoedema (MEP, 
2006).  
 
Table 7: Information and Treatments Provided  
 
 
Practitioners who personally treat lymphoedema patients were asked a series of questions on 
the provision of compression garments. The results are presented in Table 8.  
 
Table 8: Mean Number of Compression Garments Fitted and Mean Waiting Times for 
Garments  
 
 
 
 
 
 
 
 
On average respondents fit almost 70% of the patients with a compression garment and fit 
5.37 garments per month. Respondents fit more off-the-shelf compression garments than 
Information and Treatments     (n=71)  
  
Education on Skincare    93%   
Education on Diet 49.3%   
Education on When to Seek Further Medical Attention 91.5%   
Education on How to Perform Simple Lymphatic Drainage 85.9%   
Education on How to Perform Exercises   93%   
Manual Lymphatic Drainage    73.2%   
Multi-Layer Lymphoedema Bandaging   76.1%   
Education on Self-Bandaging    42.3%   
Compression Garment Fitting    76.1%   
Intermittent Pneumatic Compression Pump  11.3%   
Other (e.g. Advice on how to use Pump, Lebed Method, 9.9%   
Kinesio taping, Low Level Laser Therapy,  
Education on Overuse of Upper Limb) 
       
  n  Mean %    SD Range      
Mean Percentages regarding Compression Garment Fitting 
 
% of Patients Practitioners Fitted Compression Garments for   64   69.55     38.43   0-100 
    
% of Patients Practitioners Fitted Off-The-Shelf Compression Garments for  61    53.30     36.12  0-100  
 
% of Patients Practitioners Fitted Made-To-Measure Compression Garments for  58  30.10     33.24  0-100        
________________________________________________________________________________________________ 
        n             Mean        SD Range 
Number of Garments Fitted per Month      55  5.37    8.06     0-43 
 
Average Waiting Time for Compression Garments to be Delivered (in weeks) 46 3.09    3.19 0-20 
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made-to-measure garments. The average time waiting is 3.09 weeks and 63% of 
respondents reported that the wait time for garments affected the treatment of patients (n = 
54). Forty-two practitioners responded to an open question on the availability and delivery of 
compression garments. The themes and illustrative quotes from the open question on 
compression garments are presented in Table 9.  
 
Table 9: Themes and Illustrative Responses from the Open Question on Compression 
Garments  
 
Themes   Illustrative Responses 
Custom-Made/   Participant 14: Made-to-measure can take 2-4 weeks.  
Made-to-Measure   Participant 26: Limb shape may have changed by the time the garment arrives. I really try  
Garments take  to avoid custom-made garments for this reason.  
Longer to be  Participant 39: Previously we have had huge difficulty with timely delivery of (made-to- 
Delivered measure)….garments, there is 3-4 week wait on garment adjustments which 
does interfere with patient care. 
 Participant 84: One is inclined to fit the patient with an off-the-shelf garment rather than 
made-to-measure because of too long waiting and very expensive. 
-------------------------------------------------------------------------------------- 
Delivery from the UK  Participant 70: The fact that garments are sent to local distributors before being sent out to 
Takes Longer us really slows down … UK delivery times for custom garments is 5 days. 
-------------------------------------------------------------------------------------- 
HSE Approval Procedures    Participant 12: Biggest problem is (for) medical card holders… patients need to supply  
Delay Delivery (compression garment providers) with contact information from local HSE 
office, where nobody seems to know what to do or say regarding custom-made 
lymphoedema garments.  
Participant 34: Garment delivery is delayed by HSE red tape.  
Participant 40: Garments being paid privately arrive within 7-10 days. Garments being 
approved through medical card take up to 5 weeks.  
Participant 74: Garments requested on medical card can be anything from 4/52 (4 weeks) to > 
5/12 (greater than 5 months) waiting time and then in the latter case – had to 
re-measure.  
Participant 107: Waiting for HSE approval of funding for garments can vary, sometime up to 6 
weeks depending on the HSE office involved. Delivery of off-the-shelf garments 
is quick, but the quality is only fair. 
-------------------------------------------------------------------------------------- 
Practitioner must continue  Participant 45: Delay in receiving garments can result in changes in volume occurring between 
To Treat the Patient measurements taken following intensive (MLD) and supply of garment. 
Intensively until the  Participant 85: Patient needs continued treatment during 2 week period (waiting for garment) 
Garment Arrives – significant impact on service.  
Participant 98: Treatment must be continued until garment is supplied impacting on capacity 
to uptake new patients.  
Participant 108: Delays completion of client treatment therefore waiting lists expand as 
treatment must continue until garment is correctly fixed. 
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The main themes which emerged included delayed delivery for made-to-measure garments, 
garments manufactured in the UK or delayed approval of garments by the HSE for medical 
card holders. These delays coupled with the fact that the practitioner is required to continue 
intensive treatment of the patient until the garment arrives may discourage practitioners from 
recommending specific brands or types of garments (e.g. made-to-measure garments) to 
their patients or from recommending garments at all to medical card holders even though a 
well-fitting garment is a vital aspect of a lymphoedema management plan (MEP, 2006). 
 
Duration, Frequency and Accessibility of Treatments 
Lymphoedema is a chronic condition requiring ongoing monitoring, measurement and 
consultation yet practitioners who personally treat lymphoedema patients reported that 
patients are seen on average 11.43 times (SD = 14.16, Range = 0-68 times, n = 47). This is 
likely to be a conservative estimate as 3 practitioners gave their answer in terms of the 
amount of times a patient is seen per month, 6 practitioners gave their answer in terms of 
how many times a patient is seen per year, and 17 practitioners couldn’t indicate an average 
for how many times patients are seen. For example:  
Participant 39 (‘Other’ practitioner – MLD therapist and occupational therapist -
working in a dedicated lymphoedema service): No real average. New 
patient with lymphoedema will have initial assessment, follow up at 4-
6 weeks possibly follow up at 3 months and 6 months if needed. 
Intensive treatment may be considered if patient taking an active role 
in managing lymphoedema. Majority of patients seen every 6 months 
if being re-measured for specialist garment will need to attend for 
fitting also. Complex patients or those requiring ongoing treatment – 
I have a number of patients who attend every 2 weeks and also 
undergo 6 monthly intensive treatments, some attend monthly – it 
varies!  
Participant 72 (MLD therapist working in a service which does not solely treat 
lymphoedema patients): Depends on condition – usually 8-10 
treatments until plateau in reduction is achieved, if more severe – 
depends from patient to patient.   
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The average duration of consultations for upper limb patients is 54.26 minutes (SD = 18.22 
Range = 0-90 minutes n = 61) and for lower limb patients is 61.53 minutes (SD = 27.27, 
Range = 0-120 minutes, n = 58). This reflects the time consuming nature of lymphoedema 
consultations as often discussion of symptoms and management plan, measurement of the 
affected area and in some cases treatment of the affected area are required. This finding 
should also be viewed with some caution as the consultation duration depended on whether 
several limbs were lymphoedematous and whether the purpose of the consultation was to 
review or intensively treat. For example:  
Participant 25 (Physiotherapist working in a dedicated lymphoedema service): 20-45 
minutes (upper limb) 20-45 minutes (lower limb), MLD (manual 
lymphatic drainage) 90 minutes UL (upper limb), 90-120 minutes LL 
(lower limb).  
 
Only 18.8% of respondents who personally treat lymphoedema patients provide home visits 
(n = 69), whereas only 12.3% provide inpatient services (n = 65) despite the fact that 
lymphoedema in the lower limb(s) can seriously affect patients’ mobility.  
 
According to respondents who personally treat patients, the mean greatest distance travelled 
by lymphoedema patients to get to their lymphoedema service was 71.44 km (SD = 64.84, 
Range = 0 – 350km, n = 62). However the broad range implies that there is substantial 
variation in the distance patients are required to travel to access treatment. Participants were 
asked to indicate what percentage of their caseload lives within a 10 kilometre radius of their 
service and the average was 47.46 (SD = 33.11, Range = 0 – 100, n = 63). Participants were 
also asked what percentage of their caseload lives more than 50 kilometres from their service 
and the average was 23.74 (SD = 24.96, Range = 0-100, n = 58). This suggests that travel 
distance may be a considerable barrier to treatment for a sizeable minority of patients.  
Waiting Lists 
Participants who personally treat lymphoedema patients were asked how long patients had to 
wait for treatment. According to respondents, on average patients spend 4.35 weeks waiting 
for lymphoedema treatment (Range = 0-16 weeks, SD = 4.94, n=46). Thirty-seven percent 
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of respondents who personally treat lymphoedema patients employed a prioritisation system 
for patients on the waiting list (n=57). Participants who do employ a prioritisation system 
were asked to provide further details in response to an open question. Respondents indicated 
that patients were prioritised on the basis of the severity or type of lymphoedema (i.e. 
patients with cancer-related lymphoedema), being a newly-diagnosed or palliative patient, or 
being referred from an oncology department.  
Professional Development  
Practitioners who personally treat lymphoedema patients were asked to rate how 
knowledgeable, competent, experienced and confident they felt in treating lymphoedema on 
a Likert scale from 1 to 10 and the results are presented in Table 10 on page 82. 
 
Overall practitioners who personally treat lymphoedema patients rated themselves highest in 
terms of how competent they feel and rated themselves lowest in terms of how experienced 
they feel. This may reflect the fact that treating lymphoedema patients represents only part 
of the caseload for some practitioners. Lymphoedema nurse specialists, whose role is 
dedicated to the treatment of lymphoedema, rated themselves as the most knowledgeable, 
competent, experienced and confident out of all healthcare professionals.  
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 Table 10: Practitioners’ Ratings of how Knowledgeable, Competent, Experienced and 
Confident they feel in the Treatment of Lymphoedema  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~ Please note ‘other’ occupation includes the following: MLD Therapist and other occupation (e.g. Hospice nurse, Staff Nurse, OT, 
Physio Manager, Clinical Nurse Manager, Therapeutic Massage Therapist etc.); or Oncology Nurse. 
 
 
The 72 practitioners who personally treat lymphoedema patients were asked what training 
they have received and which methods they use to keep up to date with advances in 
        n Mean    SD 
Knowledgeable 
Practitioners who personally treat Lymphoedema Patients   71 7.38 1.768 
Breast Care Nurses       2 6.00  0.000 
Lymphoedema Nurse Specialists     2 9.00  0.000 
MLD Therapists       10 8.30 1.567 
OT/OT Managers       7 6.43 1.134 
Physiotherapists/Physio Managers     35 6.89 1.906 
Other ~        15 8.33 1.175 
 
Competent 
Practitioners who personally treat Lymphoedema Patients   71 7.49 1.731 
Breast Care Nurses       2 6.00 0.000 
Lymphoedema Nurse Specialists     2 9.00     - 
MLD Therapists       10 8.40 1.506 
OT/OT Managers       7 6.86 1.345 
Physiotherapists/Physio Managers     35 7.00 1.831 
Other ~        15 8.33 1.345 
 
Experienced 
Practitioners who personally treat Lymphoedema Patients   71 6.54 2.055 
Breast Care Nurses       2 6.50 0.707 
Lymphoedema Nurse Specialists     2 9.50 0.707 
MLD Therapists       10 8.00 1.633 
OT/OT Managers       7 5.86 1.574 
Physiotherapists/Physio Managers     35 5.97 2.079 
Other ~        15 6.80 1.971 
 
Confident 
Practitioners who personally treat Lymphoedema Patients   71 7.17 1.912 
Breast Care Nurses       2 6.00 0.000 
Lymphoedema Nurse Specialists     2 8.50 0.707 
MLD Therapists       10 8.30 1.494 
OT/OT Managers       7 6.57 1.512 
Physiotherapists/Physio Managers     35 6.60 2.018 
Other ~        15 8.00 1.690 
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lymphoedema research and treatments. All 72 practitioners responded and the results are 
presented in Table 11.  
 
Table 11: Training and Methods of keeping up to date with Advances in Lymphoedema 
Research and Treatments 
 
 
Seventy-eight percent of respondents had received specialised training from one of the 
lymphoedema schools, which is deemed essential for the appropriate treatment of 
lymphoedema (BLS, 2001a). Just over half of practitioners who personally treat 
lymphoedema patients had received training by compression garment providers on fitting 
garments. Approximately half of respondents reported keeping up to date with developments 
through journals, magazines, conferences or workshops. 
 
Practitioners were asked about opportunities for professional development. Sixty-nine 
participants or 94.5% of all respondents (n=73) indicated that they don’t think there are 
sufficient opportunities for professional development. In terms of the training needs that 
Level of Training 
Postgraduate Training in Lymphoedema Management    20.8% 
Training by Casley-Smith School      12.5% 
Training by Földi School        9.7% 
Training by Klose School        12.5% 
Training by Leduc School       8.3% 
Training by Vodder School        34.7% 
Training in Garment Fitting by Compression Garment Providers    56.9% 
Introductory Workshops on Lymphoedema Provided by Action Breast Cancer   19.4% 
Other (An Undergraduate Module, Training in Bandaging, Kinesio Taping,   16.7% 
The Lebed Method, or Training provided by the British Lymphology Society,  
the Marie Curie, Cancercare or Macmillan Centres in the UK)     
 
Methods of Keeping Up- to-Date 
Read a Relevant Journal        66.7%  
Read a Relevant Magazine       44.4%  
Attend Conferences        51.4%  
Attend Lectures, Meetings or Workshops on Lymphoedema    69.4%  
Other (Online Searches or Search Engine Updates on Lymphoedema and Breast Cancer;  33.3%  
Books; Reviews or Correspondence with a Lymphoedema School or Trainer; Collaborating  
With Colleagues, Sharing Expertise and Discussing Case Studies)     
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practitioners felt should be addressed, 69.1% of the 68 respondents agreed that modules on 
the lymphatic system and lymphoedema should be taught to all relevant disciplines (e.g. 
nursing, occupational therapy, physiotherapy, medicine etc.) at undergraduate level; 61.8% 
agreed that postgraduate training on lymphatics and lymphoedema should be available. 
79.4% indicated that more specialised training by the lymphoedema schools (such as Casley-
Smith, Földi, Vodder, Klose etc.) should be available 95.6% agreed that continuous 
professional development courses should be provided to enable practitioners to keep abreast 
of lymphoedema research and treatment developments; and finally 13.2% reported that 
‘other’ training needs should be addressed. The ‘other’ training needs suggested by 
participants included: removing the barriers for practitioners attending training (i.e. providing 
local, frequent, affordable training which practitioners are facilitated by their service to 
attend); providing specific types of training (garment fitting, unusual cases, collaborative 
multi-disciplinary, inter-departmental/hospital sessions led by a specialist team); and 
providing training available to other healthcare professionals (e.g. occupational therapists, 
general practitioners, physiotherapists, nursing staff).  
Service Standards 
Practitioners were asked to rate the standard of care received by patients with different types 
of lymphoedema on a Likert scale from 1- ‘very low’ to 5 - ‘very high’. The percentage of all 
respondents who indicated each possible response category is presented in Figure 2 on page 
85.  
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Figure 2: Practitioners’ Ratings of the Standard of Care received by Patients with Different 
Types of Lymphoedema 
 
The majority of respondents rated the standard of care received by primary lymphoedema 
patients as ‘low’ or ‘very low’ whereas the majority of respondents rated the standard of care 
received by patients with breast-cancer-related secondary lymphoedema as ‘high’. The means 
of these ratings are presented in Table 12.  
  
Table 12: Mean Practitioner Ratings of the Standard of Care received by Patients with 
Different Types of Lymphoedema 
 
 
Patients with non-cancer-related secondary lymphoedema were rated as receiving the lowest 
standard of care by all respondents. Although patients with breast-cancer-related-secondary 
lymphoedema were rated as receiving the highest standard of care, the mean was closest to 
the midpoint score.  
 
        n Mean SD 
Primary Lymphoedema       83 2.33 1.201 
Non-Cancer-Related-Secondary Lymphoedema     80 2.18 0.952 
Cancer-Related-(Not-Breast-Cancer-Related)-Secondary Lymphoedema  83 2.71 0.931 
Breast-Cancer-Related-Secondary Lymphoedema     83 3.28 0.992 
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The Welch one-way ANOVA was performed to ascertain whether there was a difference in 
how respondents rated the standard of care received by patients with various types of 
lymphoedema and this was significant: Fw (3, 179.982) = 19.701, p=0.001. Dunnett’s T3 
post-hoc tests were performed to identify between which groups the significant differences 
occurred. Practitioners’ ratings of the standard of care received by patients with non-cancer-
related secondary lymphoedema was significantly lower than their ratings of the standard of 
care received by patients with cancer-related (but not breast-cancer-related) secondary 
lymphoedema (p=0.002). Practitioners’ ratings of the standard of care received by patients 
with primary lymphoedema (p=0.001), patients with non-cancer-related secondary 
lymphoedema (p=0.001), and patients with cancer-related (but not breast-cancer-related) 
secondary lymphoedema (p=0.001) were significantly lower than their ratings of the standard 
of care received by patients with breast-cancer-related secondary lymphoedema.  
Open Questions on Lymphoedema Service Development 
Finally, practitioners were asked to complete two open questions. The first open question 
related to what factors they thought were important to patients attending lymphoedema 
services. The main themes were high quality service provision, accessible, equitable 
distributed services, and multi-faceted support. The themes, associated subthemes and 
illustrative responses are presented in Figure 3 on page 87. 
  
The second open question related to what recommendations practitioners would make if they 
could influence policy on lymphoedema service development. The main themes were high 
quality, accessible, equitably distributed services, resources and increased awareness of 
lymphoedema. The themes, associated subthemes and illustrative responses are presented in 
Figure 4 on page 88. 
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Figure 3: Themes, Subthemes and Quotes from Practitioners in Response to the Question “What do you believe is important to patients of lymphoedema services?” 
 
  Themes      Subthemes      Illustrative Quotes 
 Participant 32 (Physiotherapist working in a service which does not solely treat lymphoedema 
patients): A full time service which could provide patients with, for example, 
one hour daily of MLD or MLLB as indicated would be ideal, this would mean 
that up to 9 patients could be seen intensively for one week and studies have 
shown that if service is not consistent and intensive then benefit is minimal.  
Participant 90 (Breast Care Nurse working in a service which does not solely treat 
lymphoedema patients): Rapid access to clinics… 
Participant 72 (MLD Therapist working in a service which does not solely treat lymphoedema 
patients): A service that is available, comprehensive and regular in its 
treatment and management of their condition. 
Participant 18 (OT Manager working in a service which does not solely treat lymphoedema 
patients): To have enough trained therapists to cater for the need … (and) 
give best practice service to all who require it.  
________________________________________ 
Participant 51 (Breast Care Nurse working in a service which does not solely treat 
lymphoedema patients): It is important that they have easy access to 
treatment. This is not the situation. Some patients go privately to a 
practitioner to avail of treatment for lymphoedema.  
Participant 89 (MLD Therapist working in a service which does not solely treat lymphoedema 
patients): Easy access to service e.g. parking, wheelchair access etc. 
Participant 105 (Lymphoedema Nurse Specialist working in a dedicated lymphoedema 
service): The distance people have to travel for intensive treatment is a 
problem… 
Participant 33 (‘Other’ MLD Therapist & OT working in a service which does not solely treat 
lymphoedema patients): ….Qualified therapists in all PCCC (primary, 
community and continuing care) areas… 
Participant 36 (OT working in a service which does not solely treat lymphoedema patients): 
…No inequalities of service provision within different geographical areas. 
________________________________________ 
Participant 70 (‘Other’ Physio & MLD Therapist working in a service which does not solely 
treat lymphoedema patients): …Being covered by HSE/health insurer for 
treatment, bandages and compression hosiery. Entitlements to be clear and 
equitable. 
Participant 26 (Physio working in a service which does not solely treat lymphoedema 
patients): I believe it is important to patients that they feel well supported in 
grieving the loss of non-lymphoedema status,.  
Participant 38 (MLD Therapist&Hospice Nurse working in a service which does not solely 
treat lymphoedema patients): Support groups… Psychological support 
regarding altered body image.  
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Lymphoedema Service 
Provision  
 
 
 
Accessible, Equitably 
Distributed Services 
 
 
 
Multi-Faceted Support 
Provision of Treatment and Advice as 
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Figure 4: Themes, Subthemes and Quotes from Practitioners in Response to the Question: “If you could influence government policy in this area, what 
recommendations would you make regarding lymphoedema services in general?” 
   Themes      Subthemes            Illustrative Quotes 
   
 
High Quality, 
Accessible, Equitably 
Distributed 
Lymphoedema 
Services 
 
 
Resources 
 
 
Increased Awareness 
of Lymphoedema 
Provision of Treatment & 
Advice as Recommended by International 
Best Practice 
 
 
Services composed of Multi-Disciplinary 
Teams 
 
Centres of Excellence Supported by Local 
Satellite Centres  
 
Equitable Service  
Distribution throughout the Country 
 
Improved Referral Pathways 
 
 
 
Development of Standardised Guidelines 
 
 
 
 
Funding for Services 
 
 
 
Financial Support for Patients 
 
 
 
 
 
Among Healthcare Professionals 
 
 
 
Among Those at Risk &  
The General Public 
 
Participant 55 (Physio working in a service which does not solely treat lymphoedema patients): MLD should 
be available but maintenance treatment i.e. education, advice, skincare, positioning, 
exercises and diet should be absolutely available to all lymphoedema (patients).  
Participant 63 (Physio working in a dedicated lymphoedema service): Patients (should) receive a complete 
treatment in a multi-disciplinary unit with dietician, technical imagery, medical testing, 
nursing for wound care and physiotherapy – MLD (manual lymphatic drainage), bandage, 
exercises etc… 
Participant 5 (Physio working in a service which does not solely treat lymphoedema patients): Centres of 
excellence providing intensive treatment and satellite centres providing initial advice, 
garments, and SLD.  
Participant 66 (Physio Manager working in a dedicated lymphoedema service): A centre is needed where 
patients with severe lymphoedema can be admitted for intense treatment and 
management. Regional centres for follow up care and local centres for maintenance checks 
and garments reissued. 
Participant 38 (‘Other’ MLD Therapist & Hospice Nurse working in a service which does not solely treat 
lymphoedema patients): Every county should have a group of recognised specialists 
covering every area of Ireland…. Services at present are diabolical and if you’re not living 
in the big cities, services are practically nil… 
Participant 36 (OT working in a service which does not solely treat lymphoedema patients): …To create core 
pathways to allow for more effective referrals and assessment. 
Participant 31 (‘Other’ MLD Therapist & Hospice Nurse working in a service which does not solely treat 
lymphoedema patients): …National standardised guidelines which provide lymphoedema 
management to all cancer and non-cancer related lymphoedema patients… 
________________________________________ 
Participant 24 (Physio Manager working in a service which does not solely treat lymphoedema patients): 
Increase in resources to allow (1) staff training in effective fitting of garments etc. (2) 
computerised systems (3) all services provided in same area. 
Participant 101 (Physio working in a service which does not solely treat lymphoedema patients): …To 
provide finance to support more specialists in this field... 
Participant 57 (MLD Therapist working in a service which does not solely treat lymphoedema patients): 
Standardisation of provision of garments on drugs refund scheme…. 
Participant 72 (MLD Therapist working in a service which does not solely treat lymphoedema patients): That 
all costs involved in the treatment and maintenance /management of the condition, 
provided either in the public or private service, is completely reimbursed to the patient - 
including garments. 
________________________________________ 
Participant 31 (Other’ MLD Therapist & Hospice Nurse working in a service which does not solely treat 
lymphoedema patients): … Emphasis on training and education all HCPs (health care 
providers) in order to prevent lymphoedema occurring where possible…. 
Participant 71 (OT working in a service which does not solely treat lymphoedema patients): …Improved 
patient education – awareness campaigns. 
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Discussion of Service Provider Survey Results  
The specific aims of the service provider survey were to: ascertain information about 
lymphoedema services and practitioners providing these services; investigate service-based 
factors which may affect optimal lymphoedema service provision (e.g. cover for leave etc.); 
determine the breakdown of lymphoedema patients being seen by practitioners; investigate 
the information and treatments being provided; explore potential barriers to treatment (e.g. 
distance to lymphoedema service etc.); investigate potential inequalities in lymphoedema 
service provision; explore issues that may affect lymphoedema service development (e.g. 
barriers to accessing training) and finally to ascertain practitioners’ recommendations for 
lymphoedema service development.  
 
Each of these aims has been met and a brief summary of the results is presented below in 
addition to examples of how these results compare with previous studies of lymphoedema 
service provision conducted in other countries. The results have been categorised and are 
presented under the following headings: insufficient service provision, inequitable service 
provision and challenges to the sustainability of services.  
Insufficient Service Provision 
Lymphoedema is believed to affect at least 1.33 per 1,000 of the population (Moffatt et al., 
2003). Therefore if the population of Ireland is approximately four million people, potentially 
there are over 5,000 people experiencing lymphoedema symptoms in Ireland. Attempts were 
made to access as many lymphoedema practitioners as possible through a variety of means 
and yet the number of respondents who indicated that they personally treat lymphoedema 
patients was just 72 practitioners. The average number of healthcare professionals employed 
in each service for the treatment of lymphoedema was also low at less than one healthcare 
professional per service as in the BreastCare Victoria (2005) study. This indicates that there 
are an insufficient number of lymphoedema practitioners working in the treatment of these 
patients. Moreover of those who do work in the treatment of lymphoedema patients, many 
may be required to treat patients with other conditions. For example, only 18 practitioners 
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reported working in a dedicated lymphoedema service (i.e. services that solely treat 
lymphoedema patients and are not required to treat patients with other conditions) and as a 
result lymphoedema patients comprise only part of the majority of practitioners’ caseloads. 
This was reflected in the fact that on average practitioners spend just 8 hours per week 
treating lymphoedema patients.  Moreover the average number of patients seen per month 
for various consultations is quite low at approximately 17 patients and likewise the average 
number of patients on waiting lists for these consultations is also quite low at 12 patients. 
These results considered together suggest that while the number of practitioners is low, the 
capacity of services also appears to be minimal. This is reminiscent of the BreastCare Victoria 
(2005) as the majority of services there had the capacity to see 1-15 patients per month.  
 
The small number of dedicated services and the requirement of most lymphoedema 
practitioners to treat other patients could also be negatively influencing current service 
provision. For example when practitioners were asked to rate themselves in terms of their 
knowledgeability, competence, experience and confidence in treating lymphoedema patients, 
practitioners rated themselves lowest in terms of how experienced they feel. Additionally, 
only three quarters of respondents who personally treat lymphoedema patients provide time-
consuming treatments such as Manual Lymphatic Drainage (MLD) and compression such as 
Multi-Later Lymphoedema Bandaging (MLLB) or compression garment fitting despite the fact 
that these which are regarded by international consensus as essential for the effective 
management of lymphoedema  (MEP, 2006). Moreover only 19% of respondents indicated 
that their service provides home visits in comparison with 79% of services in the BreastCare 
Victoria (2005) study.  
 
No respondents reported working in a service that has a social worker, psychologist, or 
psychiatrist employed in the treatment of lymphoedema patients, despite the fact that as 
outlined in the literature review psychosocial difficulties can be associated with lymphoedema 
(Tobin et al., 1993; Passik et al., 1995) and best practice suggests such multidisciplinary 
input (CREST, 2008; MEP, 2006). This is in contrast to the BreastCare Victoria (2005) study 
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as practitioners reported that there were a total of 1.88 whole time equivalent social workers, 
and 0.2 whole time equivalent psychologists working in the state of Victoria.  
 
The lack of practitioners personally treating patients, dedicated services and multidisciplinary 
input all point to practitioners’ perception of inadequate service provision. This point was 
further emphasised in their ratings of the standard of care received by patients with various 
types of lymphoedema. The highest mean rating indicated by respondents was closest to the 
midpoint score and below a rating of ‘high’. Finally practitioners’ responses to open questions 
on lymphoedema service development also reiterated the need for additional resources to 
enable high quality service provision, incorporating psychological and financial support for 
patients. 
 
In addition the finding of insufficient service provision extends beyond lymphoedema services 
to the service provided by compression garment manufacturers. Practitioners expressed their 
dissatisfaction with the delivery times particularly for made-to-measure garments and 
garments manufactured in the UK. This delay can affect practitioners as they are required to 
continue intensive treatment such as MLD until such garments arrive, by which time the level 
swelling may have altered and the garments are no longer appropriate, thereby diminishing 
the effectiveness of the treatment.  
 
In summary, the theme of the insufficient, service provision is reflected in the low number of 
practitioners personally treating lymphoedema patients, practitioners working in dedicated 
lymphoedema services, practitioners providing treatment in each service,  hours spent each 
week in the treatment of lymphoedema, and the low average rating of the standard of care 
received by patients in addition to the explicit reference to a need for an improvement in 
service provision in their recommendations for service development. This finding of 
insufficient service provision also incorporates the service provided by compression garment 
manufacturers as delays may compromise patient treatment and therefore the effective 
management of the condition. The second category under which these results can be 
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presented is practitioners’ perception of the inequitable nature of current lymphoedema 
service provision in Ireland.  
 
Inequitable Service Provision 
Lymphoedema services are mostly provided in large, public hospitals situated in counties with 
major towns and cities. However, as in the Australian Lymphology Association’s (ALA) (2003) 
study and the report of lymphoedema services in Northern Ireland (DHSSPS, 2004), there 
does not appear to be any pattern to the distribution of services providing lymphoedema 
treatments. For example there were a relatively low proportion of practitioners from counties 
with large populations such as Meath and Kildare. In addition, practitioners reported that on 
average patients are required to travel over 71km to access their lymphoedema service and a 
sizeable minority patients are required to travel even lengthier distances to access services. 
This suggests that services are not located on the basis of population need. This is a 
considerably long travel distance when compared with the findings of the BreastCare Victoria 
(2005) study where patients reported being required to travel on average 18.2km in a one 
way trip in order to avail of treatment. Reports of service provision in the UK have also 
emphasised that patients living in rural areas may receive poorer lymphoedema service 
provision (DHSSPS, 2004; Moffatt et al., 2003; Morgan, 2006; Todd, 2006).  Indeed in the 
UK, this has been referred to as a “postcode lottery of care” (Boris et al., 1997 cited in 
Rankin, 2001, page 3).  
 
However such inequality in service provision applies not just in relation to the geographical 
location of services. For example, the results of the current study indicate that medical card 
holders may be receiving compromised treatment due to the delayed approval of their 
compression garments by the HSE. This is reminiscent of BreastCare Victoria’s (2005) finding 
that rural patients may be disadvantaged by the compression garment subsidy scheme as 
they are required to travel to specific garment suppliers in order to avail of the subsidies. 
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Nevertheless the vast majority of results in relation to inequitable service provision from the 
current study relate to practitioners’ perception that patients with non-cancer-related 
lymphoedema receive poorer service provision than patients with cancer-related 
lymphoedema. The most common referral source was hospital oncology clinics, and less than 
a third of respondents received referrals from alternative potential referral sources. 
Practitioners noted that in some cases this is due to poor awareness of lymphoedema among 
other healthcare professionals particularly general practitioners. This suggests that patients 
with non-cancer-related lymphoedema face barriers to service access. The BreastCare Victoria 
(2005) study and Bulley’s (2007) study of services in Fife, Scotland, also indicated that poor 
awareness of lymphoedema and lymphoedema services among healthcare professionals may 
act as a barrier to service access particularly for those with non-cancer-related lymphoedema. 
However this finding can only be verified by the inclusion of patients’ experiences.  
 
Practitioners who provide advice to those at-risk of developing lymphoedema indicated that 
this information is generally provided to those at risk of cancer-related secondary 
lymphoedema. Again this suggests an inequality in service provision on the basis of 
lymphoedema aetiology. As in the BreastCare Victoria (2005) study the majority of the 
patients seen by the sample have breast-cancer-related secondary lymphoedema in the upper 
limb(s). This was expected given the greater prevalence of cancer-related secondary 
lymphoedema in this region of the world (Rockson & Rivera, 2008). Nevertheless the low 
number of practitioners’ caseloads with non-cancer-related secondary lymphoedema in 
particular potentially signifies improved referral pathways for patients with cancer-related 
lymphoedema as mentioned above. However these results can only be corroborated by the 
inclusion of patients’ experiences.   
 
According to respondents, on average patients spend over 4 weeks waiting for lymphoedema 
treatment. As in Bulley’s (2007) study of services in Fife, Scotland, some practitioners 
reported being required to employ prioritisation systems of patients on waiting lists in order 
to maximise their use of limited resources. Examples of the prioritisation systems employed 
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by practitioners in Ireland include prioritisation based on being a newly-diagnosed or 
palliative patient, the severity of the lymphoedema, being a patient with cancer-related 
secondary lymphoedema or being referred from an oncology department. This again suggests 
that patients with non-cancer-related lymphoedema receive poorer service provision.  
 
Further evidence that practitioners consider current lymphoedema service provision to be 
inequitable was evocatively provided by their ratings of the standard of care received by 
patients with various types of lymphoedema. Patients with breast-cancer-related-secondary 
lymphoedema were rated as receiving the highest standard of care, although the mean rating 
was still below a score of ‘high’, while patients with non-cancer-related secondary 
lymphoedema were rated as receiving the lowest standard of care. The differences in the 
ratings of the standard of care received by patients with various types of lymphoedema were 
statistically significant in all cases apart from the comparison between primary lymphoedema 
patients and patients with non-cancer-related secondary lymphoedema. Finally practitioners’ 
recommendations for the development of services also signified their perception of an 
imbalance in service provision as they reiterated the need for equitably distributed service 
provision.  
 
In summary, the inequitable nature of current lymphoedema service provision was illustrated 
by the location of practitioners, the great distances a sizeable minority of patients are 
required to travel to access services, the delays practitioners reported in the approval of 
compression garments for medical card holders and variations in service provision for patients 
with different types of lymphoedema. For example, the potential improved referral pathways 
for those from oncology sources, information about lymphoedema being provided 
preferentially to those at risk of developing cancer-related lymphoedema and the prioritisation 
of patients with cancer-related lymphoedema on waiting lists. The variations in practitioners’ 
ratings of the standard of care received by patients with different types of lymphoedema 
coupled with their recommendation that services should be more equitable provided further 
emphasise the point.  These results echo results from previous studies of service provision 
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from Australia and the UK. However there is a need to corroborate the findings by the 
inclusion of patients’ perspectives. The final category of results from the service provider 
survey relates to challenges to the sustainability of services.  
Challenges to the Sustainability of Services 
The majority of lymphoedema services’ funding comes from general physiotherapy, oncology 
or palliative care budgets rather than an independent funding allocation. As the report on 
lymphoedema services in Northern Ireland pointed out such ad hoc investment and funding 
indicates scant consideration to the continuation of services for what is a chronic condition 
(DHSSPS, 2004). While the source of funding is a challenge to service sustainability, a more 
arduous challenge arises from the finding that 5 practitioners reported that their 
lymphoedema service received no funding at all.   
 
Less than 8% of respondents reported that their service had vacant posts which may reflect 
the HSE recruitment freeze when the funding for unfilled posts was no longer allocated and 
posts were then lost. This is a considerable challenge to the stability of service provision. 
Additionally, as in the report from Northern Ireland a lack of cover for leave was a pervasive 
issue for respondents (DHSSPS, 2004).  
 
While approximately 78% of practitioners have received specific training in the management 
of lymphoedema, almost all respondents requested additional training in order to keep 
abreast of developments in lymphoedema treatments as in the BreastCare Victoria (2005) 
study. However, low staffing levels in lymphoedema service and cutbacks throughout the 
health service present barriers to practitioners requesting continuous professional 
development. This in turn challenges the maintenance of service standards and the 
sustainability and development of services.  
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In summary, challenges to the sustainability of services relates to a lack of an independent 
funding stream or indeed of any funding at all for services, the loss of lymphoedema 
practitioner posts, the lack of cover for leave and the need and barriers to additional training.  
 
In many cases these results correspond with previous studies on service provision conducted 
in other countries in addition to providing information on the unique challenges experienced 
by Irish lymphoedema services. However due consideration must be given to the 
methodological limitations of this phase of the study and these are presented in the next 
section.  
Methodological Issues 
In the survey distribution an attempt was made to balance the opposing aims of dispensing 
the questionnaire as widely as possible while specifically targeting questionnaire distribution 
at practitioners with precise knowledge of lymphoedema as opposed to other forms of chronic 
swelling. Nevertheless it must be noted that not all those receiving the survey were 
necessarily lymphoedema practitioners, not all lymphoedema practitioners were necessarily 
invited to participate and that due to personnel changes or some lymphoedema practitioners 
choosing not to participate, information on all lymphoedema services was not necessarily 
included. However given the lack of an existing register of lymphoedema services in Ireland, 
and the various procedures through which practitioners were sourced, the sample was as 
representative as possible at the time of questionnaire distribution.  
 
Secondly once the results are broken down according to the practitioners who personally 
treat lymphoedema patients and according to various categories of healthcare professionals, 
the numbers of respondents are quite small. This reflects the low number of practitioners 
working in this field in Ireland, but it does make the comparison and generalisation of results 
within the study problematic.   
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Thirdly generalisation of these results beyond this study may also be problematic given the 
unique context of the Irish health service in general and specifically the unique context of 
Irish health service at present. For example the low number of practitioners reporting unfilled 
posts reflects the current financial pressures experienced within the health service rather than 
lymphoedema services operating with a full complement of staff.   
 
Finally, the various departmental structures, funding and staffing situations in hospitals and 
services were difficult to explore fully in a questionnaire format. While the addition of service 
provider focus groups would have added further clarity in these matters it was not possible 
given the time constraints of the study.  
From the Service Provider Survey to the Patient Perspective 
While bearing these methodological limitations in mind, these results provide valuable insights 
into the perspective of service providers on current lymphoedema service provision in Ireland. 
Additionally as mentioned previously in the discussion, they signpost further questions on 
lymphoedema service provision and experiences of living with the condition which can only be 
answered by investigating patients’ views, for example, differences in patients’ opinions of 
lymphoedema services according to the type of lymphoedema patients experience. Therefore 
the next phase of the study explored patients’ views through a series of nationally conducted 
focus groups.  
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Chapter 5: Focus Groups  
Introduction 
The overall aims of this study were to investigate lymphoedema service provision in Ireland, 
in addition to exploring patients’ experiences of living with lymphoedema in Ireland. In 
meeting these aims, the second phase of the research employed focus groups to explore 
patients’ experiences of living with the condition and of lymphoedema service provision. 
Patient focus groups were included in this study for several reasons.  
 
Firstly focus groups offered the potential to clarify the results of the service provider survey. 
As mentioned previously, the results of the practitioner questionnaires flagged several topics 
for exploration which required the inclusion of another perspective on lymphoedema service 
provision. For example, practitioners provided information on the distance patients are 
required to travel to access services, delays in compression garment supply, waiting times in 
accessing lymphoedema services and differences in the standard of care received by patients 
with different types of lymphoedema. The information provided by practitioners could only be 
corroborated, explored further or contradicted by asking patients themselves about their 
experiences of services. This approach of tailoring specific questions to the most relevant 
sample was employed in the BreastCare Victoria (2005) mixed methods study on 
lymphoedema service provision.  
 
Secondly, focus groups enable the exploration of patients’ personal and subjective 
experiences of living with lymphoedema.  As mentioned previously, the aims of this study 
were to explore patients’ experiences of living with lymphoedema, not just to explore 
lymphoedema service provision. While previous studies conducted in the UK had investigated 
this topic, there was no information on how Irish patients feel about living with lymphoedema 
and its impact on their quality of life. As mentioned in the chapter on mixed methods, focus 
groups capitalise on the interaction within a group and allow the comparison of participant’s 
experiences and perceptions (Morgan, 1997). Also focus groups are suitable when the intent 
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is not to generalise findings but to gain a more complete understanding of a topic (Kreuger, 
1997). Furthermore lymphoedema researchers have also argued that focus groups can be 
beneficial. For example Morgan, Franks and colleagues (2005) found that focus groups result 
in rich, experiential data if properly moderated and conducted in a non-threatening 
atmosphere. Hare (2000) suggests that focus groups can result in serendipitous findings such 
as the empowerment of participants, as they feel like experts, which can in turn be beneficial 
for participants.  
 
Finally the findings of the focus groups could be employed to inform later phases of the 
research. Focus groups have previously been used successfully to identify appropriate 
language and questionnaires for new populations (e.g. McKinley et al., 1997; Gallagher and 
MacLachlan, 2000). Therefore the patient focus groups could assist in ascertaining the most 
pertinent and appropriate topics and wordings for the lymphoedema patient questionnaire.  
Specific Aims of Focus Group Phase 
The broad aims of the patient focus group phase were to explore patients’ experiences of 
living with lymphoedema and of lymphoedema service provision. These general aims can be 
broken down into more specific objectives, which were to: 
• Explore patients’ experiences of seeking an explanation for their lymphoedema 
symptoms, obtaining a diagnosis and accessing information and treatment.  
• Investigate barriers to patients’ compliance with their lymphoedema management 
plans (e.g. difficulty in putting on compression garments; dissatisfaction with 
compression garments; difficulties with compression garment provision). 
• Explore barriers in accessing treatment (e.g. distance to lymphoedema service, cost 
of treatments, level of financial support from private health insurers for treatment 
etc.).  
• Assess the impact of lymphoedema on patients’ daily life (e.g. limitations on 
employment, activities and socialising) and the impact of lymphoedema on their 
quality of life.  
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Method  
Identifying a Sample 
Drawing on the information from the service provider phase which mapped current 
lymphoedema service provision in Ireland, participants were recruited through hospitals in 
what were formerly known as the four Regional Health Authority Areas in Ireland, and 
through organisations which provide information and support to lymphoedema patients (e.g. 
Lymphoedema Ireland). The hospitals and organisations were contacted and permission was 
sought to purposively select volunteers to invite to focus group sessions held at a local venue. 
In hospitals, the cooperation of the manager of the lymphoedema clinic (or equivalent in 
physiotherapy, occupational therapy and/or vascular care department) was sought to 
facilitate the purposive sampling that allowed participants to be selected to participate in 
focus groups. The focus groups were also advertised in relevant newsletters and websites 
(e.g. Lymphoedema Ireland website and newsletter, MLD Ireland website) so that people 
who are not in direct contact with support organisations or hospitals but who were interested 
in the study could be sent information with a view to deciding if they would like to participate. 
 
Purposive sampling was used to ensure that the focus groups reflected a variety of age 
ranges, types of lymphoedema and duration of lymphoedema symptoms. All participants had 
a diagnosis of lymphoedema, were over eighteen years of age and were deemed capable of 
informed consent by their lymphoedema practitioner. Patients who have chronic oedema (i.e. 
oedema of multiple origins with the original cause not being malformation, impairment or 
absence of part of the lymphatic system) were excluded in order to focus the research 
specifically on the experiences of lymphoedema patients. Patients under the age of eighteen 
were excluded as all participants were required to give their own informed consent. Palliative 
patients were also excluded from the study. Given the variety in health status among patients 
defined as receiving palliative care and the rate at which palliative patients’ health status can 
change it was decided that they should not be sent information about the study in order to 
avoid unnecessary distress for either the patients themselves or their relatives.  
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A total of 5 focus groups were conducted, one in each of what were formerly known as the 
four Regional Health Authority Areas in Ireland, except in the east of the country where two 
groups were held, due to the density of the population there. Morgan (1997) suggests that it 
is advisable for focus groups to have between 6 and 8 participants in order to encourage 
interaction and contributions from all participants. With this in mind, each focus group was 
comprised of 5-8 participants.  
Focus Group Topic Guide  
In order to elicit information on patients’ experiences predetermined open-ended questions 
were arranged into a focus group topic guide. Potential topics and question wordings were 
developed through three processes: the review of literature, expert opinion of the research 
advisory group (composed of lymphoedema patients, lymphoedema practitioners, consultants 
in related disciplines of venous disease and oncology, and research psychologists), and the 
results of the service provider survey. The topic guide covered subjects similar to those 
included in the study by Johansson et al. (2003) (e.g. first awareness of symptoms, ongoing 
management of lymphoedema) and the study by Williams, et al. (2004) (e.g. experiences of 
treatment, impact of lymphoedema on daily life). The focus group topic guide and sample 
questions are outlined in Table 13 on page 102. 
 
The focus group topic guide was piloted in the first focus group. No changes were made to 
the topic guide on the basis of the pilot and therefore the topic guide was employed in the 
subsequent focus groups.  
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Table 13: Focus Group Topic Guide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Procedure 
Potential participants accessed through hospitals were advised verbally about the focus 
groups by their lymphoedema practitioner. Patients were asked if they would be willing to be 
put forward to receive further information about the focus groups. Those patients were then 
provided with a letter from their lymphoedema practitioner, an information sheet outlining the 
study and requesting their participation, and a consent form. Potential participants accessed 
through organisations providing support to lymphoedema patients (e.g. Lymphoedema 
Ireland) were posted the same letter but from a named person in the Irish Cancer Society, 
with an information sheet outlining the study and requesting their participation, and a 
consent form. Those willing to take part were asked to sign and return FREEPOST the 
Initial Reaction to Symptoms of Lymphoedema: 
• Can you tell me what it was like for you when you first became aware of swelling in your body?  
• What do you think triggered your lymphoedema? 
Interaction with Services before Diagnosis: 
• Can you tell me about your experience of services when you were seeking an explanation for your 
lymphoedema symptoms? 
Diagnosis: 
• Can you tell me about your experience of receiving a diagnosis? 
Access to Information about Lymphoedema: 
• Had you been told previously that you were at risk of developing lymphoedema?  
• How did you find the process of accessing information about lymphoedema?  
Experiences of Services since Diagnosis: 
• Can you tell me about your experiences of services since you have been diagnosed with lymphoedema?  
Experiences of Treatment: 
• Please describe your experiences of lymphoedema treatment.  
• When do you find it easier or more difficult to follow the recommended advice on the management of 
lymphoedema? 
• What would make adjusting to lymphoedema treatment and self care easier? 
Impact on Daily Life and Quality of Life: 
• Tell me more about how lymphoedema has affected you and your daily life?  
• What are the most difficult things about having lymphoedema?  
• Can you tell me about any positive aspects associated with having lymphoedema? 
Closing Questions: 
• Is there anything that you feel should be included in our questionnaire that we haven’t spoken about yet 
today?  
• If you could change government policy on lymphoedema services in one way what would it be? 
• What’s the one message that you want us to take away with us and include in our report on the experiences 
of people with lymphoedema? 
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informed consent form indicating their agreement to participate. As some research ethics 
committees required specific wordings in the cover letter, information sheet and/or consent 
form distributed to the patients under their remit there were slight variations in the text of 
these. However a sample cover letter, information sheet and consent form are presented in 
Appendix E, F and G respectively.  
 
On receipt of the signed informed consent document, those agreeing to participate were sent 
information regarding their scheduled session. Participants had the option of choosing the 
focus group session that was located most conveniently for them. Participants were informed 
that they could withdraw from the study at any time in the research process and that they 
would not be required to provide a reason to do so. At the outset of the focus group, 
demographic information about the participants was gathered using a short demographic 
questionnaire for the purposes of transcription (see Appendix H). A trained oncology nurse 
familiar with the area and capable of dealing with any issues that may arise was present at all 
of the focus groups. Each focus group was audio-taped and written notes were taken by the 
two note-takers. Participants were assured of confidentiality at all times. The end point of the 
patient focus group phase was when there was saturation of the data (i.e. when no new 
information was emerging from additional focus groups). As a result a total of 5 focus groups 
were conducted nationwide. 
Ethics 
Ethical Approval 
For this phase of the study, approval was sought and granted from Dublin City University 
Research Ethics Committee and from seven hospitals nationwide, to invite patients who met 
the inclusion criteria to participate in the focus groups.  
Informed Consent 
As mentioned previously, patients were provided with a letter from their lymphoedema 
practitioner or support organisation, an information sheet outlining the study and requesting 
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their participation, and a consent form. Both the letter and information sheet invited patients 
to contact the researcher if they had any questions about the study. This option was available 
to patients at all stages of the research. Those willing to take part were asked to sign and 
return FREEPOST the informed consent form indicating their agreement to participate. As 
some research ethics committees required specific wordings in the consent form distributed 
to the patients under their remit there were slight variations in the text of this. However a 
sample consent form is presented in Appendix G.  
Confidentiality  
All participants were assured of confidentiality and anonymity at all times and through all 
stages of the research. All information divulged during the focus groups was treated 
confidentially. In transcribing the data from the focus groups, identification numbers were 
substituted for participants’ names and their individual identities were not linked to the 
information they provided. The thesis does not contain any identifying information. 
Furthermore, only three previously identified people were allowed to view the data collected 
through the focus groups: the researcher, the oncology nurse present at the focus groups 
and the research supervisor. Furthermore, the tapes are being stored in a locked filing 
cabinet in the researcher’s office which only members of the research team have access to 
and they will be destroyed on completion of the study. The transcripts were inputted directly 
onto the researcher’s computer, which is password protected to ensure the confidentiality of 
all electronic records. Hard copies of the demographic questionnaires and signed consent 
forms are being stored in a locked filing cabinet in the researcher’s office which only 
members of the research team have access to. All identifying information will be shredded 
and disposed of five years after completion of the study by Dr. Pamela Gallagher, supervisor 
of this study. 
Risk Management 
Since the research study employed focus groups which are a non-invasive data collection 
procedure, it was anticipated that there would be no adverse implications for the participants. 
However, there was the potential for raising anxiety given the sensitivity of discussing a 
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chronic condition such as lymphoedema. Asking patients about their experience of first 
identifying swelling in their body, and being diagnosed or seeking treatment could have 
potentially caused the recollection of unpleasant memories or past negative experiences. This 
issue was acknowledged and safeguards were set up to deal with such situations and to 
minimise the risk of distress to participants.  
 
In focus groups, there was a moderator/facilitator and two note-takers. This three person 
approach assisted with the sensitive handling of the group dynamics and individual issues 
that arose. An oncology nurse who has over 10 years first hand experience working with 
cancer patients and therefore has an understanding, awareness of and sensitivity to the 
needs of this group, was present at all focus groups. If any participants had displayed signs 
of discomfort or distress during the focus group then the option of withdrawing would have 
been automatically and immediately offered to them. The three person approach also 
facilitated the late arrival or early departure of participants as the second note-taker could 
assist in escorting participants to and from the venues where the focus groups were being 
held.  
 
Participants were alerted to the Irish Cancer Society’s Action Breast Cancer FREEFONE 
Helpline, through which all patients could receive information, support and counselling if 
required, and access to the support services provided by Lymphoedema Ireland in the patient 
information sheet. All participants at all stages of the research had this service available to 
them. The focus group topic guide was piloted at the first focus group to ensure that issues 
were explored in the most sensitive manner possible.  
Data Analysis 
The tapes of the discussions were transcribed verbatim. As the transcripts did not reflect non-
verbal communication, they were supplemented with additional observational data obtained 
by the two note-takers during the session. The goal of the analysis was to identify themes as 
described by the participants and to describe the range of issues and experiences within each 
  106 
theme. These themes were identified both through the analysis of individuals’ narratives and 
through the analysis of the dynamic construction of social meaning that occurs in focus group 
interactions (See Wilkinson, 1998a, 1998b). Data was analysed line by line to code for 
recurrent themes and coding categories. Following the coding of all transcripts, 60% of the 
transcripts were double coded to assess inter-rater reliability. The findings are presented 
below in the next section.  
Findings 
Focus Group Participant Information 
Five focus groups were undertaken throughout Ireland each consisting of between 5 and 8 
participants. The sample breakdown of the 33 focus group participants is presented in Figure 
5. As expected the majority of participants were female, over 50 years old, with breast-
cancer-related secondary lymphoedema in their upper limb(s). The rest of the sample 
reported that they have primary lymphoedema; lymphoedema secondary to gynaecological 
cancers, lymphoma or melanoma; or that they didn’t know what type of lymphoedema they 
have.  
Male, 3
Female, 30
Aged 36-50 Years, 8
Aged 51-66 Years, 19
Over 67 Years Old, 6
Breast Cancer 
Related, 22
Primary, 3
Gynae Cancer , 3
Lymphoma, 2
Melanoma, 2
Don’t Know , 1
Upper Limb(s), 21
Lower Limb(s), 7
Upper&Lower , 3
Upper Limb&Torso, 1
Not Specified, 1
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
 
Figure 5: Focus Group Sample Breakdown  
 
    Gender                         Age Range              Type of Lymphoedema         Location of Lymphoedema 
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On average participants had experienced lymphoedema symptoms for 60.52 months (SD = 
48.77, Range= 5-192, n=33) and had been diagnosed 57.76 months ago (SD = 46.55, 
Range= 3-192, n=33). The demographic and clinical details of each of the focus group 
participants are presented in Appendix I.  
 
The main themes and subthemes which arose from the analysis of the focus group transcripts 
are presented in Table 14 and are elaborated on with illustrative quotes in later sections.    
 
Table 14: Main Themes and Subthemes from Patient Focus Groups  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Barriers to Treatment 
The first theme that emerged from the focus groups was the various barriers for patients 
attempting to access appropriate, sufficient and continued treatment. The first subtheme 
related to the insufficient number of services available to meet the needs of lymphoedema 
Main Themes  Subthemes 
Barriers to Treatment -  Insufficient Services  
   -  Existing Services Overwhelmed 
    -  Cost of Treatment  
   -  Compression Garment Delays and Difficulties 
-------------------------------------------------------------------------------------- 
Tension with Healthcare  -  Not Pre-warned therefore not Prepared 
Professionals  -  Questions without Answers  
   -  Dismissive Attitude towards Lymphoedema 
-------------------------------------------------------------------------------------- 
Lymphoedema Affecting  -  Making Space for Lymphoedema 
Daily Life   -  Finding Clothes and Shoes to Cover Lymphoedema  
-  Limitations imposed on Daily Activities 
-------------------------------------------------------------------------------------- 
Emotional Factors -  Incapacity to Process Susceptibility to Developing Lymphoedema 
 -  Constant Reminder of Cancer Treatment 
-  Adapting to the ‘New Body’  
-  Distress Following the Reactions of Others 
-  Fears for an Uncertain Future 
-------------------------------------------------------------------------------------- 
Taking an Active Role  -  Taking Responsibility through Self-Management  
   -  Appealing for Treatment 
-------------------------------------------------------------------------------------- 
Deriving Positives  -  Preferable to an Advancing Cancer 
 -  Desire to Warn Others  
-  Acceptance from Others who Speak the Language  
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patients. The second subtheme related to existing services being oversubscribed and under-
resourced hampering access to continued treatment. The third subtheme related to how the 
cost of treatments discourages participants from supplementing public services with private 
treatment. Finally difficulties with the delivery, fit or appearance of compression garments 
were reported as lessening participants’ adherence to lymphoedema management plans. Each 
of these subthemes is elaborated on with illustrative quotes below.  
Insufficient Services  
The insufficient number of services available to meet the needs of lymphoedema patients was 
a prominent concern among participants: 
I don’t understand why the, you know, facilities are so limited really, (for) something that 
a lot of people seem to have. 
FG 2, Participant 3 
 
They sent me literally … a list of all the people who do (manual) lymphatic (drainage) and 
it’s a very short list, there was nobody in (name of city) … there were 2 people in (name 
of town), which would have been the nearest place, but it’s still an awful long drive with a 
leg, which you shouldn’t be moving around and shouldn’t really be driving … and I thought 
this is absolutely ridiculous, people are not being trained … but … it’s impossible. You 
know the way we all fight for a slot with (name of practitioner). 
FG 2, Participant 2 
 
As a result, some participants expressed concern regarding the sustainability of services: 
(Name of practitioner) is the only person … that’s trained for this …I’m just worried 
because … I’m wondering who’d take over from (the practitioner, if the practitioner had to 
go on leave). There’s nobody. There’s nobody trained to fill (the practitioner’s) place. 
FG 3, Participant 4 
 
When participants were asked what final point they would like to make about current 
lymphoedema service provision before the end of the focus groups, the majority of responses 
related to the need for additional trained staff (e.g. Manual Lymphatic Drainage therapists) 
and services:  
 (There’s) still a lack of care and treatment…particularly (for) youngish people there’s only 
one (practitioner) in (name of hospital; they need) someone on the wards going 
around…More people trained in manual lymph drainage. 
FG 5, Participant 6 
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One participant suggested the following:  
There is no one stop place, we’re all having different experiences of where we went what 
we found out, there’s nowhere you can go and say everything you need is there.  
FG 3, Participant 6 
Existing Services are Overwhelmed 
The subtheme of insufficient services is related to the second subtheme of existing services 
being oversubscribed and under-resourced. For example the following quote outlines that due 
to resource limitations they could not access prophylactic treatment at a preclinical stage, 
when the swelling may not have been visible but there was pain or other sensations present:  
I knew if I could get it seen quickly, ehm, I had read that if it was caught at an early 
stage to maybe keep it, keep it minimal, there was no real swelling, (but) it was painful … 
I knew that obviously there’s a huge … lack of resources and huge lack of knowledge 
‘cause I have a friend who’s a physio in this area and she works … in England … because 
… if you feel swelling or you get in pain in where she works you’re immediately bandaged 
and you’re immediately given treatment and in fact over there, the best practice, after 
surgery you’re given 8-10 MLD (manual lymphatic drainage) sessions anyway, and you’re 
given things, and you’re measured and it’s continuous education, and continuous 
heightening awareness of the fact that it can happen to anybody … I don’t feel it was 
handled as well as it should’ve been because (the arm) wasn’t huge but it was huge FOR 
ME, relative to ME it was huge, that’s the problem and I think that’s where the resource 
issue is. 
FG 4, Participant 4 
 
For other participants the issue was that although they had accessed treatment they found 
that appointments were rushed and it was difficult to make contact with the practitioner to 
arrange follow up appointments: 
I was referred to (name of hospital)… from my experience it’s massively understaffed, and 
massively overworked… quite a lot of the time a phone call isn’t returned or it’s very 
difficult to get an appointment … you know you’ve only got (the practitioner) while you’re 
in there, (for) that few minutes, that half an hour because (the practitioner has) got a 
backlog out there, there was even a knock on the door when I was in there … we’re also 
going from almost a one-on-one situation … when we’re having our cancer treatment or 
whatever and you go from that to just (being) one of many, suffering, get in the queue it, 
it, it’s hard to get used to the fact that this is what you’ve to get used to… you can go 
private but we can’t all afford that. 
FG 3, Participant 6 
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As a result of the oversubscription of services, participants reported having difficulties 
accessing continued treatment: 
There’s weeks in between (treatments), it’s like a peanut to a monkey, having one 
therapy once every so often. Now (name of practitioner) tried the compression therapy on 
me but I need it everyday, and I’m in pain, I can’t work, ehm, every afternoon my arm is 
sore, in fact it’s getting worse, it upsets me.  
FG 1, Participant 7 
 
Cost of Treatment 
The cost of accessing ongoing private treatment to supplement what they perceived to be 
insufficient treatment from the public health service was a subtheme that featured 
prominently in all focus groups:  
I think that’s a big issue, too … You have to pay. Everything…. You have to have the 
money. I think around the whole care and money and costs for people that you know that 
it’s ongoing … that’s not taken into account, like you know the ongoing difficulties and the 
ongoing costs. 
FG 1, Participant 4 
 
The services (are) very, very bad, yeah and with, you know with having lymphoedema you 
can, your tissues can get… hard, and (so) it’s very important that you have your 
treatment, your, your massage treatment and to go privately it’s €60 and €70 to go to 
somebody, you know. (Private health insurance company) don’t cover it, at all.  
 FG 2, Participant 7 
 
Well, ehm, can everybody afford €75 a week? That’s what I’d like to know. 
FG 1, Participant 7 
 
The cost of private treatment can extend beyond the private practitioners’ fees to 
compression garments and bandaging:  
And it depends… some tights they’re €400 for 2 pairs, and when I went to (a 
lymphoedema clinic in) Austria you could buy the tights, they were thick ones like these 
and they were €600 I think for one pair… It would cost me about €5,000 a year, to be 
honest…to keep my leg from becoming to the situation where it would get really bad. 
FG 2, Participant 1 
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The following interaction from Focus Group 5 illustrates that participants also incurred costs 
attending public lymphoedema services:  
Participant 5: At the end of the day, I went to (the practitioner)… (the practitioner) asked 
me to bring in the bandaging (for Multi-Layer Lymphoedema Bandaging) 
that I had actually gotten from (a private practitioner) that I had gotten 
privately, so I didn’t want to say anything, I was glad to get in. 
Participant 6: They will wash (the bandages)… (the) HSE will not spend much money, as 
little as they can. 
 
Compression Garment Delays and Difficulties 
The final subtheme related to the barriers to treatment theme was compression garment 
delays and difficulties. Compression garments are an integral part of the self-management of 
lymphoedema as they contain the swelling and promote lymphatic drainage. However poorly 
fitting garments can be at best ineffectual and at worst counterproductive (MEP, 2006). 
Participants reported that their lymphoedema treatment was compromised by difficulties with 
compression garments, for example long delays in the ordering of garments due to HSE 
approval procedures or in the delivery of garments by garment suppliers.  
I got them from the medical card and I was waiting three months for it… three months I 
was waiting for the sleeve. I could’ve knitted it myself in that time.  
FG 1, Participant 5 
 
This is further illustrated by the following exchange from the second focus group: 
Participant 8: (Name of practitioner) measured my arm this time last year for a sleeve and 
I still haven’t got it… (Name of practitioner) hasn’t forgotten it (practitioner) 
has ordered it but wherever they’re ordered in from, from some other 
country, I’m not sure where… It’s missing somewhere in the system….He 
hasn’t forgotten it he has ordered it but wherever they’re ordered in from, 
from some other country, I’m not sure where… It’s missing somewhere in 
the system.  
Participant 4: It’s in the system, the system, we know the system. 
 
For others, the compression garments funded by the HSE were poor fitting and unlikely to be 
encouraging lymph flow. 
You can get (compression garments that)… look finer and they’ve better colour and I’ve 
said it to (practitioner) but (practitioner) said ‘I can only get what the HSE is contracted 
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with the company’… I had problems, they were rolling, the sleeve was rolling down and 
cutting into my arm here, so ehm, like these ones are made to fit … but what happens is it 
gets very loose after a while, it slips, slips, it doesn’t cut in but it slips down … think this 
was my problem, I had two (garments) joined here, and the hand started swelling up it 
was actually quite like a golf ball there.  
FG 3, Participant 5 
 
First garment I got I more or less demanded, it was too big, I had asked pretty directly, to 
tighten up on it (as) I knew it had to be compressed but because it wasn’t 3 times the size 
of this (other) arm (my arm) was too small to bother (with), maybe when you’re in there, 
it wouldn’t kill them to measure you… prevention could, could do it initially, (practitioners 
should) give you a garment that is tight enough which you could wear if you notice a 
change (increase in swelling).  
FG 5, Participant 4 
 
The (compression garments) the hospital gave me, they (weren’t) self-supporting, they 
just used to roll over at the top, you pull them up like a pair of socks and they just used to 
roll over creating a thick band, and all I know about anatomy is you’re supposed to have 
drainage, and this was like a tourniquet. So I found self-supporting ones which are 
absolutely marvellous because they don’t have the same restriction or the bulge but I 
order them off the internet … because the hospital doesn’t provide them. The two pairs 
cost me just over €100. 
FG 3, Participant 4 
 
The following exchange from the first focus group illustrates that the discomfort participants 
experience while wearing compression garments can discourage them from wearing 
compression garments for sufficient amounts of time: 
Participant 1: I find by 5 o’clock in the evening I have to take (the compression garment) 
off, it’s so painful.  
Participant 7: Yeah, it cuts. 
 
Another aspect of this subtheme was that the uncomfortable nature of the garments coupled 
with how unsightly they can be makes it difficult for participants to wear them. 
The colour of the garments alone… (and) they’re very heavy, and the heat … I find the 
garments are very cumbersome, or dry, they could be a bit finer and skin-like… (make) it 
into a skin-like stocking.  
FG 5, Participant 5 
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Tension with Healthcare Professionals 
The second major theme was tension with healthcare professionals. This included 
participants’ anger at not being pre-warned about the risk of developing lymphoedema and 
as a result they weren’t prepared. The second subtheme was the perceived lack of knowledge 
of some healthcare professionals resulting in participants’ questions being unanswered. The 
final subtheme related to this theme was the perceived dismissive attitude of some 
healthcare professionals towards their lymphoedema.  
Not Pre-warned and therefore not Prepared 
Participants expressed their frustration that they had not been warned that they were at risk 
of developing lymphoedema. As a result participants couldn’t avoid risk factors or engage in 
preventative measures and weren’t prepared for the development of their lymphoedema:  
Nobody told me about lymphoedema, which I, I feel a bit sore about now, that nobody 
told me … (I) feel sore I could’ve taken more precautions with the arm and I’m frustrated 
… that there isn’t something else really … it just feels crazy that this is all there is, you 
know. 
FG 2, Participant 3 
 
You do go and you get diagnosed with cancer and they say ‘we’re going to do this 
operation on you’ and …they don’t tell you that the exercises… you do initially when you’re 
feeling really, really, really bad, that if you don’t do those exercises, you won’t have the 
use of your arm, never mind you know lymph, lymphoedema…you’re having to face the 
fact that you have cancer … you’re left thinking…  ‘Am I the only one who gets this?’ 
...’Am I the only one who’s sore after 8 years?’ ...Nobody tells you, I have to ask 
people…does the pain ever go away and they say ‘not really’… Six years later you’re told 
this whereas you should be told everything. 
FG 2, Participant 5 
 
I didn’t know what caused it; then they said it could’ve been the flight… I had a 4 hour 
flight, … I suppose what upset me was if I’d known in advance of going on the flight that I 
could’ve gotten a sleeve… the breast care nurse said it would have helped, but nobody 
had told me, and I had told everybody in the (oncology) unit, my own doctor, that I was 
going on this holiday … and is there anything I need to do and nobody mentioned (a 
sleeve), nobody really knows a lot about lymphoedema, nobody’s sitting you down (to tell 
you), so I was a bit disappointed … so I always say to people who fly (to) wear a sleeve.  
FG 4, Participant 3 
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Participants spoke of their upset at not being advised that their condition is irreversible:  
I mean I was never told that it wouldn’t go away… I thought we’re going to get to the end 
of this and that’ll be it, you know it took a while (for the healthcare professional) to say it’s 
not going to go away, like the condition is going to be there, you know. Which was, which 
was awful really, very, very kind of depressing as well, you know, it can be, you know…  
FG 3, Participant 2 
 
Participants who had been warned that they were at risk of developing lymphoedema 
reported that the risk of developing lymphoedema and the consequences of doing so should 
have been stressed more:  
We’re not made aware of how serious it is… it’s not made dramatic enough for the patients 
in the hospital and I genuinely feel we should be called back and reminded … you can never 
forget about it…  
FG 4, Participant 4  
 
Questions without Answers 
Tension also resulted from participants’ perception that some healthcare professionals lacked 
knowledge about lymphoedema. As a result participants were left frustrated as their 
questions about their condition remained unanswered. The majority of quotes in relation to 
this subtheme referred specifically to participants’ general practitioners: 
I was diagnosed almost by mistake I knew I had something wrong with my leg for about, 9, 
8 or 9 or maybe even 10 years, I had a path worn to my GP… I was even having trouble 
really getting anyone to do anything definite with that… eventually I was sent by, I think, 
eventually, having battered them nearly, eh, the GP… I don’t have any big hang up, except 
it took five years for it to be diagnosed and really it wasn’t for want of ME trying to find out 
what the heck was wrong with my leg… medical people should get information… they know 
nothing… they don’t take any notice. 
FG 2, Participant 2 
 
Especially the GPs, like I mean, your first port of call is your GP and in the main, most GPs 
don’t know anything very much about it. Ok …surgeons might know a bit about 
lymphoedema but your ordinary GPs don’t know anything about it.  
FG 1, Participant 3 
 
I went to my own GP and said I couldn’t go anywhere, you know because you get tired 
listening to yourself… no-one knew nothing… I didn’t know where to go or where to turn; 
I couldn’t get them (garments) here. My GP wrote a letter to (the practitioner, and) they 
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only heard of (lymphoedema) and (were) just beginning to learn about it and that was 6 
years ago. 
FG 5, Participant 2 
 
(The GP) did the testing this way and (the GP) said ‘oedema alright but it’s not the usual 
swelling, em, it’s probably lymphoedema and there’s not a lot you can do about it’ …. (The 
GP) wasn’t unsympathetic but (the GP) wasn’t offering anything. 
FG 1, Participant 2 
 
Other participants referred to the lack of knowledge among healthcare professionals in 
general:  
I went to several doctors that I was attending for my check ups in (name of hospital) … I 
said it to one doctor, I said ‘my arm is like an elephant’s trunk’ (the practitioner) said ‘I 
don’t know what what’s wrong with you’ … (I replied) ’somebody told me about 
lymphoedema’ (the practitioner) said ‘I never heard of it’ - in a major hospital, you know 
what I mean? 
FG 1, Participant 5 
 
You’re relying on the professionals, obviously … but they don’t understand lymphoedema 
and they’re not lymphoedema specialists because we’re all surviving (cancer) so there’s a 
huge need… I feel there’s a huge lack of awareness and then when you do go in (to the 
hospital) there’s a lack of a management programme.  
FG 4, Participant 4 
 
From the lymphoedema support group, the biggest problem (for most patients) was just 
to find a medical person who could do something for them, who could see if they had 
something wrong and guide them and tell them what to do. Lots of people absolutely 
didn’t know what to do until they … came to the (Lymphoedema Ireland) meeting and saw 
what was there, their own GP or their own nurse… or whatever in most cases didn’t seem 
to be able to help them, almost unable to identify what was wrong. 
FG 1, Participant 2 
Dismissive Attitude towards Lymphoedema 
The final subtheme related to the tension with healthcare professionals theme was 
participants’ perceiving that some healthcare professionals had a dismissive attitude towards 
their lymphoedema. Essentially this related to participants’ frustration that some healthcare 
professionals had underestimated the impact of the lymphoedema diagnosis or of living with 
the condition on patients: 
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It’s not life threatening (but) if you get these infections (cellulitis); you’ve all that to deal 
with. I think that’s why (healthcare professionals are) not treating it as too important. 
FG 4, Participant 1 
  
(The doctor) said ‘would you be very upset if it didn’t go down’, like this jollying you along 
as if you were an eegit, you know, like not treating you like an adult. 
FG 1, Participant 3 
 
Later on in the same focus group another participant commented: 
Yes there’s… a dismissiveness. 
FG 1, Participant 4 
 
While some participants with cancer-related lymphoedema acknowledged the significance of 
their cancer survivorship, this did not negate the need for their current discomfort and 
distress to be adequately accepted and considered by others:  
I went back to (hospital) for a check up six months after and I did say to the doctor there 
and eh, (the doctor) said ‘well aren’t you lucky’, that’s what (the doctor) said, and that 
was it and I should be thankful that I only had lymphoedema after having the surgery. I 
felt that. 
FG 1, Participant 5 
 
Lymphoedema affecting Daily Life 
The third theme was lymphoedema affecting daily life. This referred to subthemes of making 
space for lymphoedema through the daily management plan; difficulties in finding clothes 
and shoes to cover the affected area of the body and the limitations imposed on daily 
activities or employment.     
Making Space for Lymphoedema 
The daily self-management of lymphoedema can involve time consuming skincare, exercises, 
simple lymphatic drainage, the use of compression garments and in some cases self-
bandaging. The difficulty in dedicating the time to follow this daily self-management plan 
emerged from the focus groups: 
Life gets in the way. 
FG 2, Participant 5 
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Making space for lymphoedema extended beyond the self-management of lymphoedema to 
the actual treatments themselves. The difficulty of living with lymphoedema treatment was 
also highlighted:   
(Name of practitioner) wants me to go back for bandaging, but I can’t for work. I couldn’t 
bear that at all, it’s just so cumbersome and I could not do a single thing at home. 
FG 4, Participant 1 
Finding Clothes and Shoes to Cover Lymphoedema 
The final subtheme of lymphoedema affecting daily life related to participants’ difficulties in 
finding clothes and shoes to cover the lymphoedematous areas of their body: 
You buy a pair of trousers off the peg, and you get home and now they won’t go over the 
knee and you have to go back into the shop to change it and they look at you, ‘we’ve sold 
how many pairs of these trousers why are you bringing them back’. And you can’t explain 
it to them, that one leg is different to the other. And eh, it’s happened me, trying to buy 
gloves in the winter, I can buy woollen ones but they don’t last too long, I can get normal 
ones or the nearest you can get to your size and you can get them on but you cant get 
them back off afterwards, and I don’t bother … any more. 
FG 1, Participant 6 
 
(I) have to wear long skirts or long dresses, shoes, when you have (lymphoedema) in the 
foot, certain shoes, stocking that came to here (ankle) only so you didn’t notice (the 
lymphoedema) … (but) going to a wedding or something, (you) couldn’t wear high heels. 
FG 5, Participant 5 
 
This was also illustrated in the following exchange from Focus Group 2: 
Participant 3: And, and I find like for clothes, you know, you go into a shop ‘oh that’s a nice 
jacket’ and then you try it on. 
Participant 5: Won’t fit this arm.  
Participant 4: Yeah you won’t get it on, you won’t get it on. Can’t get the coat off. 
Participant 3: It’s awful. It does affect your life you know.  
Participant 7: It’s very hard.  
Limitations Imposed on Daily Activities 
The restrictions imposed by lymphoedema on participants’ ability to engage in daily activities, 
hobbies and in some cases employment emerged as an important subtheme. In relation to 
restrictions on hobbies, this depended on the location of participants’ swelling: 
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I can’t do any fine movements, I can’t play golf, knit or sew; they’re the pleasurable 
things, but even the daily, daily work. 
FG 1, Participant 7 
 
When you can’t have the lifestyle … that you really did have, you miss it so much, the 
exercise I’d be talking about.  
FG 2, Participant 2 
 
Difficulties performing household chores or taking care of children were also highlighted: 
Like you’re trying to hoover and wash the floor in one go, it’s impossible with one arm, like 
a lot of the time you have to treat it like you have one arm, and that’s what I’ve been told, 
you know, but like if I hoover the floor and then have to wash it, I can’t physically do both 
in one day… I suppose they’re minor (things)… But it’s irritating… Again you know, when 
you’ve small, a small child at home and (the child) doesn’t understand, (the child) is 
jumping on top of you, you know, ‘can you carry this mum?’, ‘no I cant’… (It’s like) I’ve 
only one arm. 
FG 1, Participant 1 
 
I find it very upsetting at times… I can’t lift (my siblings’) children, I can’t let them lean on 
this arm, they’re important things to know, I mean my arm isn’t genuinely that bad but 
what I’m hearing is that I need to be proactive …not to be upsetting yourself, you have 
the tears… with my nieces and nephews I can’t look after them. 
FG 4, Participant 4 
 
Participants with lymphoedema in their lower limb reported that their mobility can be 
affected: 
You can’t stand in queues you know, going to the, if you’re delayed in the airport or 
something like that and you feel ‘oh my gosh’, it starts the tingling and you know you 
want to sit down and people think ‘what are you?’, it is, it’s just horrid. 
FG 3, Participant 4 
 
A number of participants reported being required to accept significant lifestyle changes 
following the onset of lymphoedema. For example, a lessened capacity for work, being 
required to change job or being unable to return to work: 
I’m using my arm all the time and (name of practitioner) has said that I, I’m making it 
worse but you have to work….I should wear the sleeve when I’m working but I can’t … 
I’m going to have to devise some sort of glove, waterproof glove or something but I know 
I’m making it worse but I have to work ‘cause I’m, it’s only me that’s bringing in an 
income so I have no choice. 
FG 2, Participant 3 
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It’s a massive transformation, I was self employed … and partly because of the 
lymphoedema … I was unable to continue, I had to completely reassess my life … 
downsize, get a smaller house, it completely and totally changed my life, but what can you 
do, I, I had a physical job and I’m no longer capable of doing it. 
FG 3, Participant 6 
 
I haven’t returned to my work yet and ehm, I don’t know when I’ll be able to because it’s 
(a) physical (job) … I don’t know when I’ll be able to return to that …  
FG 3, Participant 7  
Emotional Factors 
The fourth theme relates to emotional factors. This includes the subtheme that participants’ 
distress following their cancer diagnosis and treatment resulted in incapacity to process their 
susceptibility to developing lymphoedema. Other subthemes include lymphoedema as a 
constant reminder of cancer treatment; being required to adapt to a ‘new body’; distress in 
response to the reactions of others; and fears for an uncertain future.   
Incapacity to Process Susceptibility to Developing Lymphoedema 
Participants at risk of developing cancer-related secondary lymphoedema reported that 
emotions played a role at the very initial stages before they had developed lymphoedema. 
They described not being able to process the fact that they were at risk of lymphoedema 
because of their distress following their cancer diagnosis and treatment:  
You finish surgery; you’re facing treatment; the last thing you want to hear is another 
condition that you might get. I think no matter what they say to you, like I do remember 
(practitioner) coming round to us with a list, I put it in the drawer and left it there. 
FG 1, Participant 1 
 
I, I was very much in shock and in denial and I didn’t, didn’t, relate it at all to myself and 
didn’t take it on board…. a lot of information that you should get, you know, or make sure 
you absorb, you might’ve been given it but to make sure because of the psychological 
effect of the diagnosis on you…. I think to recognise that people don’t, you’re in denial, I 
didn’t want to know any more, your psychological effects of (the cancer) diagnosis, you’re 
very traumatised, you need to have somebody to come back to make sure did you hear 
it…. I’d normally read things but I was suffering, this hadn’t really hit me yet. 
FG 1, Participant 4 
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Constant Reminder of Cancer Treatment 
Participants with cancer-related secondary lymphoedema reported that the difficulty of living 
with lymphoedema was compounded by the knowledge that lymphoedema would represent a 
constant reminder of their prior cancer treatment: 
Every time my arm swelled, it was like as if the water was being released through my eyes 
I would cry, like, you know, it had this effect on me, I think it had more effect on my than 
the cancer did, the lymphoedema, you know. 
FG 1, Participant 3 
 
It’s initially very upsetting, desperately traumatic, because you’ve had cancer etc. and it’s 
the last thing you need, you have your short sleeved t shirts and your high tops and then 
you lose that… you lose a breast, you lose everything…you’re crumbling, I’m losing every 
option really…I thought I was fine. I thought I’d gotten away with it. It’s very upsetting. 
FG 4, Participant 4 
Adapting to the ‘New Body’  
Participants spoke of their self-consciousness as they adapt to their ‘new body’:  
My whole arm had swelled up and it was really like an elephant’s trunk… Yes I hate 
wearing it (compression garment) I wouldn’t wear short sleeves I never wear short 
sleeves, except if I’m going out maybe the odd time for dinner or a night out I might take 
it off but everyone says to you ‘did you break your arm’, … I just say ‘yes’. I always say 
yes…. I never go into details, I just say I had an accident I don’t tell anybody, I mean 
when people seem to say, ‘what is that’, ‘it’s something to do with, you know, an 
operation’, very few people know what it is, I mean even, the name you don’t realise, 
‘after effects of operation’ I say. 
FG 1, Participant 5 
 
I’m very conscious of my arm, I am really. 
FG 2, Participant 7 
 
(People ask) ‘What’s wrong with you?’… constantly, constantly. I take that off (end of the 
compression sleeve covering bottom of hand) and shove it up my sleeve….  I say I’ve a 
sprain (or)…  I say it’s a little present from breast cancer. 
FG 2, Participant 5 
 
You have to get used to this new body…You’re trying to live in this new body, it’s not you 
anymore. 
FG 3, Participant 5 
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Distress in Response to the Reactions of Others 
Participants’ self-consciousness was heightened in response to the reactions of others:  
(In the) first few weeks you’re very self conscious, I was very self conscious, no matter 
what I did because you knew it was there and you can see people looking but I don’t 
notice anymore. But now for me personally the biggest bugbear is there’s no quick answer 
is there… it’s hard to tell them they just (yawns) and they say ‘oh I get that’, no you don’t! 
FG 3, Participant 6 
 
When you go to socialise, that’s when you really notice people pull their hand back (when 
you try to shake hands with them), and that was a complex I had when I was growing up, 
that was when I was a child in school and you know, you’re different you’re going to be 
picked on…  
FG 1, Participant 6 
 
This lack of awareness about lymphoedema among the wider public can result in patients 
feeling isolated: 
Isolation, feeling that nobody else knows about it or understands it and it’s not a major 
deal but it’s just you’ve nobody to talk to about it, no-one understands, sufferers or 
people. I went to the doctor the other day and he said ‘what’s up with your hand’ and I 
said ‘oh lymphoedema’, he said ‘how come’ and I said ‘cause of treatment’, wow, what a 
relief I was able to say it, and somebody understood and we could carry on. There is this 
feeling that no-one really knows.  
FG 3, Participant 6 
Fears for an Uncertain Future 
In some cases participants reported fears that a healthcare professional’s lack of knowledge 
about lymphoedema meant they could inadvertently make the lymphoedema worse:  
I was in (hospital) a couple of weeks ago for a procedure and you know they, they bring 
you in now for a pre-op, a week before, (so I asked) ‘will you put a note somewhere on the 
file (or) should I write on my arm do not touch’ - and I was deadly serious - because the 
nurse just looked at me as if ‘what do you mean, your arm’ …I’ve often wondered about 
that (having blood or blood pressure taken or an injection into the arm) if I was knocked 
down (by a car).  
FG 1, Participant 1 
 
Concerns regarding the progressive nature of lymphoedema were also highlighted: 
It is depressing because you know it’s gonna get worse and worse and when I’m a little 
old lady and, trying to get these garments on which are really very difficult to get on…I’m 
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doing everything by the book I think and yet (my leg is) still getting bigger, what’s it going 
to be like, this, this is eight years now so what’s it going to be like in sixteen (years)? 
FG 3, Participant 4 
 
Because people that come abroad to the (lymphoedema) clinic in Germany, international 
people are usually fairly end stage and it is scary stuff. When you see that stuff… When you 
see what’s there, so it would motivate you to eh, keep yourself from getting that far. 
FG 2, Participant 6 
 
For those with primary lymphoedema there was the added concern of the condition being 
passed on to their children: 
Long term worry with primary (lymphoedema)… I would be worried about hereditary, my 
children, is it going to come on them at a later stage… you don’t know like if it’s going to 
come they’re all terrified. 
FG 3, Participant 2 
Taking an Active Role  
The fifth theme arising from the focus groups was participants taking an active role. This 
related to participants taking responsibility for the self-management of their lymphoedema 
and participants actively seeking and appealing for lymphoedema treatment.  
Taking Responsibility through Self-Management  
Participants taking responsibility for their lymphoedema referred to the adoption of 
measures to prevent an increase in swelling or the development of complications such 
as cellulitis: 
I keep (a compression garment) in my bag and I keep one in the glove box (of my car, in 
case) I see (my arm) start to (swell). 
FG 3, Participant 5 
 
I take one tablet for maintenance to keep the infection (cellulitis) out …. When I go 
anywhere the GP makes sure I have the emergency penicillin ‘cause I could be anywhere 
and if there’s nobody in reach… blood poisoning sets in very fast in about what within 5 
hours I’m a hospital case, it’s so bad. So I carry for emergencies everywhere I go. 
FG 2, Participant 4 
 
This subtheme also related to participants conscientiously following their lymphoedema 
management plan:  
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The whole management is boring you don’t get any quick eh, solutions or results, but all I 
can say to you is when you stop the procedures, the problems start building up again and 
it’ll take you twice as long… to get back to where you were before you started getting 
lazy… it involves very strict discipline… …. it’s that boring thing of getting a routine going 
and sticking to it ‘cause we’re not robots, we’re humans, and you cant do it everyday, 
everyday, yeah you cant, it’d just be impossible… I am a firm believer in this life, living in 
Ireland, of being responsible (for your health) as much as you can… for your own 
treatment. 
FG 2, Participant 6 
Appealing for Lymphoedema Treatment 
Participants also reported that they are required to actively seek and appeal for lymphoedema 
treatment: 
I think that it’s very essential as you all have said that we continue to grab on to whoever 
we have to give us a bit of treatment. 
FG 2, Participant 2 
 
That’s how I’m managing …just (by)… doggedly keeping pushing, pushing, pushing all the 
time to get myself into as much as I can of services…. How about kind of giving you 75% 
of a service rather that zero - 100% would be perfect… but how about 75% rather than 
zero. 
FG 2, Participant 6 
 
I haven’t found the services that great for primary (lymphoedema patients), I have to 
say.… what are they doing like for me, nothing… since I started demanding stuff … they’re 
offering me stuff now, because I informed myself … I went back and demanded it. But I 
don’t find (service provision) the same for primary lymphoedema. 
FG 3, Participant 2 
Deriving Positives  
The final theme from the patient focus groups is participants deriving positives. This includes 
the subthemes such as living with lymphoedema is preferable to an advancing cancer; 
patients using their experiences to altruistically caution others about the risks of developing 
cancer and lymphoedema; and the benefits of meeting other lymphoedema patients.  
Lymphoedema is Preferable to the Alternative of an Advancing Cancer  
Several participants with cancer-related secondary lymphoedema expressed feeling thankful 
that they are living with lymphoedema rather than battling an advancing cancer: 
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It’s better than the alternative - dying from cancer.  
FG 3, Participant 6 
 
You’ve been through cancer, you’ve been through chemo, and you’ve been through the 
mental anguish, and you’re on your feet again (so) I don’t dwell on it. 
FG 4, Participant 5 
  
We’re all lucky to be over the worst and moving on. If that’s all I have I’m not going to be 
too worried about it. 
FG 5, Participant 1 
Desire to Warn Others  
Other participants reported that while their experiences of cancer and living with 
lymphoedema have been challenging, these experiences have motivated them to altruistically 
warn others about the risks of developing lymphoedema or cancer: 
This lady came in (to the hospital)…she hadn’t got a sleeve on, but her hand was swollen, 
… I started to talk to her about it and she had never heard about (lymphoedema) … I 
gave her the little book about lymphoedema and was telling her about skincare and all the 
rest, and never, didn’t have contact with her around that, but at least I told her, you know 
and eh, hopefully she did… do something about it… because she didn’t know. 
FG 1, Participant 3 
 
I make a point of telling people who ask me (about my arm) because I think that then 
they know somebody else…who has an arm swelling that it may be, it may filter to, to 
them, to that person to go and talk to someone about it. 
FG 1, Participant 7 
 
I find if people ask me why am I wearing the sleeve, if they bring it up in conversation, 
depending on where it was, you know, I might just say I sprained my arm but if it was 
someone my own age who was at risk of breast cancer I would tell them what it was and 
why, and they didn’t know it existed, because they didn’t make the connection, they would 
always be totally amazed, but I think if it makes them do a breast self examination then 
it’s worth telling them but you do shock them, that’s what I find. 
FG 3, Participant 5 
Benefits of Meeting Others who Speak the Language 
Finally participants reported the benefits of meeting other lymphoedema patients in that they 
are not required to explain their condition and can freely share their experiences. This had a 
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positive influence on participants by lessening their isolation and making them feel accepted 
and understood: 
(After going to the Lymphoedema Ireland meeting) I realised I wasn’t on my own and it 
made a great difference, it didn’t improve it or anything but you felt other people were out 
there with the same thing. You weren’t a freak. 
FG 1, Participant 3 
 
I was at a Lymphoedema Ireland meeting… it was great; I felt I’m now part of a group. 
FG 1, Participant 7 
 
Indeed some participants reported that attending the focus group itself was also beneficial as 
it involved the sharing of information and promoted feelings of belonging:  
It’s funny it does show you that it’s really worthwhile to have people talking (at the focus 
group) because if you’re filling in a questionnaire (on your own) … and sometimes you just 
answer them in your own head, (but here) you’re thinking and it widens your opinion.  
FG 4, Participant 2 
 
For me, personally meeting you guys (at the focus group)… knowing I’m not the only 
one… (having lymphoedema) is a bit like being an alien isn’t it? (Laughter)…  There’re 
other people out there and you’re not alone.  
FG 3, Participant 6 
 
This was reflected in the fact that several of the participants at each focus group 
spontaneously exchanged numbers with each other so that they could keep in touch in the 
future.  
 
Discussion of Focus Group Findings 
The specific aims of the patient focus groups were to: explore patients’ experiences of initial 
symptoms, diagnosis and treatment; explore barriers to patients’ compliance with their 
lymphoedema management plans and in accessing treatment (e.g. difficulties with 
compression garments, cost of treatments etc.); and assess the impact of lymphoedema on 
patients’ daily life and quality of life. Each of these aims has been met and a brief summary 
of the themes and subthemes is presented below in addition to examples of how these 
findings compare with previous literature and the results of the service provider surveys. 
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The first theme emerging from the data was barriers to treatment. This related to 
participants’ perception of an insufficient number of services being provided, existing services 
being overwhelmed and as a result difficulties in accessing continued treatment. This 
corresponds with the review of lymphoedema services in Northern Ireland which also found 
that patients experience difficulties accessing continued treatment (DHSSPS, 2004). 
Additionally this subtheme is reminiscent of the results of the results of the service provider 
survey which emphasised the under-resourced and overstretched nature of current 
lymphoedema service provision in Ireland. Although the majority of the focus group 
participants had cancer-related lymphoedema, those with primary lymphoedema were vocal 
about the added difficulties they experienced in accessing treatment. This also corresponds 
with practitioners’ opinions of the inequitable nature of service provision according to 
lymphoedema aetiology. Another barrier to treatment was the cost of private treatment 
discouraging those wishing to supplement their treatments from the public service. Delivery 
delays and discomfort associated with compression garments was another barrier as it 
impinged on participants’ ability to wear the garments in accordance with their lymphoedema 
management plan. Problems with compression garment supply for rural patients in particular 
also featured in the results of the BreastCare Victoria (2005) study.  
 
The second theme was tension with healthcare professionals. This resulted from participants 
not being warned that they were at-risk of developing lymphoedema and as a result they 
were not prepared for the condition. Similarly in a previous quantitative study conducted in 
the UK, 61% of respondents with a history of cancer had not been told that they could 
develop lymphoedema (Lam et al., 2006). Tension also resulted from some healthcare 
professionals being unable to answer participants’ questions. This corresponds with the 
findings of the patient phases of the BreastCare Victoria (2005) study, Bulley’s (2007) patient 
interviews and themes from previous qualitative studies, such as ‘fishing in the dark’ for 
information (Bogan et al., 2007) and ‘nowhere to turn’ (Williams et al., 2004). Another 
subtheme was tension resulting from healthcare professionals’ dismissive attitude towards 
lymphoedema. This reiterates Hare’s (2000) and William et al.’s (2004) findings that patients 
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considered some healthcare professionals to underestimate the impact of living with the 
condition.  
 
The third theme was lymphoedema affecting daily life. This theme included participants’ 
difficulties in making space for lymphoedema and the daily management plan and this was 
also reported by Bogan et al. (2007) and Johansson et al. (2003). Focus group participants 
spoke of their difficulties in buying clothes and shoes to cover the lymphoedematous part of 
their bodies and this reiterates Johansson et al.’s (2003) findings. In addition, participants 
emphasised how lymphoedema limits their ability to engage in daily activities and 
employment. Similarly Johansson et al. (2003) reported patients’ difficulties in asking for help 
with daily chores and Moffatt et al. (2003) found that lymphoedema affected more than 80% 
of their respondents’ ability to work.   
 
The fourth theme was emotional factors in living with lymphoedema. One subtheme related 
to this was participants’ distress following cancer treatment resulting in incapacity to process 
their susceptibility to developing lymphoedema. Similarly Bogan et al. (2007) and Williams et 
al. (2004) found that a lack of knowledge about lymphoedema can be hugely frustrating for 
patients in the initial stages of the condition. Participants with cancer-related secondary 
lymphoedema also reported that the condition can act as a constant reminder of their cancer 
treatment. This has also been reported in previous studies (Carter, 1997 cited in Hare, 2000; 
Woods 1993). An additional subtheme was participants’ self-consciousness as they adapt to 
their ‘new body’ and deal with reactions of others. Participants reported feeling isolated by 
others’ lack of awareness much like the participants in Hare’s (2000) study. This is also 
reminiscent of Williams et al.’s (2004) finding of participants rehearsing a reaction to other 
people’s comments before learning to open up. This is reminiscent of the ‘self-controlling’ 
coping style identified by Folkman and Lazarus (1988), whereby individuals experiencing 
stressful circumstances try to keep their emotions to themselves (cited in Lazarus, 1999). 
Furthermore, participants reported their fears for an uncertain future regarding the risk of an 
uninformed healthcare professional inadvertently worsening the condition, the progressive 
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nature of the condition or the risk of the condition being heritable. Primary lymphoedema 
patients concerns regarding the potential heritability of their condition had also been 
identified in a previous qualitative study (Waters, 2007).  
 
The fifth theme was patients taking an active role in lymphoedema management for example 
through prophylactic or self-management measures. As mentioned previously, patients’ 
difficulties with the daily management plan was also reported by Bogan et al. (2007) and 
Johansson et al. (2003). The ‘active role’ theme is reminiscent of the ‘fighting spirit’ coping 
style exhibited by some cancer patients (Greer et al., 1979 cited in Burton & Watson, 1988). 
The theme is also similar to the ‘accepting responsibility’ and ‘planful problem solving’ coping 
styles (Folkman & Lazarus 1988, cited in Lazarus, 1999). The ‘active role’ theme also included 
the subtheme of patients actively appealing for lymphoedema treatment. This subtheme had 
not been identified in previous studies of lymphoedema patients.  However this subtheme is 
similar to the confrontive coping style identified by Folkman and Lazarus in 1988 (cited in 
Lazarus, 1999).  
 
The final theme referred to participants deriving positives. Participants with cancer-related 
lymphoedema reported that they consoled themselves that lymphoedema is preferable to the 
alternative of an advancing cancer. This finding is reminiscent of Hare’s (2000) theme of 
‘counting blessings’. Moreover it is similar to Johansson and colleagues’ (2003) finding of 
patients consciously considering lymphoedema as a less important aspect of their lives in 
order to regulate their emotional distress. In turn these themes are related to Watson et al.’s 
(1994) finding that some cancer patients cope by engaging in cognitive avoidance by blocking 
off worrying thoughts or feelings rather than denying they have an illness (cited in Burton & 
Watson, 1998). Furthermore it is suggestive of the positive reappraisal coping style (Folkman 
& Lazarus, 1988, cited in Lazarus, 1999). Participants in the current study also reported that 
their experiences have motivated them to actively warn others about the risks of developing 
cancer and lymphoedema. This had not been reported in previous studies of lymphoedema 
patients. Finally participants reported that meeting others who understand their experiences 
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and speak the same language as such, promotes feelings of acceptance. These benefits were 
derived from support group meetings and indeed from the focus group itself. This 
serendipitous finding of focus groups being beneficial for lymphoedema patients was also 
reported by Hare (2000). Moreover the ‘seeking social support’ coping style has previously 
been identified by Folkman and Lazarus in 1988 (cited in Lazarus, 1999).  
 
These findings provide useful insights into patients’ experiences of current lymphoedema 
service provision in Ireland and of living with the condition. In many cases the themes and 
subthemes correspond with findings from previous studies and with the service provider 
survey results. Moreover the findings present subthemes which have not previously been 
reported such as patients’ fears of an uninformed healthcare professional inadvertently 
worsening their condition or patients’ desire to warn others about the risks of developing 
cancer and lymphoedema. However due consideration must be given to the methodological 
limitations of this phase of the study and these are presented in the next section. 
  
Methodological Issues  
Firstly, while purposive sampling was employed in order to include both male and female 
participants with varied ages, types of lymphoedema and locations of lymphoedema, none of 
the focus group participants had non-cancer-related secondary lymphoedema, i.e. 
lymphoedema following infection, inflammation or venous disease.  
 
Secondly, focus groups capitalise on interactions between participants encouraging the 
sharing and comparison of experiences. However given the sensitive nature of living with a 
chronic condition and the focus group setting, the investigators were careful not to explore 
topics which were too invasive. Therefore topics discussed in previous studies such as the 
impact of lymphoedema on patients’ sexuality were not explored (Passik et al., 1995). 
Therefore it is possible that individual qualitative interviews would be more appropriate to 
explore the more personal consequences of living with lymphoedema.  
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Finally, focus groups or interviews involving patients’ families and friends would have added a 
further dimension to this phase of the study by appreciating the effects of lymphoedema 
beyond the individual patient. However this was not possible given the time constraints of the 
study and is recommended in future research. 
 
From Focus Groups to the Patient Survey 
The focus groups have provided valuable information on patients’ experiences of 
lymphoedema service provision in Ireland and of living with the condition. As mentioned 
previously their intention was not to generalise but to explore patients’ experiences of 
lymphoedema. Yet the findings do pose questions as to how frequent these participants’ 
experiences are among a broader sample of lymphoedema patients. As such, an alternative 
quantitative data collection approach is required to answer this question. Therefore the next 
phase of the study involved a survey of a wider group of lymphoedema patients to explore 
these topics further. 
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Chapter 6: Patient Survey 
Introduction 
The overall aims of this study were to investigate lymphoedema service provision in Ireland 
from both service provider and patient perspectives, in addition to exploring patients’ 
experiences of living with lymphoedema in Ireland. The final phase of the research employed 
patient questionnaires for the following reasons.  
   
Firstly, as mentioned previously the patient survey offered the potential to ascertain how 
representative various experiences of lymphoedema and lymphoedema service provision are 
among a broader sample of patients. This facilitated the comparison of Irish lymphoedema 
patients’ experiences with those of lymphoedema patients in other countries.  
 
Secondly a patient survey format was compatible with quantitatively measuring the impact of 
lymphoedema on patients’ quality of life in Ireland for the first time. As mentioned previously 
in the literature review, most of the studies on the impact of lymphoedema on patients’ 
quality of life focused on comparing the experiences of patients with breast-cancer-related 
secondary lymphoedema with breast cancer survivors who hadn’t developed lymphoedema 
(e.g. Velanovich et al., 1999; Coster et al., 2001; Beaulac et al., 2002; Mak et al., 2009). 
Conversely the intention of the current study was to explore the impact of lymphoedema on 
the quality of life of patients with all types of lymphoedema.  
 
Finally the results of a patient survey would provide additional information to correspond 
with, expand on or contradict the findings of the service provider survey and patient focus 
group phases.  
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Specific Aims of Patient Surveys 
The broad aims of the patient survey phase were to explore patients’ experiences of living 
with lymphoedema and of lymphoedema service provision. These general aims can be broken 
down into more specific objectives, which were to: 
• Explore patients’ experiences of seeking an explanation for their lymphoedema 
symptoms, obtaining a diagnosis and accessing information and treatment. This 
would enable the investigation of whether patients with different types of 
lymphoedema have quantitatively or significantly different experiences of diagnosis 
and treatment (e.g. waiting time between first symptoms and diagnosis, waiting time 
for first treatment, awareness of being at-risk prior to developing lymphoedema, 
waiting time since last treatment etc.). 
• Explore patients’ perspective on lymphoedema service provision by investigating 
patients’ experiences of service providers and treatments, and their ratings of the 
standard of care they are receiving.  
• Investigate barriers to patients’ compliance with their lymphoedema management 
plans (e.g. dissatisfaction with compression garments; difficulties with compression 
garment provision; availability of written or audiovisual material to enable the revision 
of techniques in lymphoedema exercises, SLD and self-bandaging). 
• Explore barriers in accessing treatment (e.g. distance to lymphoedema service, cost 
of treatments, level of financial support from private health insurers for treatment 
etc.).  
• Assess the impact of lymphoedema on patients’ daily life (e.g. limitations on 
employment, activities and socialising; hospitalisation for the treatment of associated 
infections) and on the physical health, psychological health, social relationships and 
environment domains of the WHOQOL-BREF quality of life measure.  
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Method  
Identifying a Sample 
Using the information from the service provider phase which mapped current lymphoedema 
service provision in Ireland, participants were recruited through a total of sixteen hospitals, 
services and organisations. Participants were recruited through teaching, regional or general 
public hospitals that currently or have previously provided a dedicated lymphoedema service 
and therefore have a patient list or waiting list on file. Participants were also recruited 
through cancer support services that provide lymphoedema treatment and through 
organisations which provide information and support to lymphoedema patients (e.g. 
Lymphoedema Ireland). The hospitals, services and organisations were contacted and 
permission was sought to post questionnaires to their patients. The survey was also 
advertised in relevant newsletters and websites (e.g. the Lymphoedema Ireland website and 
newsletter, and the MLD Ireland website) so that people who are not in direct contact with 
hospitals, services or support organisations but who would like to participate could be sent a 
copy of the questionnaire for inclusion in the study.  
 
In hospitals and services, the cooperation of the manager of the lymphoedema clinic (or 
equivalent in the physiotherapy or occupational therapy department) was sought to act as 
gatekeeper by facilitating the identification of patients who met the inclusion criteria.  
 
The inclusion criteria were patients over eighteen years of age with a diagnosis of 
lymphoedema that were deemed capable of informed consent by their lymphoedema 
practitioner. Patients under the age of eighteen were excluded as all participants were 
required to give their own informed consent. Patients with chronic oedema (i.e. oedema of 
multiple origins with the fundamental cause not being malformation or impairment of the 
lymphatic system) were excluded in order to focus the research specifically on the 
experiences of lymphoedema patients. Palliative patients were also excluded from the study. 
Given the variety in health status among patients defined as receiving palliative care and the 
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rate at which palliative patients’ health status can change it was decided that they should not 
be sent a questionnaire in order to avoid causing unnecessary distress either to the patients 
themselves or their relatives.  
Questionnaire Design 
As a means of avoiding false or irrelevant structures and ensuring the full range of possible 
responses, questionnaire content and subsequent item selection was developed through four 
processes: the review of literature, expert opinion (of the research advisory group which is 
composed of lymphoedema patients, lymphoedema practitioners, consultants in related 
disciplines of venous disease and oncology, and research psychologists), the findings of the 
service provider phase of the research and the themes arising from the focus groups that 
revealed issues requiring further exploration. The majority of previous studies on service 
provision did not involve patient questionnaires. Rather they asked specific groups of service 
providers or a small group of patients with a specific type of lymphoedema for their 
experiences. The BreastCare Victoria (2005) study measured opinions of lymphoedema 
service provision and impact on daily living and as a result approval was sought and granted 
for the use and amendment of the questionnaire used by that research team. However the 
questionnaire employed in the current study included additional items (such as the rating of 
healthcare professionals on various characteristics such as knowledge, experience and overall 
satisfaction) and a quality of life measure.  
 
The majority of research on the impact of lymphoedema on patients’ quality of life has 
compared the scores of patients with breast-cancer-related secondary lymphoedema with 
survivors of breast cancer who hadn’t developed lymphoedema. The exception was Moffatt et 
al.’s (2003) prevalence study. However as mentioned previously they didn’t indicate what 
proportion of their sample had various types of lymphoedema and didn’t compare them as a 
result. Therefore these studies offered less guidance to the current study as the intention was 
to explore the impact of lymphoedema on the quality of life of all lymphoedema patients and 
compare across patients with different types of lymphoedema.  
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The content of the survey includes the following:  
• First identification of lymphoedema symptoms, experience of diagnosis, and location 
and type of lymphoedema.  
• Treatment: experience of seeking treatment, factors influencing access to treatment, 
average cost, personal expense, treatments received, and experiences of treatment.  
• Perception of practitioners (e.g. knowledge, competency, experience, attitude etc.).  
• Satisfaction with funding and treatment.  
• Implications of lymphoedema on daily life and quality of life.  
• Recommendations for lymphoedema service development.  
 
In exploring the impact of lymphoedema on patients’ quality of life, the World Health 
Organisation (WHO)’s definition of quality of life was employed. The WHO has defined quality 
of life as: 
 Individuals’ perception of their position in life in the context of the culture and value 
 systems in which they live and in relation to their goals, expectations, standards and 
 concerns. It is a broad ranging concept affected in a complex way by the person's 
 physical health, psychological state, level of independence, social relationships,  personal 
 beliefs and their relationship to salient features of their environment  
               (WHO, 1997, Page 1). 
 
As a result, the World Health Organisation’s abbreviated Quality of Life measure (WHOQOL-
BREF) was included at the end of the questionnaire. The WHOQOL-BREF is a 26 item 
measure that assesses four major domains: physical, psychological, social relationships and 
environment (WHO, 1996). The physical domain includes items on activities of daily living; 
dependence on medical treatment; energy and fatigue; mobility; pain and discomfort; sleep 
and rest; and work capacity. The psychological domain includes items on bodily image and 
appearance; positive and negative feelings; self-esteem; spirituality; thinking, learning, 
memory and concentration. The social relationships domain includes items on personal 
relationships; social support and sexual activity. Finally the environment domain includes 
items on financial resources; freedom, physical safety and security; accessibility and quality of 
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health and social care; home environment; opportunities for acquiring new information; 
opportunities for and participation in leisure activities; aspects of the physical environment 
such as pollution, noise, traffic and climate; and transport (WHO, 1996).  The WHOQOL-BREF 
was designed to facilitate the understanding of medical conditions and therefore is 
appropriate for use in the current study (WHO, 1996).  
 
While previous studies exploring the impact of lymphoedema on quality of life have not 
employed the WHOQOL-BREF, these studies have provided guidance as to the domains of 
quality of life which may be impacted upon by the experience of lymphoedema. For example, 
as mentioned previously in the literature review, lymphoedema patients’ physical wellbeing 
can be affected by their experience of lymphoedema whether through altered sensation, pain 
or acute infection (Lam et al., 2006; Muscari, 2004; Moffatt et al., 2003; Passik & McDonald, 
1998). Additionally previous studies have shown that the experience of lymphoedema may 
compromise psychological wellbeing through self consciousness, distress, impaired body 
image and depression (Lam et al, 2006; McWayne & Heiney, 2005; Passik et al., 1995; Tobin 
et al., 1993). The social relationships domain may also be of relevance given previous 
findings on the impact of the condition on the wider family group and on patients’ social lives 
through the mediating variable of self consciousness (Lam et al., 2006; Radina & Armer, 
2001). Finally the environment domain may also be of relevance as the physical limitations of 
lymphoedema may require patients to rely more on public services.  
 
The WHOQOL-BREF domain scores demonstrate good discriminant validity. This was 
measured by t tests between ‘ill’ and ‘well’ participants’ scores on the four domains with 
resulting p values of between 0.001 and 0.01 (The WHOQOL Group, 1998). The measure also 
demonstrates good internal consistency with alpha levels for the four domains ranging 
between 0.66 and 0.84. Finally the WHOQOL-BREF’s test-retest reliability was measured by 
correlations of scores on the four domains at two time points ranging between 0.66 and 0.87 
(The WHOQOL Group, 1998).  
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The questionnaire was piloted with six lymphoedema patients. The pilot participants varied in 
terms of gender, age range, county of residence, type of lymphoedema, duration of 
lymphoedema symptoms and time since diagnosis. Subsequent to the pilot, amendments 
were made to ensure the questionnaire was as succinct and clear as possible. The 
questionnaire was then reviewed and approved by the research advisory group (composed of 
lymphoedema patients, lymphoedema practitioners, consultants in related disciplines of 
venous disease and oncology, and research psychologists) prior to its distribution. A copy of 
the questionnaire employed in the current study is included in Appendix L. 
Procedure 
In hospitals and services, the cooperation of the manager of the lymphoedema clinic (or 
equivalent in the physiotherapy or occupational therapy department) was sought to act as a 
contact person by facilitating the identification of patients who met the inclusion criteria. In 
keeping with data protection, the research team did not request hospitals or organisations to 
provide the research team with the names and addresses of lymphoedema patients. This was 
in order to ensure that the questionnaires remained anonymous and confidentiality wasn’t 
breached. However, assistance was offered to the hospital or organisation when required, 
with mail-merging patients’ names and addresses onto the cover letters and envelopes, in 
order to minimise any disruption to the hospital or organisation.  The electronic database 
containing the patients’ details was saved by the hospital or organisation and was not 
retained by the researcher.  
 
Potential participants accessed through hospitals were posted a cover letter from their 
lymphoedema practitioner with an information sheet, questionnaire and a FREEPOST 
envelope, with which to return the questionnaire. Potential participants accessed through 
organisations providing support to lymphoedema patients (e.g. Lymphoedema Ireland) were 
posted the same cover letter but from a named person in the support organisation. As some 
research ethics committees required specific wordings in the cover letters and/or information 
sheets distributed to the patients under their remit there were slight variations in the text of 
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these. However a sample cover letter, sample information sheet, and the actual patient 
questionnaire employed in this study are presented in the Appendix J, K and L respectively.  
 
A thank you/reminder letter was sent to patients approximately two weeks after the initial 
questionnaire mailing to thank those who had participated and to prompt those who had not 
participated but wished to do so. The letter reminded recipients that they were not obliged to 
participate and could contact the research team at any time. These reminder letters were 
mail-merged at the time of the original cover letters. The letters were retained for 
approximately two weeks by the contact person in the particular organisation and 
subsequently posted to patients by the contact person. This was to ensure that the research 
team did not leave the hospital, service or organisation with the contact details of patients, 
thereby preserved the confidentiality of patients’ details. A sample thank you/reminder letter 
is presented in Appendix M.   
Ethics 
Consent  
Approval was sought and granted from thirteen hospitals nationwide to invite patients who 
met the inclusion criteria to participate in the focus groups. Approval was also sought and 
granted from Dublin City University Research Ethics Committee to enable the research team 
to invite patients from three services and organisations outside the remit of a hospital ethics 
committee. This was to ensure that participants who might not be currently receiving 
treatment from a hospital or service were included in the sample. Participants were not 
requested to sign a consent form in order to protect their anonymity. Consent was assumed 
by the completion and return of the questionnaire. Participants were informed that they could 
decline the opportunity of completing the questionnaire and were not required to pay for the 
return of the questionnaire to the investigators. 
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Confidentiality 
All participants were assured of confidentiality and anonymity at all times and through all 
stages of the research. The research team did not record the names and addresses of 
patients that were sent the questionnaire. The research team had no way of tracking which 
individuals were sent the questionnaire or which individuals chose to participate. The 
questionnaires did not request participants to include their name on them and consent was 
assumed from the completed questionnaire and it was intended that the questionnaires 
would be anonymous. However fifty-nine participants chose to provide their name and/or 
contact details at the end of the questionnaire and invited the research team to contact them 
if further clarification of their responses was required. Therefore the questionnaires are being 
stored in a locked filing cabinet which only members of the research team have access to. 
Anonymous data was inputted directly onto the researcher’s computer, which is password 
protected to ensure confidentiality of all electronic records. All identifying information and 
questionnaires will be shredded and disposed of five years after completion of the study by 
Dr. Pamela Gallagher, supervisor of this study. 
Risk Management 
Since the research study employed questionnaires which are a non-invasive data collection 
procedure it was anticipated that there would be minimal adverse implications for the 
participants. However there was the potential for raising anxiety given the sensitivity of 
discussing a chronic condition such as lymphoedema. Asking patients about their experience 
of first identifying swelling in their body, being diagnosed or seeking treatment could have 
potentially caused the recollection of unpleasant memories or past negative experiences. This 
issue was acknowledged and safeguards were set up to deal with such situations and to 
minimise the risk to participants.  
 
Participants were alerted to the Irish Cancer Society’s Action Breast Cancer FREEFONE 
Helpline on the information sheet, through which all patients could receive information, 
support and counselling if required, and access to the support services provided by 
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Lymphoedema Ireland. All participants at all stages of the research had this service available 
to them. As mentioned previously the questionnaire was piloted by six lymphoedema patients 
to ensure that issues were also explored in the most sensitive manner possible.  
Data Analysis 
Questionnaire data was entered into the Statistical Program for the Social Sciences (SPSS) 
Version 17.0. Each participant did not respond to each item of the questionnaire. Therefore 
the results presented are based on the number of respondents to the individual question 
rather than on the overall sample of 735 participants. Descriptive statistics such as 
frequencies and means were performed to present trends in the data. Due to space 
limitations some information is presented in the Appendices and where that occurs, reference 
is made in the main results section.  
 
In terms of inferential statistics, correlations were performed to explore relationships between 
variables - for example whether there was a relationship between those who had been 
diagnosed less recently and the time they had to wait for their first treatment.  The Chi-
square test of independence was performed to explore whether a particular category of 
participants were more likely to indicate a particular response - for example whether there is 
an association between patients who knew they were at-risk of developing lymphoedema and 
the type of lymphoedema they subsequently developed. Independent sample t tests were 
performed to explore differences by comparing the means of two groups - for example 
whether gender had an influence on participants’ scores on the various domains of the quality 
of life measure. However in some cases the Levene’s test for homogeneity of variance was 
significant and as a result the non-parametric equivalent, the Mann Whitney U was 
performed. Standard one-way analyses of variance (ANOVAs) were performed to explore 
differences by comparing the means of more than two groups – for example whether 
participants in various age ranges responded differently to quality of life items. Tukey post 
hoc tests were subsequently performed to identify between which groups any significant 
differences occur. In comparing the means of patients with different types of lymphoedema – 
  141 
for example whether participants with different types of lymphoedema responded differently 
to time between first symptoms and treatment - the Levene’s test for homogeneity of 
variance was significant. As a result the Welch one-way ANOVA and Dunnett’s T3 post hoc 
test were performed as these are more robust when this assumption has been violated (Field, 
2005; Pallant, 2007; Roth, 1983). Where effect sizes were available, this information is 
provided in the text. Responses to open questions were typed into Microsoft Word (2003 
Version) and analysed thematically. The findings are presented below in the results section.  
Results 
Sample Characteristics 
A total of 1,529 questionnaires were posted to patients. As questionnaires were sent to 
patients from a total of sixteen hospitals, services and organisations, some patients may have 
received multiple copies of this questionnaire. If this arose, patients were advised to complete 
one questionnaire and return the completed questionnaire and the additional blank 
questionnaire(s) in each of the FREEPOST envelopes provided. The overall response rate was 
55.79%. One hundred and eighteen of the responses involved patients who were unable to 
complete the questionnaire due to having received more than one copy, ill health or various 
other reasons. Therefore out of a potential total of 1,411 questionnaires, 735 completed 
questionnaires were received, resulting in a completed questionnaire response rate of 
52.09%. Table 15 on pages 142 and 143, presents a breakdown of the sample in terms of 
gender, age range, and type and location of lymphoedema and county of residence.  
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Table 15: Sample Characteristics 
 
 
Gender (n=732)          
Female         93.2% 
Male          6.8% 
 
Age Range (n=728) 
18-35 Years Old        3.0%   
36-50 Years Old        22.7% 
51-66 Years Old        45.6% 
Over 66 Years Old        28.7% 
 
Type of Lymphoedema (n=726) 
Primary Lymphoedema 
Primary Lymphoedema       6.5% 
 
Cancer-Related Secondary Lymphoedema  
Lymphoedema Secondary to Breast Cancer     73.1% 
Lymphoedema Secondary to Gynaecological Cancers    3.9%  
Lymphoedema Secondary to Melanoma      3.0% 
Lymphoedema Secondary to Other Cancer (Unspecified)    0.8% 
Lymphoedema Secondary to Lymphoma      0.7% 
Lymphoedema Secondary to Bladder Cancer     0.4% 
Lymphoedema Secondary to Throat Cancer     0.4% 
Lymphoedema Secondary to Sarcoma      0.4% 
Lymphoedema Secondary to Bowel Cancer     0.1% 
Lymphoedema Secondary to Skin Cancer     0.1% 
Lymphoedema Secondary to Leukaemia      0.1% 
Secondary to Breast & Gynaecological Cancer     0.1% 
 
Primary and Cancer-Related Secondary Lymphoedema  
Primary Lymphoedema & Lymphoedema Secondary to Breast Cancer   0.6% 
Primary Lymphoedema & Lymphoedema Secondary to Lymphoma   0.1% 
 
Non-Cancer-Related Secondary Lymphoedema 
Lymphoedema Secondary to Infection (e.g. Cellulitis, Lymphadenitis, Filariasis etc.) 2.9% 
Lymphoedema Secondary to Trauma/Tissue Damage (e.g. Burns, Scarring, Wounds etc.) 1.2% 
Lymphoedema Secondary to Gland Removal (unspecified whether due to cancer)  0.6% 
Lymphoedema Secondary to Venous Disease (e.g. DVT, Chronic Venous Insufficiency etc.) 0.4% 
Lymphoedema Secondary to Infection & Inflammation (e.g. Arthritis, Sarcoidosis etc.) 0.1% 
Lymphoedema Secondary to Infection & Injury     0.1% 
Lymphoedema Secondary to Infection & Venous Disease    0.1% 
Lymphoedema Secondary to Venous Disease, Infection & Immobility   0.1% 
 
Don’t Know 
Don’t Know Type of Lymphoedema      3.1% 
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Table 15: Sample Characteristics (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ninety-three percent of the sample was female and 6.8% was male. The majority of the 
present sample (74.3%) was aged over 50 years of age which was expected given the 
greater prevalence of the condition among those who are middle aged and older. Indeed the 
Location of Lymphoedema (n=733)      
Left Upper Limb        43.8% 
Right Upper Limb        35.1% 
Left Lower Limb        19.5% 
Right Lower Limb        19.3% 
Chest/Breast        5.0% 
Abdomen         2.6% 
Head/Neck/Face        1.8% 
Groin/Genitals        0.6% 
Back/Shoulders        0.4% 
Other - Not Specified       0.1% 
 
County (n=708)        
Carlow         1.6% 
Cavan         0.7%   
Clare         2.3% 
Cork         12.7%  
Donegal         4.5% 
Dublin          36.4% 
Galway         2.0% 
Kerry         0.7% 
Kildare         4.9% 
Kilkenny         1.8% 
Laois         2.8% 
Leitrim         0.4% 
Limerick         3.8% 
Longford         0.3% 
Louth         2.0% 
Mayo         1.0% 
Meath         4.7% 
Monaghan        1.1% 
Offaly          2.1% 
Roscommon        0.6% 
Sligo         0.7% 
Tipperary         3.0% 
Waterford        3.5% 
Westmeath        0.9% 
Wexford         3.0%   
Wicklow         2.7% 
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mean age of participants in the current study was 58.89 years (SD=12.65, Range=18-97 
years, n=728).  
 
There were a much higher proportion of patients with breast-cancer-related secondary 
lymphoedema (73.1%) than patients with cancer-related (but not breast-cancer-related) 
secondary lymphoedema (9.9%), patients with non-cancer-related secondary lymphoedema 
(5.5%) and patients with primary lymphoedema (6.5%). A greater proportion of participants 
indicated that they have lymphoedema in the upper limb(s) than in any other part of their 
bodies.  The majority of the sample lives in Dublin, which reflects the high population density 
there. However there was a representation of patients from all counties in the Republic of 
Ireland. 
Obtaining a Lymphoedema Diagnosis 
On average, participants had experienced lymphoedema symptoms for 78.45 months (SD = 
101.94, Range = 2-804, n=689). Participants had received a diagnosis on average 62.08 
months ago (SD = 77.00, Range = 0-600, n=668). As a result, it was possible to calculate 
how long in months patients were waiting from the time they became aware of symptoms to 
the time when they received a diagnosis of lymphoedema for those symptoms. The findings 
for all respondents and for patients with various categories of lymphoedema are presented 
below in Table 16. Please note a number of participants could not be placed in the following 
categories of type of lymphoedema as they had experienced two forms of lymphoedema or 
they indicated that they had glands removed but not whether this was part of cancer 
treatment or treatment for another condition.  
 
Table 16: Average Time Spent Waiting for a Diagnosis  
 
 
      n Mean (Months)    SD   Range 
All Respondents     654 14.36     53.76  0-624 
Primary Lymphoedema    42 78.17      131.78  0-528 
Non-Cancer-Related Secondary Lymphoedema  40 20.55  39.18  0-228 
Cancer-Related (but not BC-Related) Lymphoedema 64 8.17  17.00  0-77 
Breast-Cancer-Related Secondary Lymphoedema  474 4.84  17.69  0-240 
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From Table 16 it appears that patients with primary lymphoedema spent much longer waiting 
for a diagnosis when compared with patients with other types of lymphoedema. Patients with 
non-cancer-related secondary lymphoedema were waiting longer than patients with cancer-
related (but not breast-cancer-related) secondary lymphoedema. Patients with breast-cancer-
related secondary lymphoedema received a diagnosis in nearly half the time that patients 
with cancer-related-(but not breast-cancer-related)-secondary lymphoedema received a 
diagnosis. The Welch one-way ANOVA was performed and found to be highly significant: FW 
(3, 81.441) = 6.855, p=0.001. Post hoc analysis revealed that primary lymphoedema patients 
waited significantly longer than patients with cancer-related (but not breast-cancer-related) 
secondary lymphoedema (p=0.008) and patients with breast-cancer-related secondary 
lymphoedema (p=0.005).   
 
Forty-two percent of respondents indicated that they knew they were at-risk of developing 
lymphoedema (n=716). Yet while 51.6% of patients with breast-cancer-related secondary 
lymphoedema knew they were at-risk (n=519); only 23.5% of those with cancer-related (but 
not breast-cancer-related) lymphoedema (n=68); 6.7% of primary lymphoedema patients 
(n=45) and just 4.8% of those with non-cancer-related secondary lymphoedema (n= 42) 
knew they were at-risk of developing the condition. A Chi-square test for independence 
indicated there was a highly significant association between patients who knew they were at-
risk of developing lymphoedema and the type of lymphoedema they subsequently developed, 
x2(3, n=674) = 75.658, p=0.001. The test also indicated a medium effect size, Cramer’s 
V=0.335 (Pallant, 2007). Based on the odds ratio patients with breast-cancer-related 
secondary lymphoedema were 3.47 times more likely than patients with cancer-related (but 
not breast-cancer-related) secondary lymphoedema, 21.35 times more likely than patients 
with non-cancer-related secondary lymphoedema, and 14.95 times more likely than primary 
lymphoedema patients to know they were at-risk of developing lymphoedema (Field, 2005).  
 
Participants were asked to indicate all of the various healthcare professionals they consulted 
when they were originally seeking an explanation for their lymphoedema symptoms. Out of 
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the 704 respondents 44.9% went to a consultant, 27.6% went to a general practitioner, 
23.3% went to a breast care nurse, 20.2% went to a physiotherapist, 19.3% went to a 
lymphoedema nurse specialist, 9.2% went to a manual lymphatic drainage therapist, 5.1% 
went to an occupational therapist and 1.8% contacted another healthcare professional (i.e. 
general nurse, helpline nurse or radiotherapist). This suggests a wide variety of healthcare 
professionals are required by patients to be informed about lymphoedema and lymphoedema 
services. 
 
Participants were also asked to rate the healthcare professional(s) they consulted at that time 
in terms of attitude, knowledge, support, time taken to diagnose, and overall satisfaction on a 
Likert scale from 1 - ‘very dissatisfied’ to 5 - ‘very satisfied’. The frequencies of various 
responses are presented in Table 17. Apart from in the case of emotional support and time to 
diagnose, over 60% of respondents were satisfied or very satisfied with the healthcare 
professionals they consulted when they were seeking an explanation of their symptoms. 
However a sizeable minority of approximately 20-30% were ‘dissatisfied’ or ‘very dissatisfied’ 
with the healthcare professionals on all measures.  
 
Table 17: Frequency Data on Participants’ Ratings of Satisfaction with the Healthcare 
Professionals (HCPs) they consulted when they were seeking an explanation of their 
symptoms  
 
 
The mean ratings of each of the healthcare professionals are presented in Table 18 on pages 
147 and 148. The lowest rated healthcare professionals were general practitioners and in 
almost all cases, lymphoedema nurse specialists were rated the highest. Most participants, 
regardless of which healthcare professional they were rating, rated them highest in terms of 
    n V Dissatisfied Dissatisfied Neutral  Satisfied             V Satisfied 
Attitude 605 12.6% 10.7% 13.4% 34.2% 29.1%  
Knowledge 596 11.9% 11.9% 10.2% 33.6% 32.4% 
Practical Support 573 11.7% 12.9% 12.2% 31.4% 31.8% 
Emotional Support 549 15.3% 14.8% 20.4% 23.5% 26.0% 
Time to Diagnose 557 12.6% 14.2% 13.8% 30.2% 29.3% 
Overall Satisfaction 607 13.8% 11.5% 12.4% 32.8% 29.5% 
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knowledge and lowest in terms of emotional support. However even the highest overall rating 
was still below a rating of ‘satisfied’. 
 
Table 18: Average Ratings of Healthcare Professionals Consulted when Seeking Explanation 
of Symptoms, according to Type of Healthcare Professional 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       n Mean SD 
Attitude  
Mean Rating of all Healthcare Professionals   605 3.57 1.341 
General Practitioner      171 3.06 1.355 
Breast Care Nurse      146 3.78 1.262 
Consultant      276 3.51 1.344  
Physiotherapist      125 3.59 1.345 
Occupational Therapist     31 4.06 1.031 
Lymphoedema Nurse Specialist    109 3.90 1.209 
MLD Therapist      55 3.47 1.359 
Other (Nurse, Helpline Nurse, Radiotherapist)   13 3.77 1.536 
 
Knowledge 
Mean Rating of all Healthcare Professionals   596 3.63 1.356 
General Practitioner      157 2.97 1.450 
Breast Care Nurse      143 3.90 1.165 
Consultant      278 3.54 1.387 
Physiotherapist      129 3.64 1.385 
Occupational Therapist     28 3.93 1.184 
Lymphoedema Nurse Specialist    111 4.04 1.228 
MLD Therapist      55 3.20 1.520 
Other (Nurse, Helpline Nurse, Radiotherapist)   13 3.77 1.536 
 
Practical Support 
Mean Rating of all Healthcare Professionals   573 3.59 1.357 
General Practitioner      153 2.94 1.382 
Breast Care Nurse      140 3.87 1.240 
Consultant      270 3.53 1.373 
Physiotherapist      125 3.53 1.400 
Occupational Therapist     28 3.89 1.197 
Lymphoedema Nurse Specialist    107 4.02 1.141 
MLD Therapist      54 3.37 1.418 
Other (Nurse, Helpline Nurse, Radiotherapist)   13 3.38 1.660 
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Table 18: Average Ratings of Healthcare Professionals Consulted when Seeking Explanation 
of Symptoms, according to Type of Healthcare Professional (continued)  
 
 
 
Participants’ satisfaction with the healthcare professional they consulted when they were 
seeking an explanation for their lymphoedema symptoms were then broken down according 
to the type of lymphoedema that the respondents experience. These results are presented in 
Table 19 on page 149.  
 
       n Mean SD 
Emotional Support 
Mean Rating of all Healthcare Professionals   549 3.30 1.396 
General Practitioner      145 2.74 1.339 
Breast Care Nurse      137 3.64 1.283 
Consultant      261 3.19 1.442 
Physiotherapist      122 3.18 1.342 
Occupational Therapist     28 3.54 1.374 
Lymphoedema Nurse Specialist    96 3.80 1.303 
MLD Therapist      51 3.14 1.312 
Other (Nurse, Helpline Nurse, Radiotherapist)   13 2.92 1.498 
 
Time Taken to Diagnose 
Mean Rating of all Healthcare Professionals   557 3.49 1.370 
General Practitioner      151 3.00 1.400 
Breast Care Nurse      135 3.67 1.327  
Consultant      261 3.39 1.414 
Physiotherapist      120 3.39 1.416 
Occupational Therapist     27 3.52 1.282 
Lymphoedema Nurse Specialist    103 3.89 1.267 
MLD Therapist      51 3.22 1.433 
Other (Nurse, Helpline Nurse, Radiotherapist)   13 3.23 1.536 
 
Overall Satisfaction 
Mean Rating of all Healthcare Professionals   607 3.53 1.380 
General Practitioner      170 2.99 1.406 
Breast Care Nurse      140 3.80 1.259  
Consultant      284 3.43 1.411 
Physiotherapist      129 3.40 1.417 
Occupational Therapist     31 3.77 1.309 
Lymphoedema Nurse Specialist    112 3.94 1.232 
MLD Therapist      53 3.21 1.446 
Other (Nurse, Helpline Nurse, Radiotherapist)   13 3.38 1.446 
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Table 19: Average Ratings of Healthcare Professionals Consulted when Seeking Explanation 
of Symptoms, according to Type of Lymphoedema 
 
 
       n Mean SD 
Attitude  
All Respondents      605 3.57 1.341 
Primary Lymphoedema     43 2.93 1.421       
Non-Cancer-Related Secondary Lymphoedema   34 3.09 1.334   
Cancer-Related (but not BC-Related) Lymphoedema  58 3.45 1.404   
Breast-Cancer-Related Secondary Lymphoedema   435 3.70 1.292   
 
Knowledge 
All Respondents      596 3.63 1.356 
Primary Lymphoedema     42 2.74 1.449       
Non-Cancer-Related Secondary Lymphoedema   34 2.94 1.324   
Cancer-Related (but not BC-Related) Lymphoedema  56 3.29 1.423   
Breast-Cancer-Related Secondary Lymphoedema   432 3.82 1.279  
 
Practical Support 
All Respondents      573 3.59 1.357 
Primary Lymphoedema     41 2.68 1.404       
Non-Cancer-Related Secondary Lymphoedema   32 2.97 1.231   
Cancer-Related (but not BC-Related) Lymphoedema  53 3.34 1.400   
Breast-Cancer-Related Secondary Lymphoedema   415 3.77 1.298  
 
Emotional Support 
All Respondents      549 3.30 1.396 
Primary Lymphoedema     38 2.42 1.244       
Non-Cancer-Related Secondary Lymphoedema   33 2.70 1.311   
Cancer-Related (but not BC-Related) Lymphoedema  53 2.98 1.366   
Breast-Cancer-Related Secondary Lymphoedema   394 3.52 1.352  
 
Time Taken to Diagnose 
All Respondents      557 3.49 1.370 
Primary Lymphoedema     40 2.73 1.414       
Non-Cancer-Related Secondary Lymphoedema   32 2.50 1.586  
Cancer-Related (but not BC-Related) Lymphoedema  54 3.28 1.406   
Breast-Cancer-Related Secondary Lymphoedema   401 3.69 1.271  
 
Overall Satisfaction 
All Respondents      607 3.53 1.380 
Primary Lymphoedema     42 2.69 1.352       
Non-Cancer-Related Secondary Lymphoedema   35 2.91 1.358   
Cancer-Related (but not BC-Related) Lymphoedema  60 3.28 1.403   
Breast-Cancer-Related Secondary Lymphoedema   436 3.73 1.318  
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Participants with breast-cancer-related secondary lymphoedema were more satisfied with the 
healthcare professionals they consulted than participants with other types of lymphoedema. 
Participants with primary lymphoedema rated the healthcare professionals lowest on 
measures of attitude, knowledge, practical and emotional support and overall satisfaction, 
whereas patients with non-cancer-related secondary lymphoedema rated the healthcare 
professionals lowest in terms of time taken to diagnose them.   
 
It was intended to perform one-way ANOVAs to explore whether the difference in 
participants’ ratings were significantly different according to the type of lymphoedema they 
experience. The data did not violate the homogeneity of variance assumption of ANOVAs in 
the case of ratings of the professional’s attitude, practical support, emotional support and 
overall satisfaction. Therefore standard one-way ANOVAs were performed and are presented 
in Table 20 in addition to the associated effect sizes, calculated using eta squared. Given the 
discrepancy in the sample size in the groups the Welch one-way ANOVAs for these items are 
also presented.  In the case of knowledge and time taken to diagnose the Levene’s test 
indicated that the homogeneity of variance assumption had been violated. Therefore Welch 
one-way ANOVAs were performed and these are also presented below in Table 20. The 
results were highly significant in all cases indicating that participants’ ratings of these items 
were associated with the type of lymphoedema that they’re experiencing.  
 
Table 20: Inferential Statistics on Difference in Average Ratings of Healthcare Professionals of 
Healthcare Professionals Consulted when Seeking Explanation of Symptoms, according to 
Type of Lymphoedema 
 
 
   Standard ANOVA          Effect Size  Welch One-Way ANOVA  
Attitude   F (3,566) = 6.543 *         0.03 Small-Medium FW (3, 80.131) = 5.907 *  
Knowledge       FW (3, 78.422) = 12.386 *  
Practical Support  F (3,537) = 12.186*        0.06 Medium  FW (3, 75.662) = 11.440 *  
Emotional Support  F (3,514) = 11.999 *       0.06 Medium  FW (3, 76.211) = 12.773 *  
Time Taken to Diagnose      FW (3, 73.705) = 11.196 *  
Overall Satisfaction  F (3,569) = 12.055*        0.06 Medium  FW (3, 81.783) = 11.537 * 
    
*Significance at 0.001 level 
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A series of post hoc analyses were conducted in order to explore between which types of 
patients these significant differences occurred. Where the assumption of homogeneity of 
variance was not violated (i.e. in the case of professional’s attitude, practical support, 
emotional support and overall satisfaction) Tukey post-hoc tests were performed and where 
the assumption was violated (i.e. in the case of knowledge and time taken to diagnose) 
Dunnett’s T3 post-hoc tests were performed.  
 
The analyses revealed that primary lymphoedema patients (p=0.001 and p=0.001 
respectively) and patients with non-cancer-related secondary lymphoedema (p=0.04 and 
p=0.003 respectively) rated healthcare professionals significantly lower in terms of their 
attitude and overall satisfaction than patients with breast-cancer-related secondary 
lymphoedema. Primary lymphoedema patients (p=0.001) and patients with cancer-related 
(but not breast-cancer-related) secondary lymphoedema (p=0.005) rated healthcare 
professionals significantly lower in terms of their practical support than patients with breast-
cancer-related secondary lymphoedema. Primary lymphoedema patients (p=0.001), patients 
with non-cancer related secondary lymphoedema (p=0.004) and patients with cancer-related 
(but not breast-cancer-related) secondary lymphoedema (p=0.033) rated healthcare 
professionals significantly lower in terms of their emotional support than patients with breast-
cancer-related secondary lymphoedema. Primary lymphoedema patients (all had a 
significance level of p=0.001) and patients with non-cancer-related secondary lymphoedema 
(p=0.004 and p=0.001 respectively) rated healthcare professionals significantly lower in 
terms of their knowledge and time taken to diagnose than patients with breast-cancer-related 
secondary lymphoedema.  
 
Participants were asked to indicate which practitioner suggested that their symptoms might 
be indicative of lymphoedema. Although participants were asked to indicate only one 
practitioner, 80 participants ticked more than one box. The results are presented in Table 21 
on page 152.  
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Table 21: Healthcare Professionals who Diagnosed Participants  
 
 
Just over half of respondents were diagnosed by a consultant whereas a relatively low 
proportion of the sample was diagnosed by other healthcare professionals. This may reflect 
the relatively high proportion of the sample with breast-cancer-related secondary 
lymphoedema as these patients are more likely to be seeing a consultant. Once again a wide 
array of healthcare professionals is being consulted regarding this condition requiring many 
groups of healthcare professionals to be aware of lymphoedema, its treatment and the 
location of services. 
Information  
Participants were asked whether they had received information about lymphoedema from 
various sources following their diagnosis and if so, what types of information they had 
received. Participants were also asked how satisfied they were with this information. The 
results of these questions are presented in Table 22 on page 153.  
 
 
 
 
 
 
Diagnosing Healthcare Professionals (n=714) 
Consultant      50.3% 
Breast Care Nurse      15.0% 
Lymphoedema Nurse Specialist    14.3% 
Physiotherapist      13.6% 
General Practitioner      10.4% 
Occupational Therapist     3.6% 
Self-Diagnosed      2.4% 
Oncology Nurse      1.0% 
Friend/Relative      0.8% 
Radiotherapist      0.6% 
MLD Therapist      0.4% 
Radiologist      0.3% 
Other (e.g. Compression Garment Fitter or Unspecified)  0.3% 
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Table 22: Sources, Types and Satisfaction with Information Received Following Diagnosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
The main source of information for patients following their diagnosis was their lymphoedema 
practitioner, while very small proportions of the sample had received information from MLD 
Ireland, Lymphoedema Ireland, the Irish Cancer Society, their general practitioner, other 
websites and other sources. In terms of the content of the information received, over two-
thirds of the sample had received education on skincare, almost 40% had received education 
on when to seek further medical attention but only about one-fifth of the sample had 
received education on diet and how this can affect lymphoedema symptoms. Regarding 
satisfaction with information received, the majority of respondents were satisfied or very 
satisfied, however sizeable minority of 21.7% were dissatisfied or very dissatisfied with the 
information they received and the mean satisfaction rating was 3.52 which is close to the 
midpoint (SD=1.23, n=700).  
 
Participants were asked an open question on how the information lymphoedema patients 
receive could be improved and 357 participants responded. One of them main themes was 
that patients should be told in advance of medical treatment, specifically cancer treatment, 
Sources of Information (n=690) 
Lymphoedema Practitioner (i.e. Physiotherapist, OT, MLD Therapist etc.)  60.3% 
MLD Ireland Website      13.5% 
Other Lymphoedema Patients      13.0% 
Lymphoedema Ireland Website     12.2% 
General Practitioner       11.2% 
Lymphoedema Ireland Support Group Meetings    9.6% 
Lymphoedema Ireland Newsletters     9.6% 
Irish Cancer Society Helpline      6.2% 
Other Websites (e.g. UK, German, Australian, US websites)   5.7% 
Other (e.g. Booklet, Encyclopaedia, Books etc.)    4.3% 
 
Types of Information (n=713) 
Education on Skincare      69.0% 
Education on When to Seek Further Medical Attention   39.3% 
Education on Diet       22.4% 
------------------------------------------------------------------------------------------- 
Satisfied with Information Received (n=700) 
Very Dissatisfied 9.4%         Dissatisfied 12.3% Midpoint 18.0%       Satisfied 37.4% Very Satisfied 22.9% 
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that it may predispose them to developing lymphoedema. In addition some participants noted 
that the repetition of this information is important as patients’ distress following cancer 
diagnosis and treatment can result in them not being able to process that information 
initially:  
Participant 105 (with breast-cancer-related secondary lymphoedema): To tell us 
before cancer treatment that it can happen and not only in the arm.  
Participant 339 (with breast-cancer-related secondary lymphoedema): More 
information throughout the cancer journey/procedures. It is such an 
emotionally stressful time that it may take time to absorb the 
information.  
 
The second theme related to the presentation and content of the information in that it 
shouldn’t solely focus on the physical consequences of lymphoedema, for example:  
Participant 55 (with breast-cancer-related secondary lymphoedema): Information 
pack including Lymphoedema Ireland DVD could be given to 
patients at time of diagnosis.  
Participant 580 (with breast-cancer-related secondary lymphoedema): On diagnosis 
a simple booklet should be available, written in plain English, 
covering topics on (1) the diagnosis (2) what to expect ongoing (3) 
how you can help yourself through diet, skincare, exercise etc.  
Participant 731 (with non-cancer-related secondary lymphoedema): By being put in 
touch with other sufferers, given more all round information.  
 
The final theme related to the importance of informing healthcare professionals about 
lymphoedema to enable them to impart accurate information on the condition, for example:    
Participant 443 (doesn’t know type of lymphoedema): Probably informing GPs 
about lymphoedema so they could treat patients at local level and 
be more aware of the complaint.  
Lymphoedema Services 
Eighty-nine percent of respondents indicated that they have received lymphoedema 
treatment (n=720). However of the 76 participants who reported that they haven’t received 
lymphoedema treatment and who responded to items relating to types of treatment, 89.7% 
have had a compression garment prescribed for them (n=58), 77.6% use compression 
garments (n=58), 65.5% have been taught lymphoedema exercises (n=55), 43.6% have 
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been taught simple lymphatic drainage (SLD) (n=55), 12.5% have received manual lymphatic 
drainage (n=56), and 5.4% have received multi-layer lymphoedema bandaging (n=56). 
Therefore it is possible that this item was not accurately answered or that participants who 
have received compression garments, or have been taught exercises or SLD do not consider 
themselves to have received lymphoedema treatment as such. Many of the following results 
in this section are based on the 644 participants who indicated that they have received 
treatment unless otherwise specified.  
 
Sixty-five percent of respondents who indicated that they have received treatment received it 
in a public service, 15.2% in a private service and 20% attended a mix of public and private 
services (n=626). Participants were asked what setting their main lymphoedema service is in. 
Although participants were asked to tick one box, 28 participants ticked more than one. 
Seventy-eight percent reported that their lymphoedema service is in a hospital, 13.8% 
indicated that it is in a cancer support centre, 10.8% private practice, 2.3% community 
health centre and 0.2% indicated that it is in a lymphoedema clinic abroad (n=632).  
 
One potential barrier to accessing treatment is distance. Participants reported that on average 
they had to travel 27.88 kilometres in a one way trip to their lymphoedema service 
(SD=34.27, Range=1-250km, n=550). Nineteen percent of respondents reported that travel 
distance did limit their ability to avail of lymphoedema treatment (n=610).  
 
Participants were asked what type of practitioner provides the treatment in their main 
lymphoedema service. Forty respondents ticked more than one box. Thirty-seven percent 
indicated that a physiotherapist is their main lymphoedema practitioner, 30.6% ticked 
lymphoedema nurse specialist, 23.6% MLD therapist, 12.7% occupational therapist, 0.5% 
general practitioner, 0.3% garment distributors, 0.2% consultant, 0.2% breast care nurse, 
0.2% an amatsu massage therapist, 0.2% chemist, 0.2% tissue viability nurse, 0.2% nurse in 
health centre, 0.2% and other – not specified (n=614). Again this indicates that a number of 
healthcare professionals can be involved in the care and treatment of lymphoedema patients.  
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Participants who had received treatment were asked to rate the practitioner in their main 
lymphoedema service on a Likert scale from 1 to 10 in various categories and the frequencies 
are presented in Table 23. Over 78% of respondents rated the practitioner in their main 
lymphoedema service as 7 or higher on all measures.  
 
Table 23: Frequency Responses in Ratings of Practitioners in Main Lymphoedema Service 
 
 
The means and the breakdown according to those who indicated one of the three main 
professions associated with the treatment of lymphoedema - physiotherapist, occupational 
therapist or MLD therapist, are presented in Table 24 on pages 157 and 158. Overall, 
practitioners were rated highest in terms of their attitude, confidence and competence; and 
lowest in terms of emotional support, time taken to diagnose and practical support.  
 
 
 
 
 
 
 
 n  1 2 3 4 5 6 7 8 9 10 
Knowledgeable 598 1.8% 0.7% 1.0% 1.8% 2.7% 1.8% 5.9% 11.5% 11.7% 61.0% 
Competent 589 0.8% 0.7% 1.2% 1.4% 2.0% 1.9% 4.4% 10.9% 13.6% 63.2% 
Experienced 591 1.5% 1.2% 1.2% 1.4% 2.4% 2.0% 5.2% 9.5% 13.9% 61.8% 
Confident 592 0.7% 1.0% 1.0% 1.4% 2.2% 1.7% 5.1% 9.5% 13.2% 64.4% 
Attitude 586 1.2% 1.0% 0.9% 0.7% 2.7% 2.0% 3.4% 8.9% 11.6% 67.6% 
Practical Support 586 2.7% 1.2% 1.4% 1.4% 2.7% 3.1% 6.5% 12.1% 12.8% 56.1% 
Emotional Support 564 5.3% 2.5% 1.6% 1.4% 5.9% 5.3% 7.1% 9.9% 9.6% 51.4% 
Time Available 586 2.4% 1.7% 2.0% 2.2% 6.8% 3.2% 5.3% 9.2% 12.5% 54.6% 
Overall Satisfaction  598 2.8% 1.1% 1.3% 0.7% 4.4% 3.1% 3.8% 11.7% 12.5% 58.6% 
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Table 24: Patients’ Mean Ratings of their Main Lymphoedema Practitioners  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      n Mean SD 
Knowledgeable 
All Respondents     581 8.89 1.929 
Physiotherapist     196 8.85 1.914 
Occupational Therapist    69 8.74 1.899  
MLD Therapist     115 9.19 1.420 
 
Competent 
All Respondents     571 9.07 1.696 
Physiotherapist     194 8.96 1.675 
Occupational Therapist    65 9.18 1.424 
MLD Therapist     115 9.24 1.455 
 
Experienced 
All Respondents     575 8.95 1.909 
Physiotherapist     194 8.86 1.992 
Occupational Therapist    65 8.83 1.701 
MLD Therapist     115 9.23 1.512 
 
Confident 
All Respondents     574 9.09 1.702 
Physiotherapist     193 8.99 1.718 
Occupational Therapist    66 8.98 1.767 
MLD Therapist     115 9.33 1.275 
 
Attitude  
All Respondents     569 9.14 1.722 
Physiotherapist     193 9.09 1.731 
Occupational Therapist    62 9.23 1.453 
MLD Therapist     115 9.26 1.499 
 
Practical Support Provided 
All Respondents     568 8.69 2.135 
Physiotherapist     189 8.72 2.008 
Occupational Therapist    65 8.32 2.251 
MLD Therapist     111 8.94 1.744 
 
Emotional Support Provided 
All Respondents     548 8.14 2.637 
Physiotherapist     185 7.93 2.760 
Occupational Therapist    57 7.56 3.082 
MLD Therapist     110 8.37 2.334 
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Table 24: Patients’ Mean Ratings of their Main Lymphoedema Practitioners (continued)  
 
 
 A series of one-way ANOVAs were performed to ascertain whether there was a difference in 
participants’ ratings according to which type of healthcare professional is their main 
lymphoedema practitioner however none of these were significant.  
 
All participants were asked to rate the standard of care they are receiving on a Likert scale 
from 1 – ‘very low’ to 5 – ‘very high’. The frequency of various responses is presented in 
Table 25. While 74.3% of respondents with breast-cancer-related secondary lymphoedema 
rated the standard of care they’re receiving as high or very high, 47.8% of respondents with 
primary lymphoedema rated likewise.  
 
Table 25: Frequencies of Participants’ Ratings of the Standard of Care They are Receiving  
 
The mean ratings are presented in Table 26 on page 159.  
 
 
 n V Low Low Midway  High V High 
All Respondents 645 7.4% 5.1% 18.3% 36.4% 32.7% 
Participants Who Have Received Lymphoedema Treatment 586 5.8% 4.3% 17.6% 37.7% 34.6% 
Participants Who Haven’t Received Lymphoedema Treatment 52 23.1% 9.6% 26.9% 26.9% 13.5% 
 
Primary Lymphoedema 44 25.0% 2.3% 25.0% 27.3% 20.5% 
Non-Cancer-Related Secondary Lymphoedema 34 11.8% 8.8% 26.5% 26.5% 26.5% 
Cancer-Related (not-BC-Related) Secondary Lymphoedema 56 10.7% 5.4% 17.9% 32.1% 33.9% 
Breast-Cancer-Related Secondary Lymphoedema  475 4.8% 3.4% 17.5% 38.9% 35.4% 
 
      n Mean SD 
Time Available to Deal with You 
All Respondents     568 8.46 2.328 
Physiotherapist     192 8.35 2.477 
Occupational Therapist    65 8.35 2.146 
MLD Therapist     110 8.51 2.204 
 
Overall Satisfaction 
All Respondents     591 8.74 2.146 
Physiotherapist     200 8.67 2.082 
Occupational Therapist    69 8.65 1.939 
MLD Therapist     117 8.93 1.874 
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Table 26: Patients’ Ratings of the Standard of Care they are receiving 
 
 
 
 
 
 
 
Consistent with previous findings, patients with breast-cancer-related secondary 
lymphoedema gave the highest rating of the standard of care they are receiving whereas 
patients with primary lymphoedema gave the lowest rating of the standard of care they are 
receiving when compared with patients with other forms of lymphoedema. However the 
highest mean rating is still below the score of 4, which represents a high standard of care.  
 
The Welch one-way ANOVA was performed to ascertain whether there was a significant 
difference in ratings of standard of care according to type of lymphoedema. This was found 
to be highly significant: FW (3, 75.630) = 5.838, p=0.001. Post hoc analysis revealed that 
participants with primary lymphoedema rated their standard of care significantly lower than 
participants with breast-cancer-related secondary lymphoedema (p=0.005).  
Lymphoedema Treatments 
Participants were asked how soon after their lymphoedema diagnosis they received treatment 
and how many months since they last received lymphoedema treatment. The results are 
presented below in Table 27 on page 160.  
 
 
 
 
 
 
        n Mean SD 
All Respondents       645 3.82 1.163  
Participants Who Have Received Lymphoedema Treatment   586 3.91 1.100 
Participants Who Haven’t Received Lymphoedema Treatment   52 2.98 1.365 
 
Patients with Primary Lymphoedema      44 3.16 1.462 
Patients with Non-Cancer-Related Secondary Lymphoedema   34 3.47 1.308 
Patients with Cancer-Related (not-BC-Related) Secondary Lymphoedema 56 3.73 1.286 
Patients with Breast-Cancer-Related Secondary Lymphoedema   475 3.97 1.049 
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Table 27: Time between Diagnosis and First Treatment and Time since Last Treatment 
 
 
Overall respondents were waiting 42 weeks, approximately 10 months, for treatment 
following their lymphoedema diagnosis. However if we consider how long participants with 
various types of lymphoedema were waiting, participants with primary lymphoedema were 
waiting on average nearly 4 years for treatment while participants with breast-cancer-related 
secondary lymphoedema were waiting on average nearly 25 weeks– still a considerable 
length of time at approximately 6 months. The Welch one-way ANOVA was performed to 
ascertain if there was a significant difference in waiting time according to type of 
lymphoedema. This was highly significant: FW (3, 60.198) = 3.943, p=0.012. Post hoc 
analysis revealed that primary lymphoedema patients were waiting longer than patients with 
breast-cancer-related secondary lymphoedema and this result approached significance 
(p=0.067). However it is worth noting the very large ranges and standard deviations 
associated with these means, which suggests that there is huge variation in time spent 
waiting even among patients with the same category of lymphoedema.  
 
A Pearson product-moment correlation coefficient was performed to ascertain if the 
relationship between time since diagnosis and time between diagnosis and first treatment 
was significant. There was a strong positive correlation between the two variables, r=0.558, 
n=499, p=0.01 and time since diagnosis helped to explain 34.57% of the variance in time 
        n Mean   SD Range 
Time between Diagnosis and First Treatment (in Weeks) 
All Respondents       536 42.80 142.62 0-1560  
Participants Who Have Received Lymphoedema Treatment   514 41.63 143.15 0-1560 
Patients with Primary Lymphoedema     35 199.83 388.72 0-1560 
Patients with Non-Cancer-Related Secondary Lymphoedema   25 94.40 163.24 0-676 
Patients with Cancer-Related (not-BC-Related) Secondary Lymphoedema 51 34.39 64.12 0-364 
Patients with Breast-Cancer-Related Secondary Lymphoedema   396 24.62 86.40 0-1040 
 
Time since Last Treatment (in Months) 
All Respondents       579 10.17 33.51 0-540  
Participants Who Have Received Lymphoedema Treatment   554 9.13 25.54 0-360 
Patients with Primary Lymphoedema     43 34.05 99.09 0-540 
Patients with Non-Cancer-Related Secondary Lymphoedema   29 10.21 17.30 0-72 
Patients with Cancer-Related (not-BC-Related) Secondary Lymphoedema 52 7.40 11.22 0-68 
Patients with Breast-Cancer-Related Secondary Lymphoedema   424 7.68 19.09 0-229 
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between diagnosis and first treatment. This indicates that participants who have been 
diagnosed more recently are seen quicker. This may suggest a greater availability of services 
and practitioners which enables quicker treatment. Alternatively participants who have been 
diagnosed more recently may have more accurate recall of the time taken to receive 
treatment following their diagnosis.  
 
On average respondents received their last treatment 10.17 months ago. Patients with 
primary lymphoedema had their last treatment on average 34.05 months ago whereas 
patients with cancer-related (but not breast-cancer-related) secondary lymphoedema had 
their last treatment 7.4 months ago. Again the ranges and standard deviations are quite large 
particularly for patients with primary lymphoedema which suggests that there is huge 
variation in the time since treatment has been received even among patients with the same 
type of lymphoedema. The Welch one-way ANOVA was performed to ascertain if there was a 
significant difference in time since last treatment according to type of lymphoedema. The 
result was not significant: FW (3, 74.889) = 1.198, p=0.317. 
 
Compression Garments 
Ninety-five percent of respondents reported that they had been prescribed a compression 
garment (n=705). Eighty-eight percent of respondents reported that they currently use 
garments (n=694). Participants who currently use garments reported that they are using on 
average 2.47 garments (SD=1.46, Range=0-12, n=573). The broad range may reflect the 
fact that several participants have lymphoedema in several limbs or that some participants 
experience greater fluctuation in their swelling and therefore require a greater number of 
garments.   
 
Forty-five percent of respondents who currently use garments are using off-the-shelf 
garments, 31.1% are using custom-made or made-to-measure garments, 18.6% are using 
both types of garments and 5.1% didn’t know what type of garments they are using (n=591). 
Participants who currently use garments reported that they have to wait on average 22.82 
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days for garments to be delivered (SD=51.41, Range=0-730, n=439). When type of garment 
is taken into consideration, participants who currently use off-the-shelf garments have to wait 
on average 15.62 days (SD=37.58, Range=0-365, n=181) whereas those using custom-made 
garments have to wait on average 25.87 days (SD=29.05, Range=0-210, n=156). Given the 
huge ranges and standard deviations, this again suggests that different patients have very 
different experiences of garment provision which could interfere with their ability to follow 
their lymphoedema management plan.  
 
One potential barrier to using compression garments, particularly for ageing patients with 
arthritis can be the application of the garments. Eighteen percent of participants who 
currently use garments reported that they need another person to help them put on and take 
off their garments (n=593), while 15.5% use an assistive device for this purpose (n=595).  
 
When asked how often they wear their garments, 63.8% of participants who currently use 
garments wear them daily but not at night, 22.5% wear them some of the time, when doing 
chores etc., 6.8% wear them rarely, 4.3% wear them all the time 24 hours a day, 0.7% wear 
them only when swelling is bad or when travelling or on a flight, and 0.2% wear them for 
each of the following: for 6 hours during the day, for 1-2 hours daily,  when walking, every 
other day, or never (n=605). 
 
Participants who currently use garments were asked if they wear their garment during 
various activities. The results for those who currently use garments and for when the activity 
was deemed relevant are presented in Table 28 on page 163. There appears to be relatively 
high use of compression garments during chores or flights but relatively low use of 
compression garments while socialising, child minding and during employment, sports or 
hobbies among respondents.   
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Table 28: Use of Compression Garments during Various Activities 
 
 
Participants who currently use garments were also asked if they wear their compression 
garment as often as they have been advised to and 75.1% indicated that they do (n=571). 
The 142 participants, who don’t wear the compression garment as often as they have been 
advised to, were asked for the reasons why, in order to explore the barriers to compliance 
with recommendations that compression garments should be worn. Fifty-four percent 
reported that they find the compression garment uncomfortable, 33.6% consider the 
garment unsightly, 22.9% find the garment difficult to put on or take off, 38.6% reported 
that they don’t need to wear the garment all the time to maintain the swelling at a 
comfortable level and 25.7% gave another reason - the compression garment is too tight, 
too hot or a poor fit; causes pain or additional swelling; isn’t practical for activities or chores; 
the garment is reminder that they have been ill or had cancer and invites questions from 
others; and because they have forgotten to wear it (n=140).  
 
Participants who currently use garments were asked to rate their satisfaction with various 
aspects of their compression garments on a Likert scale from 1 – ‘very dissatisfied’ to 5 – 
‘very satisfied’. The frequency of the various responses is presented in Table 29 on page 164. 
Although the majority of respondents scored the garments as neutral or better, a sizeable 
           n % who wear a Garment 
Walking       506  72.1% 
Swimming      349  14.0% 
Other Sports Activities     337  49.6% 
Social Activities (e.g. Visiting Friends)    530  61.5% 
Daily Household Indoor Chores (e.g. Cleaning, Hoovering)  548  82.5% 
Daily Household Outdoor Chores (e.g. Shopping, Gardening)  535  81.9% 
Taking Care of Children     333  51.7% 
Personal Care (e.g. Taking a Shower, Combing Hair etc.)  508  14.0% 
Taking a Flight      501  84.2% 
When on Holidays      497  70.6% 
Employment/Occupation     353  56.7% 
Other (e.g. While Driving, Playing Musical Instruments,   170  18.8% 
Doing Craftwork, When Standing for Long Periods or When Sleeping)  
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minority of approximately or greater than 20% in almost all cases were dissatisfied or very 
dissatisfied, particularly with compression garments’ appearance and temperature.  
 
Table 29: Frequency of Participants who are currently using Garments’ Responses in Ratings 
of Compression Garments  
 
 
The mean results are presented in Table 30. Participants rated the compression garments 
lowest in terms of appearance when worn, temperature and comfort, and rated them highest 
in terms of fit, quality and overall satisfaction. However all of the scores clustered around 3, 
the midpoint score.  
 
Table 30: Mean Ratings of Compression Garments  
 
 
The international consensus of lymphoedema practitioners is that an individual with one 
lymphoedematous limb should receive a minimum of two garments every three to six months 
    n V Dissatisfied    Dissatisfied   Neutral   Satisfied V Satisfied 
Colour 567 7.4% 13.6% 22.0% 44.4% 12.5%  
Appearance  551 12.3% 18.5% 27.4% 33.8% 8.0% 
Comfort 557 7.0% 16.0% 18.1% 48.8% 10.1%  
Fit 548 4.0% 10.9% 12.6% 59.3% 13.1% 
Texture 535 6.5% 13.3% 21.7% 48.4% 10.1% 
Temperature 528 6.8% 20.5% 22.3% 43.6% 6.8% 
Quality 526 3.6% 7.4% 21.5% 54.4% 13.1% 
Value for Money 455 6.6% 10.8% 25.5% 41.8% 15.4% 
Overall  534 4.7% 8.8% 20.0% 52.1% 14.4% 
      n Mean SD 
Colour      567 3.41 1.100 
Appearance when Worn    551 3.07 1.155 
Comfort      557 3.39 1.087 
Fit      548 3.67 0.973 
Texture      535 3.42 1.052 
Temperature     528 3.23 1.065 
Quality       526 3.66 0.924 
Value for Money     455 3.49 1.082 
Overall Satisfaction     534 3.63 0.990 
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or even more frequently if the patient is active (MEP, 2006). This permits the washing of one 
garment while another is worn and ensures that the level of compression provided by the 
garment is optimal. Thirty-four percent of respondents who currently use compression 
garments receive two garments per year from their main lymphoedema service, 25.9% 
receive two every six months, 14.6% don’t receive any, 14.3% receive one per year, 3.4% 
only ever received two garments, 3.2% only ever received one garment, 2.6% receive 
garments as needed, 0.8% receive 2 every 4 months, 0.6% receive 2-3 every 3 months, 
0.4% receive 3 per year, 0.2% receive 3 over 6 years, 0.2% receive 4 every 6 months, and 
0.2% originally received 2 every 6 months but has received none since (n=533). A relatively 
high proportion of respondents (70.1%) do not receive the minimum amount of compression 
garments from their main lymphoedema service.   
 
Sixty-one percent of those who currently use garments have a medical card (n=599), and of 
those approximately one-fifth (18%) considered that HSE approval procedures for the 
expenses of medical card holders slowed down the delivery of their compression garments 
(n=311).  
 
Participants who currently use garments were asked how much they spend of their own 
money per calendar year on compression garments. Fifty-eight percent of the 366 
respondents to that question don’t pay anything towards their compression garments. Those 
who do pay reported that they spend on average €165.94 of their own money per calendar 
year on compression garments (Range=2-1000, SD=164.01, n=154). Given the large range 
and standard deviation, it appears that there is a huge variation in the financial burden on 
patients.  For example the participant who reported spending €1,000 per year explained that 
due to weight loss and difficulties in getting an appropriate fit for her swelling meant that she 
regularly needs new compression garments. Furthermore, only 5 participants who currently 
use garments have private health insurance that contributes towards the cost of compression 
garments and on average these respondents receive €188 from their insurer (SD=141.67, 
Range=50-410, n=5).  
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Participants were asked how often they replace their garments. Fifteen percent of 
respondents replace their garments less than once a year, 20.7% replace them once a year, 
50.8% replace twice a year, 6.5% three times a year, 5.1% four times a year, and 1.8% 
more than four times a year (n=508). Seventeen percent indicated that the cost of garments 
affected whether they replaced them, 33.3% reported that cost didn’t affect whether they 
replaced their garments and 49.5% reported that it wasn’t applicable as they don’t pay for 
garments (n=550). However as mentioned previously those relying purely on garments from 
their main lymphoedema service may not be receiving a sufficient number of garments to the 
appropriately manage their condition.  
 
Nine percent of respondents who currently use garments reported having difficulties getting 
re-measured (n=524). The reasons for this included practitioners being too busy to measure 
patients; lymphoedema services being discontinued, patients not knowing where to go to be 
re-measured and finally that due to cutbacks in hospital services there is no funding for the 
appropriate custom-made compression garment.   
 
Finally participants who currently use garments were asked to rate their satisfaction with the 
process of receiving garments on a Likert scale from 1 – ‘very dissatisfied’ to 5 – ‘very 
satisfied’. The mean ratings are presented below in Table 31.  
 
Table 31: Ratings of Satisfaction with the Process of Receiving Compression Garments  
 
  
The mean rating of the total group of those who currently use compression garments was 
3.62, which is above the midpoint level. It is interesting to note the disparity between the 
        n Mean SD 
Participants who currently use Compression Garments   575 3.62 1.189 
Patients with Primary Lymphoedema     41 3.17 1.395  
Patients with Non-Cancer-Related Secondary Lymphoedema   28 3.25 1.323  
Patients with Cancer-Related (not-BC-Related) Secondary Lymphoedema 53 3.09 1.148  
Patients with Breast-Cancer-Related Secondary Lymphoedema   417 3.74 1.136  
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ratings of patients with breast-cancer-related secondary lymphoedema when compared with 
patients with other types of lymphoedema. Patients with cancer-related (but not breast-
cancer-related) secondary lymphoedema rated their satisfaction with the process of getting 
compression garments the lowest. Again the homogeneity of variance assumption was 
violated so a Welch one-way ANOVA was performed and found to be highly significant: FW (3, 
72.254) = 6.916, p=0.001. Post hoc analysis revealed that participants with cancer-related 
(but not breast-cancer-related) secondary lymphoedema rated their satisfaction significantly 
lower than participants with breast-cancer-related secondary lymphoedema (p=0.002). 
Lymphoedema Exercises and Simple Lymphatic Drainage  
Eighty-one percent of respondents reported that they had been taught how to perform 
specific lymphoedema exercises (n=695), whereas 52.8% of respondents reported that they 
had been taught how to perform specific simple lymphatic drainage (SLD) or self-massage 
(n=684). The 563 participants who had been taught exercises and the 361 participants who 
had been taught SLD were asked to tick one box to indicate how they were taught these 
exercises or SLD. However 46 of respondents who were taught exercises and 22 participants 
who were taught SLD ticked more than one box. Participants were also asked in an open 
question how often they perform the specific lymphoedema exercises and SLD. The results of 
these questions are presented in Table 32 on page 168. 
 
The majority of respondents were taught lymphoedema exercises or SLD in a once-off 
individual consultation whereas a very small proportion had been taught in repeated 
consultations or provided with a book, leaflet or DVD to enable them to revise their 
technique. The majority of respondents indicated that they perform exercises or SLD on a 
daily basis. 
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Table 32: Lymphoedema Exercises and Simple Lymphatic Drainage  
 
 
 
Manual Lymphatic Drainage and Multi-Layer Lymphoedema Bandaging 
Fifty-six percent of respondents reported that they had received manual lymphatic drainage 
(MLD) a specialised form of massage of the treatment of lymphoedema (n=670). 35.4% of 
respondents reported that they had received multi-layer lymphoedema bandaging (MLLB) 
(n=667). The number of times respondents have received MLD and MLLB are presented in 
Table 33 on page 169.  
 
There appears to be considerable variation in lymphoedema patients’ access to MLD and 
MLLB.  The most common responses were that participants receive MLD every 2-3 months 
and have received MLLB only 1-3 times.  
 
 
 
      Lymphoedema Exercises  Simple Lymphatic Drainage 
Method that Exercises/SLD were taught to Participants (n= 519)   (n=326)   
Once-Off Individual Consultation with Practitioner   52.0%   60.4% 
Repeated Individual Consultations with Practitioner  30.1%   29.8% 
Written Format      17.9%   9.5% 
DVD        7.7%   4.9% 
Group Consultation       2.1%   2.5% 
 
How often Exercises/SLD are performed by Participants (n= 511)    (n=335) 
Daily       51.5%   40.3% 
‘Very Often’      0.2%   0.3% 
‘As Often as Possible’     1.0%   0.6% 
Twice a Week      1.6%   2.7% 
3-4 Times a Week      10.0%     - 
Once a Week      3.9%   6.6% 
Once Every Two Weeks       -   0.3% 
Occasionally      4.9%   5.1% 
Once a Month        -   0.9% 
When the Swelling is Bad     6.8%   7.5% 
Twice a Year      0.4%   0.4% 
Not Performed Often     13.7%   16.1% 
Before Leaving the Hospital Only    0.2%     - 
Never       5.9%   10.4% 
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Table 33: Manual Lymphatic Drainage and Multi-Layer Lymphoedema Bandaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How Often Participants have Received These Treatments  MLD  MLLB 
        (n=361)  (n=208) 
Not Received Regularly or Intensively    
1-3 Times        13.0%  31.3% 
4-9 Times        4.6%  2.9% 
10-19 Times       0.6%  0.5% 
 
Received Regularly 
Once a Year       5.6%  9.6% 
Once Every 6 Months      9.6%  8.7% 
Once Every 4 Months      0.3%    - 
Once Every 2-3 Months      23.1%  5.3% 
Once Every 6 Weeks      1.2%  0.5% 
Once a Month       16.1%  6.8% 
2-3 Times a Month       7.6%  3.8% 
Once a Week       4.3%  2.4% 
 
Intensive Treatment Once or Twice 
Intensive Treatment of 3-5 Times for One Week Once   0.6%  0.5% 
Intensive Treatment of 3-5 Times for More than One Week Once  6.0%  5.4% 
Intensive Treatment of 3-5 Times for More than One Week Twice    -  0.5% 
 
Intensive Treatment Once a Year or Less Frequently 
Twice a Week for 6 Weeks Every Other Year    0.3%  0.5% 
Intensive Treatment of 3-5 Times for One Week, Once a Year  2.9%  5.8% 
Intensive Treatment of 3-5 Times for More than One Week, Once a Year 3.2%  3.9% 
 
Intensive Treatment Every Four/Six Months 
Intensive Treatment of 3-5 Times for One Week, Every Four Months  0.3%    - 
Intensive Treatment of 3-5 Times for One Week, Every Six Months  1.7%  3.4% 
Intensive Treatment of 3-5 Times for More than One Week, Every Four Months   -  0.5% 
Intensive Treatment of 3-5 Times for More than One Week, Every Six Months 0.8%  1.4% 
 
Other Intensive Treatment  
5 Times Per Week for 2 Months, 4 Times Per Week for 3 Months etc.  0.3%    - 
Once a Week for One Month or 6 Weeks Twice a Year   0.9%    - 
 
Other 
Twice a Week in November, January and February Abroad   0.3%    - 
As Needed – When Swelling is Bad     0.9%  2.4% 
When MLD doesn’t work sufficiently after an infection     -  0.5% 
Privately - As Required; In Hospital Only in Extreme Circumstances    -  0.5% 
As Often as I can afford it      0.3%  0.5%  
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Participants who have received MLLB reported that on average they spent €39.80 of their 
own money on bandages to enable them to receive MLLB from their lymphoedema 
practitioner (SD=116.96, Range=0-1000, n=125). Only 1.5% of these participants reported 
that they had received assistance from their private health insurer to assist them in paying for 
these bandages (n=199). None of these participants indicated how much money they have 
received from their private health insurer. 
 
Sixty-four participants or 29.1% of respondents who have received MLLB reported that they 
had been taught how to self-bandage (n=220)  and of those, 48.3% had been taught in a 
once-off individual consultation with their lymphoedema practitioner, 44.8% had been taught 
in repeated individual consultations, and 6.9% were taught in a group consultation (n=58). 
None of the respondents reported being provided with a book, leaflet or DVD to enable them 
to revise their technique. 
Cost of Treatments 
Ten percent of respondents reported that they pay a fee to see the practitioner in their main 
lymphoedema service (n=634).  The mean amounts paid by participants for initial and review 
consultations, sessions of intensive treatments of MLD or MLLB, or home visits varied 
between €60 and €75. Eighty-six percent of respondents who pay a fee to see their 
lymphoedema practitioner reported having private health insurance (n=62) and of those 
25.5% indicated that their health insurer pays money towards their consultation fees (n=51). 
However financial support from private health insurers were subject to certain stipulations, 
e.g. the lymphoedema treatment being classified as ‘physiotherapy’, and a limit to how much 
could be claimed.  
 
Participants were then asked an open question on the cost of lymphoedema treatments in 
general. A total of 307 participants responded. While the majority of respondents indicated 
that they don’t pay for treatment, the first theme related to the difficulties these patients 
would encounter if they were required to pay for their treatment:  
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Participant 105 (with breast-cancer-related secondary lymphoedema): During the 
first 1.5 years when I was waiting to be treated in the hospital I 
saw private physios to do MLD. I spent approximately €2,000 on 
treatment – it nearly bankrupted us.  
Participant 133 (with breast-cancer-related secondary lymphoedema): Luckily I 
have my treatment at the hospital. The one time I went to an MLD 
private person it cost €60. If there wasn’t any other person to go to 
I would not be able to afford private treatment.  
Participant 178 (with breast-cancer-related secondary lymphoedema): I am lucky to 
receive treatment in the hospital … I could not pay for this privately 
– it should be available to all in need.  
Participant 585 (with breast-cancer-related secondary lymphoedema): For someone 
on average 3 day/week employment with other health problems as 
well, it could become costly, once the medical card is no longer 
available! 
 
The second theme related to respondents who do pay for their treatment viewing the 
treatment as essential to their wellbeing:  
Participant 260 (with breast-cancer-related secondary lymphoedema): Expensive 
but well worth the money in terms of service provided… 
Participant 522 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): Recognise the value in what I receive but wonder 
about which could be covered/contribution from insurance.   
Participant 524 (with breast-cancer-related secondary lymphoedema): They are 
expensive but these therapists paid for their own training and had 
to get it abroad, so for the relief of discomfort and body distortion I 
would pay anything to look NORMAL in my clothes.  
 
The final theme related to the views of the sizeable minority of respondents who reported 
experiencing great difficulty in paying for the treatment of this chronic condition: 
Participant 15 (with breast-cancer-related secondary lymphoedema): Very 
expensive, couldn’t afford it so didn’t go anymore.  
Participant 87 (with breast-cancer-related secondary lymphoedema): As a life-time 
condition, one will never be finished with treatment so costs are 
ongoing.  
Participant 195 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): I have had to borrow to pay €300 per week for 
intensive treatment and €285 for made to measure stockings and 
€100+ for bandages. I’m disgusted and won’t be able to do this on 
an ongoing basis.  
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Participant 310 (with primary lymphoedema): Costs other than treatment significant 
– have to have trousers (custom) made etc.  
Participant 511 (with breast-cancer-related secondary lymphoedema): It is 
prohibitive. I have to think really hard before going for treatment 
and go less often and receive fewer garments than I would like 
to/need.  
Treatment Abroad 
Twenty-two participants or 3.3% of respondents reported having gone abroad for 
lymphoedema treatment (n=662).  Forty-two percent of those who had gone abroad for 
treatment had done so once, 10.5% had gone abroad for treatment twice, 21.1% went three 
times, 10.5% went four times, 10.5% went five times and 5.3% went 6 times (n=19). On 
average participants had gone abroad for treatment 2.53 times (n=19). Sixty-three percent 
reported having received financial assistance for their trip from the HSE, whereas the 
remaining 36.8% reported receiving no assistance (n=19). Fourteen participants wrote 
comments about the financial assistance they had received for accessing lymphoedema 
treatment abroad or the difficulties they had experienced in accessing treatment abroad: 
Participant 618 (with breast-cancer-related secondary lymphoedema): The HSE 
funded me completely. I only paid my flight and for my 
compression garment and daily rate for accommodation. 
Participant 54 (with primary lymphoedema): Had to chase HSE/put a very strong 
case forward/numerous letters and follow up required as well as 
medical letter of referral.  
Participant 418 (with primary lymphoedema): (Funding) was very difficult to obtain 
and did not cover the full cost.  
Participant 217 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): Very expensive, airport runs, phone calls home and 
very lonely abroad! 
 
While other participants who hadn’t accessed treatment abroad commented that accessing 
treatment abroad is not a suitable solution for patients:  
Participant 463 (with non-cancer-related secondary lymphoedema): Very hard to 
get, first you have to get a lot of forms fill in by doctors and the 
HSE could take weeks (to approve it). But going abroad is not the 
answer; we could (provide treatment) a lot better here in (this) 
country (rather) than going abroad (for treatment). 
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General Comments on Lymphoedema Treatments 
Participants were asked whether they receive sufficient treatment to manage their 
lymphoedema effectively. The results are presented below in Table 34.  
 
Table 34: Participants who Indicated that They Receive Sufficient Treatment to Manage Their 
Lymphoedema Effectively 
 
Sixty-seven percent of patients with breast-cancer-related secondary lymphoedema 
considered themselves as receiving sufficient treatment whereas 47.8% of primary 
lymphoedema patients considered themselves as receiving sufficient treatment. A Chi-square 
test for independence was performed and indicated a significant association between type of 
lymphoedema and whether participants considered themselves to be receiving sufficient 
treatment: x2(3, n=559) = 15.660, p=0.001, Cramer’s V=0.167 indicating a small-medium 
effect size (Pallant, 2007). This represents the fact that based on the odds ratio patients with 
breast-cancer-related secondary lymphoedema were 2.20 times more likely than patients with 
cancer-related (but not breast-cancer-related) secondary lymphoedema, 2.17 times more 
likely than patients with non-cancer-related secondary lymphoedema, and 2.11 times more 
likely than primary lymphoedema patients to indicate that they receive sufficient treatment 
(Field, 2005).  
 
Participants were asked an open question on how lymphoedema services could be improved 
and 439 participants responded. The themes, subthemes and illustrative responses are 
presented in Figure 6 on page 174.  The themes related to the need for more practitioners 
and services, equitably distributed and provided services, emotional support and increased 
awareness of lymphoedema and lymphoedema services among various groups.  
         n    % 
All Respondents        598 61.2%  
Participants Who Pay a Fee to See their Lymphoedema Practitioner   60 40.0% 
Patients with Primary Lymphoedema      46 47.8% 
Patients with Non-Cancer-Related Secondary Lymphoedema    33 48.5% 
Patients with Cancer-Related (not-BC-Related) Secondary Lymphoedema  54 48.1% 
Patients with Breast-Cancer-Related Secondary Lymphoedema    426 67.1% 
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Figure 6: Themes, Subthemes and Quotes from Patients in Response to the Open Question on How Lymphoedema Services could be improved 
   Themes      Subthemes      Illustrative Quotes 
  
 
 
Increased Funding 
 
Equitable Services 
 
More Information about 
Lymphoedema and 
Lymphoedema Services  
To Provide More Treatments, Garments 
and Bandaging  
To Provide More Practitioners to Enable 
Provision of More Services  
To Support Patients with the Cost of 
Treatments and Associated Expenses 
Distributed Throughout the Country  
Provided to Patients with all Types of 
Lymphoedema 
 
Provided to Healthcare Professionals 
Provided to Lymphoedema Patients 
Provided to Those At-Risk and To the 
General Public 
Participant 46 (with breast-cancer-related secondary lymphoedema): There needs to be 
more physios performing MLD, there is too long a waiting list to get same. 
Participant 195 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): More compression garments provided … At least 2 x 6 week 
intensive treatments provided by HSE per year if needed, Free bandages…  
Participant 551 (with breast-cancer-related secondary lymphoedema): Cancer and 
lymphoedema themselves are traumatic enough without being worried as to 
cost of travel to and from venue.  
________________________________________ 
Participant 97 (with cancer-related but not breast-cancer-related secondary lymphoedema): 
Improved geographic distribution of clinics. 
Participant 230 (with primary lymphoedema): If MLD therapists or specialist lymphoedema 
nurses or physiotherapists could be accessed through local clinics it would be 
simpler.  
 Participant 48 (with non-cancer-related secondary lymphoedema): More MLD as people 
with cancer get seen first there is no one in (name of hospital) that does 
(MLD) for people that have it through other way - as I was waiting 5 ½ 
years and my leg just got too big to even walk. 
_________________________________________ 
Participant 410 (with breast-cancer-related secondary lymphoedema): Offer counselling, an 
emergency helpline…Facilitate meetings among patients to share 
experiences… 
Participant 428 (with breast-cancer-related secondary lymphoedema): It would be nice to 
meet other patients to see how they cope. It is very distressing coping with 
lymphoedema.  
_________________________________________ 
Participant 165 (with primary lymphoedema): Educate doctors and medical students. 
Educate patients and families. It is all about control and not allowing the 
fluid to take over our bodies and our lives.  
Participant 466 (with breast-cancer-related secondary lymphoedema): The health 
professionals need to get more involved and informed … only at chronic 
stage was I taken seriously.  
Participant 359 (with breast-cancer-related secondary lymphoedema): Providing sufficient 
treatment information to the patient with lymphoedema, help, especially for 
younger women, and … teaching patients how to manage it by themselves. 
Participant 443 (know type of lymphoedema): Maybe a lymphoedema awareness campaign 
would be a good way of letting people know of the symptoms, then they 
could begin to access services.  
 
 
Emotional Support for Patients 
Provision of Counselling for Those who 
Need it 
Patient Support Groups Nationwide 
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Impact of Lymphoedema on Daily Life and Quality of Life 
Impact of Lymphoedema on Daily Life 
Participants were asked how much lymphoedema affected various aspects of their daily lives. 
The results of those who responded to the question and considered the activity relevant to 
their lives are presented in Table 35.  
 
Table 35: Impact of Lymphoedema on Daily Life 
 
 
The limitations that lymphoedema imposes on patients’ lives were more keenly felt with 
regard to their ability to perform indoor and outdoor chores, wear clothes/shoes, and go on 
holidays. Table 36 on pages 176 and 177 presents the results of Chi-square tests for 
independence which were performed to ascertain if there is a difference in the limitations 
lymphoedema presents for participants with different types of lymphoedema, in different age 
ranges, or of different genders.  
 
 
 
 
              n         Limited a Lot     Limited a Little    Not Limited at All      
Walking     509  16.5%  28.9%  54.6% 
Swimming            349  18.9%  29.5%  51.6%   
Other Sports Activities  324  35.8%  39.5%  24.7%  
Daily Indoor Chores (Cleaning) 641  28.9%  48.8%  22.3%   
Daily Outdoor Chores (Gardening)      614  35.0%  45.9%  19.1% 
Taking Care of Children            317  24.0%  37.5%  38.5%  
Buying Clothes/Shoes            562  38.6%  32.7%  28.6%  
Wearing Clothes/Shoes            590  38.0%  39.8%  22.2%  
Social Activities (Visiting Friends)        506   11.3%  19.0%  69.8%  
Work/Employment             389  32.4%  30.8%  36.8%  
Sexual Activity             368  12.8%  24.2%  63.0%  
Sleeping              574  16.6%  44.3%  39.2%  
Going on Holidays                             543  25.4%  42.7%  31.9%  
Other (Driving, Repetitive Tasks)        65  36.9%  15.4%  47.7% 
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Table 36: Impact of Type of Lymphoedema, Age or Gender on the Limitations Lymphoedema 
Presents 
 
 
 
        Chi Square Test of Independence  Effect Size 
Walking 
Type of Lymphoedema   x2(6, n=473) = 129.219 *  Cramer’s V=0.370  Large Effect 
Age Group   x2(6, n=506) = 6.093  Cramer’s V=0.078 
Gender    x2(2, n=508) = 8.378 ^  Cramer’s V =0.128  Small-Medium Effect 
  
Swimming 
Type of Lymphoedema   x2(6, n=332) = 16.367 ^  Cramer’s V=0.157 Medium-Large Effect 
Age Group   x2(6, n=345) = 24.257 *  Cramer’s V=0.187 Small-Medium Effect 
Gender    x2(2, n=348) = 6.533 ^  Cramer’s V=0.137 Small-Medium Effect 
 
Other Sports Activities 
Type of Lymphoedema   x2(6, n=309) = 25.264 *  Cramer’s V=0.202 Medium-Large Effect 
Age Group   x2(6, n=321) = 20.189 ~  Cramer’s V=0.177 Small-Medium Effect 
Gender    x2(2, n=323) = 3.503  Cramer’s V=0.104 
 
Daily Indoor Chores (Cleaning)  
Type of Lymphoedema   x2(6, n=609) = 28.192 *  Cramer’s V=0.152  Small-Medium Effect 
Age Group   x2(6, n=636) = 20.503 ~  Cramer’s V=0.127 Small-Medium Effect 
Gender    x2(2, n=639) = 13.214 ~  Cramer’s V=0.144 Small-Medium Effect 
 
Daily Outdoor Chores (Gardening)     
Type of Lymphoedema   x2(6, n=585) = 29.579 *  Cramer’s V=0.159 Small-Medium Effect 
Age Group   x2(6, n=609) = 18.195 ~  Cramer’s V=0.122 Small-Medium Effect 
Gender    x2(2, n=613) = 10.046 ^  Cramer’s V=0.128 Small-Medium Effect 
  
Taking Care of Children  
Type of Lymphoedema   x2(6, n=301) = 14.229 ^  Cramer’s V=0.154 Small-Medium Effect 
Age Group   x2(6, n=314) = 7.125  Cramer’s V=0.107  
Gender    x2(2, n=315) = 8.384 ^  Cramer’s V=0.163 Small-Medium Effect 
            
Buying Clothes/Shoes 
Type of Lymphoedema   x2(6, n=526) = 59.198 *  Cramer’s V=0.237 Medium-Large Effect 
Age Group   x2(6, n=557) = 4.228   Cramer’s V=0.062  
Gender    x2(2, n=561) = 0.582  Cramer’s V=0.032 
              
Wearing Clothes/Shoes  
Type of Lymphoedema   x2(6, n=552) = 53.136 *  Cramer’s V=0.219 Medium-Large Effect 
Age Group   x2(6, n=584) = 3.476  Cramer’s V=0.055 
Gender    x2(2, n=589) = 3.884 ^  Cramer’s V=0.081 Small-Medium Effect 
                          
* p=0.001   ~ p<0.009 ^ p<0.05  ! Violated Minimum Expected Cell Frequency Assumption 
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Table 36: Impact of Type of Lymphoedema, Age or Gender on the Limitations Lymphoedema 
Presents (Continued) 
 
 
In relation to the ‘other’ category in all cases over 50% of cells had an expected count of less 
then 5, violating a basic assumption of Chi-Square. As a result these analyses were not 
reliable (Pallant, 2007).  
 
The results for type of lymphoedema were significant in all cases apart from 
work/employment. Participants with non-cancer-related secondary lymphoedema experienced 
greater limitation than participants with other types of lymphoedema in walking, swimming, 
         Chi Square Test of Independence Effect Size 
Social Activities (Visiting Friends)    
Type of Lymphoedema   x2(6, n=480) = 36.293 *  Cramer’s V=0.194 Medium-Large Effect 
Age Group   x2(6, n=502) = 14.517 ^  Cramer’s V=0.120 Small-Medium Effect 
Gender    x2(2, n=505) = 3.279  Cramer’s V=0.081 
 
Work/Employment 
Type of Lymphoedema   x2(6, n=369) = 6.447   Cramer’s V=0.093  
Age Group   x2(6, n=385) = 24.320 *  Cramer’s V=0.178 Small-Medium Effect 
Gender    x2(2, n=387) = 2.095  Cramer’s V=0.074 
 
Sexual Activity  
Type of Lymphoedema   x2(6, n=349) = 36.182 *  Cramer’s V=0.228  Medium-Large Effect 
Age Group   x2(6, n=365) = 12.781 ^  Cramer’s V=0.132 Small-Medium Effect 
Gender    x2(2, n=367) = 8.968 ^  Cramer’s V=0.156 Small-Medium Effect 
  
Sleeping  
Type of Lymphoedema   x2(6, n=542) = 17.865 ^   Cramer’s V=0.128 Small-Medium Effect 
Age Group   x2(6, n=570) = 12.927 ^  Cramer’s V=0.106 Small-Medium Effect 
Gender    x2(2, n=572) = 8.935 ^  Cramer’s V=0.125 Small-Medium Effect 
 
Going on Holidays 
Type of Lymphoedema   x2(6, n=515) = 42.173 *  Cramer’s V=0.202 Medium-Large Effect 
Age Group   x2(6, n=539) = 19.371 ^  Cramer’s V=0.134 Small-Medium Effect 
Gender    x2(2, n=542) = 0.017  Cramer’s V=0.006 
 
Other (Driving, Repetitive Tasks)  
Type of Lymphoedema   x2(6, n=61) = 6.030 !  Cramer’s V=0.222 
Age Group   x2(6, n=65) = 2.641 !  Cramer’s V=0.143 
Gender    x2(2, n=64) = 0.164  !  Cramer’s V=0.051  
 
* p=0.001   ~ p<0.009 ^ p<0.05  ! Violated Minimum Expected Cell Frequency Assumption 
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performing other sports, performing outdoor chores, taking care of children, buying 
clothes/shoes, wearing clothes/shoes, socialising, sexual activity, sleeping, and going on 
holidays. For example based on the odds ratio, participants with non-cancer-related 
secondary lymphoedema were 3.33 times more likely to experience limitations in walking 
than participants with primary lymphoedema, 6.57 times more likely to experience limitations 
in walking than participants with cancer-related (but not breast-cancer-related) secondary 
lymphoedema, and 32.55 times more likely to experience limitations in walking than 
participants with breast-cancer-related secondary lymphoedema.    
 
Participants with breast-cancer-related secondary lymphoedema experienced greater 
limitation than participants with other types of lymphoedema in performing indoor chores. For 
example based on the odds ratio, participants with breast-cancer-related secondary 
lymphoedema were 2.79 times more likely to experience limitations in performing indoor 
chores than participants with primary lymphoedema, 1.13 times more likely to experience 
limitations in performing indoor chores than participants with non-cancer-related secondary 
lymphoedema, and 3.49 times more likely to experience limitations in performing indoor 
chores than participants with cancer-related (but not breast-cancer-related) secondary 
lymphoedema.    
 
The results for age range were significant in all cases apart from walking, taking care of 
children, buying clothes/shoes, and wearing clothes/shoes. Participants in the 18-35 age 
range experienced greater limitation than participants in other age ranges in terms of going 
on holidays. For example based on the odds ratio participants in the 18-35 age range were 
1.29 times more likely to be limited in going on holidays than participants in the 36-50 age 
range, 1.62 times more likely to be limited in going on holidays than participants in the 51-66 
age range and 1.87 times more likely to be limited in going on holidays than participants in 
the 67+ age range. 
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Participants in the 36-50 age range experienced greater limitation than participants in other 
age ranges in terms of performing other sports, and working. For example based on the odds 
ratio participants in the 36-50 age range were 2.31 times more likely to be limited in 
performing other sports than participants in the 18-35 age range, 1.06 times more likely to be 
limited in performing other sports than participants in the 51-66 age range and 3.42 times 
more likely to be limited in performing other sports than participants in the 67+ age range. 
 
Participants in the 51-66 age range experienced greater limitation than participants in other 
age ranges in terms of swimming and performing outdoor chores.  For example based on the 
odds ratio participants in the 51-66 age range were 3.95 times more likely to be limited in 
swimming than participants in the 18-35 age range, 1.15 times more likely to be limited in 
swimming than participants in the 36-50 age range and 1.88 times more likely to be limited in 
swimming than participants in the 67+ age range.  
 
Finally, participants in the 67+ age range experienced greater limitation than participants in 
other age ranges in terms of performing indoor chores, socialising, sexual activity, and 
sleeping. For example based on the odds ratio participants in the 67 + age range were 4.06 
times more likely to be limited in performing indoor chores than participants in the 18-35 age 
range, 1.37 times more likely to be limited in performing indoor chores than participants in 
the 36-50 age range and 1.05 times more likely to be limited in performing indoor chores 
than participants in the 51-66 age range. 
 
The results in relation to gender were significant in all cases apart from other sports activities, 
buying clothes/shoes, social activities, work/employment and holidays. Male participants 
experienced greater limitation than female participants in terms of walking, swimming, and 
sexual activity whereas female participants experienced greater limitations than male 
participants in terms of performing indoor and outdoor chores, taking care of children, 
wearing clothes/shoes, and sleeping. For example based on the odds ratio male participants 
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were 3.10 times more likely to be limited in walking than female participants, whereas female 
participants were 2.83 times more likely to be limited in indoor chores than male participants.   
 
Therefore in summary, the degree of limitation participants experienced in swimming, indoor 
chores, outdoor chores, sexual activity and sleeping was influenced by the type of 
lymphoedema they experienced, their age and their gender. The degree of limitation 
participants experienced in other sports, social activities and going on holidays was influenced 
by the type of lymphoedema they experienced and their age but not their gender. The 
degree of limitation participants experienced in walking, taking care of children and wearing 
clothes or shoes was influenced by the type of lymphoedema they experienced and their 
gender but not their age. Finally, the degree of limitation participants experienced in buying 
clothes and shoes was influenced by the type of lymphoedema they experienced and but not 
their age or gender while the degree of limitation participants experienced in their ability to 
work was influenced by their age rather than the type of lymphoedema they experienced or 
their gender.  
 
In terms of other factors associated with lymphoedema which may affect patients’ daily lives, 
participants were asked whether they had ever had cellulitis, an infection in the layers of the 
skin, commonly associated with lymphoedema. Twenty-nine percent of all respondents 
reported that they had experienced a bout of cellulitis (n=682). However eleven participants 
wrote in the margins that they didn’t know what cellulitis is. As cellulitis can require 
hospitalisation for its treatment, the 200 participants who reported that they had experienced 
a bout of cellulitis were asked how often they had been hospitalised for its treatment. Thirty-
nine percent of respondents had never been hospitalised for the treatment of their cellulitis, 
30.5% had been hospitalised once, 7.9% had been hospitalised twice, 10.7% had been 
hospitalised three times and the remaining 12.2% had been hospitalised 4 or more times 
(n=177). On average respondents had been hospitalised for the treatment of their cellulitis 
1.69 times. (SD=2.88, Range=0-20, n=177). However the large range suggests that this 
associated condition of lymphoedema can have a significant impact on some patients’ lives.  
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Impact of Lymphoedema on Quality of Life 
Participants were then asked to fill in the World Health Organisation’s shorter Quality of Life 
measure (WHOQOL-BREF). The percentage responses for each item of the WHOQOL-BREF 
are presented in Appendix N. Interestingly one item asked participants “whether physical pain 
prevents you from doing what you want to do” and 42.5% reported that it did prevent them 
doing what they want to do either to a moderate extent, very much or an extreme degree.  
 
The first two items of the WHOQOL-BREF asked participants to rate their quality of life and 
their satisfaction with their health on a Likert scale from 1 – ‘very poor/dissatisfied’ to 5 – 
‘very good/satisfied’. The frequencies of responses to these items are presented in Table 37.  
 
Table 37: Frequency of Responses to Items on Quality of Life and Satisfaction with Health 
 
 
Approximately 20% of respondents with primary, non-cancer-related-secondary or cancer-
related (but not breast-cancer-related) secondary lymphoedema reported that their quality of 
life was poor or very poor. Less than 7% of patients with breast-cancer-related secondary 
lymphoedema rated their quality of life as poor or very poor. Likewise, in relation to 
satisfaction with their health approximately 35% of patients with primary or non-cancer-
related-secondary lymphoedema rated their satisfaction negatively compared with 14.4% of 
patients with breast-cancer-related secondary lymphoedema.  
 
   n V Poor Poor Neither Good V Good 
Quality of Life 
All Respondents 718  1.4% 8.1% 17.4% 49.9% 23.3%  
Primary Lymphoedema 47 2.1% 19.1% 21.3% 44.7% 12.8%  
Non-Cancer-Related Secondary Lymphoedema 42 7.1% 19.0% 26.2% 33.3% 14.3% 
Cancer-Related (not-BC-Related) Secondary Lymphoedema 66   - 18.2% 13.6% 42.4% 25.8%  
Breast-Cancer-Related Secondary Lymphoedema  518 0.6% 4.8% 15.1% 53.3% 26.3% 
 
Satisfaction with Health     
All Respondents 715 3.4% 15.0% 18.9% 48.7% 14.1%  
Primary Lymphoedema 47 6.4% 27.7% 19.1% 38.3% 8.5%  
Non-Cancer-Related Secondary Lymphoedema 42 7.1% 28.6% 31.0% 21.4% 11.9% 
Cancer-Related (not-BC-Related) Secondary Lymphoedema 69 3.0% 15.2% 13.6% 50.0% 18.2%  
Breast-Cancer-Related Secondary Lymphoedema  531 2.1% 12.3% 17.1% 53.3% 15.2% 
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The means for these items are presented in Table 38. Participants with non-cancer-related 
secondary lymphoedema rated their quality of life and satisfaction with their health lowest 
whereas participants with breast-cancer-related secondary lymphoedema rated their quality 
of life and satisfaction with their health highest.   
 
Table 38: Participants’ Ratings of their Quality of Life and Satisfaction with their Health, 
according to Type of Lymphoedema, Age Range and Gender 
 
 
           n Mean SD 
Quality of Life 
All Respondents      718 3.86 0.91 
 
Patients with Primary Lymphoedema       47 3.47 1.02  
Patients with Non-Cancer-Related Secondary Lymphoedema  42 3.29 1.15  
Patients with Cancer-Related (not-BC-Related) Lymphoedema 66 3.76 1.04  
Patients with Breast-Cancer-Related Secondary Lymphoedema  518 4.00 0.81 
 
Patients in the 18-35 Age Range    22 3.73 1.08  
Patients in the 36-50 Age Range    164 3.93 0.92  
Patients in the 51-65 Age Range    328 3.88 0.88  
Patients in the 67 + Age Range    198 3.80 0.93 
 
Male Participants      48 3.56 1.09  
Female Participants      667 3.88 0.90  
 
Satisfaction with Health 
All Respondents      715 3.55 1.02 
 
Patients with Primary Lymphoedema       47 3.15 1.12  
Patients with Non-Cancer-Related Secondary Lymphoedema  42 3.02 1.14  
Patients with Cancer-Related (not-BC-Related) Lymphoedema 66 3.65 1.05  
Patients with Breast-Cancer-Related Secondary Lymphoedema  514 3.67 0.95  
 
Patients in the 18-35 Age Range    22 3.23 1.23  
Patients in the 36-50 Age Range    162 3.50 0.99  
Patients in the 51-65 Age Range    329 3.59 1.04  
Patients in the 67 + Age Range    196 3.59 0.96 
 
Male Participants      48 3.33 1.26  
Female Participants      664 3.57 1.00  
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Inferential statistics were performed to ascertain if the variation in responses to these items 
were significantly different according to type of lymphoedema, age range and gender.  
 
The Welch one-way ANOVA was performed to explore whether participants with different 
types of lymphoedema rated their quality of life differently. The result was highly significant: 
FW (3, 89.500) = 9.270, p=0.001. Post hoc analysis revealed that participants with primary 
lymphoedema (p=0.006) and participants with non-cancer-related secondary lymphoedema 
(p=0.002) rated their quality of life significantly lower than participants with breast-cancer-
related secondary lymphoedema. Regarding age range the assumption of homogeneity of 
variance was not violated and therefore a standard one-way ANOVA was performed. It was 
not found to be statistically significant: F (3, 708) = 0.749, p=0.523. The effect size, 
calculated using eta squared was also poor at 0.003. In relation to gender, the Levene’s test 
indicated that the assumption of homogeneity of variance had been violated. Therefore the 
non-parametric Mann Whitney U was performed. Males (median = 4) did not significantly 
differ in their ratings of their quality of life from females (median = 4), U = 13,566.00, ns, r = 
-0.07. Thus the difference in participant’s responses to this item on quality of life is influenced 
by type of lymphoedema rather than other factors, namely age range or gender.  
 
In terms of ratings of satisfaction with health the Welch one-way ANOVA was performed to 
explore whether participants with different types of lymphoedema rated their satisfaction 
differently on this item. The result was also highly significant: FW (3, 91.596) = 7.012, 
p=0.001. Post hoc analysis revealed that participants with non-cancer-related secondary 
lymphoedema rated their satisfaction with their health lower than participants with cancer-
related (but not breast-cancer-related) secondary lymphoedema (p=0.029) and participants 
with breast-cancer-related secondary lymphoedema (p=0.005). Participants with primary 
lymphoedema (p=0.019) rated their satisfaction with their health significantly lower than 
participants with breast-cancer-related secondary lymphoedema. Regarding age range the 
assumption of homogeneity of variance was not violated and therefore a standard one-way 
ANOVA was performed. It was not found to be statistically significant: F (3, 705) = 1.142, 
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p=0.331. The effect size, calculated using eta squared was also poor at 0.004. In relation to 
gender, the assumption of homogeneity of variance was violated and as a result the non-
parametric Mann Whitney U was performed. Males (median = 4) did not significantly differ in 
their ratings of their satisfaction with their health from females (median = 4), U = 14,541.00, 
ns, r = -0.04. This suggests that the difference in participant’s responses to the item on 
satisfaction with health is influenced by type of lymphoedema rather than other factors, 
namely age range or gender.  
 
The domain scores for each of the four domains of the WHOQOL-BREF – physical health, 
psychological health, social relationships and environment - of all respondents are presented 
in Table 39. The domain scores are scaled in a positive direction (i.e. higher scores denote 
higher quality of life). The first transformation method converts scores to range between 4 
and 20. As a result the domains are comparable with each other and with scores ascertained 
with the longer version of the scale, the WHOQOL-100 (WHO, 1996).  
 
Table 39: Mean Domain Scores of the WHO QOL-BREF 
 
 
 
 
 
 
 
 
 
Overall the sample rated themselves lowest on the physical and psychological health domains 
and these scores were quite close to the midpoint score. The sample rated their quality of life 
highest on the environment and social relationships domains. The mean scores on these 
domains according to the type of lymphoedema that patients experience are presented in 
Table 40 on page 185.  
 
 
 
 
n   Range Mean SD        
Physical Health Domain Raw Score  678 4-20 14.27 3.16  
Psychological Health Domain Raw Score 697 7-20 14.76 2.69  
Social Relationships Domain Raw Score 680 5-20 15.10 3.45  
Environment Domain Raw Score  692 5-20 15.24 2.67  
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Table 40: Mean Domain Scores of the WHO QOL-BREF, according to Type of Lymphoedema 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to ascertain whether the type of lymphoedema participants experience influenced 
their scores on these domains, one-way ANOVAs were performed. With regard to the physical 
health and environment domains, the Levene’s test indicated that the assumption of 
homogeneity had been violated and therefore Welch one-way ANOVAs and Dunnett’s T3 post 
hoc tests were performed. In the case of the psychological health and social relationships 
domains the Levene’s test indicated that the assumption of homogeneity had not been 
violated and therefore standard one-way ANOVAs and post hoc Tukey tests were performed. 
 
With regard to the physical health domain, the Welch one-way ANOVA was highly significant: 
FW (3, 86.485) = 5.814, p=0.001 indicating that there was a significant difference in how 
participants with various types of lymphoedema rated their physical health. Post hoc analysis 
revealed that participants with non-cancer-related secondary lymphoedema scored 
  n Mean   SD       
Physical Health Domain Raw Scores   
Patients with Primary Lymphoedema    46 13.34 3.81  
Patients with Non-Cancer-Related Secondary Lymphoedema  39 12.39 3.60  
Patients with Cancer-Related (not-BC-Related) Lymphoedema 65 14.71 3.57  
Patients with Breast-Cancer-Related Secondary Lymphoedema  489 14.56 2.90  
 
Psychological Health Domain Raw Scores  
Patients with Primary Lymphoedema       46 13.88 2.92  
Patients with Non-Cancer-Related Secondary Lymphoedema  41 13.80 2.94  
Patients with Cancer-Related (not-BC-Related) Lymphoedema 67 14.76 2.93  
Patients with Breast-Cancer-Related Secondary Lymphoedema  499 14.98 2.60 
 
Social Relationships Domain Raw Scores  
Patients with Primary Lymphoedema       46 14.42 3.59  
Patients with Non-Cancer-Related Secondary Lymphoedema  38 14.02 3.88  
Patients with Cancer-Related (not-BC-Related) Lymphoedema 67 14.41 3.91  
Patients with Breast-Cancer-Related Secondary Lymphoedema  488 15.40 3.31  
 
Environment Domain Raw Score   
Patients with Primary Lymphoedema       46 13.90 2.70  
Patients with Non-Cancer-Related Secondary Lymphoedema  40 13.62 3.25  
Patients with Cancer-Related (not-BC-Related) Lymphoedema 66 14.90 3.12  
Patients with Breast-Cancer-Related Secondary Lymphoedema  498 15.60 2.47 
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significantly lower on the physical health domain than participants with cancer-related (but 
not breast-cancer-related) secondary lymphoedema (p=0.012), and participants with breast-
cancer-related secondary lymphoedema (p=0.004). 
 
In relation to the psychological health domain, the standard one-way ANOVA was highly 
significant F (3,649) = 4.474, p=0.004 indicating that there was a significant difference in 
how participants with various types of lymphoedema rated their psychological health. The 
effect size, calculated using eta squared was small at 0.02. Post hoc analysis revealed that 
while participants with primary lymphoedema (p=0.039) and participants with non-cancer-
related secondary lymphoedema (p=0.035) scored significantly lower on the psychological 
health domain than participants with breast-cancer-related secondary lymphoedema.  
 
With regard to the social relationships domain, the standard one-way ANOVA was highly 
significant F (3,635) = 3.976, p=0.008 indicating that there was a significant difference in 
how participants with various types of lymphoedema rated their social relationships. The 
effect size, calculated using eta squared was small at 0.02. Post hoc analysis revealed that 
participants with non-cancer-related secondary lymphoedema scored lower on the social 
relationships domain than participants with breast-cancer-related secondary lymphoedema 
but this only approached significance (p=0.080). 
 
In relation to the environment domain, the Welch one-way ANOVA was highly significant: FW 
(3, 88.365) = 10.142, p=0.001 indicating that there was a significant difference in how 
participants with various types of lymphoedema rated their environment. Post hoc analysis 
revealed that participants with primary lymphoedema (p=0.001) and participants with non-
cancer-related secondary lymphoedema (p=0.003) scored significantly lower on the 
environment domain than participants with breast-cancer-related secondary lymphoedema. 
 
Therefore in summary, the type of lymphoedema participants experience influenced their 
scores on the physical health domain as participants with non-cancer-related secondary 
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lymphoedema scored significantly lower than patients with cancer-related (but not breast-
cancer-related) secondary lymphoedema and patients with breast-cancer-related secondary 
lymphoedema. The type of lymphoedema participants experience influenced their scores on 
the psychological health domain as participants with primary lymphoedema and participants 
with non-cancer-related secondary lymphoedema scored significantly lower than patients with 
breast-cancer-related secondary lymphoedema. The type of lymphoedema participants’ 
experience influenced their scores on the social relationships domain. Participants with non-
cancer-related secondary lymphoedema scored lower on the social relationships domain than 
participants with breast-cancer-related secondary lymphoedema but this only approached 
significance. Finally, type of lymphoedema also influenced participants’ scores on the 
environment domain as participants with primary lymphoedema and participants with non-
cancer-related secondary lymphoedema scored significantly lower than participants with 
breast-cancer-related secondary lymphoedema. The mean scores on these domains according 
to patients’ age ranges are presented in Table 41.  
 
Table 41: Mean Domain Scores of the WHO QOL-BREF, according to Age Range 
 
 
 
 
 
 
 
 
 
 
 
 
 
n    Mean  SD       
Physical Health Domain Raw Scores   
Patients in the 18-35 Age Range  22 14.52 3.53  
Patients in the 36-50 Age Range  162 14.41 3.24  
Patients in the 51-65 Age Range  317 14.43 3.04  
Patients in the 67 + Age Range  171 13.87 3.20  
 
Psychological Health Domain Raw Scores  
Patients in the 18-35 Age Range  22 14.82 2.51  
Patients in the 36-50 Age Range  164 14.34 2.79  
Patients in the 51-65 Age Range  321 14.96 2.57  
Patients in the 67 + Age Range  185 14.87 2.74  
 
Social Relationships Domain Raw Scores  
Patients in the 18-35 Age Range  22 14.97 3.44  
Patients in the 36-50 Age Range  163 14.37 3.59  
Patients in the 51-65 Age Range  319 15.13 3.43  
Patients in the 67 + Age Range  172 15.81 3.21  
 
Environment Domain Raw Score   
Patients in the 18-35 Age Range  22 14.52 3.06  
Patients in the 36-50 Age Range  163 14.84 2.69  
Patients in the 51-65 Age Range  321 15.43 2.50  
Patients in the 67 + Age Range  181 15.44 2.81  
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In order to test whether respondents’ scores on these domains were also affected by age 
range, further inferential statistics were performed. The assumption of homogeneity was not 
been violated and therefore standard one-way ANOVAs and post hoc Tukey tests were 
performed. 
 
With regard to the physical health and psychological health domains, the standard one-way 
ANOVAs were not significant: F (3,668) = 1.352, p=0.256, and F (3,688) = 2.045, p=0.106 
respectively. The effect sizes, calculated using eta squared were also low, 0.006 and 0.009 
respectively. This indicates that there was no significant difference in how participants in 
various age ranges scored on the physical and psychological health domains.  
 
In relation to the social relationships domain, the standard one-way ANOVA was highly 
significant: F (3,672) = 4.985, p=0.002 indicating that there was a significant difference in 
how participants in various age ranges rated their social relationships. The effect size, 
calculated using eta squared was small at 0.02. Post hoc analysis revealed that participants in 
the 36-50 age range (p=0.001) scored significantly lower on the social relationships domain 
than participants in the 67 + age range. 
 
With regard to the environment domain, the standard one-way ANOVA was significant F 
(3,683) = 2.677, p=0.046 indicating that there was a significant difference in how 
participants in various age ranges rated their environment. The effect size, calculated using 
eta squared was small at 0.01. Post hoc analysis revealed that participants in the 36-50 age 
range scored lower on the environment domain than participants in the 51-66 age range 
(p=0.092) however this test only approached significance.  
 
In summary, participants’ age did not influence their scores on the physical health and 
psychological health domains. However there was a significant difference in how participants 
in various age ranges rated their social relationships as participants in the 36-50 age range 
scored significantly lower on the social relationships domain than participants in the 67 + age 
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range. There was also a significant difference in how participants in various age ranges rated 
their environment. Participants in the 36-50 age range scored lower on the environment 
domain than participants in the 51-66 age range but this only approached significance.  
Finally the mean scores on these domains according to patients’ gender are presented in 
Table 42.  
 
Table 42: Mean Domain Scores of the WHO QOL-BREF, according to Gender 
 
 
 
 
 
 
 
 
 
 
 
In order to test whether gender influenced participants’ scores on these domains, further 
inferential statistics were performed. In the case of the physical health, social relationships 
and environment domains the Levene’s test indicated that the assumption of homogeneity 
had not been violated and therefore independent sample t tests were performed. However 
with regard to the psychological health domain, the Levene’s test indicated that the 
assumption had been violated and therefore a non-parametric Mann Whitney U was 
performed. 
 
With regard to the physical health domain, the independent sample t test indicated that on 
average, females (mean = 14.30, SE= 0.124) scored higher than males (mean = 13.77, SE = 
0.546) and this difference was not significant t (673) = -1.093, p = 0.275. In relation to the 
n    Mean  SD       
Physical Health Domain Raw Scores   
Male Participants    46 13.77 3.70  
Female Participants    629 14.30 3.12  
 
Psychological Health Domain Raw Scores  
Male Participants    46 14.27 3.08  
Female Participants    648 14.79 2.66  
 
Social Relationships Domain Raw Scores  
Male Participants    46 14.03 3.60  
Female Participants    631 15.18 3.43  
 
Environment Domain Raw Score   
Male Participants    47 14.18 2.97  
Female Participants    643 15.32 2.63  
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psychological health domain, the non-parametric Mann Whitney U was performed. Females 
(median = 15.33) did not significantly differ in their scores on this domain from males 
(median = 15.33), U = 13,679.500, ns, r= -0.04. With regard to the social relationships 
domain, the independent sample t test indicated that on average, females (mean = 15.18, SE 
= 0.136) scored higher than males (mean = 14.03, SE = 0.531) and this difference was 
significant t (675) = -2.185, p = 0.029. With regard to the environment domain, the 
independent sample t test indicated that on average, females (mean = 15.32, SE = 0.104) 
scored higher than males (mean = 14.18, SE = 0.433) and this difference was significant t 
(688) = -2.822, p = 0.005.  
 
Therefore in summary, gender did not influence participants’ scores on the physical and 
psychological health domains but did in the case of the social relationships and environment 
domains, where females scored significantly higher than males.  
 
Overall, participants’ scores on the physical health and psychological domains were influenced 
by the type of lymphoedema they experienced, rather than their age or their gender. 
Participants’ scores on the social relationships and environment domains were influenced by 
the type of lymphoedema participants experienced, their age and their gender.   
Open Question on Patients’ Experiences of Lymphoedema Services and of Living 
with the Condition 
The final question of the questionnaire asked participants whether there were any other 
comments that they would like to make with regard to seeking a lymphoedema diagnosis, 
lymphoedema services, compression garments, the standard of care they’re receiving, or 
living with lymphoedema. A total of 428 participants responded to the open question. While 
the majority of responses were patients’ accounts of their experiences of cancer treatment, 
explanations for the delay in returning the questionnaire or expressions of thanks to their 
lymphoedema practitioner and the research team, the remaining responses related either to 
lymphoedema services or the impact of the condition on patients’ lives.  
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With regard to comments on lymphoedema service provision, 76 respondents referred to the 
need for healthcare professionals to be better informed about lymphoedema and its impact 
on patients:  
Participant 109 (with breast-cancer-related secondary lymphoedema): I think 
lymphoedema is not given enough publicity and doctors do not know 
much about it.  
Participant 142 (with non-cancer-related secondary lymphoedema): Lymphoedema as 
a medical problem is not highlighted enough. Awareness of this 
condition should be made more easily available to the general public 
and in some cases to the local GPs. I have had this swelling for years 
and my GP never referred to anyone!  
Participant 152 (with breast-cancer-related secondary lymphoedema): …All 
anaesthetists and nurses should be adequately trained to deal with 
mastectomy patients and be aware of the dangers of causing 
lymphoedema in patients by mistreating those at-risk.  
Participant 382 (with breast-cancer-related secondary lymphoedema): Lymphoedema 
is definitely on the back burner… (it) needs to be brought to the fore 
medically. 
Participant 524 (with breast-cancer-related secondary lymphoedema): What it all 
boils down to is – in medical circles CANCER (TREATABLE), is an 
easier word than LYMPHOEDEMA (NOT TREATABLE) to talk about 
and many a time I felt like telling my surgeons that if they suffered 
from it their jobs would be over and life as they enjoyed ENDED. 
 
Seventy respondents indicated that services should be coordinated, accessible, continued and 
regular, standardised and available to all lymphoedema patients:  
Participant 7 (with breast-cancer-related secondary lymphoedema): Lymphoedema 
services should be available at local level, i.e. (at a) local health clinic 
and should be free for everybody.  
Participant 548 (with primary lymphoedema): I feel that people with primary 
lymphoedema in my area are really neglected, because there may not 
be very many of us. We may not be so visible. Have been to a few 
open days I think oncology patients are getting on better because of 
their overall treatment. We seem to be with vascular or general 
departments who I feel do not know enough about the problem. I 
support a few people (with lymphoedema) who do not leave the 
house anymore and this scares me.  
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Participant 516 (with primary lymphoedema): Why should primary lymphoedema 
(patients) be treated differently now (to those with lymphoedema) 
brought on by trauma/surgery… 
 
Fifty-nine comments related to the need for additional lymphoedema services and funding for 
those services:  
Participant 45 (with breast-cancer-related secondary lymphoedema): … The bottom 
line is there are lack of facilities and resources for the professionals to 
do their job properly. 
Participant 60 (with breast-cancer-related secondary lymphoedema): … I feel there 
are an appalling lack of services available and a huge shortage of 
specialist nurses.   
 
Thirty-six comments related to the necessity of informing patients that they are at-risk of 
developing the condition: 
Participant 1 (with breast-cancer-related secondary lymphoedema): … Patients should 
be made aware of (the) possibility (of developing lymphoedema) and 
shown how to prevent and/or treat it. 
Participant 175 (with breast-cancer-related secondary lymphoedema): People like me 
should be TOLD before surgery that there is a great risk of this 
condition as there is no cure for it, only how to maintain it. 
 
Comments that didn’t relate to service provision, focused on the impact of lymphoedema on 
patients. Thirty-nine participants wrote about the impact of lymphoedema on their self-image 
and self-confidence: 
Participant 104 (with breast-cancer-related secondary lymphoedema): …The very 
hard part of it is the altered body image. I found it hard to accept 
wearing the compression garments… 
Participant 77 (doesn’t know type of lymphoedema): I have lymphoedema in my left 
foot and lower leg. This makes it impossible for me to wear shoes 
other than hiking boots. This has a huge effect on how I can dress, 
compromising my self expression and image. Have you ever tried 
going to a wedding in hiking boots?!  
Participant 43 (with breast-cancer-related secondary lymphoedema): I am reluctant 
to have photos taken now and if I do have to I try to ensure they are 
taken on my left side so that my right arm isn't visible...don't like 
wearing sleeveless outfits without a cardigan to cover my arm… (I 
am) self conscious. 
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Thirty-four comments focused on the financial implications of living with lymphoedema:  
Participant 40 (with breast-cancer-related secondary lymphoedema): The price of 
compression garments is way too high €162 for 1 sleeve made to 
measure.  
Participant 442 (with primary lymphoedema): …I have tried to get the HSE in (name 
of county) to repay my bills for my stockings and toe-caps, but have 
been unsuccessful. I got a letter to say I wasn’t entitled to payment 
as I didn’t have a medical card and they weren’t a prescribed 
medication. It seems very unfair to be penalised when there’s no 
other cure for the condition.  
 
Thirty-two comments explained the frustration, sadness and depression some participants 
feel as a result of living with lymphoedema:  
Participant 65 (with non-cancer-related secondary lymphoedema): (It) can get you 
down, no matter how happy and outgoing you are. Spells of these 
feelings need to be got over as soon as possible or depression sets in. 
Participant 252 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): …Every evening I cry with pain - secretly.  
Participant 707 (with primary lymphoedema): I get very low with not being able to 
wear shoes like every other woman, having to go out in long skirts to 
cover the shape of my leg, not being able to go up stairs as the leg is 
so hard to lift, not being able to dance, so many things I cant do for 
the last 30 years, things other people can do. Sometimes I wish I 
were not here. I feel like a freak.  I am crying just writing this. I am 
sure people like me say why me. They say we have to carry a cross 
but mine is a heavy cross that no one ever wants. I hope things are 
better for young people who get lymphoedema now. I hope no one 
has to go through the things and heartache that I have.  
 
Thirteen participants wrote about their feelings of isolation as they feel others can not 
understand their experiences:  
Participant 14 (with breast-cancer-related secondary lymphoedema): … (It is) 
tedious… explaining to people why the sleeve is being worn. I feel 
like wearing a sandwich-board explaining the facts!  
Participant 384 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): (I have) feelings of isolation as so few people know 
what it is. 
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Participant 202 (with breast-cancer-related secondary lymphoedema): We are ‘Third 
World’ patients and without the help of all you good people would be 
consigned to the ‘scrap heap of life’. 
 
Three participants reported viewing lymphoedema as inconsequential compared to their 
experiences of surviving cancer:  
Participant 100 (with breast-cancer-related secondary lymphoedema): I consider 
lymphoedema a small price to pay, having survived cancer. 
Lymphoedema seems a trivial complaint. I am happy to be alive!  
Participant 561 (with breast-cancer-related secondary lymphoedema): I am coping 
well with lymphoedema as I think it’s a small price to pay after breast 
cancer… 
 
Whereas for eleven participants lymphoedema signifies a constant reminder of their cancer 
diagnosis and treatment:  
Participant 149 (with breast-cancer-related secondary lymphoedema): I can accept 
my cancer and all the treatment I received. I find having 
lymphoedema the worst aspect of my condition. It is a daily reminder 
when I have to wear my compression garment that I have had cancer 
and this is the souvenir – it is difficult to find shirts to cover the whole 
arm – people often ask me what happened to my arm – I hate it!!!! 
Participant 269 (with breast-cancer-related secondary lymphoedema): … Now I 
realise that after the scars of surgery heal and chemotherapy is 
finished that the lymphoedema will remain. 
Participant 195 (with cancer-related but not breast-cancer-related secondary 
lymphoedema): … I feel that I have now swapped a death sentence 
for a life sentence. … It’s so bad now that that it affects every aspect 
of my life. … I’m so annoyed and frustrated that lymphoedema 
sufferers are forgotten about by our health system. … I’m 
embarrassed about my appearance. I can’t get nice clothes to wear 
and getting shoes are a nightmare - can’t get any to fit and any I do 
get aren’t nice or trendy. I’m only 39 I don’t want to wear granny 
shoes!! …I can’t emphasise enough how angry I feel about the whole 
system.  
 
Consequently, sixteen participants expressed their desire for support groups or counselling:  
Participant 64 (with breast-cancer-related secondary lymphoedema): …Group 
sessions it may help knowing you’re not alone and you’re not the only 
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one who lives with a bandage. You can pick up tips and can talk to 
others who know really how you’re feeling. 
Participant 55 (with breast-cancer-related secondary lymphoedema): (Patients need) 
support groups and counselling…At the very least, just one person 
who has the time to explain what is going on. I realise my answers 
paint a very negative picture but for the first time since January 2007 
I have been honest with both you and myself and this exercise has 
been very helpful. Most of the time I just pretend all is well and carry 
on. 
 
While nine participants’ responses related to thoughts of a cure for lymphoedema:  
Participant 89 (with breast-cancer-related secondary lymphoedema): … I would travel 
to the end of the world for cure and worry everyday about it getting 
worse… 
Participant 105 (with breast-cancer-related secondary lymphoedema): … I am 
considering having my breast removed if that would mean the 
lymphoedema would go away (this participant has lymphoedema in 
one breast). 
Participant 321 (with breast-cancer-related secondary lymphoedema): … MAYBE A 
CURE MIGHT BE FOUND! PLEASE!!!! 
 
Finally, seven patients that had accessed appropriate, effective treatment reported deriving 
huge benefits to their quality of life from this:  
Participant 3 (with non-cancer-related secondary lymphoedema): My life has 
completely changed for the better over the past year since I 
discovered my lymphoedema practitioner, who has made enormous 
improvements in my quality of life. 
Participant 524 (with breast-cancer-related secondary lymphoedema): The real 
heroes here are the poor unfortunate, kind, considerate therapists 
who through their own expense and expertise are the silver lining in 
an otherwise very, very dark cloud… You have found someone who 
cares and can do what they can to make your life bearable again – 
And once you’ve met one you leave with a smile and some happiness, 
AT LAST! Although getting there can be a frightening, lonely and 
desperate journey. 
Discussion of Patient Survey Results  
The specific aims of the patient survey were to: explore patients’ experiences of seeking an 
explanation for their lymphoedema symptoms, obtaining a diagnosis and accessing 
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information and treatment; explore patients’ experiences of service provision; explore barriers 
in accessing treatment; and assess the impact of lymphoedema on patients’ daily life and 
quality of life. Each of these aims has been met and a brief summary of the results is 
presented below.  
 
There is no existing data on the prevalence of lymphoedema in Ireland and as a result the 
breakdown of the current sample is compared with that of the BreastCare Victoria (2005) 
sample and Moffatt et al.’s (2003) UK prevalence study in order to give a sense of how it 
compares with the patients being seen for treatment in Victoria, Australia and in South West 
London. Ninety-three percent of the current sample was female and 7% was male which was 
almost identical to the gender breakdown of the patient sample in the BreastCare Victoria 
(2005) study (94% female; 6% male). In Moffatt et al.’s (2003) prevalence study 82.99% of 
their sample was female and 17.01% was male. In the present sample there were a much 
higher proportion of patients with breast-cancer-related secondary lymphoedema (73.1%) 
when compared with the BreastCare Victoria sample (46.5%) and a much lower proportion of 
primary lymphoedema patients (6.5%) than in the BreastCare Victoria sample (18.5%). This 
may reflect the location of many lymphoedema services in hospitals providing cancer 
treatment and the requirement of some lymphoedema services in the Republic of Ireland to 
primarily or solely treat patients with cancer-related lymphoedema. Comparison with Moffatt 
et al.’s (2003) study on this point is not possible as the authors did not indicate what 
proportion had various types of lymphoedema beyond reporting that 25% had cancer-related 
secondary lymphoedema. Due to the higher proportion of primary lymphoedema patients in 
the BreastCare Victoria sample, their sample also had a greater proportion of patients with 
lymphoedema in the lower limb(s). In Moffatt et al.’s (2003) study 41% had lymphoedema in 
their upper limb(s) and 58% had lymphoedema in their lower limb(s). 
 
The majority of the present sample is aged over 50 years of age which was expected given 
that while the overall prevalence of lymphoedema has been reported 1.33 per 1,000, 5.4 per 
1,000 of those over 65 years old and 10.3 per 1,000 of those over 85 years old were found to 
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experience lymphoedema (Moffatt et al., 2003). Indeed the mean age of participants in the 
current study was 58.89 years (Range=18-97 years, SD=12.65, n=728) while the mean age 
of participants in the BreastCare Victoria study was 61.0 years. The majority of the sample 
lives in Dublin, which reflects the high population density there. However there was a 
representation of patients from all counties in the Republic of Ireland.  
 
In relation to service provision, participants reported that they waited a substantial amount of 
time for diagnosis and treatment. Additionally there was huge variation in patients’ 
experiences of services particularly across patients with different types of lymphoedema and 
also among patients with the same type of lymphoedema.  
 
Regarding the impact of the condition on participants’ daily life and quality of life, participants 
reported that the limitations imposed by the condition were more keenly felt with regard to 
their ability to perform chores, wear clothes/shoes, and go on holidays. Participants’ ratings 
of their quality of life and satisfaction with their health were significantly influenced by the 
type of lymphoedema they had but not by other factors such as age range or gender. 
Participants’ scores on the physical health and psychological domains were influenced by the 
type of lymphoedema they experienced, rather than their age or their gender. Participants’ 
scores on the social relationships and environment domains were influenced by the type of 
lymphoedema participants experienced, their age and their gender.   
 
The next sections provide a more detailed analysis of the results, and how they compare with 
the results of previous studies and with previous phases of this study, is presented below 
under the headings: inequitable service provision and impact on daily life and quality of life.  
Inequitable Service Provision 
The majority of data on the inequitable nature of current lymphoedema service provision in 
Ireland related to inequality based on the greater prevalence of cancer-related lymphoedema 
in this part of the world. Although lymphatic filariasis is the most common cause of 
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lymphoedema worldwide, cancer treatment is the most common cause in the Western world. 
The questionnaire results starkly present the inequitable nature of current lymphoedema 
service provision based on lymphoedema aetiology. For example, patients with breast-cancer-
related secondary lymphoedema waited approximately 5 months for a diagnosis while 
patients with primary lymphoedema waited over six and a half years for a diagnosis. This 
difference was significant and comparable with the BreastCare Victoria (2005) study which 
found that patients with breast-cancer-related secondary lymphoedema waited 0.6 years for 
a diagnosis whereas patients with primary lymphoedema waited on average 9.4 years for 
diagnosis following the onset of symptoms. Patients with non-cancer-related lymphoedema 
were also less likely to know they were at-risk of developing lymphoedema and rated the 
healthcare professionals they consulted when they were seeking a diagnosis lower than 
patients with breast-cancer-related secondary lymphoedema. However it is worth noting the 
wide variety of healthcare professionals consulted by patients when they were seeking a 
diagnosis and the lack of dedicated lymphoedema clinics or designated patient streams or 
pathways may have inhibited the prompt assessment and treatment of their lymphoedema. 
 
Patients with non-cancer-related lymphoedema waited a longer time period between 
diagnosis and first treatment, had a longer time period since their last treatment; rated the 
standard of care they are receiving as lower, and rated themselves lower in terms of their 
quality of life, satisfaction with their health and on all domains of the WHOQOL-BREF than 
patients with breast-cancer-related secondary lymphoedema. All of these results were 
statistically significant. These results correspond with the study by Sitzia, Woods et al. (1998) 
which found that people with non-cancer-related lymphoedema generally wait longer for 
diagnosis, have greater severity or swelling and consequently have considerable management 
problems exacerbated by their later referral (cited in Bogan et al., 2007). Furthermore a 
study in the UK by Lam et al. (2006) also found that patients with non-cancer-related 
lymphoedema were less likely to have ongoing monitoring of their condition when compared 
with patients with cancer-related lymphoedema.  
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While patients with breast-cancer-related secondary lymphoedema scored better on these 
items the results indicate that the service they receive is far from adequate or optimal. They 
also experience relatively long periods to be diagnosed and treated. Moreover even within 
categories of patients with the same type of lymphoedema the ranges in responses were very 
large.  
 
Similarly there was evidence of inequity in terms of the distribution of services, delays for 
medical card holders and the financial burden experienced by some patients. For example, a 
sizeable minority of approximately one fifth reported that travel distance limited their ability 
to avail of lymphoedema treatment. This issue also arose in the results of the service provider 
survey. Additionally one-fifth of medical card holders reported that HSE approval procedures 
delayed the delivery of their compression garments. This was a point previously raised in 
both the service provider survey and patient focus groups. While some patients aren’t 
required to spend money on their lymphoedema treatments, bandages and compression 
garments others go to great personal expense to receive adequate treatment and supplies to 
effectively manage their symptoms. This also emerged strongly from the patient focus 
groups. While the majority of survey respondents indicated that they do not pay for their 
treatments 42% pay money towards their compression garments and 10% pay for 
consultations with their lymphoedema practitioner. The cost per calendar year can range from 
€2 to €1,000 for compression garments alone with only 5 participants indicating that they 
receive financial support from their private health insurers for such costs.  
 
In summary, the inequitable nature of service provision generally related to patients with 
non-cancer-related lymphoedema receiving poorer service provision than patients with 
cancer-related lymphoedema. Yet even among participants with the same type of 
lymphoedema, there was huge variation in experiences. Further inequalities were also 
reported with some patients being required to travel long distances, wait long periods for the 
approval of compression garments or pay large sums of money to access treatment. The final 
category of results from the patient surveys relates to the impact of lymphoedema on 
  200 
patients’ daily life and quality of life. The results in relation to this are discussed below in the 
next section.  
Impact on Daily Life and Quality of Life 
The results of the patient survey also emphasise the significant impact of the condition on 
patients’ daily lives and quality of life. As mentioned previously, this can take the form of 
considerable financial expense for some patients. For many participants this can involve the 
use of compression garments which were rated as mediocre on all measures by the current 
sample. The results indicated that participants’ dissatisfaction with the mediocrity of 
compression garments can lead to them not wearing garments as often as they have been 
advised to. Previous studies of patients’ experiences of living with lymphoedema have not 
explored their experiences of compression garments as an example of how the condition 
affects their daily lives.  
 
Regarding the limitations imposed by lymphoedema on daily activities, participants reported 
that restriction was more keenly felt with regard to their ability to perform chores, wear 
clothes/shoes, and go on holidays. Type of lymphoedema, age range and gender also had a 
significant impact on participants’ responses to these items. For example, participants with 
non-cancer-related secondary lymphoedema experienced greater limitation than participants 
with other types of lymphoedema in walking, swimming, performing other sports, performing 
outdoor chores, taking care of children, buying clothes/shoes, wearing clothes/shoes, 
socialising, sexual activity, sleeping, and going on holidays. Participants with breast-cancer-
related secondary lymphoedema experienced greater limitation than participants with other 
types of lymphoedema in performing indoor chores. This variation in restriction may reflect 
the location of the swelling experienced by participants with various types of lymphoedema, 
or the extent to which their swelling and associated symptoms are controlled through self-
management and access to regular treatments. As mentioned in the previous section, 
participants with various types of lymphoedema may experience disparity in their access to 
services.  
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Participants’ responses regarding the impact of the condition on daily life also differed 
significantly in terms of their age. Participants in the 18-35 age range experienced greater 
limitation in terms of going on holidays when compared with participants in other age ranges. 
Participants in the 36-50 age range experienced greater limitation in terms of performing 
other sports, and working when compared with participants in other age ranges. Participants 
in the 51-66 age range experienced greater limitation than participants in other age ranges in 
terms of swimming and performing outdoor chores. Participants in the 67+ age range 
experienced greater limitation in terms of performing indoor chores, socialising, sexual 
activity, and sleeping when compared with participants in other age ranges.  
 
Gender differences to responses to these items were also reported. Male participants 
experienced greater limitation than female participants in terms of walking, swimming, and 
sexual activity. Female participants experienced greater limitation than male participants in 
terms of performing indoor and outdoor chores, taking care of children, wearing 
clothes/shoes, and sleeping. Previous studies of living with lymphoedema have not measured 
the impact of the condition according to type of lymphoedema, age or gender therefore direct 
comparison cannot be made. The results may relate to the greater prioritisation of certain 
activities by certain groups. For example women may place greater emphasis on feeling 
comfortable when wearing clothes and shoes and therefore experience greater limitation 
when this is impeded by their swelling. Further investigation is required in order to explore 
why individuals of various age ranges or genders experience greater difficulties on some 
activities rather than other activities.  
 
Lymphoedema can also affect participants’ daily lives and quality of life through physical 
symptoms and associated medical conditions. For example, 42.5% of respondents reported 
that physical pain prevents them from doing what they want to do. This is a much higher 
proportion than in Lam et al.’s (2006) study where 13% of their participants indicated that 
pain, aching or tiredness affected their daily lives. This may be due to differences in the 
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phrasing of the question. Alternatively the discrepancy may be due to participants in the 
current sample having insufficient access to lymphoedema treatments which offer the 
potential to manage or reduce swelling (thereby reducing associated musculoskeletal pain for 
example) and to prevent infection (thereby reducing pain associated with these infections).  
 
An associated physical condition of lymphoedema is cellulitis an infection in the layers of the 
skin. Twenty-nine percent of respondents reported that they had experienced a bout of 
cellulitis which is identical to the proportion of Moffatt et al.’s (2003) sample that reported 
experiencing at least one such acute infection. Sixty-one percent of the respondents in the 
current sample who had experienced cellulitis reported that they had been hospitalised at 
least once for its treatment whereas only 15% in Moffatt et al.’s (2003) study reported that 
the infection(s) resulted in one or more hospital admissions. This may suggest that 
respondents in the current sample experience more serious infections due to insufficient 
treatment provision or self-management of the condition which both aim to prevent such 
serious infection.  
 
Regarding the impact of the condition on participants’ quality of life, the first two items of the 
WHOQOL-BREF asked participants to rate their quality of life and satisfaction with their 
health. Participants’ ratings on these items were significantly influenced by the type of 
lymphoedema they experienced but were not influenced by other factors such as age or 
gender. In terms of the domain scores of the WHOQOL-BREF, participants’ scores on the 
physical health and psychological health domains were influenced by the type of 
lymphoedema they experienced, rather than their age or their gender. Participants’ scores on 
the social relationships and environment domains were influenced by the type of 
lymphoedema participants experienced, and their age and gender.  
 
Previous studies exploring the quality of life of patients with chronic illness have reported 
different quality of life scores according to the type of chronic illness experienced by patients 
(Schlenk et al., 1998). Lymphoedema is a condition which can involve sometimes fluctuating 
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symptoms in various parts of the body leading to diverse implications and impairments. 
Moreover, as mentioned previously there is considerable evidence in the current study to 
suggest that individuals with different types of lymphoedema experience varying levels of 
service provision. Therefore it is reasonable to expect that the type of lymphoedema 
participants experience influenced their scores on the WHOQOL-BREF. Indeed, participants 
with non-cancer-related secondary lymphoedema scored lowest on all domains whereas 
participants with breast-cancer-related secondary lymphoedema scored highest on almost all 
domains. Previous studies of quality of life among lymphoedema patients have generally not 
included patients with all types of lymphoedema. Although Moffatt et al.’s (2003) study did 
include patients with various types of lymphoedema; comparison between them in terms of 
their scores on the quality of life measure was not undertaken. This study contributes 
considerably to the literature on lymphoedema patients’ quality of life as it is the first to 
compare quality of life scores across patients with different types of lymphoedema. Therefore 
this information could be utilised to increase healthcare professionals’ understanding of 
patients’ experiences and to develop tailored support programmes for patients with various 
types of lymphoedema.  
 
Previous quality of life research has reported differences in quality of life scores according to 
age and gender. In the current study, age and gender did not significantly influence scores 
on the physical health and psychological health domains but did influence scores on the social 
relationships and environment domains. In a study of general population scores on the 
WHOQOL-BREF younger participants scored highest on all domains while participants in the 
51-60 age range scored lowest on the physical and psychological domains and participants in 
the 31-40 age range scored lowest on the social and environmental domains (Skevington et 
al., 2004). Conversely, in the current study while participants in the 18-35 age range scored 
highest in the physical health domain, participants in the 51-65 age range scored highest in 
the psychological health domain and participants in the 67+ age range scored highest in the 
social relationships and environment domains. In terms of gender differences in quality of 
life, previous studies have reported that women score more poorly than men (Guallar-
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Castillón et al., 2005; Schwarz & Hinz, 2001). In the current study, women scored higher on 
all domains than men. Therefore in summary, the type of lymphoedema participants 
experienced was consistently associated with their quality of life scores, whereas age and 
gender did not have a significant association with all domains. Moreover where age and 
gender did appear to influence quality of life scores, the results were not in line with previous 
general literature on age, gender and quality of life.  
 
As a result it appears that it is the experience of lymphoedema rather than age or gender 
that is consistently associated with participants’ quality of life. Indeed researchers have 
argued that the experience of illness itself alters patients’ perception of the concept of quality 
of life. Sprangers and Schwartz (1999) have termed this ‘response shift'. Following a catalyst 
or the development of a condition, individuals may utilise affective, behavioural and cognitive 
processes to accommodate the catalyst. This can lead to individuals changing their standards 
of measurement or the values they place on certain components of quality of life or 
alternatively to individuals reconceptualising their personal definition of quality of life. The 
mechanism of this change can involve coping strategies, social comparison, social support, 
goal reordering, reframing of expectations or spiritual practices. Therefore it may be possible 
that the experience of lymphoedema has prompted many in the current sample to undertake 
such a response shift and that this has superseded the impact that age or gender would 
typically have on quality of life scores. Further investigation and exploration of the 
mechanisms of response shift and how this theory can be applied and utilised to support 
lymphoedema patients is required.  
 
Finally in their responses to a broad, open question, participants reiterated the considerable 
impact lymphoedema has on their wellbeing. Respondents wrote about the effect of the 
condition on their self-image and confidence, feelings of frustration, depression and isolation, 
and how lymphoedema can serve as a constant reminder of their prior cancer diagnosis and 
treatment for some participants. These responses reiterated the findings of the patient focus 
groups in the current study and the findings of previous qualitative studies of patients’ 
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experiences (e.g. Bogan et al., 2007; Hare, 2000; Johansson et al., 2003; Williams et al., 
2004). Participants expressed their desire for support groups and counselling and those that 
had accessed appropriate, effective treatment reported deriving huge benefits to their quality 
of life from such treatment. The lower rating of lymphoedema practitioners’ emotional 
support in comparison to ratings of their other characteristics suggests that practitioners have 
the ability to improve patients’ wellbeing in other ways rather than through the treatment of 
the swelling. This suggests that there are practical ways that the impact of lymphoedema can 
be minimised.  
 
In summary, the implications of living with lymphoedema can be multi-faceted – financial 
(e.g. cost of treatment, compression garments, and bandaging), physical (e.g. pain, cellulitis), 
social (e.g. activity level, socialising), emotional (e.g. sadness, frustration) and psychological 
(e.g. poor self-image, self-confidence, depression, isolation). The results suggest that there 
are huge variations in the impact of lymphoedema and that appropriate levels of treatment 
and the provision of support groups and counselling may offer the potential of lessening the 
consequences of lymphoedema for those who feel it most keenly.  
 
While these results add to our understanding of patients’ experiences of lymphoedema 
service provision and of living with the condition, they cannot be presented without due 
consideration of the methodological issues of this phase of the research. These are presented 
in the next section.  
 
Methodological Issues 
Firstly, for ethical and logistical reasons it was not possible to include individuals who had not 
been diagnosed with lymphoedema. Moreover, although attempts were made to access 
patients who may not be receiving treatment through lymphoedema support organisations, in 
reality the majority of participants were accessed through hospitals and services. As a result 
lymphoedema patients who are not or have never received treatment were less likely to be 
invited to participate and may be underrepresented. Therefore there is a possibility that the 
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experiences presented may not reflect all individuals’ experiences. Unless such an 
investigation was conducted as part of a prevalence study, accessing those who are not 
receiving treatment represents a significant challenge.  
 
Secondly, this was a postal survey and the majority of participants were accessed through 
hospitals and services. Consequently, there was the regrettable possibility of unwittingly 
posting surveys to individuals who had passed away where this information might not yet 
have been known to hospital personnel or where patient records had not been updated. 
Although it is recognised that this is a small possibility, it is an extremely sensitive area and it 
is of paramount importance to avoid causing unnecessary distress to their families. To 
minimise the possibility of sending research correspondence to people who may have passed 
away, it is recommended that all research using hospital or health service records to access 
potential participants should have a member of the relevant healthcare team identify people 
who meet the inclusion criteria from the available records and lists. This emerging list should 
be subsequently reviewed by other key personnel on the team as different members of the 
team may be more aware of individual patient circumstances than others. Furthermore it is 
also strongly recommended that the emerging list is crosschecked by making contact with 
patients’ general practitioners and by reviewing death notices (in newspapers and/or online 
(e.g. www.rip.ie). 
 
Thirdly, previous studies on the impact of lymphoedema on quality of life have compared 
lymphoedema patients’ scores with matched controls, for example breast cancer survivors 
who haven’t developed lymphoedema or with population norms. As the intention of this study 
was to concentrate specifically on lymphoedema patients the opportunity of comparing their 
scores with matched controls or population norms was not explored.  
 
Finally, while many participants reported in responses to open questions that they are 
distressed by their lymphoedema, a specific clinical measure of psychological wellbeing was 
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not included in order to keep the questionnaire as succinct as possible. Therefore it is difficult 
to ascertain what proportion of the sample experience clinical levels of distress.   
Conclusion 
The intention of the patient survey was to ascertain how representative various experiences 
of lymphoedema service provision and of living with lymphoedema are among a broader 
sample of patients. While the results provide information on how common particular 
experiences are – namely inequitable service provision and difficulties in living with 
lymphoedema – the next chapter of the thesis will present an integration of the findings from 
all three phases of the study with a view to making recommendations on the development of 
lymphoedema service provision in Ireland and the support of patients.  
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Chapter 7: Discussion 
Introduction 
The results of each phase of the research have previously been explored in individual 
chapters. The results of the service provider survey indicated that lymphoedema services are 
insufficient and inequitably provided, and that there are challenges to the sustainability of 
services. The findings of the patient focus groups included themes of barriers to treatment, 
tension with some healthcare professionals, the difficulties of living with lymphoedema and 
emotional factors. Other themes included participants taking an active role in their 
lymphoedema management and deriving positives out of their experiences. The patient 
questionnaires reiterated the inequitable nature of current lymphoedema service provision 
and further explored the impact of the condition on patients’ daily life and quality of life.   
 
This final discussion chapter presents the metainferences of the study derived from the 
integration of the findings of the three phases. There is a lack of well-known exemplars in 
order to guide the integration of mixed methods data in order to develop such 
metainferences (Bryman, 2007). As a result the approach undertaken by the researcher was 
not to focus on difficulties directly associated with the condition of lymphoedema (e.g. 
difficulties associated with swelling, a chronic condition, time consuming treatment etc.) but 
rather to identify super-ordinate themes which compound the difficulties of living with 
lymphoedema in Ireland at present.  While the initial aims of the study were separated into 
questions on lymphoedema service provision; and patients’ experiences of living with the 
condition, the super-ordinate themes transcend these aims.  
 
The individual results from each phase have previously been discussed in the relevant 
chapters with details and references provided so as to compare them with the findings of 
previous studies. As a result those details and references will not be repeated in this chapter. 
No previous study on lymphoedema has employed the integration of mixed methods data in 
this way. Therefore this study had the scope to see a broader perspective. As a result the 
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super-ordinate themes may not been identified or defined in the same way in previous 
studies although where similar points have been made by other researchers, reference will be 
made to them. As mentioned previously in Chapter 2, by integrating results from various 
methods there is the potential for various outcomes: silence (where one dataset uncovers a 
theme or example whereas another dataset is silent about it); convergence (where all 
datasets produce the same findings on a theme or example); complementarity or divergence 
(where all sets of data feature a theme but have different perspectives on that theme); and 
contradiction or discrepancy (where datasets offer different findings on a theme) (Farmer et 
al., 2006; Johnson et al., 2007). While no example of contradiction or discrepancy could be 
found, the outcomes of silence, convergence, and complementarity are discussed in the 
following sections.  The super-ordinate themes, their subthemes and examples of silence, 
convergence, and complementarity where they occur are briefly summarised in diagrams in 
order to simplify the findings. 
Super-Ordinate Themes 
The super-ordinate themes that arose from this mixed methods study are lymphoedema as 
an unacknowledged condition and the legacy of lymphoedema’s association with cancer.  
Lymphoedema – An Unacknowledged Condition 
The first super-ordinate theme is lymphoedema – an unacknowledged condition. 
Lymphoedema has been termed a ‘forgotten complication’ (Farncombe et al., 1994 cited in 
McWayne & Heiney, 2005) or an ‘underestimated health problem’ (Moffatt et al., 2003) by 
previous researchers. The intention of this part of the study is not merely to identify prevalent 
issues but also to provide evidence from the data as to why such a metainference has been 
reached.  
 
This super-ordinate theme includes the sub-themes that lymphoedema is inappropriately 
acknowledged among healthcare professionals; within the HSE; among private health 
insurers; among compression garment manufacturers; and that there are emotional 
consequences of living with an unacknowledged condition. The first super-ordinate theme, its 
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subthemes and examples of silence, convergence, and complementarity are briefly 
summarised in Figure 7 on page 211. Each of the subthemes along with the evidence 
supporting them from the various stages of the current study and examples of silence, 
convergence, and complementarity are presented in subsequent sections.  
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Figure 7: First Super-Ordinate Theme, Subthemes and Examples of Silence, Convergence and Complementarity Following Integration
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Lymphoedema Not Appropriately Acknowledged Among Healthcare Professionals 
This subtheme referred to the condition still not being appropriately acknowledged among 
some healthcare professionals. For example, practitioners reported that poor awareness of 
the condition among other healthcare professionals leads to low numbers of referrals. A 
complementary finding was that participants from both the focus groups and patient survey 
reported waiting significant periods for diagnosis and treatment. This emerged particularly for 
patients with non-cancer-related lymphoedema, where recognition of lymphoedema and its 
diagnosis is even poorer. Furthermore, focus group and to a lesser extent questionnaire 
participants reported tension with healthcare professionals when they were seeking an 
explanation of their lymphoedema symptoms regarding their lack of knowledge about 
lymphoedema and their attitude towards the condition. Indeed patient survey participants’ 
mean ratings of the healthcare professionals they consulted when they were seeking a 
diagnosis were all below a rating of 4 – ‘satisfied’ on measures of attitude, knowledge, 
practical and emotional support, time taken to diagnose and overall satisfaction. However 
while bearing these results in mind it is important to note the wide range of healthcare 
professionals consulted by patients when they were seeking a diagnosis. Therefore an 
improved awareness of lymphoedema is required not just within one discipline but across a 
wide spectrum of healthcare professionals.    
Lymphoedema Not Appropriately Acknowledged Within the HSE 
Both service providers and patients converged in reporting their frustration that 
lymphoedema is not sufficiently acknowledged within the HSE. For practitioners this referred 
to the low number of dedicated clinics, practitioners being required to treat patients with 
other conditions, the lack of a specific allocation of funding for lymphoedema services and 
difficulties in getting cover for leave - all challenges for practitioners treating an 
unacknowledged condition. Practitioners’ difficulty with cover for leave also results in 
difficulties in practitioners accessing continuous training which would ensure the maintenance 
of treatment standards. Moreover the large proportion of practitioners indicating a need for 
more training corresponds with this. A complementary finding from patients in both focus 
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groups and questionnaires was that the HSE’s poor funding of services has lead to an 
insufficient level of services being provided. This has lead to delays in diagnosis and lengthy 
waiting times for patients.  Indeed focus group participants spoke of the need to appeal for 
treatment and patient survey participants reiterated this with mediocre ratings of the 
standard of care they are receiving. 
 
Another example of the HSE inappropriately acknowledging lymphoedema related to the 
HSE’s delayed approval of medical card holders’ compression garments. This arose in 
practitioner surveys as they noted such delays affected patients’ treatment.  A 
complementary theme arose among the patient data.  Participants in patient focus groups 
were very vocal that the HSE’s poor acknowledgement of lymphoedema has resulted in some 
medical card holders being required to wait an inordinate amount of time for the approval of 
compression garments. Moreover the results of the patient survey indicated that a sizeable 
minority of 20% of respondents who are medical card holders considered HSE approval 
procedures to have delayed the delivery of their compression garments.   
Lymphoedema Not Appropriately Acknowledged Among Private Health Insurers 
Patient focus groups and questionnaire results partially converged in relation to private 
insurance companies failing to sufficiently acknowledge lymphoedema. While this theme 
featured strongly in focus groups, a small minority of patient questionnaire participants pay 
for treatment and therefore can claim for the cost from their private health insurance.  
However patients who do pay for treatment were again very communicative on the financial 
burden this places on them in their responses to the open questions on the questionnaire. 
Service providers were silent on this topic as they are less likely to be informed on patients’ 
health insurance status and claims.  
Lymphoedema Not Appropriately Acknowledged Among Compression Garment 
Manufacturers 
Service providers indicated in their responses to an open question on compression garments 
that delayed delivery of made-to-measure compression garments and garments 
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manufactured in the UK can affect patient treatment. Complementarily, patient focus group 
and survey results converged in relation to compression garment manufacturers not 
sufficiently acknowledging the difficulties in living with lymphoedema and therefore for many, 
living with compression garments. Focus group participants spoke about this topic at length. 
Moreover questionnaire participants rated compression garments as mediocre on measures of 
comfort, fit, colour, temperature etc. and many of them wrote negative comments about their 
experiences of garments.  
Emotional Consequences of Living with an Unacknowledged Condition  
Living with a chronic condition often places great strain on patients’ emotional wellbeing. 
However with lymphoedema there is the added burden of coping with an unacknowledged 
condition. Patient focus group and questionnaire results converged in relation to the powerful 
emotional consequence of living with an unacknowledged condition. Many focus group and 
questionnaire participants indicated that they tried to hide their lymphoedema but still felt 
self-conscious, upset and in some cases depressed. As a result, some patients in the focus 
group and questionnaire results reported feeling isolated. This may also reflect patient survey 
respondents’ poor rating of the level of emotional support received from their main 
lymphoedema practitioners. The patient survey results in relation to participants’ ratings on 
the quality of life item and overall scores on the domains of the WHOQOL-BREF correspond 
with this. Furthermore, both focus group and patient survey participants’ recommendations 
for the provision of support groups and counselling further emphasise this point.  
 
The emotional difficulties associated with living with an unacknowledged condition may relate 
particularly well to patients with non-cancer-related lymphoedema. As mentioned previously 
they were less likely to be informed that they were at-risk of developing the condition and 
experienced greater delays in their diagnosis and treatment. Therefore patients with non-
cancer-related lymphoedema may consider their condition to be acknowledged to an even 
lesser extent than patients with cancer-related lymphoedema. Interestingly patients with non-
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cancer-related lymphoedema also scored significantly lower on all domains of the quality of 
life measure than patients with cancer-related lymphoedema.  
 
However this is not to imply that the experience of patients with cancer-related lymphoedema 
does not present considerable difficulties. Indeed the next super-ordinate theme relates to 
the legacy of lymphoedema’s association with cancer.  
Lymphoedema and the Legacy of its Association with Cancer 
Although lymphatic filariasis is the most common cause of lymphoedema worldwide, cancer 
treatment is the most common cause in the Western world. The second super-ordinate theme 
relates to the legacy of lymphoedema’s association with cancer. It includes the subthemes 
that there is inequality in service provision based on the greater prevalence of cancer-related 
lymphoedema and some patients not being able to process their risk of developing 
lymphoedema due to their distress from their cancer diagnosis and treatment. Other 
subthemes include that patients’ prior cancer experience has affected others’ perceptions of 
the difficulties of living with lymphoedema and that for some patients lymphoedema can be a 
constant reminder of cancer diagnosis and treatment. The second super-ordinate theme, its 
subthemes and examples of silence, convergence, and complementarity are briefly 
summarised in Figure 8 on page 216. Each of the subthemes along with the evidence 
supporting them from the various stages of the current study and the examples of silence, 
convergence, and complementarity are presented in subsequent sections.  
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Figure 8: Second Super-Ordinate Theme, Subthemes and Level of Silence, Convergence and Complementarity Following Integration
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Inequality based on Greater Prevalence of Cancer-Related Lymphoedema 
For service providers the first subtheme relates to many practitioners being required to 
predominantly or solely treat patients with cancer-related lymphoedema to ensure limited 
resources are allocated according to the service’s remit. Therefore some practitioners are 
required to overlook patients with non-cancer-related lymphoedema. Practitioners’ poor 
ratings of the standard of care received by patients with non-cancer-related lymphoedema, 
further underscores their perceptions of this inequality.  
 
A complementary finding from patient questionnaires was patients’ perception of the 
inequality in service provision. Patients with non-cancer-related lymphoedema were less likely 
to know they were at-risk of developing the condition, waited longer to be diagnosed and 
receive their first treatment, were less satisfied with the healthcare professional they 
consulted when they were seeking a diagnosis, had a longer time period since their last 
treatment, were less satisfied with the process of getting compression garments, rated the 
standard of care they receive as poorer, and rated their quality of life and satisfaction with 
their health poorer than patients with cancer-related lymphoedema. This did not feature as 
strongly in the patient focus groups as the majority of focus group participants had cancer-
related lymphoedema. However patients with primary lymphoedema were vocal about the 
greater difficulties they experienced in accessing continued treatment, which suggests a 
partial convergence of findings.  
Distress following Cancer Diagnosis Leads to Incapacity to Process Lymphoedema 
Risk 
The second subtheme arose particularly in relation to focus group participants and a minority 
of questionnaire participants who recounted the difficulty they experienced in processing 
information about lymphoedema at a time of great personal distress. As a result these 
participants recommended that information on lymphoedema should be repeated to patients 
at-risk of developing cancer-related lymphoedema. Service providers were silent on this topic 
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as they are less well placed to comment in subjective experiences of cancer diagnosis and 
treatment and subsequent predisposition to lymphoedema development.  
Impact of Prior Cancer Experience on Other People’s Perception of the Difficulties 
of Living with Lymphoedema 
The third subtheme arose particularly in relation to focus group participants and a minority of 
questionnaire participants that recounted how some healthcare professionals in particular 
underestimated the impact of lymphoedema on their lives as a result of their prior cancer 
diagnosis and treatment. Participants who reported this experience indicated their hurt and 
anger at insufficient weight being placed on the difficulties of living with this chronic 
condition.  This point arose to a lesser extent in patient questionnaire results suggesting a 
partial convergence of findings. Service providers were silent on this topic as they are less 
well placed to comment on patients’ subjective experiences of previous interactions with 
healthcare professionals. Furthermore, this subtheme may be related to the super-ordinate 
theme of lymphoedema being an unacknowledged condition in its own right.  
Lymphoedema as a Reminder of Cancer Diagnosis and Treatment 
The final subtheme was that the stress of living with lymphoedema can be heightened among 
those who perceive the condition as a constant, distressing reminder of their cancer diagnosis 
and treatment. This arose very strongly in the findings of the patient focus groups and 
among a minority of responses to open questions in the patient survey where participants 
wrote of swopping “a death sentence for a life sentence” (Participant 195 with cancer-related 
but not breast-cancer-related secondary lymphoedema).  This suggests a partial convergence 
of findings. Service providers were again silent on this subtheme as they are less well placed 
to comment on patients’ subjective experience of developing lymphoedema subsequent to 
cancer treatment.    
 
While these super-ordinate themes and subthemes are intended to add further depth to the 
overall findings of the study, due consideration must be given to the overall limitations of the 
study which are presented in the next section.   
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Overall Limitations 
The overall results and findings of this study should be considered in light of its limitations. 
Firstly, it is possible that the inclusion of additional data collection methods would have 
offered further insights into experiences of lymphoedema service provision and living with the 
condition. As mentioned previously the various departmental structures, and the funding and 
staffing situations in hospitals and services were difficult to explore fully in a practitioner 
questionnaire format. While the addition of service provider focus groups would have added 
further clarity in these matters it was not possible given the time constraints of the study. 
Furthermore, individual patient interviews would have been appropriate to investigate 
sensitive topics such as the impact of living with lymphoedema on patients’ sexuality. 
Moreover, while many participants reported in responses to open questions that they are 
distressed by their lymphoedema, a specific measure of psychological wellbeing was not 
included to keep the questionnaire as succinct as possible. Therefore it is difficult to ascertain 
what proportion of the sample is experiencing clinical levels of distress.  These are areas that 
could be further explored in future research.  
 
Secondly, the generalisability of these findings is also open to question. Given the unique 
structure of the Irish healthcare system and the current changes in that system it is uncertain 
whether the results and recommendations can be applied to other countries. Furthermore, 
the pervasive media coverage on the challenges facing the Irish healthcare system and 
indeed the Irish economy at present may have affected practitioners’ and patients’ responses 
to certain items. For example the following quote was a response to the final open question 
of the patient survey which requested any additional comments:  
(Participant 714 with breast-cancer-related secondary lymphoedema): Because 
lymphoedema requires regular assessment and treatment, it is important and reassuring to 
know that you have a reliable, high standard lymphoedema service within reasonable 
access. I think (name of city) is perhaps fairly well serviced, but the less populated counties 
are probably experiencing problems. Unfortunately with the economic downturn I cannot 
see improvements being made in this regard, at least not in the immediate future.  
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Therefore it is unclear whether participants would have responded differently if this study had 
been conducted at a different juncture.  
 
Notwithstanding these limitations, the findings have important implications. A number of 
recommendations in terms of future research and policy can be made based on the findings 
and these are presented below in the next section.  
Recommendations 
The recommendations arising from this thesis have been categorised as either research or 
policy recommendations and are presented below. Some of these recommendations echo 
those made in previous reports or studies and these are referenced where appropriate.  
Research Recommendations 
As mentioned previously in the literature review, there is a paucity of research on 
lymphoedema.  It is intended that this study will encourage a general stimulation of research 
on lymphoedema and lymphoedema service provision. However there are a number of 
streams of research which are required and these are briefly outlined below.  
 
Firstly additional research on the lymphatic system and lymphoedema is required. 
Researchers are still uncertain as to the normal range of lymphatic variation in terms of 
lymph vessel numbers, functional capabilities and locations. Research is also required on the 
mechanisms of lymphatic system functioning, the aetiology and progression of lymphoedema, 
and the extent to which prior lymphatic functioning further predisposes some individuals to 
developing secondary lymphoedema (Morrell et al., 2005; Williams, 2006a). Some 
investigations into the genetic basis of primary lymphoedema have been undertaken but 
identified mutations only account for less than half the cases of primary lymphoedema and 
therefore further exploration is required (see Ferrell and Finegold, 2008 for a review of 
findings to date). This research would add weight to evidence for treatment approaches and 
enable individuals who are at a heightened risk of developing lymphoedema to adopt 
prophylactic measures and to access treatments promptly (Piller, 2006).  
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Secondly, the International Society of Lymphology (2003) called for a lymphoedema 
classification based on an improved understanding of the mechanisms underlying 
lymphoedema development including underlying genetic disturbances which could encompass 
anatomic and functional characteristics.  Following the development of such a classification 
system further research on the prevalence of all types of lymphoedema is required. A study 
on the prevalence of lymphoedema in Ireland would be particularly welcome as it would 
assist with the acknowledgement and awareness of the condition, and the strategic planning 
of lymphoedema service development.  
    
Thirdly, evidence for the effectiveness of particular treatment strategies when used singularly 
and in tandem with other treatment approaches is also sorely lacking. Furthermore, research 
into emerging treatments, such as microsurgery to repair lymphatic pathways, is required to 
ascertain whether they are effective and if so under what circumstances. More robust 
research on the effectiveness of lymphoedema treatments including their ability to prevent 
the development of cellulitis and therefore costly inpatient treatment would support the 
provision of maintenance lymphoedema treatment.  A study in the UK calculated that the 
average cost of managing lymphoedema with information and advice, an exercise 
programme, MLD and SLD training for patient, MLLB and compression garments as £468.09 
for six months treatment per patient including professional time, clinic facility and 
administrative support (Todd, 1999). The cost of such a programme in an Irish healthcare 
context needs to be calculated and offset against the alternative costs of inpatient treatment 
for cellulitis, lost workdays, disability benefits, and the subsequent reduction in revenue 
contributions, in order to bolster the argument that the provision of lymphoedema services 
would be cost effective (DHSSPS, 2004; Moffatt et al., 2003). Research into the effectiveness 
of lymphoedema treatments would also increase awareness of these treatments among the 
wider healthcare community and consolidate patients’ claims for financial support from 
private health insurance companies.  
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Fourthly, while this study aimed to contribute to research on the impact of lymphoedema, 
further research is required. For example the impact of lymphoedema on particular groups 
that were not included in the current study, such as palliative patients with lymphoedema, 
children with primary lymphoedema and their carers. While the impact of lymphoedema on 
patients’ sexuality was explored to a certain extent by two items of the patient questionnaire, 
the topic could not be explored in the group setting of the focus groups. Individual interviews 
would allow for a more comprehensive investigation of the impact of the condition on 
sensitive aspects of patients’ lives. Alternatively a multi-element study could explore the 
impact of the condition from the perspectives of the patient, their partner or significant other, 
children, friends etc. (McWayne & Heiney, 2005). Furthermore as mentioned previously, the 
current study did not include a measure of psychological wellbeing and therefore it is 
uncertain what proportion of the sample of Irish lymphoedema patients are experiencing 
clinical levels of distress.  
 
Finally, research on the impact of the condition on patients must be practically employed 
(McWayne & Heiney, 2005). For example, studies should be undertaken to ascertain 
appropriate methods of promoting patients’ self-management. Furthermore specific quality of 
life measures and measures of psychological wellbeing should be developed for use in applied 
settings so that patients who may require additional support can be identified and supported. 
The results of the current study correspond with previous studies which reported that 
lymphoedema patients may experience difficulties with their self-image, isolation and distress. 
Undoubtedly interventions can be adapted or specifically developed in order to support these 
patients. Further research is required to develop, pilot and assess them with a view to 
integrating such evidence-based psychosocial interventions into lymphoedema service 
provision (Rockson, 2002).  
Policy Recommendations 
To encourage acknowledgement of lymphoedema among healthcare professionals, private 
health insurers, compression garment manufacturers, all other relevant stakeholders, and 
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within the HSE, information on lymphoedema, and the results of the current study should be 
presented to them. As mentioned in the previous section on research recommendations 
private health insurance companies would be assisted in acknowledging lymphoedema by the 
dissemination of research on the prevalence of lymphoedema in Ireland, and studies 
indicating the cost-effectiveness of lymphoedema treatments. Regarding compression 
garment manufacturers, a forum should be provided whereby manufacturers interact with 
professionals and patients to improve understanding between the various parties.  
 
With the intention of improving the HSE’s acknowledgement of lymphoedema, the results of 
this study should be provided to the relevant bodies, for example the Health Information and 
Quality Authority (HIQA) and the National Cancer Control Programme (NCCP). In order for 
the HSE to demonstrate that lymphoedema has been sufficiently acknowledged, a number of 
recommendations need to be realised. These recommendations would focus heavily on the 
initiation and continuation of independent streams of funding to enable the strategic planning 
and provision of coordinated, equitably-located, nationally-provided, comprehensive services. 
This strategic planning would be based on the current study, a lymphoedema prevalence 
study conducted in Ireland, the recommendations of the international consensus on the best 
practice for the management of lymphoedema (MEP, 2006) and analysis of population 
distribution in Ireland.  
 
With the intention of reducing current inequalities in service provision, the capacity of existing 
lymphoedema services should be increased in order to enable services to treat all 
lymphoedema patients. Where possible, lymphoedema services should be independent and 
not branches located within cancer clinics. This would encourage the use of lymphoedema 
services among all lymphoedema patients. Patients with non-cancer-related lymphoedema 
would not assume that the service was exclusively for patients with cancer-related 
lymphoedema. Furthermore patients with cancer-related lymphoedema would not have the 
negative association of being required to attend lymphoedema consultations in the same 
department that they attended consultations relating to their previous cancer treatment.  
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Previous reports on lymphoedema service provision have recommended the hub-and-spoke 
model whereby intensive treatment is provided in specialised clinics by a multi-disciplinary 
team including breast care nurses, occupational therapists, physiotherapists, psychologists, 
podiatrists, dermatologists, tissue viability nurses or dieticians as required, as each has a 
particular perspective to bring (CREST, 2008). Maintenance of the condition would then be 
delivered more locally in satellite services (MacLaren, 2003). The specialist services would 
require project management and regular audits to ensure goals and targets are set and 
reached (DHSSPS, 2004). An example would be the audit conducted by Jeffs (2006), which 
monitored the presenting characteristics of patients, treatments undertaken and a follow up 
of outcomes.  Ideally these lymphoedema services would form a network, liaising with each 
other, working from shared protocols and standards (DHSSPS, 2004; Martlew, 1999; 
Richmond, 2003) This would complement the Irish Department of Health and Children’s 
(DOHC), and the World Health Organisation’s (WHO) aims of developing local services and 
the reorientation of health services into the community, where appropriate (DOHC, 2008; 
MacLaren, 2003).  
 
Once the establishment of multi-disciplinary teams in lymphoedema services has taken place 
lymphoedema patients should be offered individual and/or group psychological support, 
where required, in order to assist them in adapting to living with lymphoedema. Psychological 
support would not only improve patients’ wellbeing but also offers the potential to assist in 
patients’ compliance with lymphoedema management plans (Rockson, 2002). In addition, 
such psychological support would assist patients in dealing with the specific difficulties they 
may have. For example, patients with cancer-related lymphoedema may need assistance with 
dealing with feelings that lymphoedema is a constant reminder of their previous cancer 
diagnosis and treatment while for primary lymphoedema patients there are the added 
concerns of heritability.  
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Furthermore in order to encourage the acknowledgement of lymphoedema among healthcare 
professionals and appropriate referral of patients, a series of educational programmes is 
required. Given the wide range of healthcare professionals patients reportedly contacted 
when they were seeking a diagnosis and treatment, education on the lymphatic system and 
lymphoedema should be provided across the spectrum of healthcare professionals, from 
primary care teams (e.g. general practitioners, community nurses etc.) and secondary health 
professionals (e.g. those working in areas such as cancer, vascular surgery, wound care or 
tissue viability, dermatology, palliative care, plastic surgery etc.) to lymphoedema specialists 
themselves (Augustine et al., 1998; Bogan et al., 1997; Runowicz, 1998). The anatomy, 
physiology and pathophysiology of the lymphatic system, and the prevention, development 
and treatment of lymphological disorders should be included in the undergraduate curricula of 
these professionals (CREST, 2008; DHSSPS, 2004).  
 
Information on lymphoedema, its treatment and available services should also be provided 
through continuous professional development programmes for existing healthcare 
professionals. Moreover in order to ensure the standardised treatment of all patients, 
publication of precise patient streams in addition to general practice guidelines are required, 
such as the guidelines produced by CREST (2008) in Northern Ireland.  A cadre of 
lymphoedema practitioners could cascade their training to facilitate and monitor the 
awareness of lymphoedema by their colleagues, improving service-wide lymphoedema 
awareness, which would in turn improve referral pathways and healthcare professionals’ 
appreciation of the difficulties of living with the condition (DHSSPS, 2004).  General 
practitioners and those in primary care should be specifically targeted as they are in a 
privileged position to identify patients with non-cancer related lymphoedema. For example, 
resources such as the CREST (2008) decision tree would assist healthcare professionals in 
identifying the type of chronic oedema patients are experiencing and therefore the most 
appropriate referral option. Moreover lymphoedema practitioners themselves require repeated 
training to ensure that the standard of treatment patients receive is optimal. Guidelines on 
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the level of training required by practitioners feature in the British Lymphology Society’s (BLS) 
(2001a) framework for education.  
 
Standardised prevention programmes should be provided for all patients who may be at-risk 
including those at risk of non-cancer-related secondary lymphoedema and those with a 
genetic risk of developing primary lymphoedema (McWayne & Heiney, 2005). These 
programmes would the provision of information on the condition and of available services and 
baseline measurements of the at risk area. Participants with cancer-related lymphoedema in 
the focus groups especially spoke about the difficulties of processing the information about 
lymphoedema when they were distressed following their cancer surgery or treatment.  
Therefore the provision of repeated group information sessions following patients’ discharge 
from hospital and the inclusion of patients’ spouses, friends, or children at these information 
sessions could assist with this (Runowicz et al., 1998). 
 
Treatment should be available to all lymphoedema patients at least at a subsidised rate 
through the HSE. As mentioned previously research on the cost of a lymphoedema 
maintenance programme as opposed to inpatient treatment for cellulitis, lost revenue and 
disability benefit payments would assist in lobbying for the provision of this essential care. 
Moreover timely interventions could hinder the development of many of the physical, 
functional, social and economic consequences of lymphoedema thereby benefiting not just 
the patients themselves but also limiting the financial implications of the condition on the 
economy (Person et al., 2008). 
 
However while the above mentioned proposals are undoubtedly required, recommendations 
cannot be made without consideration of the present economic situation. The Irish healthcare 
system is currently under enormous financial pressure and cutbacks are being made to what 
many consider to be essential services. While bearing this in mind, there is scope for 
recommendations which would be relatively cost-neutral by increasing coordination between 
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lymphoedema practitioners thereby resulting in negligible financial cost while nonetheless 
benefitting to patients. 
 
Firstly, the information provided to patients at-risk of developing lymphoedema, to 
lymphoedema patients and to their families should be standardised across lymphoedema 
services. Practitioners’ resources and time are limited so through the collaboration of 
practitioners perhaps through a lymphoedema support organisation, various information 
packs could be produced including general information on lymphoedema and tailored 
information for patients with different needs. This information could also be provided in 
audiovisual formats, e.g. a DVD or audio CD of general instructions for performing 
lymphoedema exercises for those with upper limb and lower limb lymphoedema.  
 
Secondly patients need to be empowered to take ownership of their lymphoedema care. 
While some patients reported taking responsibility for their lymphoedema through daily 
simple lymphatic drainage, exercises and skincare, many participants indicated they would 
like additional support from their lymphoedema service. Conversely, practitioners reported 
that their services lacked the capacity to provide frequent follow up appointments to all 
patients. At a minimum, the international consensus document states that patients should 
receive follow up appointments on a six-monthly basis (MEP, 2006). Through the use of the 
above mentioned information leaflets and audiovisual resources, patients should be 
encouraged to continue with the self-management of their condition while retaining the 
option of contacting the service for advice or a prompt appointment in the intervening period 
if required. 
 
Finally, in a related point, patients also need to be empowered and mobilised to initiate local 
fora for patients to share experiences, information and ideas and to encourage and support 
each other on a regional and regular basis. Lymphoedema patients are the most appropriate 
individuals to support other lymphoedema patients as they best understand the realities of 
the condition. Additionally, local practitioners could be invited on a rota basis to discuss 
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particular topics with such support groups where possible and required (for example, a 
workshop on how to perform specific lymphoedema exercises). Family members and friends 
could be included in these psycho-educational programmes to train them in lymphoedema 
management techniques (e.g. compression garment and bandage application, simple 
lymphatic drainage etc.). This could encourage them to support their loved ones, thereby 
improving patients’ adherence to their management plan and increasing the level of involved, 
informed social support patients receive (Person et al., 2008). Such a support group would 
not only ensure patients and their families are informed and encouraged it would also have 
the benefits of combating feelings of isolation and maximising the use of limited resources. 
Overall Conclusions 
Lymphoedema rates are likely to increase worldwide due to the widely predicted increase in 
the number of people affected by cancer, surviving cancer and experiencing longer cancer 
remissions; the increase in life expectancy rates, particularly among women; the increase in 
obesity levels and decrease in exercise levels; and the increase in lymphatic filariasis 
infections in endemic countries. One of the outcomes of this report is to highlight the dearth 
of research in lymphoedema and given the predicted rising lymphoedema prevalence rates, 
gaps in service provision and the impact of the condition on patients’ quality of life it is of 
paramount importance that the recommended areas of research are investigated promptly. It 
is intended that the current study, the first conducted in this country, will stimulate research 
on lymphoedema in the Republic of Ireland and further afield. 
 
Lymphoedema is one of many conditions that require investment to enable the development 
of appropriate service provision in Ireland. While bearing this in mind, it is intended that by 
highlighting the pressures endured by practitioners working with limited resources and the 
challenges endured by patients, lymphoedema will no longer be perceived as an 
unacknowledged condition.    
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Appendix A 
 
Service Provider Questionnaire Cover Letter 
 
 
 
 
<Address of Practitioner> 
 
<Date>  
 
 
 
 
Dear <Mr. / Ms. Surname of Practitioner>, 
The Irish Cancer Society, in conjunction with the School of Nursing, Dublin City University is 
conducting research into patients’ experience of living with lymphoedema and of 
lymphoedema service provision in Ireland. The overall aim is to learn more about the 
experiences of people affected by all types of lymphoedema in order to influence the 
development of nationwide service provision and policy guidelines, which directly respond to 
an identified need. 
 
The research team are involving people affected by lymphoedema and the people who 
provide the service to give them the opportunity to voice their opinion on this area, so that 
improvements can be made.  
 
We are contacting you and requesting your participation in this research because you are 
working in a service which treats lymphoedema patients and consequently, your views are 
extremely important in enhancing our understanding of current lymphoedema service 
provision in Ireland. If you are unaware of the treatments available to lymphoedema patients 
in your service, please pass this questionnaire on to the most appropriate person in your 
department or service.  
 
You will find an Information Sheet and Questionnaire enclosed with this letter. Please answer 
all questions in the Questionnaire and post it back, as soon as possible, in the enclosed 
FREEPOST envelope to FREEPOST, Susan O’Carroll, Irish Cancer Society, 43–45 
Northumberland Road, Dublin 4. 
 
Participation is on a voluntary basis. You are under no obligation to take part in this research 
study. All your answers to the Questionnaire will remain strictly confidential.  
 
If you would like further information about the study please don’t hesitate in contacting 
Maeve Murray from the School of Nursing in DCU on 01 7007793 or Susan O’Carroll from the 
Irish Cancer Society on 01 2310594. We would greatly appreciate your support in this project. 
 
 
Yours sincerely, 
 
 
Susan O’Carroll 
 
Clinical Coordinator  
Irish Cancer Society  
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Appendix B  
 
Service Provider Survey Information Sheet 
 
1. Title of research project: 
Exploring the Provision of Lymphoedema Services in Ireland.  
2. Introduction: 
You are being invited to take part in a study. Before you decide to take part or not, it is 
important that you understand why the study is being done and what it will involve. Please 
read the following information carefully and discuss it with others, if you wish. If you require 
further information, or would like to ask any questions, please contact Maeve Murray from 
the School of Nursing in DCU on 01 7007793 or Susan O’Carroll from the Irish Cancer Society 
on 01 2316606.  
Lymphoedema is a chronic, incurable condition that can lead to pain, susceptibility to 
infections as well as compromised mobility. However, with early diagnosis and intervention, 
the condition can be well controlled. As a result, prompt diagnosis and appropriate treatment 
is an essential part of the management process. However, in Ireland there has been no 
research on lymphoedema service provision to date.  
The overall aim of this research is to learn more about the experiences of patients in the 
diagnosis, treatment and management of lymphoedema. People affected by lymphoedema 
and professionals who provide the service will be involved in the research, so that 
improvements in this area can be made. This research is funded by Action Breast Cancer (a 
project of the Irish Cancer Society); and was devised by a research team consisting of Ms. 
Susan O’Carroll, Irish Cancer Society, and Dr. Pamela Gallagher and Ms. Maeve Murray, the 
School of Nursing, Dublin City University.  
3. Procedures: 
You are being contacted about this study because you currently hold or have held a position 
in a hospital/service that treats lymphoedema patients in the past six months.  
You are being asked to take part in a survey about the lymphoedema treatments and support 
services available by filling out a questionnaire.  
If you would like to take part, you are asked to complete the questionnaire and to return it to 
FREEPOST, Susan O’Carroll, Irish Cancer Society, 43-45 Northumberland Road, Dublin 4.  
4. Benefits: 
There are no direct benefits to taking part in this study. However, the information that will be 
collected will help develop guidelines to improve equity, availability and quality in 
lymphoedema service provision. Research that helps develop policy in this way will, in turn, 
benefit professionals working in the services.  
5. Risks: 
Asking you about your experiences of treating lymphoedema may bring about unpleasant or 
upsetting memories. If you feel uncomfortable or distressed at any stage, you can withdraw 
without any consequences. You can also contact Maeve Murray from the School of Nursing in 
DCU on 01 7007793 or Susan O’Carroll from the Irish Cancer Society on 01 2316606.  
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6. Exclusion from participation: 
If you have not held a position in a hospital/service that treats lymphoedema patients in the 
past six months, you will be unable to take part in the study.  
7. Confidentiality: 
If you agree to take part, all information collected will be kept strictly confidential.  
The study findings will form the basis for preparation of policy documents, reports, academic 
publications, conference papers and other scientific publications.  
8. Voluntary participation: 
You have volunteered to take part in this study. You may withdraw your participation at any 
time. If you decide not to participate, or if you quit, you will not be penalised. There will be 
no penalty for withdrawing before all stages of the research study have been completed.  
9. Permission: 
This research project has been approved by Dublin City University Research Ethics 
Committee.  
10. Further Information: 
If you need more information about your participation in the study, your rights, or answers to 
your questions about the study, contact Maeve Murray from the School of Nursing in DCU on 
01 7007793 or Susan O’Carroll from the Irish Cancer Society on 01 2316606.  
If participants have concerns about this study and wish to contact an independent person, 
please contact: The Secretary, Dublin City University Research Ethics Committee, c/o Office of 
the Vice-President for Research, Dublin City University, Dublin 9. Tel 01-7008000 
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Appendix C 
 
Service Provider Questionnaire 
This is a questionnaire designed to investigate different aspects of lymphoedema service 
provision. We are interested in all types of lymphoedema, primary and secondary.  
Please answer every item as honestly as you can. There are no right or wrong answers.  
Your responses will remain completely confidential. 
 
SECTION 1: GENERAL INFORMATION 
 
1. What position do you hold? [   ] Breast Care Nurse 
     [   ] Lymphoedema Nurse Specialist                 
     [   ] MLD Therapist                 
     [   ] Occupational Therapist     
     [   ] Occupational Therapy Manager   
     [   ] Physiotherapist                
     [   ] Physiotherapy Manager  
     [   ] Other, please specify_________________________________ 
 
2. Do you personally treat people with lymphoedema? [   ] Yes     [   ] No  
    (IF NO, GO TO SECTION 6) 
 
2b. If yes, how long have you been treating people with lymphoedema?  
                                                                                       ______ years_____ months 
 
2c. If yes, how many hours per working week do you spend in activities related to the 
treatment of lymphoedema patients (please state number of hours)?   
                              _____________hours 
                                                                             
SECTION 2: PATIENT PROFILE  
 
3. Please estimate how many patients you are currently treating?           ___________ patients                                          
 
 
4. On average, how many patients do you treat in a month?                                       
Initial Consultation–Education, Skin Care, SLD                  ___________ patients 
Intensive Treatment – MLD/MLLB                                    ___________ patients 
Follow up appointments                     ___________ patients 
 
 
5. On average, how many times is each patient seen?       
__________________ 
 
 
6. On average, how long does each consultation last?            ____________ Upper limb patients          
                                                                                             ____________  Lower limb patients 
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7. Please estimate what percentage of the patients you have treated in the last year experience 
the following forms of lymphoedema (Please write the approximate percentage next to each 
type of lymphoedema. Leave the others blank. Your answers should total 100%): 
________% Primary lymphoedema 
________% Lymphoedema secondary to breast cancer 
________% Lymphoedema secondary to other types of cancer 
_______% Lymphoedema secondary to trauma and tissue damage (e.g. burns, 
varicose vein surgery, scarring, large wounds, self harm etc.) 
_______% Lymphoedema secondary to venous disease (e.g. DVT chronic venous 
insufficiency, intravenous drug use etc.) 
_______% Lymphoedema secondary to infection (e.g. cellulitis,   lymphadenitis, 
filariasis etc.) 
_______% Lymphoedema secondary to inflammation (e.g. rheumatoid arthritis, 
psoriatic arthritis, dermatitis/eczema, sarcoidosis etc.) 
_______% Lymphoedema secondary to immobility and dependency (e.g. dependency 
lymphoedema, obesity, paralysis etc.) 
 
 
7b. Please estimate what are the five most common types of cancers that the 
patients you have treated in the last year have experienced which have caused 
their lymphoedema (from most to least common)? (Please write the 
approximate percentage next to each type of cancer. Leave the others blank. 
Your answers should total 100%): 
 
Type of cancer % of your patients who have lymphoedema as a 
result 
1. _______% 
2. _______% 
3. _______% 
4. _______% 
5. _______% 
 
 
8. Please estimate what percentage of the patients you have treated in the last year have 
lymphoedema in the following parts of their bodies? 
_______% Unilateral upper limb  
________% Bilateral upper limb 
_______% Unilateral lower limb 
_______% Bilateral lower limb 
_______% Face and/or neck  
_______% Genitals 
_______% Other, please specify ________________________________________________ 
 
9. Please estimate what percentage of the patients you have treated in the last year were in the 
following age ranges when you first began to treat them? 
_______% Less than 18 years old 
________% 19-35 years 
________% 36-50 years 
_______% 51-65 years 
_______% Over 66 years old 
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10. What is the greatest distance a patient would travel to get to your service (approximately)?      
           ____km 
 
11. Please estimate what percentage of the patients you have treated in the last year live within 
a 10km radius of your service (approximately)?      _____%   
                                                                                                                             
12. Please estimate what percentage of the patients you have treated in the last year live more 
than 50km from your service (approximately)?      _____%
                    
SECTION 3: PATIENT REFERRAL  
 
13. Do you receive referrals from the following sources?                        If yes, can you treat them?  
Yes No  Yes No 
Hospital oncology clinics ...................... [   ]  [   ]  [   ]  [   ] 
Hospital general surgical clinics ................[   ]  [   ]  [   ]  [   ]  
Hospital physiotherapy clinics ...................[   ]  [   ]  [   ]  [   ]  
Hospital dermatology clinics ......................[   ]  [   ]  [   ]  [   ]  
Hospital leg ulcer clinics .............................[   ]  [   ]  [   ]  [   ]  
Hospital vascular clinics ..............................[   ]  [   ]  [   ]  [   ]  
Hospital general medical clinics ................[   ]  [   ]  [   ]  [   ]  
Hospital tissue viability clinics ...................[   ]  [   ]  [   ]  [   ]  
Community physiotherapy clinics .............[   ]  [   ]  [   ]  [   ]  
Community leg ulcer clinics .......................[   ]  [   ]  [   ]  [   ]  
General Practitioners ..................................[   ]  [   ]  [   ]  [   ]  
Patients self referring ................................[   ]  [   ]  [   ]  [   ]  
Family/friends of patients .........................[   ]  [   ]  [   ]  [   ]  
Other (please specify) __________________________  [   ]  [   ] 
 
14. Please indicate the 3 most common referral sources.  
     1.___________________________________________ 
  2.___________________________________________ 
  3.___________________________________________ 
 
15. If you get a referral for a lymphoedema patient that your service cannot treat at that time do 
you know where you can refer them to?    [   ] Yes [   ] No 
 
16. How often does this happen?            __________________________ 
 
17. Please estimate what percentage of the patients you have treated in the last year has gone 
abroad for treatment?                                                                                          _____%                                                                                               
 
18. Please add additional comments on the referral options for lymphoedema patients?  
_________________________________________________________________
_________________________________________________________________
_________________________________________________________________ 
 
SECTION 4: MINIMISING RISK AND TREATMENTS PROVIDED 
 
19. Do you provide advice on how to minimise the risk of developing lymphoedema to those who 
may have compromised lymphatic functioning? 
                   [   ] Yes  [   ] No 
 
19b. If yes, please give details about the content of the information you provide and to 
what types of patients.  
_____________________________________________________________________
_____________________________________________________________________ 
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20. Do you provide the following treatments in the management of lymphoedema?    
              If no, is the   
         treatment available 
within your service?  
     Yes      No          Yes           No 
Education on skincare ................................................. [   ]  [   ]       [   ]       [   ] 
Education on diet ......................................................... [   ]  [   ]       [   ]       [   ] 
Education on when to seek further medical attention ..... [   ]  [   ]       [   ]       [   ] 
Education on how to perform simple lymphatic drainage [   ]  [   ]       [   ]       [   ] 
Manual lymphatic drainage ........................................... [   ]  [   ]       [   ]       [   ] 
Education on how to perform exercises.................................[   ]   [   ]       [   ]       [   ] 
Multi-layer lymphoedema bandaging ............................. [   ]  [   ]       [   ]       [   ] 
Education on self-bandaging......................................... [   ]  [   ]       [   ]       [   ] 
Compression garment fitting......................................... [   ]  [   ]       [   ]       [   ] 
Intermittent pneumatic compression pump.................... [   ]  [   ]       [   ]       [   ] 
Other, Please specify___________________________    [   ]   [   ]       [   ]       [   ] 
 
21. Please estimate what percentage of the patients you have treated in the last year have you 
fitted lymphoedema compression garments for:             _____%
                                                 
             
21b. Please estimate what percentage of the patients you have treated in the last 
year use off-the-shelf garments?                                                         _____%
                                                  
                                                                                                                            
21c.  Please estimate what percentage of the patients you have treated in the last 
year use custom-made garments?          _____%
                
                                                                                                                        
21d.  On average, how many compression garments would you fit each month?  
         __________
                             
21e. What is the average length of time for a garment to be delivered by a supplier? 
          __________
  
21f. Does the length of time waiting for the delivery of a garment interfere with the 
treatment of patients?               [   ] Yes        [   ] No 
 
21g. Please add additional comments on the availability of garments and the 
duration spent waiting for the delivery of garments. 
________________________________________________________________
________________________________________________________________
________________________________________________________________ 
 
SECTION 5: PROFESSIONAL DEVELOPMENT  
 
22. How would you rate yourself on each of the following characteristics when thinking about 
treating patients with lymphoedema?  
Not at all            Extremely  
(i) Knowledgeable. . . . . . .      1          2   3            4        5           6        7          8      9         10 
(ii) Competent . . . . . .. . . .      1          2   3            4        5           6        7          8      9         10 
(iii) Experienced . . . . . . . . .      1          2   3            4        5           6        7          8      9         10 
(iv) Confident . . . . . . . . . . .      1          2   3            4        5           6        7          8      9         10 
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23. Do you keep up to date with current advances in lymphoedema research by…? 
           Yes No 
(i)  Reading a relevant journal? ............................................................................  [  ]  [  ] 
            (ii) Reading a relevant magazine?.........................................................  [  ] [  ] 
(iii) Attending conferences? ................................................................................... [  ] [  ] 
(iv) Attending lectures/meetings/workshops on the subject?...................  [  ] [  ] 
(v) Other (please specify)______________________________________ [  ] [  ] 
 
 
24. Have you completed any of the following forms of additional training in lymphoedema 
management? 
Yes No 
Postgraduate training in lymphoedema management .............................  [   ]  [   ] 
Training provided by the Casley-Smith School........................................  [   ]  [   ] 
Training provided by the Földi School ...................................................  [   ]  [   ] 
Training provided by the Klose School ...................................................  [   ]  [   ] 
Training provided by the Leduc School ..................................................  [   ]  [   ] 
Training provided by the Vodder School ................................................  [   ]  [   ] 
Training in garment fitting by compression garment providers ................  [   ]  [   ] 
Introductory workshops on lymphoedema provided by Action Breast Cancer [   ]  [   ] 
Other (please specify) ______________________________________________________ 
 
 
25. Do you think there is sufficient opportunity for professional development in the field of 
lymphoedema treatment?     [   ] Yes [   ] No 
  
 
25b. If no, which of the following training needs do you feel should be addressed 
(please tick one or more boxes)? 
[   ] Modules at undergraduate level on the lymphatic system and lymphoedema 
for all relevant disciplines (e.g. nursing, occupational therapy, 
physiotherapy, medicine etc.) 
[   ] Postgraduate training on lymphatics and lymphoedema 
[   ] Provision of specialised training for those working with lymphoedema 
patients (e.g. as provided by the Casley Smith, Fıldi, Klose, Leduc and 
Vodder schools) 
[   ]   Provision of Continual Professional Development lymphoedema courses to 
enable practitioners to keep abreast of lymphoedema research and 
treatment developments 
 [   ]   Other, please specify______________________________________ 
_____________________________________________________________
_____________________________________________________________ 
 
SECTION 6: YOUR SERVICE  
 
26. How long have you been working in the hospital/service that you currently work in? 
         ______ years_____ months 
 
27. In what county in Ireland is your service located?                ___________________________ 
 
28. How would you best describe your service? 
     [   ] Public  [   ] Private  [   ] Mix of public/private 
 
 
28b. If you are a private practitioner, have you been funded by the HSE to treat people 
in your       private practice?    [   ] Yes [   ] No 
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29. In what setting is your service located? 
[   ]   University/Teaching Hospital [   ]   Regional Hospital  
[   ]   General Hospital  [   ]   Private Hospital  
[   ]   Community Health Centre [   ]   Cancer Support Centre 
[   ]   Hospice   [   ]   Private Practice  
[   ]   Other, Please specify________________________________  
 
30. Is your service a dedicated service for lymphoedema patients?  [   ] Yes [   ] No 
 
30b. Please give further details.  
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
30c.If no (to Question 30), are you in the process of developing a lymphoedema 
service?       [   ] Yes    [   ] No 
  
Please give further details on the number of full time equivalent staff that is 
required by your service.  
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
30d. If yes (to Question 30), are you in the process of expanding an existing 
lymphoedema service?     [   ] Yes [   ] No 
 
Please give further details on the number of full time equivalent staff that is 
required by your service.  
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
 
31. Please estimate approximately what percentage of your service’s funding comes from each of 
the following sources? (Please write the approximate percentage next to each of your funding 
sources. Leave the others blank. Your answers should total 100%) 
 
____% Breast Care 
____% Oncology 
____% Physiotherapy 
____% Occupational Therapy 
____% Vascular 
____% Dermatology  
____% Community health 
____% Patient contributions 
____% Grant (please specify source) ________________________ 
____% Other (please specify) ______________________________ 
[   ]     Don’t Know 
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32. How many people employed in your service, work in the treatment of lymphoedema, in the 
following occupations?  
 
 Number of Staff Members 
(i) Nurses ................................................................   
(ii) Occupational Therapists.........................................  
(iii) Physiotherapists ...................................................  
(iv) Doctors ................................................................  
(v) Masseurs .............................................................  
(vi) Social workers ......................................................  
(vii) Psychologists  ......................................................  
(viii) Psychiatrists .........................................................  
(ix) Podiatrists ............................................................  
(x) Administration Staff ..............................................  
(xi) Other (Please specify) ________________________  
 
 
33. Does your service have any vacant posts for lymphoedema practitioners that have not been 
filled? 
[   ] Yes [   ] No 
 
33b. If yes, what is the reason for the vacant posts not being filled? 
[   ] Financial constraints within the service  
[   ] Lack of qualified staff 
[   ] Other, please give details______________________________________ 
 ___________________________________________________________ 
           
34. Do the lymphoedema practitioners in your service have cover for annual leave, sick leave or 
maternity leave?      [   ] Yes [   ] No 
 
34b. If no, please comment on this.  
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
 
35. How many patients are on the waiting list for the following? 
Initial Consultation–Education, Skin Care, SLD        ___________ patients 
Intensive Treatment – MLD/MLLB                         ___________ patients 
Follow up appointments            ___________ patients 
 
36. Is there a prioritisation system of patients with specific types of lymphoedema on the waiting 
list?            [   ] Yes [   ] No                      
             36b. If yes, please give details. 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
37. How long (in time) is the waiting list for patients requiring lymphoedema treatment in your 
service?                                                                                             ________________ 
   
 
   251 
                                                                                                                           
38. Approximately how many lymphoedema patients per month does your service have the 
capacity to manage?  
Initial Consultation–Education, Skin Care, SLD        ___________ patients 
Intensive Treatment – MLD/MLLB                         ___________ patients 
Follow up appointments            ___________ patients 
 
39. On average, how many patients does your service treat in a month?  
Initial Consultation–Education, Skin Care, SLD        ___________ patients 
Intensive Treatment – MLD/MLLB                         ___________ patients 
Follow up appointments            ___________ patients 
 
40. Does your service offer home visits?    [   ] Yes [   ] No 
 
  40b. If yes, please give details. 
________________________________________________________________
________________________________________________________________ 
 
41. Does your service offer inpatient services specifically for the management of lymphoedema 
(that is where a person is admitted as an inpatient for the management of their 
lymphoedema, not admitted for another condition but also has lymphoedema)? 
         [   ] Yes [   ] No  
 
41b.If yes, how many inpatients can you accommodate in a month?   ____________ 
 
 
SECTION 7: SERVICE STANDARDS 
 
42. Please tick the standard of care you believe primary lymphoedema patients are receiving? 
[   ] 
  Very low 
standard of care 
[   ] 
Low standard of 
care 
[   ] 
Neither high nor low 
standard of care 
[   ] 
High standard of 
care 
[   ] 
Very high 
standard of care                   
 
43. Please tick the standard of care you believe non-cancer-related secondary lymphoedema 
patients are receiving? 
[   ] 
  Very low 
standard of care 
[   ] 
Low standard of 
care 
[   ] 
Neither high nor low 
standard of care 
[   ] 
High standard of 
care 
[   ] 
Very high 
standard of care                   
 
44. Please tick the standard of care you believe cancer-related (but not breast-cancer-related) 
secondary lymphoedema patients are receiving? 
[   ] 
  Very low 
standard of care 
[   ] 
Low standard of 
care 
[   ] 
Neither high nor low 
standard of care 
[   ] 
High standard of 
care 
[   ] 
Very high 
standard of care                   
 
45. Please tick the standard of care you believe breast-cancer-related secondary lymphoedema 
patients are receiving? 
[   ] 
  Very low 
standard of care 
[   ] 
Low standard of 
care 
[   ] 
Neither high nor low 
standard of care 
[   ] 
High standard of 
care 
[   ] 
Very high 
standard of care                   
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46. What do you believe is important to patients of lymphoedema services? 
 
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
 
47. If you could influence government policy in this area, what recommendations would you 
make regarding lymphoedema services in general? 
 
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
 
48. In order to ensure we accurately map lymphoedema services in the Republic of Ireland it is 
important that we have the contact details of your service. Any of your details used in the 
final report will only be those ordinarily available to members of the public. Sensitive 
information you have provided in this questionnaire such as patient numbers etc. will be 
treated in a highly confidential manner.  
 
Under these conditions, are you agreeable to providing your details? If yes, could you please 
complete the following: 
 
Your name: ________________________________________________________________________  
Name of your lymphoedema service: ____________________________________________________  
Address:___________________________________________________________________________  
Phone number: _____________________________________________________________________  
Email: _____________________________________________________________________________  
Other:_____________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
__________________________________________________________________________________  
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE. 
 
PLEASE RETURN THE QUESTIONNAIRE IN THE FREEPOST ENVELOPE PROVIDED AS SOON AS 
POSSIBLE. 
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Appendix D 
 
Service Provider Survey Thank You/Reminder Letter 
 
 
 
 
< Address of Practitioner> 
 
 
 
 
<Date> 
 
 
Dear <Mr. / Ms. Surname of Practitioner>, 
On the <date>, the Irish Cancer Society posted out questionnaires as part of their research, 
in conjunction with the School of Nursing, Dublin City University, into patients’ experiences of 
living with lymphoedema and of lymphoedema service provision in Ireland. The overall aim is 
to learn more about the experiences of people affected by all types of lymphoedema in order 
to influence the development of nationwide service provision and policy guidelines, which 
directly respond to an identified need. 
 
A cover letter, information sheet and questionnaire were sent to you to request your 
participation in this research because you are working in a service which treats lymphoedema 
patients. Consequently, your views are extremely important in enhancing our understanding 
of current lymphoedema service provision in Ireland.  
 
If you have completed the questionnaire and sent it back to us, thank you for your 
participation in the research study.  
 
If you have not completed the questionnaire and are working in a service which treats 
lymphoedema patients we would appreciate it if you would complete the questionnaire and 
return it as soon as possible to: FREEPOST, Susan O’Carroll, Irish Cancer Society, 43–45 
Northumberland Road, Dublin 4. Participation is on a voluntary basis. You are under no 
obligation to take part in this research study. All your answers to the questionnaire will 
remain strictly confidential.  
 
If you would like further information about the study or would like an additional questionnaire 
please don’t hesitate in contacting Maeve Murray from the School of Nursing in DCU on 01 
7007793 or Susan O’Carroll from the Irish Cancer Society on 01 2316606. We would greatly 
appreciate your support in this project. 
 
Yours sincerely, 
 
Susan O’Carroll 
 
Clinical Coordinator  
Irish Cancer Society  
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Appendix E 
 
Patient Focus Group Cover Letter 
 
 
 
 
 
 
 
 
<Date> 
 
 
 
Dear Sir/Madam,  
 
The Irish Cancer Society, in conjunction with the School of Nursing, Dublin City University is 
conducting research into patients’ experiences of living with lymphoedema and of 
lymphoedema service provision in Ireland. The overall aim is to learn more about the 
experiences of people affected by all types of lymphoedema – in particular the diagnosis, 
treatment and management of the condition. People affected by lymphoedema and 
professionals who provide the service will be involved in the research, so that improvements 
in this area can be made. 
 
Previously you indicated your interest in receiving further information about the study with a 
view to considering whether you would like to participate.  
 
Please take the time to read the enclosed information sheet about the first stage of the 
research which will involve focus groups.  
 
Please note that you are not obliged to participate in this research, but if you would like to 
participate please complete the enclosed consent form and return it as soon as possible to 
FREEPOST, Susan O’Carroll, Irish Cancer Society, 43-45 Northumberland Road, Dublin 4. 
 
If you would like further information about the study please contact Maeve Murray from the 
School of Nursing in Dublin City University on 01 7007793 or Susan O’Carroll from the Irish 
Cancer Society on 01 2316606. 
 
 Yours sincerely,  
 
 
 
Susan O’Carroll 
 
Clinical Coordinator  
Irish Cancer Society  
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Appendix F 
 
Patient Focus Group Information sheet 
 
 
1. Title of research project: 
Exploring the Provision of Lymphoedema Services in Ireland.  
 
2. Introduction: 
You are being invited to take part in a study. Before you decide to take part or not, it is 
important that you understand why the study is being done and what it will involve. Please 
read the following information carefully and discuss it with others, if you wish. If you require 
further information, or would like to ask any questions, please contact Maeve Murray from 
the School of Nursing in Dublin City University on 01 7007793 or Susan O’Carroll from the 
Irish Cancer Society on 01 2316606.  
 
Lymphoedema is a chronic, incurable condition that can lead to pain, susceptibility to 
infections as well as compromised mobility. However, with early diagnosis and intervention, 
the condition can be well controlled. As a result, prompt diagnosis and appropriate treatment 
is an essential part of the management process. However, in Ireland there has been no 
research of lymphoedema service provision to date.  
 
The overall aim is to learn more about the experiences of people affected by all types of 
lymphoedema - in particular their experiences of the diagnosis, treatment and management 
of the condition. People affected by lymphoedema and professionals who provide the service 
will be involved in the research, so that improvements in this area can be made. This 
research is funded by Action Breast Cancer (a project of the Irish Cancer Society); and was 
devised by a research team consisting of Ms. Susan O’Carroll, Irish Cancer Society, and Dr. 
Pamela Gallagher and Ms. Maeve Murray, the School of Nursing, Dublin City University.  
 
3. Procedures: 
You are being contacted about this study because you have a diagnosis of lymphoedema and 
are over eighteen years of age.  
 
You are being asked to take part in a group discussion about your experiences of living with 
lymphoedema, and lymphoedema services. The group discussion will be led by an oncology 
nurse who has over 10 years experience working with cancer patients. The group will consist 
of 6-8 people who have a diagnosis of lymphoedema and will last approximately one hour. 
This discussion will be tape recorded and transcribed so that the data can be analysed. No 
one will listen to these tapes except the members of the research team. Information will be 
kept confidential at all times.  
 
If you are willing to take part, you are asked to sign and return a consent form informing you 
of the research, indicating that you agree to take part and for the session to be tape recorded 
to FREEPOST, Susan O’Carroll, Irish Cancer Society, 43-45 Northumberland Road, Dublin 4. 
When we receive your consent form, you will be sent information regarding your scheduled 
session.  
 
4. Benefits: 
There are no direct benefits to taking part in this study. However, the information that will be 
collected will help develop guidelines to improve equity, availability and quality in 
lymphoedema service provision. Research that helps develop policy in this way will, in turn, 
benefit patients availing of those services. 
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5. Risks: 
Asking you about your experiences of living with lymphoedema may bring about unpleasant 
or upsetting memories. If you feel uncomfortable or distressed at any stage, you can 
withdraw without consequences. You can also contact the Irish Cancer Society’s Action Breast 
Cancer FREEFONE Helpline 1800 30 90 40 through which all patients can receive information, 
support and counselling if required, and access to the support services provided by 
Lymphoedema Ireland, who can be contacted directly on 087 693 4964. 
 
6. Exclusion from participation: 
If you do not have a diagnosis of lymphoedema, or are under eighteen years of age, you will 
be unable to take part in the study.  
 
7. Confidentiality: 
If you agree to take part, all information collected will be kept strictly confidential within the 
limitations of the law. All information will have your name and address removed so as to 
preserve confidentiality. Any information that will identify you in any way will also be 
removed. The focus group tapes will be destroyed once the anonymous transcripts have been 
completed. All data will be stored in a locked filing cabinet which only members of the 
research team can access.  
 
The study findings will form the basis for preparation of policy documents, reports, academic 
publications, conference papers and other scientific publications.  
 
8. Voluntary participation: 
You have volunteered to take part in this study. You may quit at any time. If you decide not 
to participate, or if you quit, you will not be penalised. There will be no penalty for 
withdrawing before all stages of the research study have been completed.  
 
9. Permission: 
This research project has been approved by Dublin City University Research Ethics 
Committee.  
 
10. Further Information: 
If you need more information about your participation in the study, your rights, or answers to 
your questions about the study, contact Maeve Murray from the School of Nursing in DCU on 
01 7007793 or Susan O’Carroll from the Irish Cancer Society on 01 2316606. 
 
If participants have concerns about this study and wish to contact an independent person, 
please contact: The Secretary, Dublin City University Research Ethics Committee, c/o Office of 
the Vice-President for Research, Dublin City University, Dublin 9. Tel 01-7008000 
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Appendix G 
 
Patient Focus Group Consent Form 
 
 
 
 
 
Title of Research Project: 
Exploring the Provision of Lymphoedema Services in Ireland 
 
 
 
 
 
This study and this consent form have been explained to me. The researchers have answered 
all my questions to my satisfaction. I believe I understand what will happen if I agree to be 
part of this study.  
 
 
 
I have read, or had read to me, this Consent Form. I have had the opportunity to ask 
questions about the Consent Form and all my questions have been answered to my 
satisfaction. I freely and voluntarily agree to be part of this research study, which respects 
my legal and ethical rights. I am aware that I may withdraw at any time, without giving 
reason, and without this decision affecting my future treatment or medical care. I have 
received an Information Sheet. 
 
 
Participant’s Name: ________________________ 
 
 
Participant’s Signature: _____________________ Date: _______________  
 
 
Date on which the participant was first given this form: _________________  
 
 
 
 
 
 
 
 
Statement of investigator’s responsibility: 
I have explained the nature, purpose, procedures, benefits, risks of, or alternatives to, this 
research study. I have offered to answer any questions and fully answered such questions. I 
believe that the participant understands my explanation and has freely given informed 
consent.  
 
Investigator’s Signature: ____________________ Date: _______________  
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Appendix H 
 
Patient Focus Group Demographic Questionnaire 
 
 
 
 
 
 
Gender:     
Male     [   ]  
 Female     [   ]  
 
 
Age Range:    
19-35 Years Old    [   ] 
36-50 Years Old    [   ] 
51– 66 Years Old   [   ] 
66 + Years Old    [   ] 
 
 
Cause/Type of Lymphoedema:   
Primary Lymphoedema       [   ] 
Lymphoedema Secondary to Breast Cancer    [   ] 
Lymphoedema Secondary to Other Types of Cancer   [   ] 
Non-Cancer-Related Secondary Lymphoedema (e.g. trauma etc.)  [   ] 
Don’t know         [   ] 
       
 
 
Location of Lymphoedema:   
Upper Limb    [   ] 
 Lower Limb    [   ] 
 Other __________________________ [   ] 
 
 
 
How long have you had lymphoedema symptoms for? ___________________  
 
 
How long since you were diagnosed with lymphoedema? ________________  
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Appendix I 
 
Demographic and Clinical Details of Each Focus Group Participant 
 
Table: Demographic and Clinical Details of Each Focus Group Participant 
 
 
FG1, Participant 1 Female, Aged 36-50, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 10 months, Diagnosed 6 months ago 
 
FG1, Participant 2 Female, Aged 51-66, Primary Lymphoedema in Lower Limb, Symptoms for 10-15 years, 
Diagnosed 10-12 years ago 
 
FG1, Participant 3 Female, over 66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 15 years, Diagnosed 15 years ago 
 
FG1, Participant 4 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 4 years, Diagnosed 4 years ago 
 
FG1, Participant 5 Female over 66 years old, Lymphoedema Secondary to Breast Cancer in Upper & Lower 
Limb, Symptoms for 7 years, Diagnosed 6 years ago 
 
FG1, Participant 6 Male, 36-50 years old, Primary Lymphoedema in Upper & Lower Limb, Symptoms since 
birth, Diagnosed at birth 
 
FG1, Participant 7 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 2 years, Diagnosed 2 years ago 
 
FG2, Participant 1 Female, Lymphoedema Secondary to Cervical Cancer in Lower Limb, Symptoms for 8 
years, Diagnosed 8 years ago 
 
FG2, Participant 2 Female, Aged over 66 Years Old, Doesn’t Know Type of Lymphoedema, Swelling in 
Lower Limb, Symptoms for 8/9 years, Diagnosed about 5 years ago 
 
FG2, Participant 3 Female, 51- 66 Years Old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 6 years, Diagnosed 6 years ago 
 
FG2, Participant 4 Male, 51-66 years old, Lymphoedema Secondary to Lymphoma in Upper Limb & under 
Arms, Symptoms for 16 years, Diagnosed 16 years ago 
 
FG2, Participant 5 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 6 years, Diagnosed 6 years ago 
 
FG2, Participant 6 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper & Lower 
Limb, Symptoms for 8 years, Diagnosed 8 years ago 
 
FG2, Participant 7 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 6 years, Diagnosed 6 years ago 
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Table: Demographic and Clinical Details of Each Focus Group Participant (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FG2, Participant 8  Female, Aged 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 4 years, Diagnosed 4 years ago 
 
FG3, Participant 1 Female, 36-50 years old, Lymphoedema Secondary to Lymphoma in Lower Limb, 
Symptoms for 3 years, Diagnosed 3 years ago 
 
FG3, Participant 2 Female, 36-50 years old, Primary Lymphoedema in Lower Limb, Symptoms for 4 years, 
Diagnosed 3 ½ years ago 
 
FG3, Participant 3 Female, over 66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 2 years, Diagnosed 3 ½ years ago 
 
FG3, Participant 4  Female, 51-66 years old, Lymphoedema Secondary to Melanoma in Lower Limb, 
Symptoms for 8 years, Diagnosed 8 years ago 
 
FG3, Participant 5 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 5 years, Diagnosed 5 years ago 
 
FG3, Participant 6 Male, 51-66 years old, Lymphoedema Secondary to Melanoma in Upper Limb, Symptoms 
for 2 years, Diagnosed 2 years ago 
 
FG3, Participant 7 Female, 36-50 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 10 months, Diagnosed 10 months ago 
 
FG4, Participant 1 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 16 months, Diagnosed 16 months ago 
 
FG4, Participant 2 Female, over 66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 16 months, Diagnosed 16 months ago 
 
FG4, Participant 3 Female, 36-50 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 6 months, Diagnosed 6 months ago 
 
FG4, Participant 4  Female, 36-50 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 5 months, Diagnosed 5 months ago 
 
FG4, Participant 5 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 5 years, Diagnosed 5 years ago 
 
FG5, Participant 1 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 1 and a ½ years, Diagnosed 1 and a ½ years ago 
 
FG5, Participant 2 Participant 2, Female, 51-66 years old, Lymphoedema Secondary to Gynaecological 
Cancer in Lower Limb, Symptoms for 10 years, Diagnosed 9 years ago 
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Table: Demographic and Clinical Details of Each Focus Group Participant (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FG5, Participant 3 Female, over 66 years old, Lymphoedema Secondary to Breast Cancer in Upper and 
Lower Limb, Symptoms for 6 years, Diagnosed 5 years ago 
 
FG5, Participant 4 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb, 
Symptoms for 6 months, Diagnosed 3 months ago 
 
FG5, Participant 5 Female, 51-66 years old, Lymphoedema Secondary to Gynaecological Cancer in Leg & 
Abdomen, Symptoms for 2 years, Diagnosed 2 years ago 
 
FG5, Participant 6 Female, 51-66 years old, Lymphoedema Secondary to Breast Cancer in Upper Limb , 
Symptoms for 5 years, Diagnosed 5 years ago 
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Appendix J 
 
Patient Survey Cover Letter 
 
 
 
 
 
 
<Patient’s Address> 
 
 
 
 
<Date>  
 
 
Dear <Mr. / Ms. Surname of Patient>, 
 
You are being invited to take part in a research study currently being undertaken on 
lymphoedema. Your name has been taken from the list of patients who <have previously 
been referred to or attended the lymphoedema service/ are members of this organisation>.  
  
The overall aim of this research is to learn more about the experiences of patients in the 
diagnosis, treatment and management of lymphoedema. In Ireland, the most common type 
of lymphoedema is lymphoedema following cancer treatment. However lymphoedema can 
result from a number of other conditions or can develop independently. Although this 
research is being conducted with the Irish Cancer Society, it is important to note that 
lymphoedema is not a form of cancer. The purpose of this research is to investigate the 
experiences of people with all types of lymphoedema, not just those with cancer-related-
lymphoedema.  People affected by all types of lymphoedema and professionals who provide 
the service will be involved in the research, so that improvements in this area can be made.  
 
You are being asked to take part in a survey about lymphoedema treatment and the support 
services available by filling out a questionnaire. You will find an information sheet about the 
research and a questionnaire enclosed in this envelope. Please note that you are not obliged 
to participate in this study but if you would like to participate please complete the enclosed 
questionnaire and return it in the enclosed envelope to FREEPOST, Susan O’Carroll, Irish 
Cancer Society, 43-45 Northumberland Road, Dublin 4. 
 
As the research team is sending questionnaires to patients from a number of different 
hospitals and organisations, it is possible that you may receive multiple copies of this 
questionnaire in the coming weeks. If this is the case, we would appreciate it if you could fill 
in one questionnaire and return the completed questionnaire and the additional blank 
questionnaire(s) in each of the FREEPOST envelopes provided. 
 
The research team does not have any record of the individuals that are being sent the 
questionnaire and therefore there is no way of tracking who has and has not participated in 
this aspect of the study.  
 
If you would like further information about the study please contact Maeve Murray from the 
School of Nursing in DCU on 01 7007793 or Susan O’Carroll from the Irish Cancer Society on 
01 2316606. 
 
Regards,  
 
<Name of Lymphoedema Practitioner/ Named Person from Lymphoedema Organisation> 
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Appendix K 
 
Patient Survey Information Sheet 
 
 
1. Title of research project: 
Exploring the Provision of Lymphoedema Services in Ireland.  
 
2. Introduction: 
You are being invited to take part in a research study. Before you decide to take part or not, 
it is important that you understand why the study is being done and what it will involve. 
Please read the following information carefully and discuss it with others, if you wish. If you 
require further information, or would like to ask any questions, please contact Maeve Murray 
from the School of Nursing in DCU on 01 7007793 or Susan O’Carroll from the Irish Cancer 
Society on 01 2316606.  
 
Lymphoedema is a chronic, incurable condition that can lead to pain, susceptibility to 
infections as well as compromised mobility. However, with early diagnosis and intervention, 
the condition can be well controlled. As a result, prompt diagnosis and appropriate treatment 
is an essential part of the management process. However, in Ireland there has been no 
research of lymphoedema service provision to date.  
 
The overall aim of this research is to learn more about the experiences of patients in the 
diagnosis, treatment and management of lymphoedema. In Ireland, the most common type 
of lymphoedema is lymphoedema following cancer treatment. However lymphoedema can 
result from a number of other conditions or can develop independently. Although this 
research is being conducted with the Irish Cancer Society, it is important to note that 
lymphoedema is not a form of cancer. The purpose of this research is to investigate the 
experiences of people with all types of lymphoedema, not just those with cancer-related-
lymphoedema.   
 
People affected by all types of lymphoedema and professionals who provide the service will 
be involved in the research, so that improvements in this area can be made. This research is 
funded by Action Breast Cancer (a project of the Irish Cancer Society). It was devised by a 
research team consisting of Ms. Susan O’Carroll, Irish Cancer Society; Dr. Pamela Gallagher 
and Ms. Maeve Murray, the School of Nursing, Dublin City University; and a research steering 
group composed of lymphoedema patients and a number of lymphoedema practitioners.  
 
3. Procedures: 
You are being contacted about this study because you have a diagnosis of lymphoedema and 
are over eighteen years of age.  
 
You are being asked to take part in a survey about lymphoedema treatment and support 
services available by filling out a questionnaire.  
 
If you would like to take part, you are asked to complete the questionnaire and to return it in 
the enclosed envelope to FREEPOST, Susan O’Carroll, Irish Cancer Society, 43-45 
Northumberland Road, Dublin 4. By completing and returning the questionnaire you are 
consenting to participate in this study.  
 
As the research team is sending questionnaires to patients from a number of different 
hospitals and organisations, it is possible that you may receive multiple copies of this 
questionnaire in the coming weeks. If this is the case, we would appreciate it if you could fill 
in one questionnaire and return the completed questionnaire and the additional blank 
questionnaire(s) in each of the FREEPOST envelopes provided. 
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The questionnaire includes items on the various types of treatment you may have received. 
Please note that although you have a diagnosis of lymphoedema, there are many different 
stages of lymphoedema and your symptoms may be so mild that you have not required 
treatment or certain types of treatment, as yet.  
 
4. Benefits: 
There are no direct benefits to taking part in this study. However, the information that will be 
collected will help develop guidelines to improve equity, availability and quality in 
lymphoedema service provision. Research that helps develop policy in this way will, in turn, 
benefit patients availing of those services.  
 
5. Risks: 
Asking you about your experiences of living with lymphoedema may bring about unpleasant 
or upsetting memories. If you feel uncomfortable or distressed at any stage, you can 
withdraw without consequences. You can also contact the Irish Cancer Society’s Action 
Breast Cancer FREEFONE Helpline 1800 30 90 40 through which through which all patients 
can receive information, support and counselling if required, and access to the support 
services provided by Lymphoedema Ireland on 087 6934964. 
 
6. Exclusion from participation: 
If you do not have a diagnosis of lymphoedema, or are under eighteen years of age, you will 
be unable to take part in the study.  
 
7. Confidentiality: 
Only anonymous data, that is, information that does not identify you by name, will be 
collected in the questionnaire.  
 
The study findings will form the basis for preparation of policy documents, reports, academic 
publications, conference papers and other scientific publications.  
 
8. Voluntary participation: 
You have volunteered to take part in this study. You may quit at any time. If you decide not 
to participate, or if you quit, you will not be penalised. There will be no penalty for 
withdrawing before all stages of the research study have been completed.  
 
9. Permission: 
This research project has been approved by Dublin City University and <name of hospitals> 
Research Ethics Committees.  
 
10. Further Information: 
If you need more information about your participation in the study, your rights, or answers to 
your questions about the study, contact Maeve Murray from the School of Nursing in DCU on 
01 7007793 or Susan O’Carroll from the Irish Cancer Society on 01 2316606. 
If participants have concerns about this study and wish to contact an independent person, 
please contact: The Secretary, Dublin City University Research Ethics Committee, c/o Office of 
the Vice-President for Research, Dublin City University, Dublin 9. Tel 01-7008000 
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Appendix L 
 
Patient Questionnaire 
 
 
This is a questionnaire designed to investigate different aspects of lymphoedema service provision. We 
are interested in all types of lymphoedema, primary and secondary. Please answer every item as 
honestly as you can. There are no right or wrong answers. Your responses will remain completely 
confidential. 
SECTION 1: GENERAL INFORMATION 
1.   Are you male or female?    [   ] Male [   ] Female  
2.   What age are you?                                 ____________years 
3.   In what county in Ireland do you live?       _________________________________ 
4.  What type of lymphoedema do you have (Please tick only one box)? 
[    ] Primary lymphoedema 
[    ] Lymphoedema following treatment for breast cancer (e.g. surgery, radiotherapy etc.)  
[    ] Lymphoedema following treatment for another type of cancer, Please specify type of cancer_________________ 
[    ] Lymphoedema following trauma or tissue damage (e.g. burns, varicose vein surgery etc.) 
[    ] Lymphoedema following venous disease (e.g. deep vein thrombosis, chronic venous insufficiency, etc.) 
[    ] Lymphoedema following infection (e.g. cellulitis etc.) 
[    ] Lymphoedema following inflammation (e.g. rheumatoid/psoriatic arthritis, dermatitis/eczema etc.) 
[    ] Lymphoedema following immobility or dependency  
[    ] Don’t Know  
5. Where in your body do you have lymphoedema (Please tick all that apply)?  
[    ] Left arm 
[    ] Right arm 
[    ] Head/neck/face 
[    ] Chest/breast 
[    ] Abdomen 
[    ] Left leg 
[    ] Right leg 
[    ] Other, Please specify ___________________________________________________ 
6. How long have you had lymphoedema symptoms for?       _______years _______months 
7.   How long have you been diagnosed with lymphoedema?    _______years _______months 
 
SECTION 2: GETTING A LYMPHOEDEMA DIAGNOSIS 
8.   Do you think any of the following brought on or triggered your initial lymphoedema symptoms?                
(You may have a specific cause of your lymphoedema e.g. the removal of lymph nodes during 
cancer treatment, but some of the following may have triggered your initial symptoms, Please tick all 
that apply)  
[    ] Sunburn [    ] Other burn 
[    ] Insect bite [    ] Flight 
[    ] Injection/Receiving chemotherapy into at-risk arm  [    ] Blood pressure taken from at-risk arm  
[    ] Overuse of the at-risk limb (e.g. through over-exercise, carrying a heavy load) [    ] Cut, graze or bang to at-risk area  
[    ] Other, Please Specify____________________________________________        [    ] Don’t know 
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9.  Did you know before you were diagnosed with lymphoedema that you were at risk of developing 
lymphoedema?                                [   ] Yes      [   ] No      (IF NO, PLEASE GO TO Q10 ON THIS PAGE)                            
9b. If you were told that you were at risk, which of the following healthcare professionals told you that 
you were at risk of developing lymphoedema?  
 Yes              No 
General Practitioner .......................................................... [    ]            [    ] 
Breast Care Nurse ............................................................ [    ]            [    ] 
Consultant (e.g. Surgeon, Oncologist etc.) ......................... [    ]            [    ] 
Physiotherapist ................................................................ [    ]            [    ] 
Occupational Therapist ..................................................... [    ]            [    ] 
Lymphoedema Nurse Specialist ......................................... [    ]            [    ] 
Manual Lymphatic Drainage Therapist ................................  [    ]            [    ] 
Other, Please Specify _____________________________ [    ]            [    ] 
9c. When you were told you were at risk of developing lymphoedema, were you given the following 
types of information?                                                                                           If yes, how was this                                                                  
                      information presented? 
 Yes      No   Written       Verbal      Both Written 
                         Only         Only          & Verbal 
General information about the symptoms of lymphoedema  ........  [   ]     [   ]       [   ]            [   ]            [   ]   
Education on skincare ...............................................................  [   ]     [   ]       [   ]            [   ]            [   ]   
Education on how to perform specific lymphoedema exercises ....  [   ]     [   ]       [   ]            [   ]            [   ]   
Education on how to perform simple lymphatic drainage .............  [   ]     [   ]       [   ]            [   ]            [   ]   
Education on when to seek further medical attention...................  [   ]     [   ]       [   ]            [   ]            [   ]   
Other, Please specify____________________________________  [   ]     [   ]       [   ]            [   ]            [   ]   
    
9d. If you were provided with any of the above information was the timing of this: 
           [   ] Too soon      [   ] Just right       [   ] Too late       [   ] I did not receive any information        
10. Which of the following types of healthcare professionals did you go to when you were originally 
looking for an explanation of your lymphoedema symptoms?  
 Yes              No 
General Practitioner .......................................................... [    ]            [    ] 
Breast Care Nurse ............................................................ [    ]            [    ] 
Consultant (e.g. Surgeon, Oncologist etc.) ......................... [    ]            [    ] 
Physiotherapist ................................................................ [    ]            [    ] 
Occupational Therapist ..................................................... [    ]            [    ] 
Lymphoedema Nurse Specialist ......................................... [    ]            [    ] 
Manual Lymphatic Drainage Therapist ................................  [    ]            [    ] 
Other, Please Specify _____________________________ [    ]            [    ] 
11. In general, how satisfied were you with these healthcare professionals with regard to EACH of the 
following when you were originally looking for an explanation of your lymphoedema symptoms?                            
Very 
Dissatisfied 
 
Dissatisfied 
Neither Dissatisfied 
nor Satisfied 
 
Satisfied 
Very 
Satisfied 
(i) Healthcare Professional’s Attitude. .   [   ] [   ] [   ] [   ] [   ] 
(ii) Healthcare Professional’s  Knowledge 
of Lymphoedema . . . . . . . . . . 
[   ] [   ] [   ] [   ] [   ] 
(iii) Practical Support given by Healthcare 
Professional. . . . . . . . . . . . . . . 
[   ] [   ] [   ] [   ] [   ] 
(iv) Emotional Support given by Healthcare 
Professional . . . . . . . . . . . . . . 
[   ] [   ] [   ] [   ] [   ] 
(v) Time taken to receive an appropriate 
diagnosis . . . . . . . . . . . . . . . . . 
[   ] [   ] [   ] [   ] [   ] 
(vi) Overall satisfaction . . . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
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12. Who suggested that your diagnosis was lymphoedema? (Please tick only one box)  
[    ] General Practitioner 
[    ] Breast Care Nurse 
[    ] Consultant (e.g. Surgeon, Oncologist etc.)  
[    ] Physiotherapist 
[    ] Occupational Therapist 
[    ] Lymphoedema Nurse Specialist 
[    ] Other, Please Specify ______________________________________  
 
SECTION 3: INFORMATION NEEDS 
 
13. Have you received information about lymphoedema from the following sources?  
         Yes         No         
Lymphoedema Practitioner .................................................. [   ]  [   ]        
General Practitioner ............................................................  [   ]  [   ]        
Other Lymphoedema Patients  ............................................ [   ]  [   ] 
Lymphoedema Ireland Website ............................................ [   ]  [   ]        
Lymphoedema Ireland Support Group Meetings..................... [   ]  [   ]        
Lymphoedema Ireland Newsletters ....................................... [   ]  [   ] 
Irish Cancer Society Helpline................................................ [   ]  [   ] 
Manual Lymph Drainage (MLD) Ireland ................................. [   ]  [   ]        
Other Websites, Please Specify _________________________ [   ]  [   ] 
                   Other, Please Specify _________________________________ [   ]  [   ] 
14. Have you received education on any of the following topics?  
        Yes        No         
Education on skincare ........................................................  [   ]  [   ]        
Education on diet ...............................................................  [   ]  [   ]                                            
Education on when to seek further medical attention ............  [   ]  [   ]  
 
15. How satisfied are you with the information on lymphoedema that you have received?  
 
Very 
Dissatisfied 
[   ] 
 
Dissatisfied 
[   ] 
Neither Dissatisfied 
nor Satisfied 
[   ] 
 
Satisfied 
[   ] 
Very 
Satisfied 
[   ] 
   
16. In your opinion, how could the lymphoedema information patients receive be improved?  
_________________________________________________________________________________  
_________________________________________________________________________________  
 
SECTION 4: LYMPHOEDEMA AND DAILY LIFE 
17.  For EACH of the following, does having lymphoedema limit you in these activities? 
 Yes, limited a 
lot 
Yes, limited a 
little 
No, not limited at 
all 
Not 
relevant 
(i) Walking . . . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(ii) Swimming  . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(iii) Other Sports Activities . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(iv) Daily household indoor chores (cleaning)  [   ] [   ] [   ] [   ] 
(v) Daily outdoor chores (shopping, gardening) [   ] [   ] [   ] [   ] 
(vi) Taking care of children . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(vi) Buying clothes/shoes. . . . . . . . . . . . . . . [   ] [   ] [   ] [   ] 
(vii)Wearing clothes/shoes . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(vi) Social Activities (visiting friends etc.) . . .   [   ] [   ] [   ] [   ] 
(vii)Work/employment. . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(vi) Sexual Activity . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(vii)Sleeping . . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(vii)Going on holidays. . . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] 
(vii)Other – please specify _______________ [   ] [   ] [   ] [   ] 
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SECTION 5: YOUR LYMPHOEDEMA SERVICE AND SERVICE NEEDS 
18. Have you ever received treatment for your lymphoedema?                                                                                                
[   ] Yes     [   ] No   (IF NO, PLEASE GO TO Q 26 ON THIS PAGE)                                          
19. How would you best describe the service that you mainly visit for treatment of your lymphoedema? 
                                                 [   ] Public         [   ] Private    [   ] Mix of public/private 
 
20. In what setting is your main lymphoedema service located? (Please tick only one box) 
[    ] Hospital [    ] Community Health Centre 
[    ] Cancer Support Centre [    ] Private Practice/ Private Practitioner  
[    ] Other, Please specify_______________________________________________________ 
21. How far do you have to travel to get to your main lymphoedema service (one way trip)?    _______km  
22. Does travel distance limit your ability to avail of lymphoedema treatments?    [   ] Yes [   ] No   
23. How long do you have to wait between making an appointment and being seen for the following 
consultations? 
Initial Consultation _____Weeks _____ Days [    ] Not Applicable 
Review Consultation _____Weeks _____ Days [    ] Not Applicable 
Intensive treatment of bandaging and/or Manual Lymphatic Drainage _____Weeks _____ Days [    ] Not Applicable 
Group Consultation _____Weeks _____ Days [    ] Not Applicable 
Home visit _____Weeks _____ Days [    ] Not Applicable 
 
24. What type of practitioner provides your lymphoedema treatment in your main lymphoedema service?  
                                                                                                                        (Please tick only one box)  
[    ] Physiotherapist 
[    ] Occupational Therapist 
[    ] Lymphoedema Nurse Specialist 
[    ] Manual Lymphatic Drainage Therapist 
[    ] Other, Please Specify ______________________________________  
25. How would you rate the practitioner in your main lymphoedema service on EACH of the following 
characteristics?                                                                          (Please circle one number on each line) 
 
  Not at all           Extremely  
(v) Knowledgeable. . . . . . . . . . .     1          2   3            4        5           6        7          8      9         10 
(vi) Competent . . . . . .. . . . . . . . .       1          2   3            4        5           6        7          8      9         10 
(vii) Experienced . . . . . . . . . . . . .      1          2   3            4        5           6        7          8      9         10 
(viii) Confident . . . . . . . . . . . . . . .        1          2   3            4        5           6        7          8      9         10 
(ix) Attitude . . . . . . . . . . . . . . . . .       1          2   3            4        5           6        7          8      9         10 
(x) Practical Support given . . . . . .      1          2   3            4        5           6        7          8      9         10 
(xi) Emotional Support given . . . . .      1          2   3            4        5           6        7          8      9         10 
(xii) Time available to deal with you      1          2   3            4        5           6        7          8      9         10 
(xiii) Overall satisfaction . . . . .       1          2   3            4        5           6        7          8      9         10 
 
26.  Please tick the standard of care you believe you are receiving, on average. 
Very Low Standard 
of Care 
[   ] 
Low Standard of 
Care 
[   ] 
Neither High nor Low 
Standard of Care 
[   ] 
High Standard 
of Care 
[   ] 
Very High 
Standard of Care 
[   ] 
 
Don’t Know 
[   ] 
(IF YOU DO NOT RECEIVE ANY LYMPHOEDEMA TREATMENT, PLEASE GO TO SECTION 7 ON PAGE 10)  
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SECTION 6: LYMPHOEDEMA TREATMENTS  
27. How soon after your lymphoedema diagnosis did you receive treatment?          ________________              
 
28. When was the last time you received treatment for your lymphoedema? (Please specify month and 
year)                                                                                                               ________________ 
                                                                                                                             
 
COMPRESSION GARMENTS (E.G. SLEEVES OR STOCKINGS WITH GRADUATED PRESSURE TO MANAGE 
SWELLING)  
 
29. Have you ever been prescribed a Compression Garment for the treatment of lymphoedema?  
      [   ] Yes [   ] No          
 
29b. If you have, who measured you for your last Compression Garment? (Please tick only one 
box) 
[    ] General Practitioner 
[    ] Breast Care Nurse 
[    ] Physiotherapist 
[    ] Occupational Therapist 
[    ] Lymphoedema Nurse Specialist 
[    ] Manual Lymphatic Drainage Therapist  
[    ] Other, Please Specify ______________________________________  
 
30. Do you use Compression Garments for the treatment of lymphoedema?                                                                                                      
[   ] Yes           [   ] No   (IF NO, PLEASE GO TO Q47 ON PAGE 7)    
                           
31. How many Compression Garments are you currently using?  
(You may have two garments for the same part of the body (e.g. a glove and sleeve) and you might have 
one to wash and one to wear, if this is the case please include all garments)?         
                                                                                                           _______________garments 
32. What type of Compression Garment do you use?  
[    ] Off-the-shelf [    ] Custom-made/made-to-measure  
[    ] Both off-the-shelf and made-to-measure garments [    ] Don’t know 
33. On average, how long do you have to wait for your Compression Garments to be delivered?                                                      
________Weeks_________ Days 
34. Do you need help from another person to get your Compression Garments on? [   ] Yes      [   ] No  
35. Do you use an assistive device or aid to help you to get your Compression Garments on?                                           
[   ] Yes       [   ] No                                                                                                                           
36. How often do you wear your Compression Garment? 
[    ] All of time (24 hours a day, including night time) [    ] Most of the time (e.g. daily but not at night) 
[    ] Some of the time (when doing activities, chores etc.) [    ] Rarely 
[    ] Other, please specify ___________________________  
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37. In general, do you wear a Compression Garment for EACH of the following activities? 
 Yes No Not relevant to me 
(i) Walking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] 
(ii) Swimming . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [   ] [   ] [   ] 
(iii) Other sport activities  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] 
(iv) Social activities (e.g. visiting friends, going to the theatre) . . . . . . . . . . [   ] [   ] [   ] 
(v) Daily household indoor chores (e.g. cleaning, hoovering etc.). . . . . . . .  [   ] [   ] [   ] 
(vi) Daily outdoor chores (e.g. shopping, gardening). . . . . . . . . . . . . . . . .  [   ] [   ] [   ] 
(vii) Taking care of children . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [   ] [   ] [   ] 
(viii) Personal care (taking showers, combing hair etc.) . . . . . . . . . . . . . . . . [   ] [   ] [   ] 
(ix) Taking a flight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] 
(x) When on holidays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] 
(xi) Employment/occupation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [   ] [   ] [   ] 
(xii) Other, please specify _____________________________ . . . . . . . . . .  [   ] [   ] [   ] 
 
38. Do you wear your Compression Garment as often as you have been advised to?   [   ] Yes   [   ] No        
 
38b. If no, please explain why. (Please tick all that apply) 
[    ] The garment is uncomfortable [    ] The garment is unsightly 
[    ] It’s too difficult to put on and take off [    ] I don’t need to wear it all the time to maintain the 
swelling at a comfortable level 
[    ] Other, Please specify_____________________________________________________________________ 
39. Please tick the box that represents the extent to which you are satisfied with EACH of the following 
aspects of the Compression Garment(s) that you wear most regularly.  
 
Very 
Dissatisfied 
 
 
Dissatisfied 
Neither 
Dissatisfied 
nor Satisfied 
 
 
Satisfied 
 
Very 
Satisfied 
(i) Colour . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(ii) Appearance when worn . .  [   ] [   ] [   ] [   ] [   ] 
(iii) Comfort . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(iv) Fit . . . . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(v) Texture . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(vi) Temperature . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(vii) Quality . . . . . . . . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(viii) Value for money . . . . . . .  [   ] [   ] [   ] [   ] [   ] 
(ix) Overall satisfaction . . . . .  [   ] [   ] [   ] [   ] [   ] 
40. How many Compression Garments are provided by your main lymphoedema service?  
[    ] I do not receive any garments from my lymphoedema service, I pay for all my garments myself 
[    ] One per year 
[    ] Two per year  
[    ] Two every six months 
[    ] Other, Please Specify _____________________________________  
41. Do you have a Medical Card?   [   ] Yes [   ] No 
41b. If you have a Medical Card, does this delay/slow down the delivery of your Compression 
Garments?                                                          [   ] Yes  [   ] No 
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42. On average, how much of your own money do you spend per calendar year on Compression 
Garments?                                                                                                              €______ 
42b. If you have Private Health Insurance, do you receive any assistance from your insurer in paying 
for your Compression Garments?                        [   ] Yes      [   ] No      [   ] Not applicable   
42c. If you receive assistance from your insurer how much does your insurer pay towards your 
Compression Garment costs per calendar year?                                                  €_____
                                                                                                        
43. Have you ever had any difficulty getting re-measured for replacement Compression Garments?                                                               
[   ] Yes                  [   ] No      
43b. If you have had difficulty getting re-measured, please give further details.         
________________________________________________________________________________  
________________________________________________________________________________                           
  
 44. On average how many times per year do you replace your Compression Garments?  
[    ] Less than Once a Year [    ] Once a Year 
[    ] Twice a Year (i.e. Every 6 months) [    ] Three Times a Year (i.e. Every 4 months) 
[    ] Four Times a Year (i.e. Every 3 months) [    ] More than Four Times a Year 
 
45. Does the cost of Compression Garments influence how often you replace them?                                                                                                     
[   ] Yes          [   ] No       [   ] Not applicable 
   
46. How satisfied are you with the process of getting Lymphoedema Compression Garments? 
Very 
Dissatisfied 
[   ] 
 
Dissatisfied 
[   ] 
Neither Dissatisfied 
nor Satisfied 
[   ] 
 
Satisfied 
[   ] 
Very 
Satisfied 
[   ] 
 
LYMPHOEDEMA EXERCISES 
 
47. Have you ever been given specific lymphoedema exercises to do?                                                                         
[   ] Yes  [   ] No    (IF NO, PLEASE GO TO Q50 ON THIS PAGE)                            
 
 
48. How were you taught these specific lymphoedema exercises? (Please tick only one box)  
[    ] Once-off individual consultation 
[    ] Repeated individual consultations 
[    ] Group consultation  
[    ] Written format only 
[    ] Instructional DVD 
[    ] Other, Please Specify ______________________________________  
 
49. How often do you do these specific lymphoedema exercises? _____________________________ 
 
SIMPLE LYMPHATIC DRAINAGE (SELF-MASSAGE FOR THE MANAGEMENT OF LYMPHOEDEMA) 
 
50. Have you ever been taught how to perform Simple Lymphatic Drainage (self-massage)?                                
[   ] Yes [   ] No  (IF NO, PLEASE GO TO Q53 ON PAGE 8)                            
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51. How were you taught to perform Simple Lymphatic Drainage (self-massage)? (Please tick only one 
box)  
[    ] Once-off individual consultation 
[    ] Repeated individual consultations 
[    ] Group consultation  
[    ] Written format only 
[    ] Instructional DVD 
[    ] Other, Please Specify ______________________________________  
 
52. How often do you perform Simple Lymphatic Drainage (self-massage)? ______________________ 
 
MANUAL LYMPHATIC DRAINAGE (SPECIALISED MASSAGE FOR THE TREATMENT OF LYMPHOEDEMA) 
 
53. Have you ever received Manual Lymphatic Drainage (specialised massage for the treatment of 
lymphoedema)?                               [   ] Yes [   ] No    (IF NO, PLEASE GO TO Q56 ON THIS PAGE)                            
                       
54. On average, how often do you receive Manual Lymphatic Drainage (specialised massage)?  
[    ] Once  
[    ] Once a year 
[    ] Once every 6 months 
[    ] Once every 2-3 months 
[    ] Once a month 
[    ] 2-3 times a month   
[    ] Once a week  
[    ] Intensive treatment of 5 times per week for one week once a year  
[    ] Intensive treatment of 5 times per week for one week every 6 months 
[    ] Intensive treatment of 5 times per week for more than one week once a year 
[    ] Intensive treatment of 5 times per week for more than one week every 6 months 
[    ] Other, please specify ____________________________________________________ 
 
55. How long, on average, does your Manual Lymphatic Drainage session last (i.e. how long is a session of 
specialised massage for lymphoedema that doesn’t include bandaging)?  
 
[    ] 30 minutes or less [    ] 31 to 60 minutes  
[    ] 61 to 90 minutes  [    ] 91 to 120 minutes 
[    ] More than 2 hours [    ] Other, please specify ___________________________ 
 
MULTI-LAYER LYMPHOEDEMA BANDAGING  
 
56. Have you ever received Multi-Layer Lymphoedema Bandaging?                                                                                                    
[   ] Yes      [   ] No        (IF NO, PLEASE GO TO Q60 ON PAGE 9)                            
                       
57. On average, how often does your practitioner provide you with Multi-Layer Lymphoedema 
Bandaging? 
[    ] Once  
[    ] Once a year 
[    ] Once every 6 months 
[    ] Once every 2-3 months 
[    ] Once a month 
[    ] 2-3 times a month   
[    ] Once a week  
[    ] Intensive treatment of 5 times per week for one week once a year  
[    ] Intensive treatment of 5 times per week for one week every 6 months 
[    ] Intensive treatment of 5 times per week for more than one week once a year 
[    ] Intensive treatment of 5 times per week for more than one week every 6 months 
[    ] Other, please specify ____________________________________________________ 
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58. On average, how much of your own money do you spend per calendar year on these bandages?  
€______ 
58b. If you have Private Health Insurance, do you receive any assistance from your insurer in paying 
for these bandages?                                 [   ] Yes        [   ] No          [   ] Not applicable   
58c. If you do receive assistance, how much does your insurer pay towards your bandage costs 
per calendar year?          €______                                                              
                                                                                 
59. Have you been taught how to self-bandage?                                               [   ] Yes           [   ] No                                    
 
59b. If yes, how were you taught to self-bandage?  
[    ] Once-off individual consultation 
[    ] Repeated individual consultations 
[    ] Group consultation  
[    ] Written format only 
[    ] Instructional DVD 
[    ] Other, Please Specify ______________________________________  
 
COST OF TREATMENTS 
 
60.  Do you pay a fee to see the practitioner in your main lymphoedema service? [   ] Yes [   ] No   
 
60b. If yes, how much do you pay for each of the following, where applicable?  
Initial Consultation €______ [    ] Not Applicable  
Review Consultation €______ [    ] Not Applicable  
Intensive Treatment of Bandaging and/or Manual Lymphatic Drainage  €______ [    ] Not Applicable 
Group Consultation €______ [    ] Not Applicable 
Home Visit  €______ [    ] Not Applicable 
61. Do you have Private Health Insurance? [   ] Yes    [   ] No (IF NO, PLEASE GO TO Q62 ON THIS PAGE)                            
61b. If you have Private Health Insurance, do you receive any assistance from your insurer in paying 
for appointments with the practitioner in your main lymphoedema service?                                                                   
                                                           [   ] Yes [   ] No                                                                                                                 
61c. If you do receive assistance, how much does your insurer pay towards each of the following, 
where applicable?  
Initial Consultation €______ [    ] Not Applicable  
Review Consultation €______ [    ] Not Applicable  
Intensive Treatment of Bandaging and/or Manual Lymphatic Drainage  €______ [    ] Not Applicable 
Group Consultation €______ [    ] Not Applicable 
Home Visit  €______ [    ] Not Applicable 
62. Have you ever gone abroad for lymphoedema treatment?                                                                            
 [   ] Yes   [   ] No (IF NO, PLEASE GO TO Q63 ON PAGE 10)                            
62b. If you have, how many times have you gone abroad for lymphoedema treatment?  ___________               
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62c. Do you receive any assistance from the following sources in paying for lymphoedema treatment 
abroad?              
[    ] Private Health Insurance [    ] HSE 
[    ] Both Private Health Insurer and HSE [    ] I don’t receive any financial assistance for my treatment abroad 
[    ] Other, Please specify_____________________________________________________________________ 
62d. If you receive assistance, how much do you receive towards the cost of lymphoedema treatment 
abroad?                                                                                                                  €_____ 
62e. Please comment on the availability of financial assistance for lymphoedema treatment 
abroad.       
______________________________________________________________________________
______________________________________________________________________________ 
63. Please comment on the cost of lymphoedema treatments, in general.  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
 
 
64. Do you believe you receive sufficient treatment to manage your lymphoedema effectively?  
                                                                                                                   [   ] Yes    [   ] No 
 
65. Please discuss how lymphoedema services could be improved.  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
 
SECTION 7: FINAL QUESTIONS  
 66. The following questions ask how you feel about your quality of life, health, or other areas of your 
life. Please choose the answer that appears most appropriate. If you are unsure about which 
response to give to a question, the first response you think of is often the best one. Please keep in 
mind your standards, hopes, pleasures and concerns. We ask that you think about your life in the last 
four weeks.    
(Please circle a number on each line)    
              
  Very poor Poor Neither poor nor 
good 
Good Very good 
a How would you rate your quality of life? 1 2 3 4 5 
 
  Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
b How satisfied are you with your health? 1 2 3 4 5 
 
The following questions ask about how much you have experienced certain things in the last four weeks. 
 
  Not at all A little A moderate 
amount 
Very 
much 
An extreme 
amount 
c To what extent do you feel that physical 
pain prevents you from doing what you 
need to do? 
5 4 3 2 1 
d How much do you need any medical 
treatment to function in your daily life? 
5 4 3 2 1 
e How much do you enjoy life? 1 2 3 4 5 
f To what extent do you feel your life to 
be meaningful? 
1 2 3 4 5 
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  Not at all A little A moderate 
amount 
Very 
much 
Extremely 
 
g How well are you able to concentrate? 1 2 3 4 5 
h How safe do you feel in your daily life? 1 2 3 4 5 
i How healthy is your physical 
environment? 
1 2 3 4 5 
 
The following questions ask about how completely you experience or were able to do certain things in the last four 
weeks. 
  Not at all A little Moderately Mostly Completely 
j Do you have enough energy for 
everyday life? 
1 2 3 4 5 
k Are you able to accept your bodily 
appearance? 
1 2 3 4 5 
l Have you enough money to meet your 
needs? 
1 2 3 4 5 
m How available to you is the information 
that you need in your day-to-day life? 
1 2 3 4 5 
n To what extent do you have the 
opportunity for leisure activities? 
1 2 3 4 5 
  Very poor Poor Neither poor nor 
good 
Good Very good 
o How well are you able to get around? 1 2 3 4 5 
  Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
p How satisfied are you with your sleep? 1 2 3 4 5 
  Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
q How satisfied are you with your ability to 
perform your daily living activities? 
1 2 3 4 5 
r How satisfied are you with your capacity 
for work? 
1 2 3 4 5 
s How satisfied are you with yourself? 1 2 3 4 5 
t How satisfied are you with your personal 
relationships? 
1 2 3 4 5 
u How satisfied are you with your ability to 
perform your sex life? 
1 2 3 4 5 
v How satisfied are you with the support 
you get from your friends? 
1 2 3 4 5 
w How satisfied are you with the conditions 
of your living place? 
1 2 3 4 5 
x How satisfied are you with your access 
to health services? 
1 2 3 4 5 
y How satisfied are you with your 
transport? 
1 2 3 4 5 
 
The following question refers to how often you have felt or experienced certain things in the last four 
weeks. 
  Never Seldom Quite often Very 
often 
Always 
z How often do you have negative feelings 
such as blue mood, despair, anxiety, 
depression? 
5 4 3 2 1 
 
67. Have you ever had cellulitis?                                  [   ] Yes  [   ] No 
 
67b. If you have had cellulitis, how many times have you been admitted to hospital to have the 
cellulitis treated?                                                                                     ______________ 
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68. If there are any other comments that you would like to make with regard to seeking a lymphoedema 
diagnosis, lymphoedema services, compression garments, the standard of care you’re receiving, or living 
with lymphoedema, please do so here. (Please use the back of this page to continue your comments if 
necessary)  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
_______________________________________________________________________________________   
_______________________________________________________________________________________  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
_______________________________________________________________________________________  
Thank you for taking the time to complete this questionnaire
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Appendix M 
 
Sample Patient Survey Thank You/Reminder Letter 
 
 
 
 
 
 
 
 
<Address> 
 
 
 
 
<Date> 
 
Dear <Mr. / Ms. Surname of Patient>, 
The Irish Cancer Society and the School of Nursing, Dublin City University are conducting a 
study into patients’ experiences of living with lymphoedema and of lymphoedema service 
provision in Ireland. The overall aim is to learn more about the experiences of people 
affected by all types of lymphoedema in order to influence the development of nationwide 
service provision and policy guidelines, which directly respond to an identified need. 
On <date>, a questionnaire was sent to you to request your participation in this study. If you 
have completed the questionnaire and sent it back to the research team they would like to 
thank you for your participation in the research study.  
 
If you have not completed the questionnaire and would like to participate, the research team 
would appreciate it if you would complete the questionnaire and return it as soon as possible 
to: FREEPOST, Susan O’Carroll, Irish Cancer Society, 43–45 Northumberland Road, Dublin 4. 
Participation is on a voluntary basis.  
 
You are under no obligation to take part in this research study. All your answers to the 
questionnaire will remain strictly confidential.  
 
If you would like further information about the study or would like an additional questionnaire 
please don’t hesitate in contacting Maeve Murray from the School of Nursing in DCU on 01 
7007793 or Susan O’Carroll from the Irish Cancer Society on 01 2316606.  
 
The research team would greatly appreciate your support in this project. 
 
 
 
 
Regards,  
 
<Name of Lymphoedema Practitioner/ Named Person in Lymphoedema Organisation> 
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Appendix N 
 
 
Percentage Responses to Each Item of the WHOQOL-BREF 
 
  n Very poor Poor Neither poor nor 
good 
Good Very good 
a How would you rate your quality of life? 718 1.4% 8.1% 17.4% 49.9% 23.3% 
   Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
b How satisfied are you with your health? 715 3.4% 15.0% 18.9% 48.7% 14.1% 
   Not at all A little A moderate 
amount 
Very 
much 
An extreme 
amount 
c To what extent do you feel that physical 
pain prevents you from doing what you 
need to do? 
696 26.3% 31.2% 27.7% 11.2% 3.6% 
d How much do you need any medical 
treatment to function in your daily life? 
673 30.6% 26.3% 27.6% 11.6% 3.9% 
e How much do you enjoy life? 699 0.6% 6.2% 25.3% 50.9% 17.0% 
f To what extent do you feel your life to be 
meaningful? 
688 
 
1.9% 5.7% 20.6% 44.6% 27.2% 
g How well are you able to concentrate? 714 1.3% 7.4% 36.8% 42.0% 12.5% 
h How safe do you feel in your daily life? 707 1.1% 4.1% 27.3% 47.0% 20.5% 
i How healthy is your physical environment? 704 0.7% 4.1% 21.0% 49.0% 25.1% 
j Do you have enough energy for everyday 
life? 
713 5.9% 10.8% 33.1% 41.1% 9.1% 
k Are you able to accept your bodily 
appearance? 
715 
 
5.5% 11.3% 22.4% 40.3% 20.6% 
l Have you enough money to meet your 
needs? 
713 7.0% 6.3% 24.1% 41.1% 21.5% 
m How available to you is the information that 
you need in your day-to-day life? 
671 
 
4.8% 8.5% 24.7% 44.7% 17.3% 
n To what extent do you have the 
opportunity for leisure activities? 
683 7.3% 15.7% 32.9% 32.9% 11.1% 
   Very poor Poor Neither poor nor 
good 
Good Very good 
o How well are you able to get around? 706 2.5% 6.7% 13.5% 35.6% 41.8% 
   Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
p How satisfied are you with your sleep? 698 5.9% 22.9% 22.3% 34.2% 14.6% 
   Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
q How satisfied are you with your ability to 
perform your daily living activities? 
705 
 
2.7% 13.8% 19.9% 48.7% 15.0% 
r How satisfied are you with your capacity 
for work? 
662 
 
8.2% 18.4% 22.2% 39.9% 11.3% 
s How satisfied are you with yourself? 690 2.2% 10.1% 21.9% 47.4% 18.4% 
t How satisfied are you with your personal 
relationships? 
677 
 
3.1% 6.4% 16.0% 41.8% 32.8% 
   n Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
u How satisfied are you with your ability to 
perform your sex life? 
550 15.3% 12.7% 28.0% 29.5% 14.5% 
v How satisfied are you with the support you 
get from your friends? 
685 2.6% 4.5% 16.2% 37.7% 39.0% 
       
 279 
   Very 
dissatisfied 
Dissatisfied Neither satisfied 
nor dissatisfied 
Satisfied Very 
satisfied 
w How satisfied are you with the conditions of 
your living place? 
703 
 
0.7% 3.0% 9.0% 32.9% 54.5% 
x How satisfied are you with your access to 
health services? 
699 
 
5.0% 7.6% 21.3% 39.6% 26.5% 
y How satisfied are you with your transport? 690 3.8% 4.8% 11.9% 39.0% 40.6% 
   Never Seldom Quite often Very 
often 
Always 
z How often do you have negative feelings 
such as blue mood, despair, anxiety, 
depression? 
711 8.6% 54.4% 28.6% 7.7% 0.7% 
 
